archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010866,0.7419,0.72551,1,1
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,3.4805e-05,0.70451,0.73643,1,1
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00031664,0.69761,0.56811,1,1
1,GO OPTIC NERVE DEVELOPMENT,0.0012758,0.66084,0.56713,1,1
1,GO RESPONSE TO POTASSIUM ION,0.0012071,0.64682,0.46673,1,1
1,GO DISTAL TUBULE DEVELOPMENT,0.0015041,0.64114,0.52728,1,1
1,GO COMMISSURAL NEURON AXON GUIDANCE,3.9936e-05,0.60691,0.57444,1,1
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0010798,0.59975,0.48588,1,1
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,8.3641e-05,0.59555,0.5293,1,1
1,GO PREPULSE INHIBITION,0.00091199,0.56294,0.4856,1,1
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00040321,0.55783,0.46141,1,1
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0049572,0.55315,0.42434,1,1
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00026348,0.55217,0.48902,1,1
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00033648,0.5503,0.52304,1,1
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0010209,0.54074,0.42119,1,1
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,3.248e-05,0.53831,0.56194,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,3.248e-05,0.53217,0.55199,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00042807,0.53012,0.55505,1,1
1,GO SYNAPTIC MEMBRANE ADHESION,0.00023283,0.52584,0.52305,1,1
1,GO HISTONE H3 K36 METHYLATION,2.636e-05,0.52168,0.53628,1,1
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00010181,0.52014,0.51633,1,1
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00051151,0.51081,0.47173,1,1
1,GO BEHAVIORAL RESPONSE TO COCAINE,8.3461e-06,0.50631,0.589,1,1
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00012367,0.50494,0.52021,1,1
1,GO URETER DEVELOPMENT,0.0038653,0.50377,0.48417,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00029789,0.49779,0.41295,1,1
1,GO MALE SEX DETERMINATION,0.0012758,0.49671,0.40433,1,1
1,GO REPLICATION FORK PROCESSING,3.9936e-05,0.49539,0.4772,1,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00035748,0.49299,0.54392,1,1
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0010798,0.48975,0.51902,1,1
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00018128,0.4854,0.40343,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00054254,0.48498,0.42596,1,1
1,GO STARTLE RESPONSE,0.00042807,0.47448,0.43127,1,1
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,2.4576e-05,0.47299,0.47304,1,1
1,GO DNA DOUBLE STRAND BREAK PROCESSING,4.2763e-05,0.469,0.41216,1,1
1,GO MICROTUBULE DEPOLYMERIZATION,0.00031664,0.4687,0.42737,1,1
1,GO MEIOTIC CHROMOSOME SEPARATION,0.00021879,0.46507,0.4598,1,1
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.4947e-05,0.46155,0.55799,1,1
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00054254,0.46109,0.3965,1,1
1,GO NEURAL CREST FORMATION,0.0031545,0.45937,0.38017,1,1
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00051151,0.45862,0.41707,1,1
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00010866,0.45681,0.39721,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,3.9936e-05,0.4567,0.44401,1,1
1,GO ANATOMICAL STRUCTURE REGRESSION,0.00029789,0.45632,0.47173,1,1
1,GO POSTSYNAPSE ASSEMBLY,0.0010209,0.4559,0.41583,1,1
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0060238,0.45226,0.37266,1,1
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00057531,0.45161,0.3903,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00035748,0.45142,0.425,1,1
1,GO FOREBRAIN REGIONALIZATION,0.00014989,0.45136,0.49809,1,1
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.034576,0.44539,0.30917,1,1
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00048214,0.44215,0.44774,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0034935,0.44205,0.37455,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00051151,0.4401,0.41153,1,1
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00064645,0.43945,0.3863,1,1
1,GO ASTRAL MICROTUBULE ORGANIZATION,5.9985e-05,0.43917,0.48606,1,1
1,GO HOMOLOGOUS RECOMBINATION,7.8298e-05,0.43896,0.38836,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.008797,0.43855,0.3512,1,1
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.019548,0.43584,0.38856,1,1
1,GO RETINA LAYER FORMATION,0.00023283,0.43502,0.45512,1,1
1,GO CELL PROLIFERATION IN HINDBRAIN,0.0012071,0.43498,0.37116,1,1
1,GO KINETOCHORE ORGANIZATION,5.2428e-05,0.43293,0.45226,1,1
1,GO REGULATION OF NEURON MIGRATION,0.00051151,0.4324,0.45638,1,1
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00024771,0.4306,0.45316,1,1
1,GO MAGNESIUM ION HOMEOSTASIS,0.0010798,0.42939,0.40406,1,1
1,GO REGULATION OF COLLATERAL SPROUTING,0.00028019,0.42836,0.48807,1,1
1,GO KINETOCHORE ASSEMBLY,0.00010866,0.42761,0.42622,1,1
1,GO VOCALIZATION BEHAVIOR,0.0020776,0.42682,0.39304,1,1
1,GO ACROSOME ASSEMBLY,0.00014062,0.42571,0.40027,1,1
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.034576,0.42323,0.29806,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,1.2939e-05,0.42268,0.43877,1,1
1,GO CENTRIOLE ASSEMBLY,1.4947e-05,0.4208,0.43594,1,1
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00013188,0.42052,0.49365,1,1
1,GO LIMB BUD FORMATION,0.0024341,0.41979,0.3932,1,1
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0049572,0.4177,0.41911,1,1
1,GO HISTONE H3 K27 METHYLATION,0.00014062,0.41707,0.438,1,1
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,9.5377e-05,0.41659,0.40157,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.028348,0.41634,0.28522,1,1
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,8.3641e-05,0.41519,0.44314,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,1.2939e-05,0.4132,0.40422,1,1
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00028019,0.41187,0.4437,1,1
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00024771,0.40979,0.39353,1,1
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0054671,0.40838,0.34022,1,1
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00031664,0.40825,0.38405,1,1
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00010181,0.40543,0.42493,1,1
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00013188,0.4052,0.45402,1,1
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00096503,0.40414,0.40612,1,1
1,GO SPERMATID NUCLEUS DIFFERENTIATION,4.5779e-05,0.4029,0.38167,1,1
1,GO NEURAL TUBE PATTERNING,0.00031664,0.40213,0.3365,1,1
1,GO P BODY ASSEMBLY,2.4576e-05,0.40059,0.42663,1,1
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.2907e-05,0.39996,0.40455,1,1
1,GO DOSAGE COMPENSATION,6.8565e-05,0.39986,0.40117,1,1
1,GO CENTROSOME DUPLICATION,1.6059e-05,0.39865,0.39389,1,1
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0034935,0.39856,0.35322,1,1
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00021879,0.39842,0.4211,1,1
1,GO MITOTIC RECOMBINATION,3.9936e-05,0.39775,0.39025,1,1
1,GO HISTONE H3 K9 DEMETHYLATION,0.00014062,0.39774,0.4135,1,1
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,1.6059e-05,0.3977,0.42584,1,1
1,GO RESPONSE TO AUDITORY STIMULUS,0.00033648,0.39766,0.41667,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,8.9327e-05,0.39531,0.42334,1,1
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00010181,0.39502,0.39135,1,1
1,GO MYOBLAST MIGRATION,0.0010798,0.3949,0.36796,1,1
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00020554,0.39374,0.40187,1,1
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0083971,0.39245,0.28534,1,1
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0003797,0.39154,0.36769,1,1
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00072571,0.39151,0.38792,1,1
1,GO MRNA SPLICE SITE SELECTION,8.3641e-05,0.39048,0.42625,1,1
1,GO RESPONSE TO COCAINE,1.4947e-05,0.38993,0.42877,1,1
1,GO CEREBELLAR CORTEX DEVELOPMENT,4.2763e-05,0.38898,0.3843,1,1
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.4947e-05,0.3874,0.41585,1,1
1,GO SEX DETERMINATION,0.0040644,0.38714,0.28304,1,1
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00091199,0.38675,0.47854,1,1
1,GO REGULATION OF CHROMATIN BINDING,2.636e-05,0.3862,0.40595,1,1
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0034935,0.38594,0.40115,1,1
1,GO REGULATION OF SPINDLE CHECKPOINT,5.6086e-05,0.38579,0.39493,1,1
1,GO REGULATION OF CELL CYCLE CHECKPOINT,4.8997e-05,0.38475,0.38593,1,1
1,GO HISTONE H3 K9 METHYLATION,1.7249e-05,0.38473,0.45343,1,1
1,GO NERVE DEVELOPMENT,0.00076864,0.38189,0.37511,1,1
1,GO CELL PROLIFERATION IN FOREBRAIN,0.0036751,0.38098,0.3412,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.00040321,0.38084,0.37841,1,1
1,GO HISTONE H3 K4 TRIMETHYLATION,0.00040321,0.38075,0.44062,1,1
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.00010866,0.37994,0.38252,1,1
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0012758,0.3798,0.37449,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,7.8298e-05,0.37889,0.3666,1,1
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00018128,0.37886,0.39931,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,4.5779e-05,0.37848,0.39076,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,2.1347e-05,0.37814,0.43801,1,1
1,GO SPINAL CORD PATTERNING,0.0021907,0.37795,0.42878,1,1
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00012367,0.37739,0.39589,1,1
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0010209,0.37718,0.36918,1,1
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0017696,0.37459,0.34889,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00029789,0.37057,0.39505,1,1
1,GO NOSE DEVELOPMENT,0.0047188,0.36949,0.3695,1,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.00014062,0.3684,0.37636,1,1
1,GO RESPONSE TO INSECTICIDE,0.010101,0.36781,0.28853,1,1
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,1.6059e-05,0.3676,0.37083,1,1
1,GO INHIBITORY SYNAPSE ASSEMBLY,0.00026348,0.36719,0.51255,1,1
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,2.2907e-05,0.36691,0.4159,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00010866,0.36595,0.36567,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00015974,0.36591,0.36633,1,1
1,GO LOOP OF HENLE DEVELOPMENT,0.0047188,0.3655,0.41373,1,1
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0011418,0.36487,0.3332,1,1
1,GO BRAIN MORPHOGENESIS,9.5377e-05,0.36352,0.37163,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00054254,0.36294,0.35662,1,1
1,GO REGULATION OF CHROMATIN ASSEMBLY,8.3641e-05,0.36281,0.38642,1,1
1,GO REGULATION OF GROWTH HORMONE SECRETION,0.0012758,0.36266,0.4666,1,1
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,4.5779e-05,0.36229,0.38994,1,1
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0013481,0.36156,0.32281,1,1
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00026348,0.36006,0.34696,1,1
1,GO NUCLEUS LOCALIZATION,9.5377e-05,0.35979,0.45671,1,1
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00029789,0.35915,0.37335,1,1
1,GO MITOTIC SISTER CHROMATID COHESION,9.6689e-06,0.35885,0.41541,1,1
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0096484,0.35873,0.36095,1,1
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0010209,0.35856,0.34351,1,1
1,GO EPITHELIAL CELL CELL ADHESION,0.0029965,0.35696,0.33735,1,1
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0021907,0.35692,0.31562,1,1
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,8.3641e-05,0.35659,0.35889,1,1
1,GO VAGINA DEVELOPMENT,0.021265,0.35605,0.30875,1,1
1,GO FORELIMB MORPHOGENESIS,0.00010866,0.35579,0.41413,1,1
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00064645,0.35546,0.35146,1,1
1,GO MEIOSIS I CELL CYCLE PROCESS,3.9936e-05,0.35527,0.33904,1,1
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,7.3279e-05,0.35523,0.36929,1,1
1,GO CRANIAL NERVE MORPHOGENESIS,0.016475,0.3542,0.28653,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,3.4805e-05,0.35385,0.41643,1,1
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.00010181,0.35383,0.34708,1,1
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,6.8565e-05,0.35349,0.31833,1,1
1,GO METENCEPHALON DEVELOPMENT,3.9936e-05,0.35324,0.35867,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00068502,0.35314,0.3635,1,1
1,GO CORPUS CALLOSUM DEVELOPMENT,0.00013188,0.35251,0.39657,1,1
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0003797,0.35202,0.34624,1,1
1,GO CEREBELLAR CORTEX FORMATION,0.00019306,0.35171,0.38196,1,1
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,1.1191e-05,0.35145,0.4059,1,1
1,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.0003797,0.35131,0.35631,1,1
1,GO HISTONE METHYLATION,2.4576e-05,0.3513,0.3777,1,1
1,GO GROWTH HORMONE SECRETION,0.0017696,0.35119,0.3847,1,1
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,8.9327e-05,0.3506,0.37657,1,1
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.00020554,0.35017,0.36011,1,1
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00076864,0.34996,0.41264,1,1
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,6.4139e-05,0.34985,0.44737,1,1
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00021879,0.34948,0.37031,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.018736,0.34921,0.28705,1,1
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.011574,0.34892,0.32577,1,1
1,GO OTIC VESICLE DEVELOPMENT,0.0060238,0.34837,0.29695,1,1
1,GO G0 TO G1 TRANSITION,1.3909e-05,0.3483,0.40411,1,1
1,GO ADULT BEHAVIOR,0.00014989,0.34801,0.33589,1,1
1,GO NUCLEAR MIGRATION,0.00014062,0.34743,0.45455,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.00033648,0.3471,0.31112,1,1
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00042807,0.34699,0.32736,1,1
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0013481,0.34625,0.31582,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.00026348,0.34579,0.35124,1,1
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0066311,0.34567,0.29775,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.0083971,0.34512,0.26688,1,1
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,2.4576e-05,0.34505,0.38177,1,1
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,3.7287e-05,0.34503,0.39815,1,1
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,3.9936e-05,0.34498,0.4046,1,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.00024771,0.34452,0.30717,1,1
1,GO SISTER CHROMATID COHESION,1.8524e-05,0.34446,0.37825,1,1
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,3.4805e-05,0.34414,0.38002,1,1
1,GO CHROMOSOME SEPARATION,3.248e-05,0.34408,0.35634,1,1
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0029965,0.34384,0.32138,1,1
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0036751,0.3431,0.35393,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.006955,0.3428,0.38688,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.01266,0.34271,0.32171,1,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,6.4139e-05,0.34221,0.41164,1,1
1,GO PEPTIDYL LYSINE DIMETHYLATION,7.8298e-05,0.34197,0.37521,1,1
1,GO MICROTUBULE ANCHORING,0.00024771,0.34189,0.36237,1,1
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0036751,0.34172,0.3044,1,1
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,5.2428e-05,0.34138,0.35548,1,1
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,8.3641e-05,0.34095,0.39401,1,1
1,GO RECOMBINATIONAL REPAIR,1.3909e-05,0.34067,0.36938,1,1
1,GO PEPTIDYL LYSINE METHYLATION,2.8267e-05,0.34025,0.38244,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,5.6086e-05,0.34021,0.36162,1,1
1,GO HISTONE H3 K9 MODIFICATION,3.248e-05,0.33939,0.39257,1,1
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00068502,0.33864,0.32287,1,1
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.007293,0.33834,0.32367,1,1
1,GO DNA STRAND ELONGATION,0.00012367,0.3382,0.33406,1,1
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0076456,0.33818,0.30155,1,1
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.00017019,0.33738,0.36049,1,1
1,GO DORSAL SPINAL CORD DEVELOPMENT,0.00096503,0.33724,0.39419,1,1
1,GO DENDRITE MORPHOGENESIS,7.8298e-05,0.33676,0.36063,1,1
1,GO COLLATERAL SPROUTING,0.0011418,0.33669,0.39333,1,1
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.0012071,0.33545,0.33241,1,1
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,4.5779e-05,0.3352,0.34442,1,1
1,GO CENTROMERE COMPLEX ASSEMBLY,3.0304e-05,0.33488,0.40932,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.00018128,0.33479,0.30626,1,1
1,GO REGULATION OF CILIUM ASSEMBLY,0.00042807,0.3347,0.3351,1,1
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0047188,0.33448,0.3026,1,1
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.5779e-05,0.33429,0.37116,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,1.8524e-05,0.33392,0.33766,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.9985e-05,0.33329,0.35043,1,1
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00015974,0.33316,0.34342,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0057394,0.33224,0.28919,1,1
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0034935,0.33202,0.30128,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.00018128,0.33201,0.32965,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,6.4139e-05,0.33187,0.35923,1,1
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0060238,0.33163,0.33039,1,1
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,1.6059e-05,0.33161,0.37848,1,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,7.8298e-05,0.33153,0.34826,1,1
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00015974,0.33146,0.31389,1,1
1,GO INNERVATION,0.0017696,0.33106,0.45282,1,1
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.00013188,0.33075,0.35818,1,1
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.02951,0.33052,0.22886,1,1
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00051151,0.33043,0.32715,1,1
1,GO MICROTUBULE NUCLEATION,0.00021879,0.3304,0.36669,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.6086e-05,0.33003,0.35611,1,1
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,1.9888e-05,0.33001,0.40136,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0023095,0.32919,0.40825,1,1
1,GO GENITALIA MORPHOGENESIS,0.00096503,0.32868,0.37048,1,1
1,GO HISTONE H3 K9 TRIMETHYLATION,6.8565e-05,0.32802,0.37492,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0080134,0.32773,0.26727,1,1
1,GO SYNAPTIC VESICLE MATURATION,0.0076456,0.32695,0.36017,1,1
1,GO SYNAPSE ASSEMBLY,0.00054254,0.32648,0.33186,1,1
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,7.8298e-05,0.32638,0.33526,1,1
1,GO PRESYNAPSE ORGANIZATION,0.00048214,0.32604,0.34014,1,1
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00014989,0.326,0.35523,1,1
1,GO MITOTIC DNA REPLICATION,0.00010866,0.32587,0.39077,1,1
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0028457,0.32581,0.31643,1,1
1,GO INTERSTRAND CROSS LINK REPAIR,1.7249e-05,0.32566,0.37025,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,1.2939e-05,0.32551,0.35433,1,1
1,GO ACTIN CROSSLINK FORMATION,0.0014241,0.32543,0.35062,1,1
1,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00031664,0.32518,0.38088,1,1
1,GO LONG TERM SYNAPTIC DEPRESSION,0.0019699,0.325,0.31928,1,1
1,GO MRNA METHYLATION,3.0304e-05,0.32444,0.3598,1,1
1,GO PROTEIN HETEROTETRAMERIZATION,0.00018128,0.3238,0.30547,1,1
1,GO PROTEIN PALMITOYLATION,0.00010181,0.32361,0.38498,1,1
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.00076864,0.32298,0.30298,1,1
1,GO REGULATION OF CENTROSOME CYCLE,3.0304e-05,0.32296,0.32528,1,1
1,GO HIPPO SIGNALING,0.00021879,0.32291,0.36914,1,1
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,1.2939e-05,0.32286,0.35231,1,1
1,GO REGULATION OF RECEPTOR CLUSTERING,0.0027019,0.32266,0.4059,1,1
1,GO HISTONE H3 K4 METHYLATION,4.8997e-05,0.3226,0.36322,1,1
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.00033648,0.32257,0.33023,1,1
1,GO GOLGI RIBBON FORMATION,0.00021879,0.32253,0.37627,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,2.8267e-05,0.32226,0.32765,1,1
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,2.8267e-05,0.32213,0.35652,1,1
1,GO RESPONSE TO NICOTINE,0.00028019,0.32176,0.32827,1,1
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.007293,0.32159,0.32704,1,1
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.013235,0.32151,0.30283,1,1
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0024341,0.32127,0.28698,1,1
1,GO REGULATION OF SISTER CHROMATID COHESION,1.1191e-05,0.32027,0.42531,1,1
1,GO CHROMOSOME SEGREGATION,2.4576e-05,0.32004,0.32898,1,1
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0092139,0.31979,0.33769,1,1
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0012758,0.31877,0.31547,1,1
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00042807,0.31862,0.32322,1,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,7.1973e-06,0.31861,0.40002,1,1
1,GO RESPONSE TO L GLUTAMATE,0.0028457,0.31836,0.29282,1,1
1,GO KERATINOCYTE DEVELOPMENT,0.013235,0.31816,0.3106,1,1
1,GO GLIAL CELL FATE COMMITMENT,0.0028457,0.31788,0.32206,1,1
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,3.248e-05,0.31768,0.35167,1,1
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0080134,0.3172,0.40597,1,1
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00010866,0.31679,0.3241,1,1
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.4947e-05,0.31654,0.35945,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0044907,0.31649,0.28803,1,1
1,GO NOREPINEPHRINE SECRETION,0.011574,0.31638,0.31366,1,1
1,GO NON MOTILE CILIUM ASSEMBLY,9.5377e-05,0.31574,0.3396,1,1
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00096503,0.31554,0.31518,1,1
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00010181,0.31524,0.30958,1,1
1,GO HISTONE H4 K16 ACETYLATION,4.2763e-05,0.31503,0.36731,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.0031545,0.31481,0.29673,1,1
1,GO NEURON MIGRATION,0.00014062,0.31412,0.37121,1,1
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.020391,0.314,0.29759,1,1
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00048214,0.31384,0.33241,1,1
1,GO CELL JUNCTION MAINTENANCE,0.0018673,0.31372,0.33659,1,1
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.008797,0.31342,0.36456,1,1
1,GO FEAR RESPONSE,0.00072571,0.31162,0.28742,1,1
1,GO FOREBRAIN NEURON DEVELOPMENT,0.016475,0.31161,0.25182,1,1
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0057394,0.31154,0.29738,1,1
1,GO CARNITINE SHUTTLE,0.0016767,0.31149,0.29629,1,1
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,2.4576e-05,0.31136,0.37746,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,7.8298e-05,0.31113,0.36159,1,1
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0016767,0.31101,0.32284,1,1
1,GO SPINAL CORD DEVELOPMENT,0.00011593,0.31098,0.39648,1,1
1,GO THALAMUS DEVELOPMENT,0.00017019,0.31084,0.37194,1,1
1,GO MISMATCH REPAIR,1.9888e-05,0.31058,0.33732,1,1
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,9.5377e-05,0.31042,0.32429,1,1
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,8.9327e-05,0.31028,0.30645,1,1
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.00057531,0.31007,0.33025,1,1
1,GO STRESS GRANULE ASSEMBLY,1.0403e-05,0.30984,0.36177,1,1
1,GO CELL CYCLE DNA REPLICATION,3.248e-05,0.30953,0.36649,1,1
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00035748,0.30889,0.32562,1,1
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,1.9888e-05,0.30884,0.36439,1,1
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00012367,0.30875,0.33725,1,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,5.6086e-05,0.30854,0.38774,1,1
1,GO NEUROTRANSMITTER SECRETION,0.00064645,0.30852,0.31331,1,1
1,GO PROTEIN METHYLATION,1.8524e-05,0.30811,0.35638,1,1
1,GO V D J RECOMBINATION,0.00057531,0.30804,0.31135,1,1
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00076864,0.30779,0.35135,1,1
1,GO DENDRITIC SPINE MORPHOGENESIS,0.00051151,0.30705,0.32993,1,1
1,GO REGULATION OF EXIT FROM MITOSIS,7.3279e-05,0.30694,0.3654,1,1
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,5.2428e-05,0.30671,0.36028,1,1
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.00042807,0.30657,0.30108,1,1
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0080134,0.30645,0.29214,1,1
1,GO INOSITOL METABOLIC PROCESS,0.0012071,0.30643,0.34268,1,1
1,GO REGULATION OF MRNA PROCESSING,5.9985e-05,0.30635,0.30931,1,1
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00042807,0.30623,0.34544,1,1
1,GO REGULATION OF DENDRITE MORPHOGENESIS,8.3641e-05,0.3062,0.34149,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00017019,0.30618,0.37118,1,1
1,GO POSTSYNAPSE ORGANIZATION,0.00024771,0.30607,0.31804,1,1
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0012758,0.30603,0.30632,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,2.636e-05,0.30595,0.35998,1,1
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0063209,0.30591,0.27818,1,1
1,GO RESPONSE TO HYDROXYUREA,2.8267e-05,0.30583,0.3577,1,1
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.00033648,0.30578,0.28406,1,1
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0003797,0.30577,0.3531,1,1
1,GO CHROMATIN REMODELING,1.7249e-05,0.30569,0.34266,1,1
1,GO RETINAL ROD CELL DIFFERENTIATION,0.0063209,0.30537,0.2448,1,1
1,GO CHROMATIN SILENCING AT TELOMERE,0.00033648,0.3052,0.32322,1,1
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00064645,0.3045,0.29133,1,1
1,GO HISTONE H4 DEACETYLATION,5.9985e-05,0.30412,0.29122,1,1
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0010209,0.30383,0.36955,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0017696,0.30378,0.33698,1,1
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00048214,0.30377,0.35402,1,1
1,GO NEURAL RETINA DEVELOPMENT,0.00048214,0.30351,0.31746,1,1
1,GO UTERUS DEVELOPMENT,0.00023283,0.30333,0.40971,1,1
1,GO HISTONE EXCHANGE,0.00014989,0.303,0.32654,1,1
1,GO APICAL PROTEIN LOCALIZATION,0.00042807,0.30281,0.34563,1,1
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00028019,0.30243,0.33272,1,1
1,GO ATP DEPENDENT CHROMATIN REMODELING,1.6059e-05,0.30239,0.36553,1,1
1,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0012071,0.30189,0.30707,1,1
1,GO PROTEIN LOCALIZATION TO CHROMATIN,2.2907e-05,0.30177,0.36192,1,1
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00010181,0.30147,0.3751,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,2.2907e-05,0.30128,0.32075,1,1
1,GO SYNAPTIC VESICLE PRIMING,0.010572,0.30098,0.27389,1,1
1,GO SECRETORY GRANULE LOCALIZATION,0.017954,0.30028,0.29262,1,1
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0038653,0.2997,0.26703,1,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.2035e-05,0.29965,0.37951,1,1
1,GO PROSTATE GLAND MORPHOGENESIS,0.02951,0.29946,0.27904,1,1
1,GO CHROMATIN SILENCING,2.2907e-05,0.29903,0.33441,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,2.1347e-05,0.299,0.32408,1,1
1,GO LEARNING,0.00021879,0.29848,0.31438,1,1
1,GO MEMBRANE DISASSEMBLY,0.00060992,0.29771,0.33287,1,1
1,GO REGULATION OF TORC1 SIGNALING,0.00011593,0.29754,0.34045,1,1
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0047188,0.29747,0.30896,1,1
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0015882,0.29741,0.32732,1,1
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.018736,0.29722,0.2477,1,1
1,GO AMMONIUM ION METABOLIC PROCESS,0.041938,0.29714,0.22703,1,1
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00064645,0.29684,0.30275,1,1
1,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00045436,0.29672,0.33817,1,1
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00015974,0.2959,0.32495,1,1
1,GO CHROMATIN REMODELING AT CENTROMERE,0.00018128,0.29542,0.37758,1,1
1,GO SYNAPTIC TRANSMISSION GABAERGIC,8.9327e-05,0.29509,0.35772,1,1
1,GO TONGUE DEVELOPMENT,0.015776,0.29505,0.2128,1,1
1,GO MICROTUBULE POLYMERIZATION,0.00051151,0.29502,0.31864,1,1
1,GO RESPONSE TO ACETYLCHOLINE,0.0012758,0.29479,0.35534,1,1
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.00048214,0.29468,0.3033,1,1
1,GO PROTEIN DEMETHYLATION,0.00031664,0.29468,0.35257,1,1
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.00023283,0.29452,0.32847,1,1
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00048214,0.29452,0.34235,1,1
1,GO DNA RECOMBINATION,3.4805e-05,0.29424,0.29828,1,1
1,GO DENDRITE DEVELOPMENT,0.00010181,0.29402,0.34108,1,1
1,GO DENDRITIC SPINE DEVELOPMENT,5.9985e-05,0.29377,0.34562,1,1
1,GO DNA GEOMETRIC CHANGE,1.1191e-05,0.29375,0.34927,1,1
1,GO PRO B CELL DIFFERENTIATION,0.00332,0.29348,0.35802,1,1
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0024341,0.29345,0.29732,1,1
1,GO DNA DEPENDENT DNA REPLICATION,2.2907e-05,0.29342,0.35329,1,1
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.00014062,0.2934,0.34209,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00021879,0.29339,0.32872,1,1
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00081392,0.29326,0.27961,1,1
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.008797,0.29315,0.32596,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0054671,0.29312,0.25362,1,1
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0012071,0.29309,0.2873,1,1
1,GO CRANIAL NERVE DEVELOPMENT,0.0042727,0.29308,0.32678,1,1
1,GO SHORT TERM MEMORY,0.0060238,0.29262,0.26958,1,1
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0047188,0.29255,0.30375,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0028457,0.29242,0.32656,1,1
1,GO ECTODERM DEVELOPMENT,0.00026348,0.2919,0.28854,1,1
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.0092139,0.29175,0.27398,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00011593,0.29171,0.30667,1,1
1,GO NOTOCHORD DEVELOPMENT,0.025096,0.29127,0.28001,1,1
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00076864,0.29054,0.31999,1,1
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.00019306,0.29051,0.38111,1,1
1,GO SISTER CHROMATID SEGREGATION,2.636e-05,0.29048,0.32221,1,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.006955,0.29012,0.29051,1,1
1,GO ADHERENS JUNCTION ASSEMBLY,0.0042727,0.28995,0.3194,1,1
1,GO SPINDLE ASSEMBLY,4.5779e-05,0.28988,0.32861,1,1
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,3.4805e-05,0.28964,0.33011,1,1
1,GO HISTONE H2A UBIQUITINATION,2.1347e-05,0.28908,0.36978,1,1
1,GO PRIMARY MIRNA PROCESSING,0.0027019,0.28891,0.24821,1,1
1,GO EPITHELIAL CELL MATURATION,0.0036751,0.28873,0.30083,1,1
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0021907,0.28863,0.37683,1,1
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.0020776,0.28858,0.27848,1,1
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0029965,0.28834,0.29426,1,1
1,GO TORC1 SIGNALING,0.00013188,0.28833,0.34347,1,1
1,GO REGULATION OF RNA SPLICING,8.3641e-05,0.28825,0.29217,1,1
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.010101,0.28749,0.29543,1,1
1,GO POSITIVE REGULATION OF CYTOKINESIS,2.1347e-05,0.28699,0.32314,1,1
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.008797,0.28675,0.29923,1,1
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.00076864,0.28602,0.32636,1,1
1,GO REGULATION OF DENDRITE DEVELOPMENT,6.8565e-05,0.2859,0.33364,1,1
1,GO RESPONSE TO VITAMIN A,0.0017696,0.28583,0.25067,1,1
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00057531,0.28573,0.37214,1,1
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.00014062,0.28557,0.29044,1,1
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0038653,0.28512,0.27158,1,1
1,GO RESPONSE TO GLUCAGON,0.0012758,0.28509,0.2988,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,4.2763e-05,0.28471,0.34893,1,1
1,GO REGULATION OF HISTONE METHYLATION,3.0304e-05,0.28446,0.35785,1,1
1,GO HISTONE H2B UBIQUITINATION,0.0015882,0.28427,0.22407,1,1
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.013235,0.28421,0.31007,1,1
1,GO TONGUE MORPHOGENESIS,0.0083971,0.28349,0.25257,1,1
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0010798,0.28329,0.3418,1,1
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0057394,0.28326,0.27366,1,1
1,GO COVALENT CHROMATIN MODIFICATION,3.9936e-05,0.28322,0.32235,1,1
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00057531,0.28308,0.28732,1,1
1,GO CHROMATIN ORGANIZATION,3.0304e-05,0.28308,0.32596,1,1
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00051151,0.28302,0.31475,1,1
1,GO ASYMMETRIC CELL DIVISION,0.00060992,0.28278,0.29299,1,1
1,GO HISTONE DEUBIQUITINATION,0.00033648,0.28211,0.36577,1,1
1,GO MITOTIC CHROMOSOME CONDENSATION,0.00035748,0.28183,0.43688,1,1
1,GO SYNAPTIC SIGNALING,0.00054254,0.2817,0.27397,1,1
1,GO DOUBLE STRAND BREAK REPAIR,1.7249e-05,0.28162,0.33115,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0066311,0.28152,0.32906,1,1
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00035748,0.28147,0.39553,1,1
1,GO MICROTUBULE BASED PROCESS,0.00021879,0.28104,0.28465,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00019306,0.281,0.37453,1,1
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0012758,0.28083,0.32078,1,1
1,GO DNA REPLICATION CHECKPOINT,0.00035748,0.28069,0.3616,1,1
1,GO REGULATION OF CYTOKINESIS,2.8267e-05,0.28065,0.32942,1,1
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00086166,0.28056,0.25289,1,1
1,GO TUBULIN DEACETYLATION,0.0024341,0.2804,0.31301,1,1
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,7.3279e-05,0.28018,0.30177,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,2.1347e-05,0.28013,0.33175,1,1
1,GO HINDBRAIN DEVELOPMENT,5.2428e-05,0.28003,0.31076,1,1
1,GO HETEROCHROMATIN ORGANIZATION,5.2428e-05,0.28,0.33762,1,1
1,GO REGULATION OF AXONOGENESIS,0.00057531,0.27998,0.32568,1,1
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0036751,0.27996,0.28086,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.00015974,0.2797,0.29312,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,5.6086e-05,0.27907,0.33646,1,1
1,GO LATERAL VENTRICLE DEVELOPMENT,0.008797,0.2786,0.30425,1,1
1,GO HINDBRAIN MORPHOGENESIS,0.00019306,0.27843,0.30073,1,1
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,5.2428e-05,0.2782,0.33346,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,6.8565e-05,0.27805,0.2998,1,1
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.2035e-05,0.27797,0.38499,1,1
1,GO MEIOTIC CELL CYCLE PROCESS,7.8298e-05,0.2775,0.30678,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,3.4805e-05,0.27746,0.29694,1,1
1,GO MRNA CLEAVAGE,0.00023283,0.27745,0.2825,1,1
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00076864,0.27743,0.30117,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0016767,0.27705,0.28409,1,1
1,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0047188,0.27704,0.23558,1,1
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.010572,0.27703,0.25607,1,1
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.00060992,0.27672,0.31845,1,1
1,GO REGULATION OF SPINDLE ASSEMBLY,0.00042807,0.27662,0.27813,1,1
1,GO MUSCLE FIBER DEVELOPMENT,0.0054671,0.27619,0.24992,1,1
1,GO HISTONE H3 DEACETYLATION,0.00076864,0.27579,0.2846,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.00040321,0.2755,0.32722,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.028348,0.27505,0.25232,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.00013188,0.27483,0.30581,1,1
1,GO NEURON PROJECTION ORGANIZATION,0.00051151,0.27483,0.29817,1,1
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00057531,0.27475,0.35417,1,1
1,GO HISTONE DEACETYLATION,0.00064645,0.27441,0.29029,1,1
1,GO EXPLORATION BEHAVIOR,0.011063,0.27438,0.26869,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0034935,0.27435,0.29262,1,1
1,GO HISTONE H2A MONOUBIQUITINATION,3.9936e-05,0.27418,0.38416,1,1
1,GO SPINDLE ORGANIZATION,5.9985e-05,0.27391,0.32914,1,1
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.00015974,0.27347,0.32799,1,1
1,GO REGULATION OF FEEDING BEHAVIOR,0.00054254,0.27277,0.25387,1,1
1,GO DORSAL VENTRAL PATTERN FORMATION,0.00014062,0.27273,0.32555,1,1
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.010572,0.27262,0.32706,1,1
1,GO NEUROTRANSMITTER TRANSPORT,0.00064645,0.27236,0.29641,1,1
1,GO RECEPTOR CLUSTERING,0.0029965,0.27229,0.28841,1,1
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0003797,0.2719,0.31809,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0024341,0.27169,0.21201,1,1
1,GO MITOTIC SPINDLE ASSEMBLY,5.2428e-05,0.27164,0.32688,1,1
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00015974,0.27127,0.29221,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,1.6059e-05,0.27088,0.32061,1,1
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00024771,0.27086,0.30361,1,1
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0010209,0.27059,0.29825,1,1
1,GO NEUROMUSCULAR PROCESS,0.0021907,0.27039,0.26292,1,1
1,GO SYNAPSE ORGANIZATION,0.00045436,0.27036,0.29227,1,1
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0016767,0.26999,0.24316,1,1
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0034935,0.26982,0.18904,1,1
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.030713,0.26965,0.24043,1,1
1,GO MECHANOSENSORY BEHAVIOR,0.0083971,0.26948,0.41964,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,2.4576e-05,0.26938,0.32663,1,1
1,GO DNA REPLICATION,1.8524e-05,0.26934,0.3473,1,1
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00057531,0.26924,0.29681,1,1
1,GO MEIOTIC CELL CYCLE,4.5779e-05,0.26862,0.31395,1,1
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00060992,0.26843,0.28874,1,1
1,GO POST ANAL TAIL MORPHOGENESIS,0.0025648,0.26787,0.29934,1,1
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00086166,0.26782,0.2871,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.00010181,0.26766,0.28497,1,1
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0025648,0.26723,0.23794,1,1
1,GO CELLULAR COMPONENT MAINTENANCE,0.00029789,0.26711,0.31364,1,1
1,GO NEUROBLAST PROLIFERATION,0.00045436,0.2671,0.32333,1,1
1,GO DNA CONFORMATION CHANGE,1.3909e-05,0.2671,0.34717,1,1
1,GO FATTY ACID HOMEOSTASIS,0.025096,0.26676,0.19146,1,1
1,GO REGULATION OF DNA REPAIR,2.8267e-05,0.26665,0.30878,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,7.3279e-05,0.26646,0.3153,1,1
1,GO ACTIVATION OF JNKK ACTIVITY,0.0015041,0.26633,0.33067,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,2.636e-05,0.26622,0.31222,1,1
1,GO SOMITE DEVELOPMENT,0.00040321,0.26593,0.29464,1,1
1,GO EMBRYONIC AXIS SPECIFICATION,5.9985e-05,0.26591,0.30834,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0025648,0.26581,0.30309,1,1
1,GO NEPHRIC DUCT DEVELOPMENT,0.0172,0.26577,0.31521,1,1
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00072571,0.26557,0.30531,1,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.2035e-05,0.26506,0.35152,1,1
1,GO ATP TRANSPORT,0.0013481,0.26481,0.23157,1,1
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00096503,0.26448,0.28791,1,1
1,GO RNA POLYADENYLATION,6.8565e-05,0.26439,0.29138,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.00019306,0.26418,0.32953,1,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,4.2763e-05,0.26416,0.31069,1,1
1,GO POSITIVE REGULATION OF DNA REPAIR,2.636e-05,0.26353,0.30696,1,1
1,GO DNA REPLICATION INITIATION,0.00013188,0.26334,0.30915,1,1
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0012071,0.2631,0.28531,1,1
1,GO NUCLEOSOME ORGANIZATION,3.7287e-05,0.26297,0.31652,1,1
1,GO COCHLEA DEVELOPMENT,0.0025648,0.26279,0.27489,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00033648,0.2626,0.36238,1,1
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0012758,0.26238,0.27805,1,1
1,GO REGULATION OF MRNA POLYADENYLATION,9.5377e-05,0.26232,0.31151,1,1
1,GO MRNA PROCESSING,3.248e-05,0.26215,0.2752,1,1
1,GO OOCYTE MATURATION,0.0038653,0.2619,0.28408,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00028019,0.26178,0.30471,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0015882,0.26086,0.30799,1,1
1,GO CELL PART MORPHOGENESIS,0.00051151,0.26086,0.29533,1,1
1,GO HISTONE H4 K5 ACETYLATION,0.00015974,0.26075,0.32393,1,1
1,GO RRNA 3 END PROCESSING,0.00040321,0.26021,0.21417,1,1
1,GO CHROMOSOME ORGANIZATION,1.9888e-05,0.25997,0.30783,1,1
1,GO DNA PACKAGING,2.2907e-05,0.25987,0.34917,1,1
1,GO METHIONINE METABOLIC PROCESS,0.00035748,0.25944,0.28692,1,1
1,GO RNA INTERFERENCE,0.0023095,0.25934,0.24031,1,1
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.048745,0.25926,0.1624,1,1
1,GO SINGLE STRAND BREAK REPAIR,4.5779e-05,0.25819,0.32895,1,1
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0083971,0.25818,0.33926,1,1
1,GO EMBRYONIC BODY MORPHOGENESIS,0.0012071,0.25807,0.35305,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00033648,0.25799,0.26114,1,1
1,GO REGULATION OF CIRCADIAN RHYTHM,3.0304e-05,0.25796,0.31575,1,1
1,GO ORGANELLE FISSION,2.4576e-05,0.25792,0.27721,1,1
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.00072571,0.25778,0.28081,1,1
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.0044907,0.25777,0.27873,1,1
1,GO NON RECOMBINATIONAL REPAIR,1.2939e-05,0.25763,0.30702,1,1
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00029789,0.2576,0.29431,1,1
1,GO COCHLEA MORPHOGENESIS,0.013834,0.25751,0.24401,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00051151,0.25748,0.27087,1,1
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0060238,0.25706,0.23584,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00091199,0.257,0.30546,1,1
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.00042807,0.25658,0.31706,1,1
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0034935,0.25654,0.32738,1,1
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0025648,0.2564,0.25866,1,1
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0012758,0.25633,0.24184,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.00031664,0.25622,0.27987,1,1
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0012758,0.25588,0.25344,1,1
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,7.3279e-05,0.25588,0.32848,1,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.00026348,0.25562,0.31074,1,1
1,GO RRNA CATABOLIC PROCESS,0.00031664,0.25549,0.25968,1,1
1,GO MRNA 3 END PROCESSING,2.4576e-05,0.25524,0.29547,1,1
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.011574,0.25507,0.24896,1,1
1,GO AXON DEVELOPMENT,0.00072571,0.25485,0.29559,1,1
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0020776,0.25455,0.25511,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,9.5377e-05,0.25441,0.28193,1,1
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,2.636e-05,0.25413,0.32587,1,1
1,GO REGULATION OF TUBULIN DEACETYLATION,0.0047188,0.25395,0.30472,1,1
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.0092139,0.2539,0.26145,1,1
1,GO CHROMOSOME LOCALIZATION,4.2763e-05,0.2539,0.28284,1,1
1,GO TRNA CATABOLIC PROCESS,0.0013481,0.25387,0.29654,1,1
1,GO LOCOMOTORY BEHAVIOR,0.00060992,0.25377,0.29066,1,1
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00051151,0.25328,0.27754,1,1
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00064645,0.25327,0.28167,1,1
1,GO REGULATION OF CHROMATIN ORGANIZATION,9.5377e-05,0.25304,0.27618,1,1
1,GO MEMBRANE DOCKING,0.00026348,0.25301,0.27026,1,1
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00019306,0.25287,0.29354,1,1
1,GO MAINTENANCE OF CELL POLARITY,0.0015882,0.25281,0.29999,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.024086,0.25281,0.25502,1,1
1,GO HISTONE MONOUBIQUITINATION,7.3279e-05,0.25264,0.31978,1,1
1,GO FEEDING BEHAVIOR,0.0060238,0.2525,0.20957,1,1
1,GO HISTONE UBIQUITINATION,3.9936e-05,0.25245,0.32096,1,1
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.00096503,0.25236,0.24191,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0016767,0.25228,0.2665,1,1
1,GO PROTEIN MONOUBIQUITINATION,3.248e-05,0.25151,0.29946,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0029965,0.25122,0.2902,1,1
1,GO SEGMENTATION,0.0011418,0.25088,0.24759,1,1
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0038653,0.25076,0.21804,1,1
1,GO BEHAVIOR,0.00057531,0.2507,0.25953,1,1
1,GO NEURON PROJECTION ARBORIZATION,0.0031545,0.25015,0.32287,1,1
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.017954,0.25001,0.29498,1,1
1,GO RNA SPLICING,3.0304e-05,0.25,0.26674,1,1
1,GO METAPHASE PLATE CONGRESSION,4.2763e-05,0.24995,0.28693,1,1
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0021907,0.24995,0.25839,1,1
1,GO MYOTUBE CELL DEVELOPMENT,0.0040644,0.24957,0.21564,1,1
1,GO RENAL VESICLE DEVELOPMENT,0.008797,0.24945,0.28046,1,1
1,GO EXIT FROM MITOSIS,4.8997e-05,0.24945,0.2856,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,7.8298e-05,0.24937,0.30459,1,1
1,GO CHROMOSOME CONDENSATION,0.00021879,0.24929,0.37115,1,1
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.00076864,0.2491,0.25754,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.030713,0.24899,0.27401,1,1
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.00054254,0.24883,0.2742,1,1
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0014241,0.2487,0.25455,1,1
1,GO VISUAL BEHAVIOR,0.00048214,0.24835,0.24946,1,1
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.00024771,0.24831,0.27602,1,1
1,GO ADHERENS JUNCTION ORGANIZATION,0.0047188,0.24821,0.25358,1,1
1,GO REGULATION OF DNA REPLICATION,3.4805e-05,0.24817,0.29888,1,1
1,GO CEREBRAL CORTEX DEVELOPMENT,0.0010798,0.24805,0.27899,1,1
1,GO NUCLEOSOME ASSEMBLY,4.8997e-05,0.24803,0.33871,1,1
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00042807,0.248,0.28593,1,1
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0024341,0.24798,0.30646,1,1
1,GO MYELIN MAINTENANCE,0.016475,0.2478,0.24687,1,1
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00015974,0.24777,0.31584,1,1
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.016475,0.24775,0.22221,1,1
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.010101,0.24758,0.21595,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,1.9888e-05,0.24753,0.25841,1,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,5.6086e-05,0.24722,0.31508,1,1
1,GO RNA 3 END PROCESSING,3.248e-05,0.24721,0.25239,1,1
1,GO ESTROUS CYCLE,0.013834,0.24703,0.26391,1,1
1,GO DNA INTEGRITY CHECKPOINT,3.4805e-05,0.24686,0.33028,1,1
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0010209,0.24668,0.2582,1,1
1,GO REGULATION OF CYCLASE ACTIVITY,0.0010798,0.24636,0.2716,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,4.8997e-05,0.24615,0.30328,1,1
1,GO DNA LIGATION,0.00024771,0.24582,0.22918,1,1
1,GO STEM CELL DIVISION,0.024086,0.2457,0.24374,1,1
1,GO MITOTIC NUCLEAR DIVISION,2.636e-05,0.24561,0.2973,1,1
1,GO AXON EXTENSION,0.0025648,0.24557,0.27715,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0080134,0.24553,0.25953,1,1
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00021879,0.24543,0.27581,1,1
1,GO SPINDLE LOCALIZATION,0.00028019,0.24534,0.2834,1,1
1,GO DNA REPAIR,1.8524e-05,0.24534,0.29282,1,1
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,3.7287e-05,0.24511,0.27088,1,1
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.00024771,0.24468,0.24953,1,1
1,GO HISTONE PHOSPHORYLATION,0.00033648,0.24446,0.25517,1,1
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00023283,0.24432,0.30296,1,1
1,GO MESONEPHROS DEVELOPMENT,0.015776,0.24426,0.21911,1,1
1,GO HISTONE H4 ACETYLATION,6.4139e-05,0.24424,0.29771,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0057394,0.24398,0.27115,1,1
1,GO ADIPOSE TISSUE DEVELOPMENT,0.00054254,0.24349,0.27851,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0028457,0.24349,0.33671,1,1
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00024771,0.2432,0.28296,1,1
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.00014062,0.24307,0.25577,1,1
1,GO ACTIN FILAMENT BASED TRANSPORT,0.0066311,0.24301,0.2942,1,1
1,GO RNA METHYLATION,0.00020554,0.24252,0.22815,1,1
1,GO RNA EXPORT FROM NUCLEUS,3.248e-05,0.24232,0.27776,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,4.5779e-05,0.24221,0.30459,1,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.00013188,0.2422,0.2989,1,1
1,GO RESPONSE TO ALKALOID,0.00057531,0.24215,0.22616,1,1
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0036751,0.24189,0.24325,1,1
1,GO POSITIVE REGULATION OF RNA SPLICING,0.00028019,0.24184,0.26631,1,1
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0028457,0.24115,0.23594,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.010101,0.24113,0.2791,1,1
1,GO PATTERN SPECIFICATION PROCESS,0.0013481,0.24072,0.2287,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,5.9985e-05,0.2406,0.28003,1,1
1,GO REGULATION OF HELICASE ACTIVITY,0.0013481,0.24058,0.23613,1,1
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.010101,0.24048,0.21469,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0021907,0.24045,0.293,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.8298e-05,0.23979,0.2354,1,1
1,GO NEUROBLAST DIVISION,0.0040644,0.23973,0.27994,1,1
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0015882,0.23941,0.29477,1,1
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0020776,0.23906,0.28462,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.0012071,0.23906,0.27722,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.050584,0.23868,0.21148,1,1
1,GO NEUROTRANSMITTER REUPTAKE,0.0015882,0.23863,0.2775,1,1
1,GO DETECTION OF VISIBLE LIGHT,0.00012367,0.23861,0.2147,1,1
1,GO CHEMOSENSORY BEHAVIOR,0.0040644,0.23846,0.22694,1,1
1,GO THYROID GLAND DEVELOPMENT,0.013235,0.23838,0.22957,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,5.6086e-05,0.23807,0.30741,1,1
1,GO NEURON PROJECTION EXTENSION,0.0015882,0.23771,0.27231,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00018128,0.23757,0.30235,1,1
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0066311,0.23756,0.30841,1,1
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00015974,0.23751,0.31505,1,1
1,GO REGULATION OF HISTONE MODIFICATION,0.00028019,0.23712,0.26006,1,1
1,GO HINDLIMB MORPHOGENESIS,0.0049572,0.23697,0.25633,1,1
1,GO PEPTIDYL LYSINE MODIFICATION,5.9985e-05,0.23695,0.28787,1,1
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00068502,0.23691,0.28297,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0015041,0.23688,0.27713,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00054254,0.23674,0.22275,1,1
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0096484,0.23651,0.22292,1,1
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0017696,0.23644,0.28757,1,1
1,GO METHYLATION,4.2763e-05,0.23643,0.26448,1,1
1,GO REGULATION OF BEHAVIOR,0.0015041,0.23622,0.23679,1,1
1,GO METANEPHROS MORPHOGENESIS,0.0040644,0.2362,0.27494,1,1
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00096503,0.23571,0.25446,1,1
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.00010866,0.23569,0.27199,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00017019,0.23558,0.3071,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.016475,0.23542,0.29403,1,1
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.031957,0.23529,0.36053,1,1
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.011063,0.23518,0.30595,1,1
1,GO RNA DESTABILIZATION,0.00072571,0.23514,0.28468,1,1
1,GO MACROMOLECULE DEACYLATION,0.00072571,0.23511,0.25828,1,1
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00048214,0.23441,0.27783,1,1
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.017954,0.23441,0.2357,1,1
1,GO PROTEIN MANNOSYLATION,0.0019699,0.23423,0.23944,1,1
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.012106,0.23398,0.20329,1,1
1,GO REGULATION OF CELL PROJECTION SIZE,0.027226,0.23396,0.2098,1,1
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0023095,0.23392,0.27091,1,1
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00081392,0.23346,0.28006,1,1
1,GO CELL CYCLE CHECKPOINT,4.2763e-05,0.23345,0.31817,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00023283,0.23328,0.23036,1,1
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.0023095,0.23324,0.30853,1,1
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.0031545,0.23313,0.20875,1,1
1,GO CELLULAR RESPONSE TO ALKALOID,0.0047188,0.23273,0.20824,1,1
1,GO CYTOKINESIS,3.248e-05,0.23263,0.2758,1,1
1,GO DEVELOPMENTAL CELL GROWTH,0.0015041,0.23196,0.25397,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0003797,0.23193,0.28719,1,1
1,GO MIDGUT DEVELOPMENT,0.033245,0.23192,0.20734,1,1
1,GO REGULATION OF CHROMOSOME ORGANIZATION,2.4576e-05,0.23191,0.27846,1,1
1,GO CELL MIGRATION IN HINDBRAIN,0.012106,0.23173,0.28868,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.00035748,0.23152,0.32194,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0015882,0.23121,0.30852,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.0010209,0.2312,0.27849,1,1
1,GO NEUROTRANSMITTER UPTAKE,0.00076864,0.23077,0.25788,1,1
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00051151,0.23041,0.25541,1,1
1,GO LACTATION,0.00048214,0.23005,0.27467,1,1
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0023095,0.22989,0.28415,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,3.7287e-05,0.2295,0.30092,1,1
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00054254,0.22926,0.27172,1,1
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0010798,0.22885,0.26073,1,1
1,GO REGULATION OF GLUCONEOGENESIS,0.0060238,0.22874,0.24504,1,1
1,GO REGULATION OF NEURON DIFFERENTIATION,0.00045436,0.22866,0.27506,1,1
1,GO ASSOCIATIVE LEARNING,0.00028019,0.22862,0.26403,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.0017696,0.22831,0.24869,1,1
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0021907,0.22824,0.27816,1,1
1,GO PROTEIN ACYLATION,5.2428e-05,0.22815,0.29616,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0015041,0.22797,0.28226,1,1
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0052065,0.22793,0.30256,1,1
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,5.9985e-05,0.22763,0.26804,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00021879,0.22758,0.2708,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,7.8298e-05,0.2275,0.23752,1,1
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.00068502,0.22725,0.29901,1,1
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00060992,0.22718,0.29876,1,1
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036751,0.22713,0.22369,1,1
1,GO INNER EAR MORPHOGENESIS,0.0023095,0.22712,0.26472,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,9.5377e-05,0.22694,0.28773,1,1
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0017696,0.22688,0.29006,1,1
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.037377,0.2266,0.22914,1,1
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0029965,0.22654,0.24594,1,1
1,GO RNA STABILIZATION,0.00012367,0.22651,0.26283,1,1
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,2.1347e-05,0.2264,0.2688,1,1
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.021265,0.22634,0.18346,1,1
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00072571,0.22631,0.26647,1,1
1,GO HIPPOCAMPUS DEVELOPMENT,0.00045436,0.22625,0.27005,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.021265,0.22625,0.19037,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.00045436,0.22621,0.2389,1,1
1,GO REGULATION OF TOR SIGNALING,0.00017019,0.22573,0.2642,1,1
1,GO PANCREAS DEVELOPMENT,0.00068502,0.22567,0.31903,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.00018128,0.22554,0.23863,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.006955,0.22546,0.24784,1,1
1,GO CELL DIVISION,3.9936e-05,0.22538,0.26948,1,1
1,GO REGULATION OF ACTION POTENTIAL,0.0028457,0.22492,0.26051,1,1
1,GO MRNA EXPORT FROM NUCLEUS,1.9888e-05,0.22488,0.29066,1,1
1,GO CELL FATE SPECIFICATION,0.0040644,0.22438,0.24422,1,1
1,GO SNARE COMPLEX ASSEMBLY,0.0028457,0.22431,0.22545,1,1
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,3.9936e-05,0.22421,0.26906,1,1
1,GO NEURON DEVELOPMENT,0.00051151,0.22416,0.26781,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00096503,0.22378,0.27636,1,1
1,GO FEMALE GAMETE GENERATION,0.0010209,0.22362,0.21214,1,1
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.010572,0.22346,0.29009,1,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,2.1347e-05,0.22329,0.28162,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0003797,0.22324,0.28093,1,1
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.0034935,0.22282,0.30358,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.011574,0.22271,0.23076,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,4.2763e-05,0.22259,0.26791,1,1
1,GO CENTROSOME SEPARATION,0.00033648,0.22257,0.28222,1,1
1,GO MRNA TRANSPORT,3.9936e-05,0.22241,0.26484,1,1
1,GO OOGENESIS,0.00048214,0.22235,0.23464,1,1
1,GO SOMITOGENESIS,0.00068502,0.22201,0.27736,1,1
1,GO DNA METHYLATION,0.00054254,0.22195,0.22583,1,1
1,GO REGIONALIZATION,0.0021907,0.22174,0.22665,1,1
1,GO ONE CARBON METABOLIC PROCESS,0.0020776,0.22147,0.19877,1,1
1,GO CELLULAR RESPONSE TO STEROL,0.0021907,0.22138,0.28319,1,1
1,GO MRNA MODIFICATION,0.00064645,0.22086,0.23028,1,1
1,GO LOCALIZATION WITHIN MEMBRANE,0.0040644,0.22028,0.24013,1,1
1,GO VIRAL LATENCY,0.0028457,0.21991,0.20084,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.052482,0.21964,0.20115,1,1
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0013481,0.21951,0.25656,1,1
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0016767,0.21946,0.26805,1,1
1,GO TELOMERE ORGANIZATION,4.2763e-05,0.21925,0.25832,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,5.9985e-05,0.21925,0.2506,1,1
1,GO PROTEIN ACETYLATION,6.8565e-05,0.21899,0.28291,1,1
1,GO C4 DICARBOXYLATE TRANSPORT,0.00091199,0.21894,0.24672,1,1
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,8.9327e-05,0.21885,0.27634,1,1
1,GO REGULATION OF SYNAPTIC PLASTICITY,0.0031545,0.21876,0.24808,1,1
1,GO EAR MORPHOGENESIS,0.0049572,0.21874,0.24017,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.019548,0.21837,0.26332,1,1
1,GO NEPHRON MORPHOGENESIS,0.007293,0.21803,0.24112,1,1
1,GO BASE EXCISION REPAIR,0.00018128,0.21774,0.24414,1,1
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0014241,0.2176,0.231,1,1
1,GO PEPTIDYL LYSINE ACETYLATION,8.3641e-05,0.21757,0.28893,1,1
1,GO ORGANIC CATION TRANSPORT,0.011063,0.21747,0.22121,1,1
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.041938,0.21744,0.20787,1,1
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00011593,0.2171,0.28466,1,1
1,GO REGULATION OF NUCLEAR DIVISION,3.4805e-05,0.21708,0.2571,1,1
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00332,0.21669,0.24444,1,1
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.028348,0.21664,0.25476,1,1
1,GO CELL PROJECTION ORGANIZATION,0.00064645,0.21661,0.24337,1,1
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0020776,0.21658,0.24375,1,1
1,GO TRNA METHYLATION,0.00035748,0.21649,0.2161,1,1
1,GO NEURON DIFFERENTIATION,0.00042807,0.21644,0.26447,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0054671,0.2164,0.26228,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0028457,0.21621,0.29157,1,1
1,GO KIDNEY MORPHOGENESIS,0.0063209,0.21615,0.25919,1,1
1,GO AXIS SPECIFICATION,0.00031664,0.21594,0.23786,1,1
1,GO GENITALIA DEVELOPMENT,0.0092139,0.21584,0.23132,1,1
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00024771,0.21583,0.24151,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0052065,0.21523,0.21535,1,1
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00017019,0.21516,0.27567,1,1
1,GO EPITHELIAL CELL FATE COMMITMENT,0.028348,0.21505,0.2282,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,6.8565e-05,0.21492,0.27789,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.006955,0.21482,0.21396,1,1
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.00086166,0.2144,0.27419,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0017696,0.21435,0.24862,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00011593,0.21407,0.25091,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00024771,0.21394,0.2492,1,1
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00042807,0.21386,0.25742,1,1
1,GO RESPONSE TO FOOD,0.0020776,0.21381,0.23463,1,1
1,GO GAMETE GENERATION,0.00015974,0.21377,0.23231,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.038848,0.21376,0.20635,1,1
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0076456,0.21345,0.23555,1,1
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2428e-05,0.21341,0.2515,1,1
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00023283,0.21334,0.24474,1,1
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0040644,0.21301,0.23685,1,1
1,GO DNA CATABOLIC PROCESS,0.00040321,0.21296,0.21569,1,1
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00018128,0.21279,0.2444,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0036751,0.21256,0.25159,1,1
1,GO DNA METABOLIC PROCESS,3.4805e-05,0.21238,0.24722,1,1
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0025648,0.21224,0.23401,1,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00057531,0.21207,0.23717,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0040644,0.21204,0.24212,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0003797,0.21181,0.27214,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,4.5779e-05,0.21167,0.20136,1,1
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.035953,0.21161,0.15557,1,1
1,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.012106,0.21155,0.18188,1,1
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.008797,0.2115,0.18429,1,1
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0023095,0.21136,0.33252,1,1
1,GO PROTEIN AUTOUBIQUITINATION,3.0304e-05,0.21125,0.27249,1,1
1,GO MOTOR NEURON AXON GUIDANCE,0.008797,0.21121,0.26844,1,1
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0012758,0.21118,0.26728,1,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00091199,0.21103,0.22416,1,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,6.8565e-05,0.2109,0.28858,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,7.8298e-05,0.21086,0.28057,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0016767,0.21078,0.25139,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.0011418,0.21075,0.26731,1,1
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.038848,0.21055,0.22965,1,1
1,GO MANNOSYLATION,0.00068502,0.21037,0.22428,1,1
1,GO CALCIUM ION REGULATED EXOCYTOSIS,0.014457,0.21028,0.28394,1,1
1,GO RESPONSE TO UV,0.00024771,0.21025,0.23271,1,1
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0011418,0.2098,0.25022,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,3.0304e-05,0.20955,0.28627,1,1
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.010572,0.20941,0.23472,1,1
1,GO OOCYTE DIFFERENTIATION,0.015104,0.2094,0.16752,1,1
1,GO ADULT LOCOMOTORY BEHAVIOR,0.01266,0.20933,0.20615,1,1
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00064645,0.20924,0.25215,1,1
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0027019,0.20921,0.21779,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.00014989,0.20868,0.27365,1,1
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00091199,0.20856,0.24369,1,1
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2428e-05,0.20845,0.24882,1,1
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.00033648,0.20842,0.24601,1,1
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0010798,0.20798,0.23182,1,1
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.048745,0.20789,0.20889,1,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0013481,0.20785,0.26308,1,1
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00091199,0.20778,0.28668,1,1
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00051151,0.2077,0.26336,1,1
1,GO REGULATION OF TELOMERE CAPPING,0.0057394,0.20764,0.24459,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.00029789,0.2076,0.25106,1,1
1,GO RESPONSE TO INACTIVITY,0.026142,0.20757,0.22994,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE,0.00011593,0.20731,0.23677,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00012367,0.20721,0.22512,1,1
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00014989,0.20699,0.24152,1,1
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.00332,0.20634,0.24479,1,1
1,GO COGNITION,0.00054254,0.20628,0.23212,1,1
1,GO HEAD DEVELOPMENT,0.0003797,0.20624,0.25707,1,1
1,GO UV PROTECTION,0.0083971,0.20608,0.24328,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00072571,0.20578,0.25351,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.2428e-05,0.20549,0.24681,1,1
1,GO CIRCADIAN RHYTHM,0.00020554,0.20509,0.25336,1,1
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0027019,0.20499,0.21955,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.019548,0.20478,0.21211,1,1
1,GO TRNA MODIFICATION,0.0014241,0.20442,0.17628,1,1
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00035748,0.20414,0.22428,1,1
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00332,0.20403,0.20384,1,1
1,GO SPERMATID DIFFERENTIATION,0.00064645,0.20392,0.20721,1,1
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0015882,0.2037,0.26552,1,1
1,GO RNA PROCESSING,0.00011593,0.2037,0.21349,1,1
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0020776,0.20369,0.24772,1,1
1,GO REGULATION OF LYASE ACTIVITY,0.0027019,0.20353,0.22192,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.6059e-05,0.20344,0.22633,1,1
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0029965,0.20309,0.25194,1,1
1,GO REGULATION OF DOPAMINE SECRETION,0.024086,0.20289,0.25803,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,6.4139e-05,0.20263,0.22408,1,1
1,GO HISTONE H2A ACETYLATION,0.00028019,0.20256,0.25123,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00017019,0.20242,0.24315,1,1
1,GO POSITIVE REGULATION OF FERTILIZATION,0.008797,0.20182,0.17609,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.018736,0.20179,0.22102,1,1
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00068502,0.2017,0.26733,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,3.9936e-05,0.20165,0.24591,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.013235,0.20159,0.18699,1,1
1,GO NEUROGENESIS,0.00054254,0.20138,0.24633,1,1
1,GO FOREBRAIN DEVELOPMENT,0.00018128,0.20122,0.2729,1,1
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.00040321,0.20108,0.23659,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00048214,0.20081,0.24713,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.050584,0.20067,0.18558,1,1
1,GO FAT CELL PROLIFERATION,0.0057394,0.20034,0.30639,1,1
1,GO ENERGY HOMEOSTASIS,0.013834,0.19995,0.21478,1,1
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.033245,0.19985,0.21446,1,1
1,GO MALE MEIOSIS I,0.0060238,0.19965,0.26393,1,1
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.010101,0.19955,0.21366,1,1
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0054671,0.19952,0.2192,1,1
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.024086,0.19913,0.20816,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0013481,0.19909,0.26219,1,1
1,GO GERM CELL DEVELOPMENT,0.00024771,0.19904,0.24068,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,7.3279e-05,0.19847,0.23996,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,4.8997e-05,0.19813,0.22742,1,1
1,GO NUCLEAR EXPORT,2.1347e-05,0.1981,0.2613,1,1
1,GO REGULATION OF CELL CYCLE,6.4139e-05,0.19804,0.24456,1,1
1,GO TOR SIGNALING,0.00026348,0.198,0.24559,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,2.8267e-05,0.19773,0.22827,1,1
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.048745,0.19771,0.24485,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.052482,0.19757,0.2624,1,1
1,GO ORGANELLE LOCALIZATION,0.00045436,0.19735,0.22201,1,1
1,GO REGULATION OF AXON GUIDANCE,0.020391,0.19735,0.24725,1,1
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.018736,0.19733,0.21826,1,1
1,GO FEMALE GENITALIA DEVELOPMENT,0.034576,0.19724,0.19019,1,1
1,GO TELENCEPHALON DEVELOPMENT,0.00072571,0.19718,0.25369,1,1
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0040644,0.19705,0.22153,1,1
1,GO CELL CYCLE PROCESS,3.7287e-05,0.19702,0.26369,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.00028019,0.197,0.17356,1,1
1,GO MEMORY,0.0016767,0.19698,0.24561,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,8.3641e-05,0.19695,0.21349,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00026348,0.19693,0.21398,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00096503,0.1969,0.23108,1,1
1,GO SENSORY ORGAN MORPHOGENESIS,0.00332,0.19676,0.22059,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.037377,0.1967,0.21771,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0019699,0.19665,0.2758,1,1
1,GO GENE SILENCING,0.00028019,0.19655,0.24238,1,1
1,GO MULTICELLULAR ORGANISM GROWTH,0.00029789,0.19637,0.26848,1,1
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.010572,0.1963,0.22068,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0011418,0.19607,0.22242,1,1
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00018128,0.19591,0.2572,1,1
1,GO SEXUAL REPRODUCTION,0.00020554,0.19548,0.21665,1,1
1,GO REGULATION OF NEURON MATURATION,0.0063209,0.19522,0.26374,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,4.5779e-05,0.19518,0.24183,1,1
1,GO CELLULAR RESPONSE TO PH,0.023112,0.19515,0.20158,1,1
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.00029789,0.19511,0.23845,1,1
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.0015882,0.19508,0.2929,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,3.248e-05,0.19508,0.26019,1,1
1,GO DETECTION OF LIGHT STIMULUS,0.00020554,0.19508,0.18314,1,1
1,GO MALE GAMETE GENERATION,0.00020554,0.19502,0.22397,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0010798,0.19495,0.19465,1,1
1,GO CELL CYCLE,5.6086e-05,0.19487,0.24694,1,1
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.010572,0.19478,0.23127,1,1
1,GO TRANSMISSION OF NERVE IMPULSE,0.010572,0.19476,0.22175,1,1
1,GO MECHANORECEPTOR DIFFERENTIATION,0.0015882,0.19471,0.22113,1,1
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.00332,0.19463,0.24325,1,1
1,GO ORGANELLE ASSEMBLY,0.00040321,0.19462,0.22608,1,1
1,GO FATTY ACID BETA OXIDATION,0.0025648,0.19458,0.17855,1,1
1,GO PROTEIN SUMOYLATION,8.3641e-05,0.1943,0.26109,1,1
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.00019306,0.19422,0.25104,1,1
1,GO TELOMERE CAPPING,0.0021907,0.19422,0.23889,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.033245,0.19416,0.24801,1,1
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0015882,0.19416,0.22837,1,1
1,GO REGULATION OF CELL CYCLE ARREST,6.8565e-05,0.19388,0.25882,1,1
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0014241,0.1938,0.2553,1,1
1,GO REGULATION OF MEMBRANE POTENTIAL,0.0016767,0.19374,0.21595,1,1
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00048214,0.19368,0.25011,1,1
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.0047188,0.19344,0.20486,1,1
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.00026348,0.19311,0.23075,1,1
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0096484,0.19289,0.23826,1,1
1,GO NEURAL TUBE FORMATION,0.0042727,0.19242,0.23473,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,7.8298e-05,0.19242,0.22708,1,1
1,GO REGULATION OF CELL SIZE,0.0016767,0.1924,0.2572,1,1
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.014457,0.19228,0.21543,1,1
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.00081392,0.19226,0.24606,1,1
1,GO REGULATION OF RNA BINDING,0.0015041,0.19196,0.20422,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,7.8298e-05,0.19188,0.2267,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00012367,0.19172,0.22575,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.00010866,0.19084,0.21692,1,1
1,GO MITOTIC CELL CYCLE,5.6086e-05,0.19072,0.24882,1,1
1,GO DOPAMINE TRANSPORT,0.015776,0.19056,0.27385,1,1
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0011418,0.19054,0.21355,1,1
1,GO POST EMBRYONIC DEVELOPMENT,0.0010798,0.19045,0.26141,1,1
1,GO HISTONE H3 ACETYLATION,0.0011418,0.19044,0.23977,1,1
1,GO NUCLEAR TRANSPORT,3.0304e-05,0.19024,0.23546,1,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.0052065,0.19023,0.1958,1,1
1,GO PIGMENT GRANULE LOCALIZATION,0.046961,0.19021,0.14931,1,1
1,GO CAMERA TYPE EYE DEVELOPMENT,0.00091199,0.1902,0.24664,1,1
1,GO DIENCEPHALON DEVELOPMENT,0.0021907,0.19008,0.26603,1,1
1,GO POSITIVE REGULATION OF CELL MATURATION,0.011574,0.18991,0.22861,1,1
1,GO PEPTIDE HORMONE SECRETION,0.0012071,0.18989,0.2282,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00014062,0.18986,0.2415,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0083971,0.18936,0.22433,1,1
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.037377,0.18934,0.15735,1,1
1,GO HISTONE H3 K14 ACETYLATION,0.0021907,0.18916,0.26909,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0047188,0.18915,0.22,1,1
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0021907,0.1891,0.25203,1,1
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0044907,0.18897,0.23677,1,1
1,GO MAINTENANCE OF CELL NUMBER,0.0003797,0.18875,0.24367,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00096503,0.18857,0.19529,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0049572,0.18838,0.22913,1,1
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0012071,0.18831,0.23766,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00040321,0.18819,0.21782,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00064645,0.18818,0.1871,1,1
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0023095,0.18787,0.23336,1,1
1,GO REGULATION OF GLUCOSE IMPORT,0.0029965,0.18778,0.20894,1,1
1,GO RNA LOCALIZATION,6.4139e-05,0.18769,0.22268,1,1
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0038653,0.18767,0.22586,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.035953,0.1873,0.22253,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00017019,0.18719,0.2505,1,1
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.006955,0.18681,0.23239,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.013834,0.18677,0.2118,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00020554,0.18674,0.24388,1,1
1,GO TRNA TRANSPORT,0.00014989,0.18672,0.25079,1,1
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00021879,0.1867,0.23038,1,1
1,GO BILE ACID METABOLIC PROCESS,0.0060238,0.18641,0.18624,1,1
1,GO APPENDAGE MORPHOGENESIS,0.0011418,0.18636,0.28451,1,1
1,GO MESENCHYMAL CELL PROLIFERATION,0.052482,0.1862,0.21299,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.008797,0.18611,0.27627,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.0049572,0.18605,0.23672,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0015041,0.18592,0.20134,1,1
1,GO INCLUSION BODY ASSEMBLY,0.00091199,0.18558,0.28138,1,1
1,GO LYSOSOMAL TRANSPORT,0.0012071,0.18542,0.24769,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,0.0052065,0.1853,0.25517,1,1
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.00091199,0.18523,0.20442,1,1
1,GO REGULATION OF MITOPHAGY,0.008797,0.1851,0.23297,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.00019306,0.18499,0.23241,1,1
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0028457,0.18497,0.22985,1,1
1,GO PROTEIN DEPOLYMERIZATION,0.0014241,0.18452,0.25096,1,1
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0083971,0.18451,0.20666,1,1
1,GO RESPONSE TO AMINO ACID STARVATION,0.00042807,0.18445,0.22968,1,1
1,GO CHROMATIN DISASSEMBLY,0.041938,0.18409,0.19059,1,1
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00076864,0.18405,0.20026,1,1
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00060992,0.1836,0.20163,1,1
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.022172,0.18359,0.18628,1,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0012758,0.18346,0.27429,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00040321,0.18344,0.23618,1,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.016475,0.18326,0.18071,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0066311,0.18322,0.23738,1,1
1,GO NCRNA CATABOLIC PROCESS,0.0024341,0.18313,0.19992,1,1
1,GO LATERAL MESODERM DEVELOPMENT,0.014457,0.183,0.23974,1,1
1,GO POLYOL CATABOLIC PROCESS,0.0016767,0.18274,0.23329,1,1
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.011574,0.18273,0.20429,1,1
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.050584,0.18272,0.19578,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00064645,0.18263,0.20761,1,1
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0016767,0.18224,0.21088,1,1
1,GO HISTONE H3 K9 ACETYLATION,0.0063209,0.18219,0.19063,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0034935,0.18215,0.2032,1,1
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.015104,0.18215,0.17234,1,1
1,GO REGULATION OF CELL DIVISION,0.00021879,0.182,0.23173,1,1
1,GO MITOCHONDRIAL RNA PROCESSING,0.015776,0.18198,0.18228,1,1
1,GO IMPORT INTO NUCLEUS,0.00018128,0.18191,0.20975,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0023095,0.18186,0.24473,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0013481,0.18184,0.21032,1,1
1,GO MITOTIC CYTOKINESIS,0.00014989,0.18182,0.24303,1,1
1,GO CARNITINE METABOLIC PROCESS,0.019548,0.18169,0.17849,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0092139,0.18168,0.18688,1,1
1,GO CELLULAR RESPONSE TO UV,0.00072571,0.1814,0.2121,1,1
1,GO CELL CYCLE PHASE TRANSITION,4.5779e-05,0.18124,0.24085,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.0029965,0.18119,0.2524,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.00068502,0.18092,0.20965,1,1
1,GO ALDITOL METABOLIC PROCESS,0.034576,0.18091,0.16367,1,1
1,GO CELL JUNCTION ORGANIZATION,0.0031545,0.1809,0.23118,1,1
1,GO DENDRITIC SPINE MAINTENANCE,0.017954,0.18083,0.23333,1,1
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0010209,0.1807,0.22277,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00060992,0.18051,0.26649,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0096484,0.18048,0.23314,1,1
1,GO CAMP METABOLIC PROCESS,0.052482,0.18034,0.23361,1,1
1,GO STRIATUM DEVELOPMENT,0.034576,0.18032,0.20742,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.013834,0.18029,0.20201,1,1
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.008797,0.18024,0.19095,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,0.010572,0.18022,0.17191,1,1
1,GO SENSORY SYSTEM DEVELOPMENT,0.0031545,0.18007,0.22981,1,1
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0015882,0.17992,0.21215,1,1
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.014457,0.17972,0.19055,1,1
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.012106,0.17968,0.16224,1,1
1,GO CELL JUNCTION ASSEMBLY,0.0092139,0.17938,0.21533,1,1
1,GO CELL PROJECTION ASSEMBLY,0.00332,0.17934,0.21282,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.010101,0.17911,0.22735,1,1
1,GO REGULATION OF HORMONE SECRETION,0.0047188,0.17854,0.19785,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,4.8997e-05,0.17847,0.21706,1,1
1,GO RNA SURVEILLANCE,5.2428e-05,0.17845,0.20843,1,1
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.015776,0.17839,0.23612,1,1
1,GO RESPONSE TO LIGHT STIMULUS,0.00017019,0.17835,0.21677,1,1
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0080134,0.17829,0.19352,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00026348,0.1781,0.20631,1,1
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.041938,0.1781,0.1847,1,1
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.006955,0.17794,0.228,1,1
1,GO NCRNA TRANSCRIPTION,0.00010866,0.17793,0.21791,1,1
1,GO LIMBIC SYSTEM DEVELOPMENT,0.00051151,0.17789,0.23643,1,1
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0015882,0.17768,0.23416,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0012071,0.17715,0.20665,1,1
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0044907,0.17711,0.23143,1,1
1,GO EMBRYONIC PATTERN SPECIFICATION,0.00021879,0.17706,0.24292,1,1
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.022172,0.1767,0.24966,1,1
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0038653,0.17644,0.18137,1,1
1,GO CELL MORPHOGENESIS,0.0025648,0.17637,0.23657,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0013481,0.17616,0.25375,1,1
1,GO CELL CYCLE ARREST,0.00014062,0.17605,0.23382,1,1
1,GO MRNA METABOLIC PROCESS,5.6086e-05,0.17585,0.20305,1,1
1,GO EAR DEVELOPMENT,0.0036751,0.17582,0.21973,1,1
1,GO PROTEIN HETEROOLIGOMERIZATION,0.020391,0.17571,0.1658,1,1
1,GO SENSORY ORGAN DEVELOPMENT,0.0012758,0.17548,0.2285,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0003797,0.1754,0.19502,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0049572,0.17539,0.25303,1,1
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00024771,0.17519,0.22718,1,1
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00072571,0.17518,0.21905,1,1
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0013481,0.17515,0.23579,1,1
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.01266,0.17514,0.16276,1,1
1,GO POSTREPLICATION REPAIR,0.00013188,0.1751,0.21161,1,1
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0066311,0.17507,0.19389,1,1
1,GO RHYTHMIC PROCESS,0.00024771,0.17501,0.24183,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.014457,0.17498,0.21649,1,1
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0013481,0.17495,0.23517,1,1
1,GO RESPONSE TO AMINE,0.040368,0.17469,0.16199,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0052065,0.17464,0.24833,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00015974,0.1746,0.22209,1,1
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0096484,0.174,0.12812,1,1
1,GO NUCLEUS ORGANIZATION,0.00023283,0.17398,0.22214,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0015041,0.17386,0.23002,1,1
1,GO LACTATE METABOLIC PROCESS,0.0013481,0.17385,0.19601,1,1
1,GO RESPONSE TO CAFFEINE,0.011574,0.17382,0.18024,1,1
1,GO SYNAPTIC VESICLE RECYCLING,0.0057394,0.17369,0.23195,1,1
1,GO RRNA TRANSCRIPTION,0.00033648,0.17369,0.21381,1,1
1,GO MITOPHAGY,0.0066311,0.17367,0.21748,1,1
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.00019306,0.17365,0.23143,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.030713,0.17364,0.188,1,1
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.00076864,0.17363,0.21185,1,1
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.027226,0.17344,0.19545,1,1
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.00023283,0.17325,0.22916,1,1
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0057394,0.17318,0.19516,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,5.2428e-05,0.17303,0.23742,1,1
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.00064645,0.17302,0.23303,1,1
1,GO EMBRYO DEVELOPMENT,0.0049572,0.17279,0.20205,1,1
1,GO ENAMEL MINERALIZATION,0.007293,0.17278,0.23836,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012106,0.17277,0.21719,1,1
1,GO PEPTIDYL SERINE MODIFICATION,0.00081392,0.17233,0.22445,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,0.0044907,0.17177,0.21302,1,1
1,GO NUCLEAR BODY ORGANIZATION,0.0066311,0.17159,0.18796,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0063209,0.17137,0.24127,1,1
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.011574,0.1713,0.14288,1,1
1,GO STEM CELL PROLIFERATION,0.0029965,0.1712,0.24083,1,1
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.015776,0.17117,0.15818,1,1
1,GO REGULATION OF CELL DEVELOPMENT,0.0015882,0.17094,0.2211,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.033245,0.17066,0.20706,1,1
1,GO SEX DIFFERENTIATION,0.00026348,0.1705,0.22774,1,1
1,GO SNRNA TRANSCRIPTION,0.00017019,0.1705,0.21256,1,1
1,GO FEMALE SEX DIFFERENTIATION,0.00096503,0.17045,0.24295,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0066311,0.17013,0.2033,1,1
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0010798,0.17013,0.19602,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0015041,0.1701,0.19528,1,1
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.025096,0.16995,0.19253,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,9.5377e-05,0.1698,0.22867,1,1
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0038653,0.16972,0.21903,1,1
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.033245,0.16972,0.19577,1,1
1,GO REGULATION OF DEPHOSPHORYLATION,0.0028457,0.16963,0.20136,1,1
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00033648,0.16962,0.21597,1,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.00060992,0.16947,0.25231,1,1
1,GO MYOBLAST PROLIFERATION,0.028348,0.16914,0.15089,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,5.6086e-05,0.16913,0.21526,1,1
1,GO REGULATION OF MRNA BINDING,0.0096484,0.16888,0.16762,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,0.0063209,0.16885,0.22654,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0016767,0.1688,0.2048,1,1
1,GO PRESYNAPTIC ENDOCYTOSIS,0.0038653,0.16876,0.23465,1,1
1,GO PORE COMPLEX ASSEMBLY,0.0066311,0.16847,0.17038,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0034935,0.16833,0.19869,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0012758,0.16804,0.19972,1,1
1,GO PROSTATE GLAND GROWTH,0.0172,0.16794,0.17932,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0066311,0.16788,0.17962,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00048214,0.16775,0.22342,1,1
1,GO GMP METABOLIC PROCESS,0.0028457,0.1677,0.19085,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00091199,0.16769,0.19663,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.013235,0.1675,0.23238,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.010572,0.16744,0.21821,1,1
1,GO REGULATION OF EXOCYTOSIS,0.0036751,0.16735,0.21146,1,1
1,GO TRNA PROCESSING,0.0015882,0.16725,0.1546,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,4.8997e-05,0.16709,0.20131,1,1
1,GO PHOTOPERIODISM,0.0047188,0.16704,0.1996,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00031664,0.16684,0.20571,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.020391,0.16683,0.2551,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00017019,0.16676,0.23355,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00023283,0.16673,0.1728,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.0018673,0.16645,0.23974,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0040644,0.16631,0.22557,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0020776,0.16603,0.18622,1,1
1,GO LIPID DROPLET ORGANIZATION,0.0047188,0.16598,0.17227,1,1
1,GO PYRUVATE METABOLIC PROCESS,0.0019699,0.1657,0.19018,1,1
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0013481,0.16552,0.23184,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00060992,0.16548,0.1801,1,1
1,GO NERVOUS SYSTEM PROCESS,0.0028457,0.16537,0.1803,1,1
1,GO DEMETHYLATION,0.00068502,0.16516,0.23996,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00017019,0.16511,0.21791,1,1
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00040321,0.16509,0.20074,1,1
1,GO PURINE NUCLEOTIDE TRANSPORT,0.021265,0.16485,0.16257,1,1
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00081392,0.16479,0.24531,1,1
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.00081392,0.16467,0.21611,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00010181,0.16461,0.211,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00010866,0.16456,0.17823,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0010798,0.16429,0.20526,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0076456,0.16389,0.17053,1,1
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.0063209,0.16387,0.21512,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,5.2428e-05,0.16367,0.17697,1,1
1,GO POTASSIUM ION TRANSPORT,0.0076456,0.16348,0.19999,1,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.025096,0.1634,0.20468,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.013834,0.16318,0.2497,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.02951,0.16314,0.21234,1,1
1,GO BLASTOCYST GROWTH,0.0080134,0.16301,0.19764,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.00042807,0.16299,0.2063,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.022172,0.16291,0.16328,1,1
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0040644,0.16263,0.1816,1,1
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.0054671,0.16256,0.19045,1,1
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.013235,0.16248,0.20425,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,7.3279e-05,0.16235,0.2387,1,1
1,GO REGULATION OF CELL MORPHOGENESIS,0.0020776,0.16197,0.22948,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.015776,0.16185,0.17442,1,1
1,GO PHOTOTRANSDUCTION,0.00096503,0.16174,0.13819,1,1
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.019548,0.16172,0.17425,1,1
1,GO CYTOSOLIC TRANSPORT,0.0029965,0.16104,0.20463,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0014241,0.16088,0.20637,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00054254,0.16088,0.20709,1,1
1,GO EYE MORPHOGENESIS,0.0092139,0.16072,0.20948,1,1
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.018736,0.16062,0.17669,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.0020776,0.16058,0.24091,1,1
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0057394,0.16054,0.17811,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0010798,0.16048,0.17996,1,1
1,GO VACUOLAR TRANSPORT,0.0028457,0.16046,0.20494,1,1
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.027226,0.16046,0.13985,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0010209,0.16042,0.20413,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.014457,0.16035,0.16959,1,1
1,GO ADAPTATION OF SIGNALING PATHWAY,0.048745,0.16023,0.17554,1,1
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.006955,0.16009,0.17882,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.014457,0.16006,0.19615,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.010101,0.16003,0.19424,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0020776,0.15978,0.18434,1,1
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0038653,0.15976,0.13521,1,1
1,GO HORMONE TRANSPORT,0.0054671,0.1594,0.18829,1,1
1,GO L AMINO ACID TRANSPORT,0.035953,0.1593,0.16762,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.046961,0.15922,0.1529,1,1
1,GO APPENDAGE DEVELOPMENT,0.0013481,0.15903,0.25988,1,1
1,GO CYTOSKELETON ORGANIZATION,0.0025648,0.15895,0.20637,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,0.016475,0.15894,0.19835,1,1
1,GO GENETIC IMPRINTING,0.0080134,0.15889,0.2349,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.0017696,0.15842,0.24122,1,1
1,GO TRNA METABOLIC PROCESS,0.0020776,0.15829,0.1526,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.030713,0.15808,0.13893,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.006955,0.15807,0.28186,1,1
1,GO RENAL TUBULE DEVELOPMENT,0.028348,0.15789,0.1985,1,1
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0042727,0.15781,0.16397,1,1
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0031545,0.15773,0.2047,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0042727,0.15761,0.19301,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0025648,0.1575,0.1963,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00091199,0.15746,0.17462,1,1
1,GO AROMATIC AMINO ACID TRANSPORT,0.026142,0.1574,0.25158,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00072571,0.1574,0.18641,1,1
1,GO FERTILIZATION,0.0014241,0.15735,0.17464,1,1
1,GO TRANSLESION SYNTHESIS,0.00020554,0.15721,0.19809,1,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.007293,0.15691,0.24984,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.019548,0.15686,0.22163,1,1
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0063209,0.15685,0.19796,1,1
1,GO OVULATION CYCLE PROCESS,0.016475,0.15675,0.20423,1,1
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.038848,0.15658,0.1705,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.00072571,0.15657,0.23193,1,1
1,GO DNA METHYLATION OR DEMETHYLATION,0.00081392,0.15652,0.20505,1,1
1,GO SKIN EPIDERMIS DEVELOPMENT,0.010572,0.15645,0.21936,1,1
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0047188,0.15636,0.22832,1,1
1,GO REGULATION OF CELL AGING,0.0054671,0.15598,0.19678,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0057394,0.15596,0.17985,1,1
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.00060992,0.15585,0.21171,1,1
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.031957,0.15577,0.20604,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0044907,0.15571,0.17267,1,1
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0060238,0.15554,0.16533,1,1
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0044907,0.15537,0.152,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00332,0.15535,0.18457,1,1
1,GO SELECTIVE AUTOPHAGY,0.0096484,0.1551,0.18886,1,1
1,GO SECRETORY GRANULE ORGANIZATION,0.038848,0.15507,0.18411,1,1
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.008797,0.15491,0.1902,1,1
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.046961,0.1547,0.21784,1,1
1,GO RNA MODIFICATION,0.00076864,0.15462,0.16085,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.007293,0.1545,0.18353,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0044907,0.15445,0.2265,1,1
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011574,0.15441,0.24005,1,1
1,GO POSITIVE REGULATION OF ACROSOME REACTION,0.030713,0.1544,0.14521,1,1
1,GO SNRNA PROCESSING,0.0028457,0.1543,0.1416,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0010798,0.15402,0.21289,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.018736,0.154,0.23464,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.016475,0.154,0.17067,1,1
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0063209,0.15392,0.21508,1,1
1,GO REPRODUCTION,0.0016767,0.15376,0.18962,1,1
1,GO REGULATION OF PROTEIN ACETYLATION,0.0023095,0.1537,0.19127,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0083971,0.15351,0.17273,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0010209,0.15336,0.16506,1,1
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0172,0.15315,0.21764,1,1
1,GO REGULATION OF INSULIN SECRETION,0.0016767,0.15315,0.21845,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011418,0.1529,0.2239,1,1
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.025096,0.1528,0.15659,1,1
1,GO MIRNA METABOLIC PROCESS,0.0080134,0.15272,0.19527,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.019548,0.15244,0.19832,1,1
1,GO ERYTHROCYTE MATURATION,0.050584,0.15236,0.16656,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.010101,0.1523,0.20602,1,1
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0011418,0.15218,0.2022,1,1
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.008797,0.15202,0.19023,1,1
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.0054671,0.15195,0.25102,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00068502,0.15186,0.165,1,1
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0172,0.15171,0.20475,1,1
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.011063,0.15164,0.19733,1,1
1,GO DNA MODIFICATION,0.0011418,0.15156,0.18349,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0060238,0.15149,0.19319,1,1
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.013834,0.15139,0.17812,1,1
1,GO PROTEIN IMPORT,0.0010209,0.15093,0.17533,1,1
1,GO ENDOCYTIC RECYCLING,0.013235,0.15091,0.20866,1,1
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.00031664,0.15057,0.21627,1,1
1,GO RHYTHMIC BEHAVIOR,0.015776,0.15056,0.16861,1,1
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.02951,0.15052,0.30037,1,1
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0017696,0.15036,0.19455,1,1
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0013481,0.15014,0.19953,1,1
1,GO LIPID PHOSPHORYLATION,0.0083971,0.14986,0.2086,1,1
1,GO ACETYL COA METABOLIC PROCESS,0.0036751,0.14985,0.16606,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019306,0.14968,0.21817,1,1
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0066311,0.14949,0.17281,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.012106,0.14933,0.19038,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00332,0.1492,0.17236,1,1
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.00086166,0.1491,0.17623,1,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.013834,0.14863,0.24838,1,1
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0083971,0.14783,0.17601,1,1
1,GO THYMUS DEVELOPMENT,0.011063,0.14774,0.18565,1,1
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.010101,0.14757,0.18968,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.021265,0.14749,0.11878,1,1
1,GO MULTI ORGANISM PROCESS,0.0010798,0.14654,0.18148,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00081392,0.14615,0.17625,1,1
1,GO INSULIN SECRETION,0.0025648,0.1461,0.21468,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00045436,0.14592,0.1546,1,1
1,GO DEVELOPMENTAL GROWTH,0.0016767,0.14588,0.2266,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0038653,0.14579,0.18306,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.00076864,0.14575,0.24234,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0052065,0.14552,0.14625,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,3.248e-05,0.14505,0.17773,1,1
1,GO MATURATION OF 5 8S RRNA,0.012106,0.14498,0.14657,1,1
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0096484,0.14491,0.17658,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00020554,0.14481,0.20045,1,1
1,GO RESPONSE TO ACTIVITY,0.011574,0.14466,0.15841,1,1
1,GO RNA DECAPPING,0.021265,0.1445,0.18522,1,1
1,GO OVULATION CYCLE,0.019548,0.14449,0.20682,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0024341,0.14448,0.16663,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.021265,0.14442,0.14918,1,1
1,GO RESPONSE TO RADIATION,0.00068502,0.14441,0.18691,1,1
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0020776,0.1441,0.23643,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0057394,0.14403,0.17477,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00332,0.14385,0.16948,1,1
1,GO RESPONSE TO STARVATION,0.0020776,0.14377,0.18617,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00076864,0.14372,0.20204,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.013834,0.14366,0.21806,1,1
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030713,0.14365,0.21516,1,1
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0172,0.14355,0.1645,1,1
1,GO INTRACELLULAR TRANSPORT,0.00035748,0.14336,0.16653,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.021265,0.14328,0.12552,1,1
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0029965,0.14325,0.25325,1,1
1,GO GOLGI ORGANIZATION,0.0034935,0.14324,0.19978,1,1
1,GO MOLTING CYCLE,0.020391,0.14315,0.19557,1,1
1,GO SENSORY PERCEPTION OF SMELL,0.0016767,0.14291,0.14342,1,1
1,GO RRNA METHYLATION,0.02951,0.14282,0.11598,1,1
1,GO SPECIFICATION OF SYMMETRY,0.0047188,0.14257,0.20062,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0063209,0.14235,0.18447,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.00072571,0.14233,0.19195,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.041938,0.14207,0.16116,1,1
1,GO SNRNA METABOLIC PROCESS,0.00054254,0.14205,0.17,1,1
1,GO REGULATION OF HISTONE DEACETYLATION,0.050584,0.14201,0.20137,1,1
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0013481,0.14195,0.21326,1,1
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0063209,0.14188,0.19252,1,1
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.038848,0.14126,0.15424,1,1
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.007293,0.14109,0.17701,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057394,0.14109,0.21789,1,1
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.0014241,0.14106,0.19267,1,1
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0076456,0.14098,0.22164,1,1
1,GO DNA BIOSYNTHETIC PROCESS,0.00045436,0.14092,0.17259,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.011063,0.14084,0.17337,1,1
1,GO LIPID MODIFICATION,0.02951,0.14076,0.14947,1,1
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046961,0.14064,0.18808,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.012106,0.14059,0.15552,1,1
1,GO DEPHOSPHORYLATION,0.0038653,0.14048,0.16948,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.040368,0.14009,0.20239,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0049572,0.14001,0.20442,1,1
1,GO NUCLEOTIDE TRANSPORT,0.02951,0.13994,0.15272,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00332,0.13989,0.12481,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.012106,0.13988,0.18957,1,1
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0010798,0.13987,0.18776,1,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0044907,0.13974,0.19794,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.023112,0.13965,0.18617,1,1
1,GO NCRNA PROCESSING,0.0012071,0.1396,0.14197,1,1
1,GO PROTEIN REFOLDING,0.030713,0.13956,0.17807,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,0.0021907,0.13944,0.21989,1,1
1,GO TOXIN TRANSPORT,0.015776,0.13934,0.1729,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.006955,0.13915,0.15506,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.043559,0.13898,0.15682,1,1
1,GO REGULATION OF PROTEIN DEACETYLATION,0.007293,0.13893,0.23362,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.011574,0.13879,0.16111,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0057394,0.13878,0.16616,1,1
1,GO REGULATION OF HORMONE LEVELS,0.0172,0.13857,0.15115,1,1
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.010572,0.13852,0.18311,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00060992,0.13845,0.19721,1,1
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.023112,0.13834,0.16907,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.011063,0.1382,0.15153,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.015104,0.13806,0.17698,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.021265,0.13754,0.21795,1,1
1,GO MYELIN ASSEMBLY,0.01266,0.1374,0.2514,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.023112,0.13719,0.17263,1,1
1,GO VESICLE CARGO LOADING,0.024086,0.13715,0.18609,1,1
1,GO CELLULAR RESPONSE TO STARVATION,0.0018673,0.13709,0.1951,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0034935,0.13699,0.18389,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0029965,0.13696,0.16463,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.052482,0.13672,0.17109,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.0010209,0.13656,0.19538,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.038848,0.13623,0.16831,1,1
1,GO CELL CELL SIGNALING,0.0054671,0.13619,0.17241,1,1
1,GO MATURATION OF SSU RRNA,0.0036751,0.13605,0.15163,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00068502,0.13592,0.17677,1,1
1,GO REGULATION OF CELLULAR LOCALIZATION,0.012106,0.13573,0.1552,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.046961,0.13557,0.15468,1,1
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.043559,0.13555,0.15401,1,1
1,GO SIGNAL RELEASE,0.014457,0.13553,0.15722,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0060238,0.13542,0.15898,1,1
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0063209,0.13537,0.20642,1,1
1,GO ENDOSOMAL TRANSPORT,0.0028457,0.13533,0.18596,1,1
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015104,0.13527,0.17744,1,1
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.013235,0.13504,0.16652,1,1
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.034576,0.13491,0.19453,1,1
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.02951,0.13477,0.16389,1,1
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.0172,0.13444,0.16869,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.030713,0.13441,0.13966,1,1
1,GO SINGLE FERTILIZATION,0.0011418,0.13426,0.17249,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.0092139,0.13403,0.12922,1,1
1,GO REGULATION OF CELL MATURATION,0.0024341,0.13396,0.17441,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0003797,0.13379,0.17675,1,1
1,GO VESICLE LOCALIZATION,0.0031545,0.13379,0.18006,1,1
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.024086,0.13372,0.2358,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.020391,0.13365,0.1827,1,1
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0016767,0.13332,0.18012,1,1
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.016475,0.13319,0.17045,1,1
1,GO SNORNA 3 END PROCESSING,0.010572,0.1331,0.16868,1,1
1,GO CELLULAR SENESCENCE,0.017954,0.13272,0.15556,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00091199,0.13253,0.176,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.027226,0.13253,0.21741,1,1
1,GO NCRNA METABOLIC PROCESS,0.0012071,0.13204,0.14143,1,1
1,GO PERICARDIUM DEVELOPMENT,0.028348,0.13203,0.25495,1,1
1,GO MONOVALENT INORGANIC CATION TRANSPORT,0.026142,0.13195,0.15388,1,1
1,GO NEURON APOPTOTIC PROCESS,0.01266,0.13194,0.15941,1,1
1,GO TRANSPOSITION,0.037377,0.13166,0.16162,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00035748,0.13143,0.15628,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0012758,0.13128,0.16734,1,1
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.0080134,0.13099,0.16654,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00054254,0.13094,0.17313,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.008797,0.13065,0.15568,1,1
1,GO COENZYME A METABOLIC PROCESS,0.040368,0.13045,0.16264,1,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0076456,0.13041,0.17783,1,1
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.038848,0.12998,0.16202,1,1
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.038848,0.12997,0.18558,1,1
1,GO EXECUTION PHASE OF APOPTOSIS,0.0172,0.12987,0.14394,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0066311,0.12969,0.19083,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0057394,0.12967,0.19513,1,1
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.023112,0.12934,0.17443,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.006955,0.1293,0.16424,1,1
1,GO MULTI ORGANISM LOCALIZATION,0.00064645,0.12926,0.17849,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.015776,0.12908,0.20153,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0025648,0.12902,0.16892,1,1
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.052482,0.12887,0.19989,1,1
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.020391,0.12885,0.14222,1,1
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0044907,0.12878,0.18519,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.0018673,0.12877,0.17533,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0015882,0.12873,0.1888,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0063209,0.1287,0.17085,1,1
1,GO POLYOL METABOLIC PROCESS,0.0063209,0.12856,0.17353,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0054671,0.12846,0.20425,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.013235,0.12834,0.18177,1,1
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0036751,0.12825,0.15331,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00012367,0.12816,0.15717,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.030713,0.1277,0.14478,1,1
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.017954,0.12769,0.1726,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0011418,0.12765,0.15776,1,1
1,GO DETECTION OF ABIOTIC STIMULUS,0.0020776,0.12763,0.18241,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0040644,0.12715,0.15955,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0038653,0.12715,0.11774,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.022172,0.12704,0.15745,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0003797,0.1267,0.15718,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.034576,0.12653,0.15125,1,1
1,GO MAGNESIUM ION TRANSPORT,0.007293,0.12651,0.19568,1,1
1,GO LIPOPROTEIN METABOLIC PROCESS,0.0040644,0.12633,0.17213,1,1
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0047188,0.12605,0.18737,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.024086,0.12571,0.21284,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.0016767,0.1252,0.17111,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.031957,0.12513,0.15613,1,1
1,GO RESPONSE TO IONIZING RADIATION,0.02951,0.12513,0.14748,1,1
1,GO REGULATION OF SYSTEM PROCESS,0.014457,0.12489,0.17289,1,1
1,GO NUCLEOTIDE PHOSPHORYLATION,0.0066311,0.12488,0.17623,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0047188,0.12466,0.11789,1,1
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0076456,0.12449,0.17405,1,1
1,GO CELL AGING,0.023112,0.12445,0.14875,1,1
1,GO NCRNA 3 END PROCESSING,0.00086166,0.12427,0.1529,1,1
1,GO REGULATION OF CATABOLIC PROCESS,0.0063209,0.12415,0.15754,1,1
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.011063,0.12374,0.156,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0013481,0.12364,0.1832,1,1
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.045233,0.12351,0.13702,1,1
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.010101,0.12339,0.17036,1,1
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0057394,0.12331,0.1874,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.0017696,0.12324,0.16648,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.027226,0.12322,0.17054,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.00026348,0.1232,0.14695,1,1
1,GO GOLGI VESICLE TRANSPORT,0.0044907,0.12266,0.16996,1,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.02951,0.12259,0.11315,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.020391,0.12186,0.14492,1,1
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0018673,0.12184,0.15669,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.048745,0.12176,0.1682,1,1
1,GO BLASTOCYST DEVELOPMENT,0.00068502,0.12172,0.17006,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0042727,0.12164,0.16508,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.016475,0.12154,0.15014,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0011418,0.1214,0.16085,1,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.025096,0.12118,0.1512,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0003797,0.12102,0.15231,1,1
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.012106,0.12099,0.21094,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0019699,0.12097,0.16033,1,1
1,GO THIOESTER METABOLIC PROCESS,0.0024341,0.12086,0.16398,1,1
1,GO IMPORT INTO CELL,0.045233,0.12085,0.16407,1,1
1,GO REGULATION OF DNA METHYLATION,0.020391,0.12084,0.16432,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0011418,0.1207,0.14021,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.027226,0.12029,0.22889,1,1
1,GO RRNA METABOLIC PROCESS,0.0029965,0.12007,0.12891,1,1
1,GO PROTEIN CATABOLIC PROCESS,0.00332,0.12002,0.16529,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.007293,0.11976,0.18526,1,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0063209,0.11934,0.20389,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.007293,0.11927,0.1647,1,1
1,GO NEURON DEATH,0.027226,0.11925,0.15435,1,1
1,GO CATION TRANSMEMBRANE TRANSPORT,0.035953,0.11925,0.13571,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0054671,0.11923,0.15857,1,1
1,GO MALE SEX DIFFERENTIATION,0.0092139,0.11898,0.19702,1,1
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0044907,0.11875,0.16407,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0017696,0.11835,0.18354,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0021907,0.11818,0.18913,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,0.0027019,0.11784,0.14611,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.021265,0.1177,0.12286,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00068502,0.11767,0.17306,1,1
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.010572,0.11765,0.16166,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0029965,0.1174,0.16331,1,1
1,GO REGULATION OF GTPASE ACTIVITY,0.048745,0.11735,0.18881,1,1
1,GO PROTEIN DEPHOSPHORYLATION,0.0020776,0.11732,0.17044,1,1
1,GO BODY FLUID SECRETION,0.046961,0.11719,0.15468,1,1
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.010101,0.11719,0.20266,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.0057394,0.11697,0.17106,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0014241,0.11693,0.16291,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.016475,0.11691,0.19678,1,1
1,GO MITOCHONDRIAL TRANSPORT,0.00091199,0.11684,0.1457,1,1
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0060238,0.11682,0.28125,1,1
1,GO REGULATION OF GENE SILENCING,0.0016767,0.11657,0.1924,1,1
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.024086,0.11633,0.16653,1,1
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0076456,0.11633,0.1762,1,1
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0066311,0.1161,0.19444,1,1
1,GO PROTEIN STABILIZATION,0.0047188,0.11592,0.15415,1,1
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.00332,0.11585,0.2155,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0019699,0.11538,0.14311,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0054671,0.11478,0.16572,1,1
1,GO ION TRANSMEMBRANE TRANSPORT,0.026142,0.11443,0.13956,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0015882,0.11354,0.17073,1,1
1,GO PIGMENTATION,0.0172,0.1134,0.15893,1,1
1,GO CARBOHYDRATE HOMEOSTASIS,0.017954,0.11285,0.15121,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0092139,0.11284,0.14882,1,1
1,GO AMINO ACID TRANSPORT,0.015104,0.11284,0.19051,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00086166,0.11273,0.14209,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.027226,0.11258,0.13995,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.027226,0.11256,0.1895,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.0040644,0.11241,0.15314,1,1
1,GO SENSORY PERCEPTION,0.0083971,0.11189,0.14295,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.00020554,0.11174,0.1676,1,1
1,GO CELL FATE COMMITMENT,0.0172,0.11173,0.17395,1,1
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.013235,0.11169,0.15534,1,1
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00332,0.11139,0.16401,1,1
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.011574,0.11065,0.20201,1,1
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0025648,0.11064,0.12384,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.015104,0.11008,0.18137,1,1
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.018736,0.11008,0.14325,1,1
1,GO ANOIKIS,0.038848,0.10971,0.22876,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0080134,0.10969,0.15358,1,1
1,GO PROTEIN HOMOOLIGOMERIZATION,0.015776,0.10957,0.14209,1,1
1,GO RNA CAPPING,0.0014241,0.10926,0.14003,1,1
1,GO SNORNA METABOLIC PROCESS,0.0031545,0.10924,0.1755,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.033245,0.10893,0.15921,1,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.012106,0.10877,0.12488,1,1
1,GO UBIQUINONE METABOLIC PROCESS,0.0076456,0.10869,0.13709,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.038848,0.10846,0.19196,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0092139,0.1083,0.16501,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.038848,0.10786,0.15565,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.046961,0.10767,0.15625,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.015104,0.10754,0.15353,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.006955,0.10744,0.17482,1,1
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.013834,0.10662,0.19566,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.028348,0.10655,0.095777,1,1
1,GO BLASTOCYST FORMATION,0.026142,0.10605,0.12454,1,1
1,GO REGULATION OF PROTEIN STABILITY,0.015104,0.10592,0.13846,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.015104,0.10555,0.16192,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0042727,0.10517,0.16335,1,1
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.006955,0.10479,0.18004,1,1
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.052482,0.10448,0.19399,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0029965,0.10447,0.15887,1,1
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.043559,0.10433,0.13019,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.010572,0.10427,0.1685,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.015776,0.10425,0.15502,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.016475,0.10399,0.17304,1,1
1,GO CLATHRIN COAT ASSEMBLY,0.017954,0.10389,0.17372,1,1
1,GO GLUTAMATE METABOLIC PROCESS,0.037377,0.10385,0.15471,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.016475,0.10341,0.12254,1,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.050584,0.10319,0.11377,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.035953,0.10307,0.12263,1,1
1,GO ANION TRANSMEMBRANE TRANSPORT,0.021265,0.10281,0.15632,1,1
1,GO DE NOVO PROTEIN FOLDING,0.026142,0.10232,0.14512,1,1
1,GO REGULATION OF AUTOPHAGY,0.01266,0.10136,0.15787,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02951,0.10095,0.14799,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.007293,0.10061,0.12774,1,1
1,GO MACROAUTOPHAGY,0.0080134,0.10058,0.15588,1,1
1,GO CALCINEURIN MEDIATED SIGNALING,0.052482,0.10002,0.16293,1,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.008797,0.09997,0.14904,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0096484,0.099837,0.15843,1,1
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.021265,0.099601,0.17206,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0038653,0.098802,0.12356,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.013834,0.098593,0.13448,1,1
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.035953,0.098182,0.12981,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.046961,0.097774,0.1721,1,1
1,GO AMINO ACID ACTIVATION,0.050584,0.097624,0.097673,1,1
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0029965,0.097374,0.15957,1,1
1,GO RIBOSOME BIOGENESIS,0.0047188,0.09736,0.11636,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.043559,0.097167,0.14517,1,1
1,GO GLAND DEVELOPMENT,0.016475,0.09707,0.18533,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.021265,0.096754,0.16439,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00081392,0.096648,0.112,1,1
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.018736,0.096561,0.12994,1,1
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.043559,0.096447,0.1781,1,1
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.024086,0.096178,0.20309,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.026142,0.09607,0.14773,1,1
1,GO ORGANELLE DISASSEMBLY,0.015776,0.095227,0.14034,1,1
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.020391,0.094474,0.13705,1,1
1,GO GLUCOSE IMPORT,0.035953,0.093905,0.15597,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0083971,0.093898,0.13392,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.01266,0.093857,0.17569,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.041938,0.093838,0.10165,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.048745,0.093232,0.16754,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.017954,0.092534,0.14709,1,1
1,GO EPITHELIAL CELL DEVELOPMENT,0.052482,0.092361,0.18568,1,1
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.025096,0.091981,0.13885,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION,0.024086,0.091966,0.1511,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0096484,0.091888,0.15967,1,1
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.043559,0.091876,0.13912,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0040644,0.091701,0.18138,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.02951,0.091621,0.094005,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.041938,0.091361,0.1481,1,1
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.020391,0.091244,0.17384,1,1
1,GO EXCRETION,0.037377,0.090571,0.19402,1,1
1,GO FATTY ACYL COA METABOLIC PROCESS,0.0042727,0.090546,0.17547,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.018736,0.090501,0.14531,1,1
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.050584,0.090236,0.13644,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.00064645,0.089516,0.10533,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.046961,0.089386,0.12696,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0021907,0.089328,0.097653,1,1
1,GO RNA CATABOLIC PROCESS,0.0012758,0.08877,0.10874,1,1
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0060238,0.088199,0.12231,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.0015882,0.087078,0.095092,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.034576,0.086284,0.11369,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.015776,0.085238,0.16738,1,1
1,GO REGULATION OF ERAD PATHWAY,0.037377,0.084496,0.14035,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.038848,0.084325,0.12839,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.015776,0.08364,0.11193,1,1
1,GO PROTEIN INSERTION INTO MEMBRANE,0.00332,0.083214,0.12345,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.043559,0.082673,0.13597,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.011063,0.082454,0.14708,1,1
1,GO CARBOHYDRATE METABOLIC PROCESS,0.045233,0.08135,0.12512,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.015776,0.081288,0.15992,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0036751,0.080459,0.12649,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.046961,0.079321,0.17075,1,1
1,GO RESPONSE TO INSULIN,0.027226,0.07911,0.15526,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.025096,0.078603,0.10228,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.035953,0.078335,0.13425,1,1
1,GO TRANSMEMBRANE TRANSPORT,0.048745,0.076834,0.11863,1,1
1,GO MESODERM DEVELOPMENT,0.040368,0.076717,0.15474,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0049572,0.076672,0.082748,1,1
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.037377,0.076543,0.11174,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.034576,0.076224,0.16863,1,1
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0080134,0.07562,0.11257,1,1
1,GO CYTOKINETIC PROCESS,0.013235,0.074443,0.16465,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.071854,0.10087,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.013834,0.070739,0.13386,1,1
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.050584,0.070722,0.11507,1,1
1,GO RETINA HOMEOSTASIS,0.046961,0.069635,0.094153,1,1
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.046961,0.067249,0.14276,1,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.045233,0.067193,0.1047,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.023112,0.066266,0.093388,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.006955,0.065855,0.099501,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.022172,0.064643,0.099585,1,1
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.020391,0.064345,0.090782,1,1
1,GO PEPTIDE METABOLIC PROCESS,0.015104,0.0605,0.073905,1,1
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.052482,0.058169,0.15777,1,1
1,GO PROTEIN TARGETING,0.0028457,0.058049,0.077029,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.033245,0.057051,0.095215,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.045233,0.05004,0.095566,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,0.013834,0.049797,0.084325,1,1
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.0060238,1.0131,0.76432,1,1
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.0049572,0.96785,0.81503,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0044907,0.89025,0.78304,1,1
2,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.010101,0.87879,0.76163,1,1
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00332,0.8399,0.70966,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0029965,0.70061,0.63081,1,1
2,GO CHRONIC INFLAMMATORY RESPONSE,0.011063,0.69605,0.51528,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00045436,0.67591,0.66195,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00332,0.65722,0.63128,1,1
2,GO HYPERSENSITIVITY,0.0060238,0.65273,0.53112,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0034935,0.6471,0.60668,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.0031545,0.62322,0.48582,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00068502,0.61707,0.57731,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00020554,0.61552,0.6235,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0010798,0.61211,0.5695,1,1
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.0010798,0.60669,0.58112,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,0.0066311,0.60613,0.49767,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0013481,0.60467,0.56181,1,1
2,GO SYNAPSE PRUNING,0.010572,0.59603,0.56148,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0060238,0.57994,0.50455,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0042727,0.57899,0.52834,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0047188,0.57578,0.45042,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.010101,0.56242,0.49093,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0028457,0.5596,0.474,1,1
2,GO PLASMINOGEN ACTIVATION,0.00076864,0.55935,0.44736,1,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0015882,0.55648,0.59659,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0054671,0.55462,0.44,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00051151,0.55248,0.52935,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0025648,0.54269,0.44693,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0054671,0.54226,0.47551,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0015882,0.53933,0.4591,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00068502,0.53868,0.54576,1,1
2,GO FIBRINOLYSIS,0.0019699,0.53837,0.42742,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00091199,0.52634,0.5434,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0028457,0.52492,0.50695,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00332,0.52152,0.43149,1,1
2,GO NEUTROPHIL MIGRATION,0.0054671,0.51879,0.4344,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.0080134,0.51788,0.44391,1,1
2,GO LYMPHOCYTE MIGRATION,0.0052065,0.51705,0.43175,1,1
2,GO MONONUCLEAR CELL MIGRATION,0.0044907,0.51567,0.45388,1,1
2,GO NK T CELL DIFFERENTIATION,0.0096484,0.51346,0.41168,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0044907,0.51312,0.45361,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0021907,0.50699,0.49199,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00054254,0.50602,0.49721,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0027019,0.50156,0.48673,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0038653,0.5015,0.42747,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0034935,0.50003,0.44496,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0034935,0.4978,0.46296,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0044907,0.49597,0.43164,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00028019,0.4948,0.54122,1,1
2,GO DETECTION OF BIOTIC STIMULUS,0.0028457,0.49448,0.39733,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0012071,0.4938,0.46497,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.0031545,0.49351,0.45452,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0038653,0.49095,0.41007,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0060238,0.48991,0.42819,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0083971,0.48915,0.43677,1,1
2,GO T CELL MIGRATION,0.0052065,0.48563,0.44937,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0057394,0.48502,0.46686,1,1
2,GO GRANULOCYTE MIGRATION,0.0029965,0.48446,0.42605,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0031545,0.48281,0.44963,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0049572,0.48269,0.45074,1,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0016767,0.48091,0.48456,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0028457,0.48071,0.44451,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00332,0.47786,0.44629,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0038653,0.47601,0.3951,1,1
2,GO B CELL PROLIFERATION,0.0031545,0.47364,0.41503,1,1
2,GO RESPIRATORY BURST,0.0019699,0.47241,0.45434,1,1
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0034935,0.47212,0.45249,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0044907,0.47196,0.42935,1,1
2,GO GLYCINE TRANSPORT,0.034576,0.47162,0.29735,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.008797,0.47074,0.36422,1,1
2,GO CHEMOKINE SECRETION,0.0049572,0.47073,0.46568,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0003797,0.46946,0.49989,1,1
2,GO IMMUNOGLOBULIN SECRETION,0.0029965,0.46901,0.38598,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.0040644,0.46699,0.41677,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0017696,0.46644,0.43006,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0023095,0.46611,0.42577,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0036751,0.46552,0.40835,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.0057394,0.46371,0.39618,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0031545,0.46266,0.44874,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.008797,0.46221,0.39873,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00042807,0.4614,0.47567,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.0038653,0.46011,0.43536,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00086166,0.45901,0.43943,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0017696,0.45889,0.41739,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.0027019,0.45781,0.45829,1,1
2,GO CD40 SIGNALING PATHWAY,0.0047188,0.4556,0.3726,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0015041,0.45508,0.43538,1,1
2,GO REGULATION OF PLATELET ACTIVATION,0.00081392,0.45492,0.45392,1,1
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0034935,0.45475,0.39265,1,1
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0013481,0.45362,0.42901,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0027019,0.45347,0.38835,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.007293,0.45038,0.43883,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0012071,0.44752,0.46931,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0029965,0.44594,0.44895,1,1
2,GO INTERLEUKIN 2 PRODUCTION,0.011574,0.44572,0.35399,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0024341,0.44415,0.41764,1,1
2,GO REGULATION OF MYOBLAST FUSION,0.0015041,0.44407,0.48142,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,0.0018673,0.44246,0.39631,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0031545,0.44075,0.37984,1,1
2,GO NEGATIVE REGULATION OF ANOIKIS,0.0018673,0.43762,0.41236,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0028457,0.43671,0.40792,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0083971,0.43554,0.36376,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.0018673,0.43546,0.39419,1,1
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00018128,0.43518,0.49102,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0049572,0.43487,0.40095,1,1
2,GO REGULATION OF PHAGOCYTOSIS,0.0024341,0.43061,0.40686,1,1
2,GO LEUKOCYTE CHEMOTAXIS,0.0021907,0.42982,0.40117,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.012106,0.429,0.33583,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0027019,0.42831,0.39425,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0029965,0.42722,0.40959,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.0066311,0.42709,0.38966,1,1
2,GO HISTAMINE SECRETION,0.0049572,0.4268,0.3704,1,1
2,GO MACROPHAGE ACTIVATION,0.0036751,0.42584,0.422,1,1
2,GO MACROPHAGE MIGRATION,0.0023095,0.42276,0.38898,1,1
2,GO AMYLOID BETA CLEARANCE,0.0019699,0.42171,0.38721,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0076456,0.42094,0.51427,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0012071,0.41813,0.39213,1,1
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018736,0.41423,0.37038,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0057394,0.41397,0.3787,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.006955,0.41393,0.34619,1,1
2,GO CYTOKINE METABOLIC PROCESS,0.0054671,0.41277,0.34796,1,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0042727,0.41143,0.35399,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.0040644,0.41133,0.36449,1,1
2,GO RESPONSE TO FUNGUS,0.00057531,0.40936,0.37058,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.011063,0.40783,0.36726,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0018673,0.40519,0.41989,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0014241,0.4048,0.37042,1,1
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00068502,0.40384,0.42431,1,1
2,GO RESPONSE TO LIPOTEICHOIC ACID,0.00332,0.40131,0.42098,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00020554,0.40061,0.45934,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0036751,0.39943,0.35548,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00072571,0.39863,0.38682,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.0024341,0.39813,0.3838,1,1
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0023095,0.39697,0.38287,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0040644,0.39565,0.36426,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0044907,0.3927,0.33857,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0096484,0.39199,0.32781,1,1
2,GO HUMORAL IMMUNE RESPONSE,0.0014241,0.38904,0.40318,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.0040644,0.38886,0.37637,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.013235,0.38862,0.45514,1,1
2,GO REGULATION OF T CELL MIGRATION,0.0027019,0.38779,0.39332,1,1
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0038653,0.38723,0.40489,1,1
2,GO REGULATION OF PLATELET AGGREGATION,0.0016767,0.38673,0.35993,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0034935,0.38575,0.35703,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0052065,0.38556,0.34672,1,1
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0024341,0.38448,0.34019,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00086166,0.3835,0.34893,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.0013481,0.38349,0.37103,1,1
2,GO INTERLEUKIN 6 PRODUCTION,0.0047188,0.3834,0.33523,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010101,0.38294,0.3208,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0017696,0.38278,0.34481,1,1
2,GO INTESTINAL ABSORPTION,0.00026348,0.38236,0.42558,1,1
2,GO DEFENSE RESPONSE TO FUNGUS,0.00054254,0.38222,0.40685,1,1
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0034935,0.38165,0.32905,1,1
2,GO CELL CHEMOTAXIS,0.0013481,0.37621,0.37111,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031545,0.37485,0.36471,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0052065,0.37403,0.34902,1,1
2,GO PHAGOCYTOSIS,0.0021907,0.37293,0.35442,1,1
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00096503,0.37011,0.35581,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0010209,0.36972,0.36884,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042807,0.36919,0.38016,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0028457,0.36903,0.39637,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0014241,0.36878,0.3602,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0027019,0.36862,0.38014,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00332,0.36694,0.33746,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0013481,0.36611,0.32439,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0052065,0.366,0.36288,1,1
2,GO RESPONSE TO MAGNESIUM ION,0.00076864,0.36585,0.39209,1,1
2,GO INTESTINAL LIPID ABSORPTION,0.0021907,0.36502,0.34024,1,1
2,GO ZYMOGEN INHIBITION,0.0025648,0.36443,0.35571,1,1
2,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0060238,0.36398,0.32541,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0021907,0.36318,0.35997,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.0015882,0.35967,0.35394,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0013481,0.35821,0.39953,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012071,0.3581,0.34968,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0029965,0.35761,0.31752,1,1
2,GO GAP JUNCTION ASSEMBLY,0.0049572,0.35702,0.41754,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00054254,0.35503,0.42114,1,1
2,GO CHEMOKINE PRODUCTION,0.0029965,0.35262,0.33588,1,1
2,GO VASCULAR WOUND HEALING,0.0012758,0.3519,0.38938,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0028457,0.35181,0.36795,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0015882,0.35118,0.34131,1,1
2,GO NEGATIVE REGULATION OF COAGULATION,0.0012758,0.35112,0.37431,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00096503,0.35021,0.48037,1,1
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0044907,0.34993,0.39376,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028457,0.34956,0.38776,1,1
2,GO LEUKOCYTE MIGRATION,0.0015041,0.34933,0.37667,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,0.0011418,0.34932,0.34172,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0020776,0.34858,0.36465,1,1
2,GO STEROID CATABOLIC PROCESS,0.00029789,0.34764,0.35153,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0016767,0.3462,0.3335,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0010209,0.34381,0.37652,1,1
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0040644,0.34378,0.32235,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0025648,0.34079,0.31972,1,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0020776,0.33985,0.34742,1,1
2,GO LUTEINIZATION,0.0034935,0.33972,0.3294,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0025648,0.33958,0.32366,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0024341,0.33958,0.32924,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00081392,0.33956,0.36494,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.020391,0.33942,0.26414,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.0027019,0.33825,0.31819,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0080134,0.33625,0.34366,1,1
2,GO BLEB ASSEMBLY,0.010101,0.33518,0.3376,1,1
2,GO MEMBRANE INVAGINATION,0.0049572,0.33508,0.33751,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0054671,0.33495,0.33412,1,1
2,GO REGULATION OF COAGULATION,0.00064645,0.33347,0.36492,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028457,0.33342,0.31435,1,1
2,GO ZYMOGEN ACTIVATION,0.00028019,0.33285,0.35488,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0020776,0.33226,0.34402,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.006955,0.33131,0.29933,1,1
2,GO FOAM CELL DIFFERENTIATION,0.0034935,0.33016,0.30918,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0012758,0.32955,0.30643,1,1
2,GO INFLAMMATORY RESPONSE,0.0024341,0.32939,0.32586,1,1
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0044907,0.32878,0.40349,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0031545,0.3287,0.31782,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00096503,0.3286,0.32366,1,1
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0042727,0.32769,0.27722,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015882,0.32723,0.31248,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0028457,0.32496,0.29143,1,1
2,GO HISTAMINE TRANSPORT,0.006955,0.32329,0.33829,1,1
2,GO PLATELET DEGRANULATION,0.0003797,0.32325,0.36341,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0080134,0.32223,0.30403,1,1
2,GO SUPEROXIDE ANION GENERATION,0.0028457,0.32208,0.34749,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0049572,0.32204,0.33236,1,1
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.0054671,0.32116,0.30233,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0011418,0.32109,0.35956,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.01266,0.32087,0.26082,1,1
2,GO REGULATION OF FIBRINOLYSIS,0.010572,0.32047,0.31506,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0036751,0.3197,0.32676,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0024341,0.31773,0.31901,1,1
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0027019,0.31722,0.34002,1,1
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.016475,0.31632,0.28954,1,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.00096503,0.31619,0.37409,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0049572,0.3159,0.33156,1,1
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0054671,0.31569,0.35389,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0036751,0.3133,0.34544,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0047188,0.31297,0.31931,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0038653,0.31268,0.2939,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0038653,0.31237,0.29697,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0013481,0.31144,0.37321,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0016767,0.31144,0.3438,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0015041,0.31028,0.30919,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0028457,0.30829,0.28725,1,1
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0172,0.30802,0.24366,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.0017696,0.30802,0.31643,1,1
2,GO PLATELET AGGREGATION,0.0038653,0.30728,0.30506,1,1
2,GO O GLYCAN PROCESSING,0.0049572,0.30472,0.24315,1,1
2,GO ADRENAL GLAND DEVELOPMENT,0.0015041,0.30361,0.35922,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0015041,0.30218,0.36855,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.0028457,0.30189,0.31089,1,1
2,GO GALACTOSE METABOLIC PROCESS,0.00091199,0.30155,0.38942,1,1
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0017696,0.30116,0.34989,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.019548,0.301,0.2832,1,1
2,GO PLATELET ACTIVATION,0.0060238,0.29988,0.27962,1,1
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.025096,0.29969,0.24368,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00096503,0.29873,0.34124,1,1
2,GO RESPONSE TO THYROID HORMONE,0.00064645,0.29852,0.30559,1,1
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00332,0.2983,0.28653,1,1
2,GO ANDROGEN METABOLIC PROCESS,0.006955,0.29812,0.22709,1,1
2,GO LIPID DIGESTION,0.013834,0.29571,0.29583,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00060992,0.29532,0.32505,1,1
2,GO HOMOTYPIC CELL CELL ADHESION,0.0024341,0.29528,0.30449,1,1
2,GO REGULATION OF CELL FATE SPECIFICATION,0.0016767,0.29481,0.31863,1,1
2,GO HEART INDUCTION,0.0017696,0.29415,0.33302,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0014241,0.29403,0.32374,1,1
2,GO CHOLESTEROL STORAGE,0.0038653,0.29386,0.32634,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00081392,0.29383,0.30362,1,1
2,GO ENTRY INTO HOST,0.0016767,0.29376,0.29921,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0066311,0.29335,0.32012,1,1
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0040644,0.29335,0.30932,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.013235,0.29289,0.28629,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.013235,0.29274,0.29345,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0014241,0.29268,0.34733,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.050584,0.29215,0.21179,1,1
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0044907,0.28849,0.27282,1,1
2,GO PROSTANOID METABOLIC PROCESS,0.0027019,0.28794,0.28145,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0028457,0.28788,0.27574,1,1
2,GO BLOOD VESSEL REMODELING,0.0060238,0.28774,0.32917,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00051151,0.28769,0.32373,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0017696,0.28761,0.27733,1,1
2,GO PHOSPHATE ION TRANSPORT,0.0018673,0.28758,0.27839,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0012758,0.28554,0.32239,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0028457,0.28527,0.27254,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0092139,0.28445,0.26369,1,1
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00086166,0.28328,0.30694,1,1
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.0063209,0.28297,0.27547,1,1
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.012106,0.28212,0.24255,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0036751,0.28052,0.26608,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.0012071,0.2804,0.30322,1,1
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0066311,0.27951,0.26671,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,0.01266,0.27878,0.25157,1,1
2,GO REGULATION OF ANOIKIS,0.0080134,0.27869,0.30413,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.00086166,0.27815,0.27505,1,1
2,GO LEYDIG CELL DIFFERENTIATION,0.01266,0.27791,0.36186,1,1
2,GO PHAGOLYSOSOME ASSEMBLY,0.00096503,0.27771,0.33426,1,1
2,GO REFLEX,0.014457,0.27705,0.29326,1,1
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.0019699,0.27634,0.29337,1,1
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.024086,0.27621,0.24008,1,1
2,GO MAST CELL MIGRATION,0.0080134,0.27615,0.27547,1,1
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00096503,0.27532,0.40992,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.017954,0.27485,0.20413,1,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00068502,0.27406,0.28878,1,1
2,GO SECONDARY HEART FIELD SPECIFICATION,0.0014241,0.27399,0.39227,1,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.034576,0.2727,0.25266,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0013481,0.27257,0.33132,1,1
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0011418,0.27229,0.28151,1,1
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0052065,0.27056,0.28728,1,1
2,GO BONE RESORPTION,0.0027019,0.27053,0.30829,1,1
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.0038653,0.26989,0.29074,1,1
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.048745,0.26889,0.24727,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0057394,0.26768,0.30758,1,1
2,GO OSTEOBLAST PROLIFERATION,0.0014241,0.26701,0.33102,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.010572,0.26648,0.26099,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.045233,0.26618,0.22093,1,1
2,GO HORMONE CATABOLIC PROCESS,0.0044907,0.26604,0.24817,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0083971,0.26578,0.31795,1,1
2,GO STEROID ESTERIFICATION,0.0076456,0.26545,0.25408,1,1
2,GO RELAXATION OF CARDIAC MUSCLE,0.015776,0.26525,0.26328,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0054671,0.26493,0.33106,1,1
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00081392,0.26452,0.32359,1,1
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0019699,0.2643,0.26171,1,1
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.00332,0.26406,0.43972,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0034935,0.26296,0.28164,1,1
2,GO MUCUS SECRETION,0.0020776,0.26141,0.31222,1,1
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0044907,0.26099,0.26138,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0017696,0.26071,0.31365,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0013481,0.2605,0.2687,1,1
2,GO NEPHRIC DUCT DEVELOPMENT,0.024086,0.26027,0.25189,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0003797,0.25909,0.34077,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0012071,0.25804,0.27824,1,1
2,GO PROTEIN HYDROXYLATION,0.008797,0.2579,0.27512,1,1
2,GO STEROL HOMEOSTASIS,0.0047188,0.25769,0.2289,1,1
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0034935,0.25741,0.25303,1,1
2,GO COPPER ION TRANSPORT,0.00057531,0.25638,0.30176,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.015104,0.25533,0.25508,1,1
2,GO COLLAGEN FIBRIL ORGANIZATION,0.016475,0.25406,0.39516,1,1
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0066311,0.25294,0.25947,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.020391,0.25179,0.23281,1,1
2,GO RESPONSE TO LITHIUM ION,0.00011593,0.25174,0.30421,1,1
2,GO RESPONSE TO IRON ION,0.0054671,0.24845,0.22692,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0025648,0.24843,0.26594,1,1
2,GO HYALURONAN CATABOLIC PROCESS,0.00332,0.2482,0.28332,1,1
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.010101,0.24657,0.23312,1,1
2,GO BICARBONATE TRANSPORT,0.052482,0.2463,0.16185,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.013235,0.24605,0.23189,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.0052065,0.24391,0.23539,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00076864,0.24372,0.29557,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0066311,0.24331,0.23753,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00332,0.24324,0.26838,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.019548,0.24299,0.29662,1,1
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0047188,0.24204,0.33281,1,1
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.007293,0.24197,0.27903,1,1
2,GO ARACHIDONIC ACID SECRETION,0.0023095,0.2417,0.24501,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.0016767,0.24054,0.26795,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.0054671,0.24016,0.24784,1,1
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0057394,0.2398,0.22861,1,1
2,GO REGULATION OF CELL FATE COMMITMENT,0.00332,0.23729,0.25072,1,1
2,GO PANCREATIC JUICE SECRETION,0.0096484,0.23684,0.24606,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0083971,0.23488,0.27853,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00332,0.23458,0.24763,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.048745,0.23355,0.18406,1,1
2,GO LUNG ALVEOLUS DEVELOPMENT,0.0015041,0.23322,0.31304,1,1
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0024341,0.23257,0.27735,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0027019,0.23236,0.24327,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.015776,0.23167,0.23951,1,1
2,GO CELL REDOX HOMEOSTASIS,0.0015041,0.23162,0.21284,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0172,0.23136,0.31018,1,1
2,GO SUBPALLIUM DEVELOPMENT,0.041938,0.23089,0.21208,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.010572,0.23089,0.23878,1,1
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0172,0.22885,0.25522,1,1
2,GO CELL MATRIX ADHESION,0.015104,0.22872,0.25879,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0063209,0.22746,0.22952,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0057394,0.22712,0.2664,1,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0080134,0.2271,0.2254,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0047188,0.22703,0.22662,1,1
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.014457,0.22678,0.22683,1,1
2,GO AMINE BIOSYNTHETIC PROCESS,0.0024341,0.22629,0.24344,1,1
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0047188,0.22536,0.26503,1,1
2,GO RUFFLE ORGANIZATION,0.0049572,0.22519,0.24723,1,1
2,GO EPIBOLY,0.0042727,0.22439,0.28942,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0066311,0.22378,0.29881,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0047188,0.22362,0.21623,1,1
2,GO DRUG METABOLIC PROCESS,0.026142,0.22349,0.14399,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0013481,0.22254,0.30179,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.010101,0.22211,0.23888,1,1
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0036751,0.22149,0.27265,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.0096484,0.22128,0.27172,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.041938,0.22121,0.22887,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0080134,0.21876,0.31454,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0029965,0.21844,0.22732,1,1
2,GO REGULATION OF CELL MATRIX ADHESION,0.0076456,0.21834,0.2642,1,1
2,GO RELAXATION OF MUSCLE,0.018736,0.21711,0.18497,1,1
2,GO B CELL APOPTOTIC PROCESS,0.00332,0.21688,0.23362,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.010572,0.21596,0.25332,1,1
2,GO DOPAMINE METABOLIC PROCESS,0.010572,0.21521,0.22503,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.016475,0.21517,0.21117,1,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.0080134,0.21304,0.23674,1,1
2,GO ORGAN INDUCTION,0.0040644,0.21303,0.23432,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.011574,0.21238,0.25896,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.0044907,0.21181,0.24323,1,1
2,GO REGULATION OF VASCULOGENESIS,0.041938,0.21176,0.22634,1,1
2,GO LIVER MORPHOGENESIS,0.010572,0.20969,0.26763,1,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.022172,0.20968,0.20808,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.013834,0.20959,0.23719,1,1
2,GO PROTEIN KINASE C SIGNALING,0.018736,0.20933,0.24353,1,1
2,GO REGULATION OF NUCLEASE ACTIVITY,0.031957,0.20863,0.17105,1,1
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.037377,0.20842,0.28667,1,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0016767,0.20824,0.25987,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.015104,0.20781,0.2318,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015041,0.2078,0.29626,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0012758,0.20778,0.254,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.041938,0.20768,0.18086,1,1
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.021265,0.20758,0.21942,1,1
2,GO PROGESTERONE METABOLIC PROCESS,0.025096,0.20635,0.19808,1,1
2,GO STEROL TRANSPORT,0.014457,0.20581,0.20777,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0076456,0.20528,0.25127,1,1
2,GO HEART FIELD SPECIFICATION,0.007293,0.20494,0.28422,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.033245,0.20492,0.22026,1,1
2,GO AMINO ACID IMPORT,0.0080134,0.20431,0.20329,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.026142,0.20251,0.21902,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.01266,0.20248,0.20226,1,1
2,GO KERATINOCYTE DEVELOPMENT,0.031957,0.20209,0.27004,1,1
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0034935,0.20202,0.29729,1,1
2,GO LIPID IMPORT INTO CELL,0.0047188,0.20165,0.22009,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0014241,0.20125,0.25983,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.017954,0.20095,0.30058,1,1
2,GO RESPONSE TO FATTY ACID,0.013235,0.20071,0.19385,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.041938,0.20028,0.24447,1,1
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0083971,0.20002,0.19024,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00042807,0.19992,0.26035,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00042807,0.19963,0.24419,1,1
2,GO NADPH REGENERATION,0.0047188,0.19959,0.18305,1,1
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.010101,0.19959,0.20834,1,1
2,GO VASODILATION,0.0025648,0.19932,0.23957,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0063209,0.19854,0.23835,1,1
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0023095,0.19764,0.22929,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.006955,0.1975,0.28424,1,1
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.02951,0.19663,0.17446,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.013834,0.19645,0.24695,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.02951,0.19642,0.22223,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.040368,0.19634,0.27053,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.026142,0.19568,0.22478,1,1
2,GO TRACHEA MORPHOGENESIS,0.024086,0.1955,0.24984,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.01266,0.19511,0.22145,1,1
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.020391,0.19443,0.29664,1,1
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.008797,0.19436,0.20376,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015104,0.19364,0.22201,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.027226,0.19355,0.21532,1,1
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.0025648,0.19348,0.26306,1,1
2,GO STEROL METABOLIC PROCESS,0.006955,0.1934,0.17128,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.011063,0.19321,0.19339,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.02951,0.19307,0.27838,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0028457,0.19229,0.23929,1,1
2,GO DISACCHARIDE METABOLIC PROCESS,0.013235,0.19208,0.22167,1,1
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.038848,0.19197,0.23976,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0018673,0.19194,0.20461,1,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.033245,0.19155,0.22595,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.0096484,0.19122,0.20395,1,1
2,GO REGULATION OF EXOSOMAL SECRETION,0.00021879,0.19063,0.26479,1,1
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.018736,0.19031,0.19357,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.00072571,0.19006,0.21594,1,1
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0096484,0.19004,0.32732,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.021265,0.18914,0.18808,1,1
2,GO ENDOCRINE PROCESS,0.0066311,0.1889,0.22797,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.023112,0.18883,0.27817,1,1
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.035953,0.18847,0.20601,1,1
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.020391,0.18803,0.20554,1,1
2,GO RESPONSE TO REDOX STATE,0.0060238,0.18774,0.25511,1,1
2,GO MANGANESE ION TRANSPORT,0.023112,0.18772,0.18745,1,1
2,GO PROTEIN OXIDATION,0.0076456,0.1876,0.25308,1,1
2,GO RESPONSE TO MANGANESE ION,0.0080134,0.1865,0.21006,1,1
2,GO ATP BIOSYNTHETIC PROCESS,0.0052065,0.18619,0.20127,1,1
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.043559,0.18584,0.15556,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.026142,0.18554,0.14025,1,1
2,GO PLASMA MEMBRANE FUSION,0.012106,0.18502,0.2615,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.0044907,0.18423,0.22466,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.022172,0.18422,0.16829,1,1
2,GO DETECTION OF MECHANICAL STIMULUS,0.019548,0.18409,0.21393,1,1
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.024086,0.18334,0.19717,1,1
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.014457,0.18327,0.22296,1,1
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.027226,0.18021,0.22996,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0017696,0.17906,0.364,1,1
2,GO MESENCHYME MORPHOGENESIS,0.031957,0.17902,0.2343,1,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.015776,0.17863,0.21784,1,1
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0038653,0.17831,0.22552,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.012106,0.17827,0.25018,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.02951,0.17587,0.2013,1,1
2,GO INTERACTION WITH SYMBIONT,0.0057394,0.17445,0.18055,1,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0096484,0.17435,0.22519,1,1
2,GO TOXIN METABOLIC PROCESS,0.0057394,0.17433,0.23152,1,1
2,GO VACUOLAR ACIDIFICATION,0.0036751,0.17296,0.18296,1,1
2,GO LUNG CELL DIFFERENTIATION,0.0092139,0.17261,0.26538,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.019548,0.17244,0.23377,1,1
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0036751,0.17156,0.17184,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0083971,0.17097,0.25571,1,1
2,GO PHAGOSOME ACIDIFICATION,0.00060992,0.17096,0.21933,1,1
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.041938,0.17056,0.16294,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0034935,0.17017,0.19065,1,1
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.025096,0.17015,0.16969,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.020391,0.16964,0.21249,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.010101,0.16943,0.19387,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0017696,0.1692,0.21821,1,1
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00096503,0.16917,0.20829,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.024086,0.16893,0.15591,1,1
2,GO NADP METABOLIC PROCESS,0.0014241,0.16872,0.20584,1,1
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.007293,0.16862,0.2841,1,1
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.034576,0.1684,0.18871,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.027226,0.16793,0.24329,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.013834,0.16786,0.19663,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0028457,0.16785,0.21425,1,1
2,GO IRON ION HOMEOSTASIS,0.0020776,0.16762,0.20982,1,1
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.041938,0.16754,0.189,1,1
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0034935,0.16751,0.21811,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0020776,0.16737,0.18496,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.046961,0.16724,0.16654,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.038848,0.16716,0.15785,1,1
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.017954,0.16661,0.18453,1,1
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.026142,0.16639,0.22668,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,0.027226,0.16594,0.19089,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.023112,0.1659,0.16287,1,1
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.015776,0.16493,0.18179,1,1
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.016475,0.16314,0.2822,1,1
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.024086,0.16256,0.19358,1,1
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.043559,0.16153,0.16862,1,1
2,GO VITAMIN TRANSPORT,0.006955,0.16151,0.19712,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.014457,0.16135,0.27381,1,1
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0052065,0.16051,0.17598,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.023112,0.16045,0.21147,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.0060238,0.16011,0.20679,1,1
2,GO CATECHOLAMINE METABOLIC PROCESS,0.028348,0.1599,0.17482,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.040368,0.15914,0.15976,1,1
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.020391,0.15689,0.24076,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0034935,0.1558,0.19013,1,1
2,GO REGULATION OF ENDOCRINE PROCESS,0.021265,0.15508,0.19867,1,1
2,GO DETOXIFICATION,0.016475,0.15457,0.14339,1,1
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.022172,0.15279,0.24135,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.033245,0.15272,0.26829,1,1
2,GO MUSCLE ADAPTATION,0.028348,0.15204,0.17434,1,1
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.038848,0.15174,0.19235,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0029965,0.15125,0.2131,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.013834,0.15082,0.16486,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0049572,0.14995,0.19741,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0024341,0.14917,0.1461,1,1
2,GO CARBOHYDRATE TRANSPORT,0.01266,0.14895,0.16095,1,1
2,GO POSITIVE REGULATION OF CELL AGING,0.026142,0.14894,0.14474,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.015104,0.14891,0.15285,1,1
2,GO PLASMA MEMBRANE ORGANIZATION,0.024086,0.14817,0.19954,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.024086,0.14801,0.16075,1,1
2,GO IRON ION TRANSPORT,0.0015041,0.14701,0.19407,1,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.018736,0.14665,0.17508,1,1
2,GO NAD METABOLIC PROCESS,0.0031545,0.14595,0.22016,1,1
2,GO ER OVERLOAD RESPONSE,0.011574,0.14566,0.19725,1,1
2,GO MESONEPHROS DEVELOPMENT,0.046961,0.14557,0.16094,1,1
2,GO DEVELOPMENTAL INDUCTION,0.028348,0.1449,0.17774,1,1
2,GO ANIMAL ORGAN REGENERATION,0.0025648,0.14473,0.20833,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.026142,0.1442,0.18894,1,1
2,GO MUSCLE FILAMENT SLIDING,0.035953,0.14414,0.11019,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.026142,0.14389,0.13387,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.022172,0.14368,0.19672,1,1
2,GO REGULATION OF BLOOD PRESSURE,0.027226,0.14353,0.17071,1,1
2,GO STEROID METABOLIC PROCESS,0.0047188,0.14288,0.16889,1,1
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.027226,0.14269,0.15511,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.019548,0.14255,0.14633,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0054671,0.14229,0.19171,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0024341,0.14209,0.20214,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0063209,0.14094,0.19425,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.018736,0.14091,0.17097,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0012071,0.14054,0.1852,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.045233,0.14044,0.16248,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0057394,0.13991,0.19603,1,1
2,GO REGULATION OF FIBROBLAST MIGRATION,0.050584,0.13986,0.17847,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.048745,0.13925,0.18033,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.021265,0.13908,0.15432,1,1
2,GO RESPONSE TO METAL ION,0.0057394,0.13772,0.16281,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0015041,0.13767,0.16813,1,1
2,GO REGULATION OF VASCULAR PERMEABILITY,0.0172,0.13698,0.22139,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.052482,0.13654,0.13608,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.018736,0.13563,0.15942,1,1
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.037377,0.13484,0.17929,1,1
2,GO RUFFLE ASSEMBLY,0.017954,0.13405,0.17089,1,1
2,GO REGULATION OF MUSCLE ADAPTATION,0.02951,0.13383,0.17818,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.052482,0.13348,0.14831,1,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0096484,0.13346,0.1763,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.008797,0.13338,0.17708,1,1
2,GO FIBROBLAST MIGRATION,0.037377,0.13335,0.17849,1,1
2,GO AMINE METABOLIC PROCESS,0.00076864,0.13298,0.16158,1,1
2,GO ANOIKIS,0.038848,0.13281,0.21552,1,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.012106,0.13258,0.1573,1,1
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.026142,0.1325,0.12805,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.033245,0.13245,0.13564,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.052482,0.13184,0.15155,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0066311,0.13124,0.15418,1,1
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.050584,0.13067,0.1585,1,1
2,GO COPPER ION HOMEOSTASIS,0.012106,0.1304,0.17153,1,1
2,GO RESPONSE TO HYPEROXIA,0.0172,0.12984,0.20262,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.010101,0.12878,0.17876,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0057394,0.12855,0.18551,1,1
2,GO AUTOPHAGIC CELL DEATH,0.01266,0.12799,0.19382,1,1
2,GO MAINTENANCE OF CELL POLARITY,0.040368,0.12758,0.19505,1,1
2,GO MIDBODY ABSCISSION,0.010101,0.12539,0.14063,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.007293,0.12451,0.15046,1,1
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0076456,0.12446,0.13556,1,1
2,GO ETHER METABOLIC PROCESS,0.038848,0.12442,0.14026,1,1
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.043559,0.12404,0.13543,1,1
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.007293,0.12341,0.14301,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.028348,0.12315,0.16324,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.034576,0.12298,0.14043,1,1
2,GO RESPONSE TO COLD,0.026142,0.12278,0.17552,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.045233,0.12269,0.10487,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0076456,0.12213,0.16312,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0049572,0.12148,0.16516,1,1
2,GO NUCLEOTIDE TRANSPORT,0.050584,0.12104,0.13948,1,1
2,GO CHONDROCYTE DEVELOPMENT,0.023112,0.12073,0.29892,1,1
2,GO PROTEIN N LINKED GLYCOSYLATION,0.0092139,0.11911,0.14694,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.017954,0.11884,0.15625,1,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.037377,0.11821,0.12921,1,1
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.028348,0.11708,0.18054,1,1
2,GO RESPONSE TO ETHANOL,0.0080134,0.11684,0.1549,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.011574,0.11681,0.18032,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.022172,0.1168,0.14173,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.050584,0.11601,0.16145,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0015882,0.11525,0.21356,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.018736,0.11525,0.16999,1,1
2,GO SPLEEN DEVELOPMENT,0.035953,0.11442,0.13511,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0012758,0.11286,0.16426,1,1
2,GO RESPONSE TO CADMIUM ION,0.038848,0.11181,0.14059,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.033245,0.11167,0.12842,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.013235,0.11136,0.16797,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.035953,0.11093,0.17586,1,1
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.0172,0.11057,0.14018,1,1
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.043559,0.10949,0.14949,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.013834,0.10912,0.14509,1,1
2,GO SPHINGOLIPID METABOLIC PROCESS,0.045233,0.10807,0.14487,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.050584,0.10609,0.13863,1,1
2,GO ESTROGEN METABOLIC PROCESS,0.02951,0.10593,0.12085,1,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.043559,0.1029,0.1764,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.034576,0.10284,0.14785,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0036751,0.10228,0.16213,1,1
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0172,0.10134,0.11049,1,1
2,GO MESODERM MORPHOGENESIS,0.030713,0.10118,0.18903,1,1
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.048745,0.10094,0.11402,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.026142,0.097227,0.14667,1,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.030713,0.09571,0.17488,1,1
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.030713,0.095114,0.10548,1,1
2,GO VESICLE TARGETING,0.040368,0.094208,0.13243,1,1
2,GO COPII COATED VESICLE BUDDING,0.043559,0.093829,0.13388,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.031957,0.093413,0.1296,1,1
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0076456,0.093205,0.11028,1,1
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.045233,0.0893,0.12884,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.01266,0.089233,0.10793,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.012106,0.088761,0.14871,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.046961,0.087555,0.13416,1,1
2,GO VESICLE ORGANIZATION,0.027226,0.085925,0.14324,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.041938,0.083431,0.13256,1,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.033245,0.071949,0.11898,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.00091199,0.07098,0.10724,1,1
2,GO OXIDATION REDUCTION PROCESS,0.018736,0.06775,0.11199,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.023112,0.06742,0.12044,1,1
3,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.00020554,1.3009,1.1461,1,1
3,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.00028019,1.2291,1.0878,1,1
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00018128,1.1883,1.067,1,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00033648,1.1765,1.0109,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00010866,1.0674,0.98911,1,1
3,GO CHRONIC INFLAMMATORY RESPONSE,2.2907e-05,1.0497,0.94345,1,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00031664,1.049,0.81087,1,1
3,GO NATURAL KILLER CELL CHEMOTAXIS,0.00051151,1.0422,0.99377,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,5.6086e-05,1.016,0.94284,1,1
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.636e-05,1.0138,0.9719,1,1
3,GO TOLERANCE INDUCTION,0.00040321,1.0037,0.84859,1,1
3,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00035748,0.98571,0.97826,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00054254,0.97908,0.82954,1,1
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.7249e-05,0.97026,0.96774,1,1
3,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.00054254,0.95327,0.72046,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.00068502,0.95134,0.8008,1,1
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,3.4805e-05,0.94918,0.81399,1,1
3,GO T CELL TOLERANCE INDUCTION,0.00029789,0.94674,0.89537,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,7.3279e-05,0.94146,0.85868,1,1
3,GO HYPERSENSITIVITY,0.00029789,0.94002,0.84112,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00020554,0.93508,0.85164,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,6.4139e-05,0.93178,0.91268,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00017019,0.93037,0.80125,1,1
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,5.9985e-05,0.91974,0.75288,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00023283,0.91928,0.81633,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00023283,0.91016,0.78209,1,1
3,GO T CELL CHEMOTAXIS,0.00010866,0.90146,0.76269,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00015974,0.89706,0.84616,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.8267e-05,0.89653,0.89859,1,1
3,GO LYMPHOCYTE CHEMOTAXIS,3.7287e-05,0.89535,0.80607,1,1
3,GO T HELPER 1 CELL DIFFERENTIATION,3.0304e-05,0.89161,0.81485,1,1
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00017019,0.88717,0.83172,1,1
3,GO NEGATIVE T CELL SELECTION,0.00024771,0.88464,0.83842,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00015974,0.88211,0.71567,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00011593,0.87696,0.84139,1,1
3,GO DENDRITIC CELL MIGRATION,0.00019306,0.87431,0.77272,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,8.3641e-05,0.87039,0.77821,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.00021879,0.87034,0.78389,1,1
3,GO DETECTION OF OTHER ORGANISM,0.00014062,0.86494,0.73009,1,1
3,GO INTERLEUKIN 10 PRODUCTION,7.8298e-05,0.86308,0.7015,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00029789,0.86034,0.77963,1,1
3,GO SYNAPSE PRUNING,0.00026348,0.85822,0.90576,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.248e-05,0.85721,0.78346,1,1
3,GO RESPONSE TO PROTOZOAN,7.8298e-05,0.8531,0.7416,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00010181,0.85268,0.85954,1,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,7.8298e-05,0.84866,0.75973,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.8267e-05,0.84421,0.7585,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,4.2763e-05,0.83775,0.75614,1,1
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00091199,0.83715,0.71213,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,1.9888e-05,0.83496,0.79132,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,8.3641e-05,0.83281,0.79309,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00014062,0.82739,0.73412,1,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,8.9327e-05,0.82737,0.78027,1,1
3,GO T HELPER 2 CELL DIFFERENTIATION,3.7287e-05,0.82689,0.76679,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00021879,0.82552,0.70755,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0003797,0.82298,0.70471,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,8.9327e-05,0.8221,0.76501,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,9.5377e-05,0.82061,0.65961,1,1
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.81459,0.69962,1,1
3,GO POSITIVE THYMIC T CELL SELECTION,0.0010798,0.81335,0.69665,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.9985e-05,0.80976,0.6725,1,1
3,GO NEGATIVE REGULATION OF CELL KILLING,0.00015974,0.80686,0.79635,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,7.8298e-05,0.80677,0.73353,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,7.3279e-05,0.80454,0.76648,1,1
3,GO CYTOLYSIS,0.00014989,0.80082,0.81026,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,0.00020554,0.80074,0.7231,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.00051151,0.79535,0.64558,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00014989,0.79531,0.66767,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00010181,0.7939,0.71584,1,1
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,6.8565e-05,0.79218,0.82334,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.00014989,0.79218,0.66731,1,1
3,GO INTERLEUKIN 2 PRODUCTION,2.8267e-05,0.78939,0.70779,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00020554,0.78425,0.74041,1,1
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00023283,0.78321,0.76425,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00026348,0.78252,0.65755,1,1
3,GO DETECTION OF BIOTIC STIMULUS,7.8298e-05,0.78214,0.64415,1,1
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00076864,0.78121,0.8635,1,1
3,GO POSITIVE T CELL SELECTION,0.00029789,0.78111,0.67866,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.7287e-05,0.77915,0.76133,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.00013188,0.77876,0.72752,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00018128,0.77595,0.69215,1,1
3,GO MONOCYTE CHEMOTAXIS,3.4805e-05,0.7753,0.77923,1,1
3,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00042807,0.775,0.72656,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,8.3641e-05,0.77482,0.67819,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.77356,0.6748,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,7.3279e-05,0.77253,0.71699,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9985e-05,0.77151,0.75518,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.4139e-05,0.77139,0.67178,1,1
3,GO INFLAMMATORY RESPONSE TO WOUNDING,7.8298e-05,0.76988,0.6791,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00028019,0.76914,0.68875,1,1
3,GO THYMIC T CELL SELECTION,0.00091199,0.76795,0.62367,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.636e-05,0.76616,0.75688,1,1
3,GO T CELL MIGRATION,0.00017019,0.7645,0.68484,1,1
3,GO CELLULAR DEFENSE RESPONSE,0.00019306,0.76434,0.68687,1,1
3,GO INTERLEUKIN 13 PRODUCTION,9.5377e-05,0.76378,0.7212,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.9936e-05,0.76364,0.73751,1,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00028019,0.76341,0.61585,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.00017019,0.76263,0.65105,1,1
3,GO REGULATION OF T CELL CHEMOTAXIS,5.6086e-05,0.76106,0.69785,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,6.8565e-05,0.75938,0.70033,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.5779e-05,0.75901,0.70091,1,1
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00026348,0.75836,0.70455,1,1
3,GO RESPONSE TO CHEMOKINE,3.0304e-05,0.75816,0.73071,1,1
3,GO CYCLOOXYGENASE PATHWAY,5.2428e-05,0.75757,0.77294,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,3.9936e-05,0.75752,0.75532,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00013188,0.75679,0.67066,1,1
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00014062,0.7533,0.70033,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.00024771,0.75161,0.64512,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014062,0.75104,0.7207,1,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00020554,0.74938,0.68959,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,7.8298e-05,0.74799,0.68385,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,4.5779e-05,0.7477,0.69366,1,1
3,GO LEUKOCYTE AGGREGATION,7.8298e-05,0.7466,0.80474,1,1
3,GO RESPONSE TO INTERLEUKIN 15,7.8298e-05,0.74655,0.72307,1,1
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00045436,0.74591,0.61311,1,1
3,GO T CELL EXTRAVASATION,7.8298e-05,0.74508,0.65639,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00012367,0.74167,0.69216,1,1
3,GO T CELL CYTOKINE PRODUCTION,4.5779e-05,0.73949,0.65627,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00015974,0.73901,0.66224,1,1
3,GO INTERLEUKIN 12 PRODUCTION,0.00040321,0.7387,0.62479,1,1
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00023283,0.73601,0.70438,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.4139e-05,0.73368,0.68532,1,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00015974,0.73256,0.73105,1,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.00021879,0.73249,0.68364,1,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,8.9327e-05,0.73193,0.62995,1,1
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,9.5377e-05,0.73166,0.77309,1,1
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.0304e-05,0.7313,0.738,1,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,7.3279e-05,0.72914,0.67392,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012367,0.72817,0.66465,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,4.8997e-05,0.72721,0.67941,1,1
3,GO LYMPHOCYTE MIGRATION,0.00017019,0.72683,0.66909,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.9327e-05,0.72588,0.67688,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.00045436,0.72447,0.73787,1,1
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,4.8997e-05,0.72309,0.72271,1,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00011593,0.72274,0.64913,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,8.3641e-05,0.72237,0.63363,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.2539e-06,0.72219,0.82207,1,1
3,GO T CELL MEDIATED IMMUNITY,4.5779e-05,0.71945,0.62824,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,8.3641e-05,0.71889,0.65454,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,7.3279e-05,0.71835,0.65082,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,4.2763e-05,0.71784,0.65019,1,1
3,GO TYPE 2 IMMUNE RESPONSE,4.2763e-05,0.71754,0.7093,1,1
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.248e-05,0.71699,0.71385,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.4805e-05,0.71686,0.65354,1,1
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0012071,0.71632,0.57104,1,1
3,GO CHEMOKINE SECRETION,0.00024771,0.7162,0.70431,1,1
3,GO ETHANOL OXIDATION,1.2939e-05,0.71519,0.9026,1,1
3,GO REGULATION OF GLIAL CELL MIGRATION,0.00029789,0.71401,0.59863,1,1
3,GO NEUTROPHIL MIGRATION,6.4139e-05,0.71387,0.64917,1,1
3,GO HEMIDESMOSOME ASSEMBLY,0.010572,0.71281,0.53373,1,1
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00018128,0.71269,0.59748,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.6086e-05,0.71197,0.64985,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.3641e-05,0.7113,0.59567,1,1
3,GO RESPONSE TO INTERFERON GAMMA,9.5377e-05,0.71121,0.64111,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.00015974,0.71046,0.62991,1,1
3,GO MONONUCLEAR CELL MIGRATION,2.8267e-05,0.70982,0.71177,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.7287e-05,0.70973,0.70659,1,1
3,GO T CELL SELECTION,0.00033648,0.70952,0.62966,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00021879,0.70929,0.60107,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,0.00045436,0.70791,0.60377,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.00018128,0.70787,0.63969,1,1
3,GO INTERLEUKIN 8 PRODUCTION,2.1347e-05,0.70617,0.6263,1,1
3,GO GLIAL CELL ACTIVATION,0.00019306,0.70601,0.66749,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,0.0015041,0.70599,0.52958,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00081392,0.70555,0.58794,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,9.5377e-05,0.70503,0.6278,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00033648,0.70489,0.66386,1,1
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.6086e-05,0.70483,0.61351,1,1
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,8.9327e-05,0.70278,0.69727,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.00068502,0.70194,0.54341,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,9.5377e-05,0.70101,0.67591,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.00010866,0.69947,0.676,1,1
3,GO GERMINAL CENTER FORMATION,0.00054254,0.69922,0.64486,1,1
3,GO B CELL PROLIFERATION,0.00019306,0.6991,0.65755,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,0.00018128,0.69717,0.64708,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00012367,0.697,0.59916,1,1
3,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00086166,0.6968,0.6407,1,1
3,GO REGULATION OF B CELL PROLIFERATION,0.00019306,0.69358,0.6343,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.00018128,0.6927,0.62812,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,3.7287e-05,0.6906,0.63154,1,1
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,5.2428e-05,0.68967,0.69264,1,1
3,GO INTERLEUKIN 1 PRODUCTION,5.9985e-05,0.68926,0.65024,1,1
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00014989,0.68882,0.70822,1,1
3,GO REGULATION OF CELL KILLING,0.00010866,0.68822,0.63865,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00020554,0.68728,0.63942,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,8.3641e-05,0.68624,0.61156,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00014062,0.68532,0.6393,1,1
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00013188,0.68497,0.59792,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,6.8565e-05,0.68372,0.63605,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00040321,0.68259,0.62488,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00019306,0.67899,0.58222,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00029789,0.6787,0.6218,1,1
3,GO IMMUNOGLOBULIN SECRETION,0.00020554,0.67491,0.55497,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00019306,0.67432,0.55564,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.3279e-05,0.67388,0.64034,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.8298e-05,0.67353,0.59717,1,1
3,GO GRANULOCYTE MIGRATION,5.9985e-05,0.67295,0.61838,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00011593,0.67213,0.60709,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.00014989,0.67127,0.60291,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00019306,0.67077,0.58242,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00060992,0.67041,0.70391,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,8.9327e-05,0.66708,0.63313,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00013188,0.66683,0.57621,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,7.8298e-05,0.66668,0.58769,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00024771,0.66665,0.71765,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,4.8997e-05,0.66615,0.68786,1,1
3,GO INTERLEUKIN 17 PRODUCTION,9.5377e-05,0.66408,0.6232,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00014062,0.66306,0.60376,1,1
3,GO B CELL MEDIATED IMMUNITY,0.00014062,0.66279,0.60989,1,1
3,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.00040321,0.66259,0.6785,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00011593,0.66169,0.57387,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00060992,0.66044,0.58266,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00014989,0.66009,0.60277,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,7.3279e-05,0.65938,0.63967,1,1
3,GO INTERLEUKIN 5 PRODUCTION,0.0015882,0.65937,0.55348,1,1
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00014989,0.65914,0.76661,1,1
3,GO CELLULAR RESPONSE TO ETHANOL,0.00018128,0.6588,0.55264,1,1
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00064645,0.65812,0.59916,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00015974,0.65791,0.57708,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00096503,0.65738,0.54862,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00014062,0.65639,0.57553,1,1
3,GO COMPLEMENT ACTIVATION,0.00015974,0.65556,0.75405,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00010181,0.65532,0.59251,1,1
3,GO GRANULOCYTE CHEMOTAXIS,5.9985e-05,0.65487,0.6384,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00015974,0.65423,0.55798,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0015882,0.65352,0.55458,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0010798,0.65276,0.51686,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00051151,0.65186,0.55979,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,9.5377e-05,0.65166,0.56179,1,1
3,GO RESPONSE TO INTERFERON BETA,0.00014989,0.65095,0.57172,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00057531,0.65089,0.5804,1,1
3,GO RESPONSE TO LIPOTEICHOIC ACID,0.00015974,0.64947,0.63145,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00081392,0.64907,0.55885,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00013188,0.64789,0.57902,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00076864,0.64731,0.58215,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00010866,0.64711,0.62744,1,1
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00017019,0.6469,0.60957,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00096503,0.64651,0.53435,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00021879,0.64611,0.57038,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00048214,0.64574,0.54315,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00057531,0.64543,0.64225,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,3.4805e-05,0.64478,0.67808,1,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.3279e-05,0.64411,0.60425,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00014062,0.64344,0.61629,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00024771,0.64053,0.72591,1,1
3,GO MATURE B CELL DIFFERENTIATION,0.00013188,0.64046,0.63506,1,1
3,GO NEUROINFLAMMATORY RESPONSE,0.00033648,0.64033,0.5944,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.7249e-05,0.63901,0.65795,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.00018128,0.63596,0.55112,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.00018128,0.63344,0.5996,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.00045436,0.63142,0.57182,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00051151,0.62924,0.69187,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,9.5377e-05,0.62849,0.57566,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00020554,0.62753,0.59795,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00017019,0.62699,0.53995,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00020554,0.62676,0.57109,1,1
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00017019,0.6259,0.69192,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.00060992,0.62559,0.55405,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00028019,0.6251,0.54766,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00014989,0.62328,0.54595,1,1
3,GO FIBRINOLYSIS,0.00015974,0.62275,0.58643,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00010181,0.62247,0.53462,1,1
3,GO CYTOKINE METABOLIC PROCESS,6.4139e-05,0.61983,0.57842,1,1
3,GO REGULATION OF PHAGOCYTOSIS,0.00014062,0.61914,0.57387,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,8.9327e-05,0.6184,0.55117,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00017019,0.61836,0.54925,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0003797,0.61682,0.52831,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00011593,0.61663,0.54073,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.9327e-05,0.61505,0.54041,1,1
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010181,0.61407,0.62806,1,1
3,GO RESPONSE TO TYPE I INTERFERON,0.00040321,0.61285,0.52943,1,1
3,GO REGULATION OF MEMBRANE INVAGINATION,0.00072571,0.61282,0.59466,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,6.8565e-05,0.61252,0.61739,1,1
3,GO REGULATION OF MYOBLAST FUSION,0.00091199,0.61248,0.58261,1,1
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00040321,0.6123,0.61956,1,1
3,GO MACROPHAGE MIGRATION,6.4139e-05,0.61161,0.59464,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00019306,0.611,0.5338,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00020554,0.61069,0.60607,1,1
3,GO T CELL APOPTOTIC PROCESS,6.8565e-05,0.60975,0.55275,1,1
3,GO ETHANOL METABOLIC PROCESS,2.636e-05,0.6083,0.68427,1,1
3,GO AMYLOID BETA CLEARANCE,0.00018128,0.608,0.53649,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00020554,0.60736,0.50599,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012367,0.60636,0.55234,1,1
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00031664,0.60578,0.51647,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,7.3279e-05,0.60572,0.66159,1,1
3,GO T CELL PROLIFERATION,0.00021879,0.60554,0.55208,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00019306,0.60425,0.5303,1,1
3,GO REGULATION OF T CELL MIGRATION,0.00015974,0.60421,0.57141,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00018128,0.60359,0.54426,1,1
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.00011593,0.60346,0.58618,1,1
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00017019,0.60323,0.59914,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.00014062,0.60308,0.5396,1,1
3,GO I KAPPAB PHOSPHORYLATION,6.8565e-05,0.60299,0.54276,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00010866,0.60277,0.52839,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.6086e-05,0.60239,0.59064,1,1
3,GO ASTROCYTE ACTIVATION,0.00013188,0.60233,0.5252,1,1
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,3.7287e-05,0.60133,0.59237,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00023283,0.60093,0.54222,1,1
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,8.3641e-05,0.60058,0.61301,1,1
3,GO MACROPHAGE ACTIVATION,0.00017019,0.59976,0.5903,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.8298e-05,0.59973,0.59715,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0012071,0.59945,0.48524,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,5.6086e-05,0.59926,0.62029,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.00028019,0.5986,0.52359,1,1
3,GO NEUTROPHIL EXTRAVASATION,0.00019306,0.59815,0.58129,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,4.2763e-05,0.59809,0.61992,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00019306,0.59766,0.52406,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,5.9985e-05,0.597,0.56306,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00026348,0.59683,0.63502,1,1
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.00045436,0.59664,0.56567,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00015974,0.59648,0.57376,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,9.5377e-05,0.596,0.5441,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,8.3641e-05,0.59212,0.56782,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010181,0.59196,0.56953,1,1
3,GO PHAGOCYTOSIS RECOGNITION,0.00012367,0.59109,0.60962,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.00019306,0.59084,0.52045,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00028019,0.59005,0.56784,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.9327e-05,0.5891,0.54502,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.9327e-05,0.58884,0.54768,1,1
3,GO LEUKOCYTE PROLIFERATION,0.00023283,0.58708,0.54166,1,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00014062,0.58705,0.53573,1,1
3,GO MACROPHAGE CHEMOTAXIS,6.4139e-05,0.58676,0.56691,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.5377e-05,0.5856,0.52731,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015041,0.58516,0.51919,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,8.3641e-05,0.58501,0.52913,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00020554,0.58457,0.53773,1,1
3,GO PLASMINOGEN ACTIVATION,0.00040321,0.58387,0.51295,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,2.2907e-05,0.58386,0.55953,1,1
3,GO APOPTOTIC CELL CLEARANCE,0.00029789,0.58385,0.55943,1,1
3,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,3.7287e-05,0.58293,0.61753,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00019306,0.58261,0.511,1,1
3,GO BLEB ASSEMBLY,0.00064645,0.58221,0.55495,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014989,0.58165,0.54226,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0066311,0.58066,0.4703,1,1
3,GO CELLULAR EXTRAVASATION,0.00033648,0.58055,0.55431,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.58043,0.5245,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,4.2763e-05,0.57804,0.51728,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,6.8565e-05,0.57804,0.62939,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00011593,0.5777,0.52622,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.00081392,0.57734,0.53121,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00026348,0.57673,0.62654,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00018128,0.57523,0.49986,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00023283,0.57462,0.49553,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00012367,0.57423,0.52378,1,1
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.00018128,0.57358,0.60009,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00013188,0.57269,0.5719,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00033648,0.57191,0.4845,1,1
3,GO CELL KILLING,0.00017019,0.57121,0.52625,1,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00024771,0.5711,0.59117,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00051151,0.57069,0.53688,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,2.8267e-05,0.56982,0.57854,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00045436,0.5698,0.52658,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00020554,0.56842,0.53467,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00011593,0.56719,0.55328,1,1
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00060992,0.56605,0.47335,1,1
3,GO T CELL DIFFERENTIATION,0.00023283,0.5651,0.50377,1,1
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00024771,0.56499,0.61685,1,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00028019,0.56493,0.47619,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,8.9327e-05,0.56483,0.54721,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00091199,0.56355,0.51194,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00014989,0.56289,0.54564,1,1
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0012071,0.56255,0.49248,1,1
3,GO T CELL ACTIVATION,0.00021879,0.56184,0.50683,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00024771,0.5614,0.50592,1,1
3,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00081392,0.5613,0.61915,1,1
3,GO BONE TRABECULA MORPHOGENESIS,0.0052065,0.55955,0.45874,1,1
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,6.4139e-05,0.55916,0.60873,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00011593,0.55882,0.57681,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0010209,0.55858,0.5093,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00026348,0.5585,0.50153,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,0.00012367,0.55815,0.53839,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00054254,0.55776,0.53488,1,1
3,GO REGULATION OF CELL ACTIVATION,0.00024771,0.55727,0.48844,1,1
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.8565e-05,0.55649,0.60868,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,6.8565e-05,0.5564,0.53305,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,6.4139e-05,0.55637,0.60256,1,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.8298e-05,0.55601,0.58273,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.9327e-05,0.55559,0.53965,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,8.9327e-05,0.55518,0.50563,1,1
3,GO CD40 SIGNALING PATHWAY,0.00015974,0.55458,0.50763,1,1
3,GO MACROPHAGE PROLIFERATION,0.0012071,0.55386,0.64269,1,1
3,GO MACROPHAGE DIFFERENTIATION,0.00021879,0.55342,0.50354,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00014989,0.55302,0.51906,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,4.2763e-05,0.55301,0.59742,1,1
3,GO NEUTROPHIL HOMEOSTASIS,3.9936e-05,0.55299,0.5621,1,1
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,9.5377e-05,0.55176,0.53273,1,1
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00023283,0.55169,0.52882,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00026348,0.54961,0.49689,1,1
3,GO INTEGRIN ACTIVATION,0.00026348,0.54824,0.57874,1,1
3,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.0015882,0.54799,0.46495,1,1
3,GO INTERLEUKIN 6 PRODUCTION,0.00023283,0.5477,0.48731,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,5.2428e-05,0.54734,0.54601,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00068502,0.54659,0.49468,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0003797,0.54435,0.5649,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,8.9327e-05,0.54391,0.57875,1,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00042807,0.54272,0.48626,1,1
3,GO IMMUNE RESPONSE TO TUMOR CELL,3.7287e-05,0.54199,0.56364,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,8.3641e-05,0.54184,0.54232,1,1
3,GO LEUKOCYTE CHEMOTAXIS,0.00014062,0.54162,0.55211,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.8524e-05,0.54156,0.55129,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.8565e-05,0.54133,0.50338,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00042807,0.54106,0.46583,1,1
3,GO REGULATION OF B CELL ACTIVATION,0.00029789,0.54064,0.54886,1,1
3,GO CYTOKINE SECRETION,0.00010866,0.53883,0.49479,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,8.9327e-05,0.53815,0.57247,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.00026348,0.53777,0.50056,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00014989,0.53737,0.5595,1,1
3,GO RESPONSE TO INTERFERON ALPHA,0.00033648,0.53459,0.58758,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.00018128,0.53391,0.45825,1,1
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00011593,0.53324,0.60375,1,1
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0003797,0.53121,0.54559,1,1
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,2.636e-05,0.5306,0.47544,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0010209,0.53011,0.43905,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00014062,0.52945,0.53701,1,1
3,GO RESPIRATORY BURST,0.0010209,0.52929,0.46979,1,1
3,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.0010798,0.52863,0.57475,1,1
3,GO CYTIDINE TO URIDINE EDITING,0.00029789,0.52856,0.50583,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.3279e-05,0.52851,0.48844,1,1
3,GO RESPONSE TO MURAMYL DIPEPTIDE,7.8298e-05,0.52787,0.51886,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.8997e-05,0.52709,0.58131,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.5779e-05,0.52688,0.53317,1,1
3,GO PHAGOCYTOSIS,0.00015974,0.52662,0.48376,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,3.7287e-05,0.5265,0.5177,1,1
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0021907,0.52179,0.48658,1,1
3,GO ACUTE PHASE RESPONSE,2.636e-05,0.52157,0.54544,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,7.8298e-05,0.52079,0.54425,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00014062,0.52056,0.46901,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.00017019,0.52005,0.44291,1,1
3,GO NAD BIOSYNTHETIC PROCESS,2.8267e-05,0.51974,0.49127,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,6.4139e-05,0.51935,0.50657,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00010866,0.51928,0.4393,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.00021879,0.51879,0.47923,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00054254,0.51822,0.53416,1,1
3,GO MEMBRANE RAFT ORGANIZATION,0.00072571,0.5181,0.48313,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00060992,0.51752,0.50231,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00024771,0.51687,0.45394,1,1
3,GO INNATE IMMUNE RESPONSE,0.00010866,0.51676,0.46177,1,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010866,0.51662,0.49672,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.00042807,0.51467,0.43314,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00010181,0.51355,0.51055,1,1
3,GO LYMPH NODE DEVELOPMENT,0.0044907,0.5135,0.41309,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00024771,0.51205,0.52719,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.00011593,0.51181,0.52784,1,1
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0016767,0.51176,0.47257,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00028019,0.51158,0.49612,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00028019,0.51151,0.42266,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00026348,0.51137,0.47133,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00020554,0.5106,0.4652,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00012367,0.51013,0.48615,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00064645,0.50982,0.44905,1,1
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00060992,0.50977,0.52468,1,1
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.2907e-05,0.50968,0.61459,1,1
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00023283,0.50907,0.48255,1,1
3,GO HUMORAL IMMUNE RESPONSE,0.00014062,0.50903,0.57765,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,4.8997e-05,0.50873,0.5216,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00033648,0.50762,0.47162,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,8.9327e-05,0.50734,0.46705,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00011593,0.50662,0.46617,1,1
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00013188,0.50593,0.5316,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00014989,0.50566,0.49139,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00057531,0.50515,0.58965,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00033648,0.50512,0.48188,1,1
3,GO PROTEIN ACTIVATION CASCADE,0.00021879,0.50491,0.59346,1,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,5.6086e-05,0.50383,0.56492,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00014989,0.50374,0.44737,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00033648,0.50315,0.43742,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,5.9985e-05,0.50298,0.49534,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00010181,0.50266,0.49384,1,1
3,GO REGULATION OF BONE DEVELOPMENT,7.8298e-05,0.50195,0.55765,1,1
3,GO ZYMOGEN INHIBITION,0.00020554,0.50123,0.49967,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00028019,0.50068,0.41531,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00023283,0.50056,0.45926,1,1
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.3641e-05,0.50038,0.5377,1,1
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00015974,0.50017,0.47937,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.00028019,0.4995,0.45238,1,1
3,GO PEPTIDE CROSS LINKING,0.00035748,0.49936,0.50598,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00010181,0.49841,0.44393,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00015974,0.49769,0.43765,1,1
3,GO B CELL HOMEOSTASIS,0.0010209,0.49723,0.41496,1,1
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,3.248e-05,0.49631,0.59487,1,1
3,GO LYMPHOCYTE ACTIVATION,0.00023283,0.49619,0.46377,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0023095,0.49519,0.46702,1,1
3,GO CHEMOKINE PRODUCTION,7.8298e-05,0.49475,0.50537,1,1
3,GO INTERFERON ALPHA PRODUCTION,0.00028019,0.49438,0.46286,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00010181,0.49369,0.4599,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.8267e-05,0.49343,0.50187,1,1
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00040321,0.49307,0.41994,1,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0011418,0.493,0.46863,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.0014241,0.49262,0.5288,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.49156,0.502,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00014989,0.48994,0.47242,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00029789,0.4897,0.45771,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.00048214,0.48837,0.53495,1,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,8.9327e-05,0.48797,0.60511,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00012367,0.48777,0.43615,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00035748,0.48758,0.58433,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00014989,0.48748,0.44417,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.00019306,0.48575,0.45448,1,1
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0083971,0.48533,0.45172,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0018673,0.48471,0.40769,1,1
3,GO RESPONSE TO HYDROPEROXIDE,0.00054254,0.48447,0.47744,1,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0042727,0.48421,0.40983,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,6.4139e-05,0.48417,0.49659,1,1
3,GO TUMOR NECROSIS FACTOR SECRETION,3.4805e-05,0.48379,0.47443,1,1
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00054254,0.48179,0.5239,1,1
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,2.4576e-05,0.48154,0.48453,1,1
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00031664,0.48143,0.50596,1,1
3,GO CELL CHEMOTAXIS,0.00020554,0.48087,0.48922,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00014062,0.48031,0.4254,1,1
3,GO REGULATION OF PLATELET ACTIVATION,0.0010209,0.47964,0.51375,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00023283,0.47933,0.4887,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0038653,0.47916,0.43991,1,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00045436,0.47893,0.49157,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00057531,0.4775,0.47532,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023283,0.47674,0.45849,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0024341,0.47659,0.44399,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00013188,0.47596,0.4335,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.47587,0.41928,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00040321,0.47579,0.43832,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00064645,0.47557,0.44617,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,6.4139e-05,0.47525,0.47168,1,1
3,GO MULTI ORGANISM CELLULAR PROCESS,0.00031664,0.475,0.50362,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,6.8565e-05,0.47363,0.49587,1,1
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0014241,0.47264,0.47491,1,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00011593,0.47238,0.4321,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.00072571,0.47219,0.40697,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.2907e-05,0.47205,0.48325,1,1
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00017019,0.47196,0.46329,1,1
3,GO IMMUNE EFFECTOR PROCESS,0.00014062,0.47134,0.4206,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00014989,0.4703,0.48021,1,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00029789,0.46996,0.43107,1,1
3,GO THYMOCYTE APOPTOTIC PROCESS,8.3641e-05,0.46812,0.44996,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00019306,0.46807,0.46559,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.3279e-05,0.46775,0.4947,1,1
3,GO T CELL DIFFERENTIATION IN THYMUS,0.00060992,0.46759,0.4198,1,1
3,GO CYTOKINE PRODUCTION,0.00013188,0.46663,0.43181,1,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00019306,0.46586,0.46047,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00017019,0.46561,0.43361,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00019306,0.46372,0.50483,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00024771,0.46312,0.39275,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00014989,0.46224,0.47521,1,1
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00048214,0.46215,0.47436,1,1
3,GO MITRAL VALVE DEVELOPMENT,0.0036751,0.46206,0.36854,1,1
3,GO VITAMIN D METABOLIC PROCESS,0.00028019,0.46189,0.45551,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00015974,0.4612,0.40586,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00020554,0.46094,0.48613,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00014989,0.46044,0.46905,1,1
3,GO INFLAMMATORY RESPONSE,0.00015974,0.45986,0.46155,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00031664,0.45792,0.51599,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.5377e-05,0.45752,0.45416,1,1
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,6.8565e-05,0.45733,0.4992,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00051151,0.45702,0.52352,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00081392,0.45683,0.43966,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,8.9327e-05,0.45675,0.44029,1,1
3,GO MYELOID CELL APOPTOTIC PROCESS,1.7249e-05,0.45658,0.45659,1,1
3,GO T CELL LINEAGE COMMITMENT,0.00040321,0.45555,0.4837,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,0.00019306,0.45539,0.41642,1,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.00017019,0.45536,0.45763,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00026348,0.45527,0.46943,1,1
3,GO SUPEROXIDE ANION GENERATION,0.00045436,0.45474,0.43152,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00020554,0.4543,0.44627,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00011593,0.45414,0.48787,1,1
3,GO MEMBRANE INVAGINATION,0.00091199,0.45401,0.41936,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0003797,0.45391,0.38379,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.00086166,0.45379,0.57744,1,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,6.8565e-05,0.45297,0.52946,1,1
3,GO MONONUCLEAR CELL DIFFERENTIATION,2.8267e-05,0.45277,0.55663,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0036751,0.45257,0.50202,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015041,0.45245,0.4215,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.00021879,0.45216,0.41885,1,1
3,GO OSTEOCLAST DIFFERENTIATION,0.00028019,0.45194,0.40652,1,1
3,GO FEVER GENERATION,0.00018128,0.45184,0.4241,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00035748,0.45138,0.42673,1,1
3,GO OSTEOCLAST DEVELOPMENT,0.00017019,0.45102,0.55582,1,1
3,GO LEUKOCYTE MIGRATION,0.00026348,0.45057,0.46798,1,1
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00020554,0.45042,0.53017,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0015882,0.45028,0.39699,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00019306,0.44951,0.43787,1,1
3,GO LIPOPROTEIN LOCALIZATION,0.00012367,0.44937,0.42239,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00017019,0.44921,0.48163,1,1
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00024771,0.44899,0.44499,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00014989,0.44806,0.43509,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,2.8267e-05,0.44524,0.47559,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00020554,0.44421,0.43934,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.44395,0.44644,1,1
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00051151,0.44368,0.44294,1,1
3,GO AMINE CATABOLIC PROCESS,0.00015974,0.44274,0.39398,1,1
3,GO B CELL ACTIVATION,0.00024771,0.44232,0.46618,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00048214,0.4418,0.51343,1,1
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00028019,0.44016,0.63618,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00028019,0.43965,0.41615,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00020554,0.43948,0.42136,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00014989,0.43943,0.46177,1,1
3,GO RESPONSE TO INTERLEUKIN 2,0.0028457,0.43866,0.47752,1,1
3,GO RESPONSE TO BACTERIUM,0.00010181,0.4384,0.46703,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,0.00010866,0.43771,0.40351,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.00011593,0.43724,0.45871,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00045436,0.43612,0.44692,1,1
3,GO DEFENSE RESPONSE,0.00013188,0.43559,0.40516,1,1
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00068502,0.43505,0.39353,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00072571,0.4338,0.45034,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.00018128,0.43317,0.47212,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00020554,0.43299,0.46758,1,1
3,GO SOMATIC STEM CELL DIVISION,0.0042727,0.4317,0.41642,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.00096503,0.43151,0.37987,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.636e-05,0.43107,0.44268,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00057531,0.43045,0.34542,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00051151,0.42952,0.39671,1,1
3,GO ACTIN FILAMENT SEVERING,0.00045436,0.42772,0.46361,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00031664,0.4275,0.3929,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,9.5377e-05,0.42692,0.46312,1,1
3,GO RETINAL METABOLIC PROCESS,5.6086e-05,0.42681,0.50365,1,1
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.9888e-05,0.42672,0.43391,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00020554,0.42655,0.38213,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00048214,0.42641,0.41705,1,1
3,GO RESPONSE TO TUMOR CELL,0.00028019,0.42621,0.45232,1,1
3,GO CHOLESTEROL STORAGE,0.00031664,0.42593,0.45429,1,1
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00048214,0.4254,0.45249,1,1
3,GO MYOBLAST FUSION,0.00040321,0.42525,0.44474,1,1
3,GO REGULATION OF FIBRINOLYSIS,0.00021879,0.42523,0.55391,1,1
3,GO CELL ACTIVATION,0.00024771,0.4252,0.39037,1,1
3,GO REGULATION OF STEM CELL DIVISION,0.0016767,0.42492,0.45859,1,1
3,GO OSTEOBLAST DEVELOPMENT,0.0010798,0.42407,0.35488,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.7287e-05,0.42395,0.40662,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.0019699,0.42358,0.40932,1,1
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.2035e-05,0.42302,0.44041,1,1
3,GO SKIN MORPHOGENESIS,0.0049572,0.42246,0.38872,1,1
3,GO ENTRY INTO HOST,0.00018128,0.42232,0.40968,1,1
3,GO PROSTANOID METABOLIC PROCESS,6.8565e-05,0.42193,0.42539,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00035748,0.42192,0.40702,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0028457,0.42192,0.3729,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00012367,0.42174,0.44132,1,1
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0012071,0.42155,0.4439,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00048214,0.42102,0.44168,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00029789,0.42065,0.4886,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0031545,0.41939,0.44256,1,1
3,GO FLUID TRANSPORT,0.00081392,0.41935,0.43087,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.0304e-05,0.41869,0.44147,1,1
3,GO HYPOTONIC RESPONSE,0.0011418,0.41862,0.37653,1,1
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00035748,0.41862,0.45679,1,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0012758,0.41803,0.38885,1,1
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00015974,0.41779,0.42298,1,1
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00011593,0.41765,0.55349,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00015974,0.41714,0.44333,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,0.00096503,0.41706,0.4337,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0003797,0.41656,0.54926,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00011593,0.41617,0.4205,1,1
3,GO RESPONSE TO VIRUS,0.00014989,0.41608,0.39819,1,1
3,GO RESPONSE TO PROSTAGLANDIN,0.00086166,0.41556,0.40172,1,1
3,GO FOAM CELL DIFFERENTIATION,0.00060992,0.41534,0.42389,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0040644,0.41531,0.40563,1,1
3,GO WATER TRANSPORT,0.0023095,0.41385,0.42403,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.0003797,0.41369,0.35668,1,1
3,GO ASTROCYTE DEVELOPMENT,0.00017019,0.41297,0.44583,1,1
3,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0013481,0.41251,0.39137,1,1
3,GO BONE RESORPTION,0.0015882,0.41212,0.38555,1,1
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,7.8298e-05,0.41146,0.53979,1,1
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00042807,0.41101,0.47934,1,1
3,GO MACROPHAGE APOPTOTIC PROCESS,0.0016767,0.41083,0.42016,1,1
3,GO RETINOL METABOLIC PROCESS,7.1973e-06,0.41023,0.4325,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00057531,0.41003,0.44579,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00086166,0.4091,0.34004,1,1
3,GO RESPONSE TO INTERLEUKIN 1,3.248e-05,0.40885,0.37722,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.0036751,0.40841,0.40996,1,1
3,GO COLLAGEN CATABOLIC PROCESS,0.00072571,0.40786,0.4439,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,7.8298e-05,0.4072,0.46757,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0029965,0.40715,0.40734,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,7.8298e-05,0.4066,0.69543,1,1
3,GO REGULATION OF DEFENSE RESPONSE,0.00014989,0.40659,0.36767,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.00011593,0.40637,0.40586,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00021879,0.40566,0.38458,1,1
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0083971,0.40523,0.34012,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00029789,0.40498,0.40959,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0003797,0.40475,0.35126,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00035748,0.40456,0.42167,1,1
3,GO TRANSCYTOSIS,0.0025648,0.40449,0.40145,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0018673,0.40382,0.34541,1,1
3,GO PINOCYTOSIS,0.00072571,0.40306,0.3876,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,5.9985e-05,0.40294,0.43348,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00028019,0.40281,0.4002,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00015974,0.40244,0.38089,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.5377e-05,0.40179,0.38525,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00029789,0.40165,0.44156,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,6.4139e-05,0.40153,0.51201,1,1
3,GO BONE CELL DEVELOPMENT,0.00045436,0.40102,0.41498,1,1
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00051151,0.40028,0.37514,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.00011593,0.39994,0.44362,1,1
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0016767,0.39968,0.40897,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00028019,0.39929,0.37351,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00068502,0.39899,0.37336,1,1
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0019699,0.39895,0.33445,1,1
3,GO ETHANOL CATABOLIC PROCESS,0.00014062,0.39894,0.42168,1,1
3,GO SYNCYTIUM FORMATION,0.00020554,0.39817,0.43104,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.3973,0.45413,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00011593,0.39625,0.47499,1,1
3,GO ERK1 AND ERK2 CASCADE,0.00031664,0.39586,0.38213,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00010866,0.39527,0.36958,1,1
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00064645,0.39491,0.42418,1,1
3,GO MUCUS SECRETION,0.00015974,0.39365,0.43619,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,5.6086e-05,0.39336,0.47119,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,7.8298e-05,0.39323,0.33656,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00018128,0.39289,0.42913,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00048214,0.39281,0.35113,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00042807,0.39158,0.39015,1,1
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0020776,0.39121,0.34259,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00026348,0.39108,0.51055,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00035748,0.39051,0.4406,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00011593,0.39015,0.35949,1,1
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.00023283,0.38998,0.43611,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,4.5779e-05,0.38993,0.42951,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.9985e-05,0.3891,0.39176,1,1
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.00081392,0.38807,0.41067,1,1
3,GO REGULATION OF STEROL TRANSPORT,0.00040321,0.38802,0.36533,1,1
3,GO HYALURONAN CATABOLIC PROCESS,0.00010181,0.38772,0.47498,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00054254,0.38768,0.39359,1,1
3,GO ETHER BIOSYNTHETIC PROCESS,0.00024771,0.38694,0.38018,1,1
3,GO B CELL DIFFERENTIATION,0.00021879,0.3864,0.45887,1,1
3,GO RESPONSE TO CYTOKINE,0.00012367,0.38489,0.36881,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,9.5377e-05,0.38478,0.43842,1,1
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00057531,0.38465,0.42227,1,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.00060992,0.38455,0.42053,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,9.5377e-05,0.38404,0.40167,1,1
3,GO PODOSOME ASSEMBLY,0.00057531,0.38377,0.42879,1,1
3,GO PROGRAMMED NECROTIC CELL DEATH,0.00033648,0.38372,0.36441,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00014989,0.38303,0.34707,1,1
3,GO SEQUESTERING OF METAL ION,0.00057531,0.38235,0.42787,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0057394,0.38122,0.29036,1,1
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00051151,0.38093,0.39902,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0011418,0.38083,0.39532,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0020776,0.38074,0.32825,1,1
3,GO STORE OPERATED CALCIUM ENTRY,0.00028019,0.38056,0.38172,1,1
3,GO STEROL HOMEOSTASIS,8.3641e-05,0.3805,0.37674,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00035748,0.38022,0.44791,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00091199,0.38002,0.28403,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0023095,0.37973,0.35597,1,1
3,GO CELL ADHESION MOLECULE PRODUCTION,0.0012758,0.37903,0.44467,1,1
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00014989,0.37901,0.42574,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00057531,0.37879,0.37244,1,1
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00068502,0.37869,0.44487,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00010181,0.37863,0.40272,1,1
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00014062,0.37841,0.41828,1,1
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00021879,0.3783,0.36704,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00023283,0.37791,0.38216,1,1
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00054254,0.37766,0.44998,1,1
3,GO SKELETAL MUSCLE TISSUE REGENERATION,5.6086e-05,0.37676,0.37004,1,1
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0011418,0.37608,0.3578,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0020776,0.37571,0.46776,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.248e-05,0.37545,0.41898,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0025648,0.37485,0.35836,1,1
3,GO T CELL HOMEOSTASIS,0.0014241,0.37484,0.33041,1,1
3,GO NIK NF KAPPAB SIGNALING,8.9327e-05,0.37439,0.33251,1,1
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00057531,0.37381,0.42651,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.0023095,0.37372,0.30848,1,1
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.0016767,0.37328,0.36045,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0020776,0.37319,0.41103,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.0014241,0.37315,0.35439,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00076864,0.3728,0.3058,1,1
3,GO REGULATION OF LIPASE ACTIVITY,5.9985e-05,0.37253,0.39164,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,7.3279e-05,0.37237,0.38824,1,1
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0010209,0.37219,0.42305,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.00091199,0.37217,0.38261,1,1
3,GO PROTEIN TRIMERIZATION,0.00033648,0.37202,0.45139,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00019306,0.37198,0.35645,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0015882,0.37151,0.41089,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,5.9985e-05,0.37035,0.46266,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,8.3641e-05,0.37002,0.41518,1,1
3,GO PROTEIN NITROSYLATION,0.00026348,0.36994,0.36197,1,1
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0036751,0.36978,0.37065,1,1
3,GO VAGINA DEVELOPMENT,0.010101,0.36953,0.32016,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0003797,0.36891,0.4275,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00035748,0.36829,0.37879,1,1
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.8267e-05,0.36804,0.42352,1,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.00076864,0.36776,0.3454,1,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022172,0.36742,0.28925,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,8.9327e-05,0.36706,0.49417,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.019548,0.36645,0.25817,1,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8524e-05,0.36601,0.40652,1,1
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.0019699,0.36529,0.52962,1,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,5.9985e-05,0.36523,0.38959,1,1
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,5.6086e-05,0.36514,0.39902,1,1
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0015882,0.36509,0.35119,1,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.00018128,0.36477,0.36919,1,1
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.010572,0.36473,0.30624,1,1
3,GO PYROPTOSIS,0.00091199,0.36451,0.40629,1,1
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.7287e-05,0.3645,0.37455,1,1
3,GO DIET INDUCED THERMOGENESIS,0.0029965,0.36443,0.32821,1,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,8.3641e-05,0.36379,0.40098,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0015882,0.36342,0.3259,1,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00035748,0.36329,0.43388,1,1
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0015882,0.36273,0.34868,1,1
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0015041,0.36269,0.55526,1,1
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0042727,0.36266,0.35895,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0015882,0.36249,0.38078,1,1
3,GO COLLAGEN METABOLIC PROCESS,0.0010209,0.36174,0.40818,1,1
3,GO REGULATION OF CHEMOTAXIS,0.00035748,0.36171,0.3882,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0012071,0.36123,0.41113,1,1
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0040644,0.36089,0.36006,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,0.00017019,0.35982,0.35482,1,1
3,GO RENAL ABSORPTION,0.0003797,0.35979,0.47315,1,1
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00023283,0.35974,0.3869,1,1
3,GO INTERFERON BETA PRODUCTION,0.00072571,0.35928,0.35766,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,4.2763e-05,0.35903,0.43008,1,1
3,GO MAST CELL ACTIVATION,0.0096484,0.35893,0.33439,1,1
3,GO RESPONSE TO FUNGUS,0.0027019,0.35837,0.36829,1,1
3,GO REGULATION OF BONE REMODELING,0.006955,0.35763,0.30523,1,1
3,GO ZYMOGEN ACTIVATION,0.00033648,0.35752,0.40854,1,1
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.0021907,0.35637,0.35785,1,1
3,GO GAP JUNCTION ASSEMBLY,0.0018673,0.3563,0.45793,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026348,0.35628,0.34051,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.0015041,0.35583,0.30973,1,1
3,GO MAST CELL MEDIATED IMMUNITY,0.012106,0.35537,0.31791,1,1
3,GO INTERACTION WITH SYMBIONT,1.7249e-05,0.35537,0.36881,1,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00091199,0.35371,0.42675,1,1
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00033648,0.3533,0.3582,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00060992,0.35325,0.43098,1,1
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.00029789,0.35308,0.44708,1,1
3,GO LYMPHANGIOGENESIS,0.0013481,0.35256,0.42336,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0027019,0.35202,0.33261,1,1
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0060238,0.35159,0.4075,1,1
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00072571,0.35067,0.41681,1,1
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00012367,0.34953,0.48396,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.00018128,0.34947,0.34746,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.00028019,0.3489,0.43301,1,1
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0017696,0.34831,0.37698,1,1
3,GO COLLAGEN FIBRIL ORGANIZATION,0.0052065,0.3481,0.45821,1,1
3,GO PROSTATE GLAND GROWTH,0.00045436,0.34791,0.38977,1,1
3,GO GAS TRANSPORT,0.014457,0.34783,0.34082,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00010866,0.34769,0.3483,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00096503,0.34766,0.45502,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00021879,0.34737,0.36372,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00012367,0.34728,0.3619,1,1
3,GO LIPOXYGENASE PATHWAY,0.018736,0.34547,0.33548,1,1
3,GO TRABECULA FORMATION,0.0096484,0.34436,0.31615,1,1
3,GO DNA DEAMINATION,0.0016767,0.34299,0.35915,1,1
3,GO ENDODERMAL CELL DIFFERENTIATION,0.0025648,0.34286,0.41844,1,1
3,GO MYELOID CELL DEVELOPMENT,0.00029789,0.34276,0.36482,1,1
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0017696,0.34275,0.35547,1,1
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0038653,0.34268,0.37657,1,1
3,GO BONE REMODELING,0.0024341,0.34227,0.33189,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.00042807,0.34224,0.31554,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00054254,0.34214,0.35177,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00026348,0.34171,0.36335,1,1
3,GO REGULATION OF CELL ADHESION,0.00045436,0.34156,0.37459,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0012071,0.34085,0.33655,1,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0038653,0.33998,0.31729,1,1
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00010866,0.33977,0.43126,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0016767,0.3393,0.36281,1,1
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00010866,0.33911,0.37345,1,1
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00023283,0.33896,0.38742,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00033648,0.33869,0.32286,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,4.8997e-05,0.33842,0.35121,1,1
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00096503,0.33814,0.33691,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00035748,0.33773,0.44488,1,1
3,GO RESPONSE TO MANGANESE ION,0.00023283,0.33755,0.33528,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072571,0.33674,0.37542,1,1
3,GO MODULATION BY HOST OF VIRAL PROCESS,7.3279e-05,0.33639,0.34204,1,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.00029789,0.33593,0.34668,1,1
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.8565e-05,0.3359,0.42281,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.0049572,0.33538,0.35033,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00024771,0.33536,0.35977,1,1
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0013481,0.33529,0.32926,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,0.0028457,0.33489,0.39377,1,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00033648,0.33482,0.34945,1,1
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00091199,0.33447,0.39788,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.00057531,0.33412,0.32468,1,1
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00010866,0.33402,0.40519,1,1
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.00086166,0.33341,0.36592,1,1
3,GO LIVER MORPHOGENESIS,0.00018128,0.33333,0.36866,1,1
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.0018673,0.33324,0.37083,1,1
3,GO DRUG CATABOLIC PROCESS,0.006955,0.33242,0.24982,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00045436,0.33169,0.32167,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00045436,0.33137,0.31538,1,1
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0016767,0.33052,0.35767,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0014241,0.33039,0.35863,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,0.016475,0.33032,0.22335,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00048214,0.33031,0.40077,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.0017696,0.32996,0.3494,1,1
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00017019,0.32965,0.34933,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00014062,0.32945,0.37557,1,1
3,GO SERTOLI CELL DEVELOPMENT,0.00091199,0.32941,0.32884,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00040321,0.32864,0.36022,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00057531,0.32864,0.30572,1,1
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.015104,0.32812,0.27875,1,1
3,GO TRANSEPITHELIAL TRANSPORT,0.0024341,0.32791,0.32212,1,1
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0012758,0.32788,0.39259,1,1
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00033648,0.32706,0.39134,1,1
3,GO CELLULAR RESPONSE TO SALT STRESS,6.8565e-05,0.32699,0.41117,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0018673,0.32665,0.36346,1,1
3,GO LYMPH VESSEL DEVELOPMENT,0.0029965,0.32567,0.40659,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,3.4805e-05,0.32553,0.35846,1,1
3,GO CHONDROCYTE PROLIFERATION,0.0057394,0.3255,0.33781,1,1
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00060992,0.32536,0.3514,1,1
3,GO EPOXYGENASE P450 PATHWAY,0.00072571,0.32516,0.33631,1,1
3,GO P38MAPK CASCADE,0.00013188,0.32463,0.3814,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00042807,0.32388,0.32493,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00015974,0.32376,0.34278,1,1
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.015776,0.32373,0.34254,1,1
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0025648,0.32366,0.37191,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0017696,0.3232,0.27384,1,1
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0015041,0.32279,0.40984,1,1
3,GO CORNIFICATION,0.013235,0.32239,0.26155,1,1
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00091199,0.32225,0.29363,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0010209,0.32199,0.31444,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00015974,0.32181,0.41164,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00042807,0.32173,0.39206,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.00051151,0.3213,0.32591,1,1
3,GO STEROID ESTERIFICATION,0.0010798,0.32114,0.29437,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0052065,0.32073,0.31138,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0018673,0.32065,0.37565,1,1
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00014989,0.32049,0.31885,1,1
3,GO RETINOIC ACID METABOLIC PROCESS,0.00054254,0.32033,0.3454,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00042807,0.32016,0.40728,1,1
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.011063,0.32004,0.28072,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00045436,0.31984,0.31238,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0011418,0.31978,0.33991,1,1
3,GO CHOLESTEROL EFFLUX,0.0029965,0.31977,0.28399,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00072571,0.31943,0.31202,1,1
3,GO PLATELET ACTIVATION,0.010101,0.31881,0.30908,1,1
3,GO SEROTONIN SECRETION,0.023112,0.31821,0.31744,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.014457,0.31775,0.26655,1,1
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0025648,0.31691,0.29849,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00010866,0.31658,0.30448,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00096503,0.31631,0.38133,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00068502,0.31576,0.39389,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0010209,0.31562,0.34305,1,1
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,8.3641e-05,0.31553,0.43629,1,1
3,GO REGULATION OF PLATELET AGGREGATION,0.007293,0.31511,0.33899,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0014241,0.31505,0.35456,1,1
3,GO RESPONSE TO DSRNA,0.00045436,0.31472,0.30166,1,1
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00023283,0.31456,0.3512,1,1
3,GO DECIDUALIZATION,0.0014241,0.31422,0.3506,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00096503,0.31411,0.38702,1,1
3,GO EPIDERMIS MORPHOGENESIS,0.0047188,0.31402,0.32028,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.00072571,0.31399,0.34967,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0011418,0.31392,0.31328,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00035748,0.31338,0.31935,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.0003797,0.31313,0.33515,1,1
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00091199,0.31261,0.40289,1,1
3,GO REGULATION OF CALCIUM ION IMPORT,0.0010798,0.31143,0.338,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00091199,0.31137,0.36364,1,1
3,GO REGULATION OF LIPID STORAGE,0.00091199,0.31113,0.3162,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00060992,0.31106,0.33426,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0012758,0.31095,0.34258,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00020554,0.31027,0.35922,1,1
3,GO FIBROBLAST ACTIVATION,0.0029965,0.31024,0.29971,1,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0034935,0.31013,0.34212,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.008797,0.30971,0.29538,1,1
3,GO REGULATION OF TISSUE REMODELING,0.0047188,0.30921,0.31556,1,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0034935,0.30911,0.25987,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.01266,0.30909,0.31127,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0040644,0.30862,0.34069,1,1
3,GO AMYLOID FIBRIL FORMATION,0.0018673,0.30797,0.34285,1,1
3,GO REGULATION OF ISOTYPE SWITCHING,0.0010209,0.30779,0.35431,1,1
3,GO NOTOCHORD DEVELOPMENT,0.0172,0.30773,0.25306,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00068502,0.30733,0.33204,1,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0012758,0.30713,0.28873,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.3279e-05,0.30629,0.34046,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00064645,0.30619,0.35094,1,1
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0025648,0.30546,0.33728,1,1
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.0010798,0.30524,0.36754,1,1
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0023095,0.30478,0.27009,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00064645,0.30477,0.26394,1,1
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00031664,0.3046,0.36409,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.0013481,0.30436,0.30703,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0057394,0.30424,0.3559,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,8.3641e-05,0.30384,0.3484,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.0010209,0.3029,0.30869,1,1
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00031664,0.30275,0.3622,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00026348,0.3024,0.37115,1,1
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.0014241,0.30231,0.3277,1,1
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0017696,0.30195,0.4673,1,1
3,GO CERAMIDE TRANSPORT,0.016475,0.30061,0.24532,1,1
3,GO RIG I SIGNALING PATHWAY,0.00064645,0.3,0.28541,1,1
3,GO PLATELET DEGRANULATION,0.0013481,0.29996,0.39736,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00091199,0.29889,0.29064,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0018673,0.29845,0.28056,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.0003797,0.29841,0.26437,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.0031545,0.29835,0.27716,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00031664,0.29835,0.31797,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0034935,0.29812,0.34684,1,1
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0060238,0.29805,0.3153,1,1
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.00042807,0.29802,0.37141,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00057531,0.29763,0.39146,1,1
3,GO REGULATION OF PINOCYTOSIS,0.011574,0.29755,0.26028,1,1
3,GO RESPONSE TO THYROID HORMONE,0.008797,0.29703,0.257,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0019699,0.29701,0.23586,1,1
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00028019,0.29666,0.38418,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00042807,0.29656,0.36448,1,1
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00332,0.29632,0.29134,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00013188,0.29631,0.34137,1,1
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00051151,0.29615,0.36978,1,1
3,GO NECROTIC CELL DEATH,0.00072571,0.29506,0.29659,1,1
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0019699,0.29506,0.37539,1,1
3,GO TISSUE REMODELING,0.0017696,0.29487,0.35577,1,1
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.0063209,0.29487,0.32089,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0012071,0.29427,0.30515,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0021907,0.29427,0.32661,1,1
3,GO CALCIUM MEDIATED SIGNALING,0.0017696,0.29415,0.29907,1,1
3,GO KERATINOCYTE PROLIFERATION,0.0025648,0.29407,0.29929,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00068502,0.29405,0.25387,1,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.015776,0.29399,0.26267,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00020554,0.29389,0.30929,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00051151,0.29377,0.34324,1,1
3,GO STEM CELL DIVISION,0.010101,0.29336,0.26802,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0049572,0.29335,0.335,1,1
3,GO INTERACTION WITH HOST,0.00019306,0.29302,0.29024,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0034935,0.2926,0.21327,1,1
3,GO MAMMARY GLAND MORPHOGENESIS,0.0012071,0.29259,0.35688,1,1
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00024771,0.29253,0.29871,1,1
3,GO CELLULAR RESPONSE TO DSRNA,0.0016767,0.29226,0.3342,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00045436,0.29181,0.31789,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0010798,0.29175,0.3228,1,1
3,GO THYROID HORMONE METABOLIC PROCESS,0.0080134,0.29124,0.25246,1,1
3,GO RESPONSE TO INACTIVITY,0.014457,0.29121,0.23353,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.0003797,0.29106,0.29864,1,1
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.010572,0.29104,0.32445,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0047188,0.29085,0.32815,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.018736,0.29076,0.27632,1,1
3,GO RESPONSE TO AMYLOID BETA,0.014457,0.29072,0.27754,1,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0017696,0.28977,0.34823,1,1
3,GO ARTERY MORPHOGENESIS,0.0012758,0.28959,0.34862,1,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00026348,0.28933,0.36562,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,6.8565e-05,0.28928,0.29339,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.00023283,0.28913,0.35003,1,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00028019,0.28905,0.34613,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.00035748,0.28852,0.31574,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.0015041,0.28843,0.31798,1,1
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.011063,0.28835,0.26284,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0057394,0.28826,0.21384,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00086166,0.28795,0.37451,1,1
3,GO LUNG MORPHOGENESIS,0.00332,0.28787,0.30396,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0016767,0.28738,0.32429,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0014241,0.28735,0.26512,1,1
3,GO URETER DEVELOPMENT,0.027226,0.28734,0.21415,1,1
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.00033648,0.28624,0.33551,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.013235,0.28586,0.33146,1,1
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00332,0.28536,0.28173,1,1
3,GO TERPENOID METABOLIC PROCESS,4.2763e-05,0.28499,0.28924,1,1
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0057394,0.28477,0.32817,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00029789,0.28461,0.35123,1,1
3,GO ICOSANOID METABOLIC PROCESS,0.0003797,0.28446,0.3271,1,1
3,GO MUSCLE CELL FATE COMMITMENT,0.00076864,0.28446,0.31924,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0036751,0.28408,0.34869,1,1
3,GO COPPER ION TRANSPORT,0.0014241,0.28383,0.30026,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0010209,0.28377,0.2995,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0063209,0.28366,0.33217,1,1
3,GO RESPONSE TO GROWTH HORMONE,0.00020554,0.28301,0.29421,1,1
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00012367,0.28285,0.30411,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0018673,0.28261,0.33444,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.0049572,0.28258,0.28026,1,1
3,GO MYOBLAST MIGRATION,0.035953,0.28252,0.22564,1,1
3,GO GLIAL CELL PROLIFERATION,0.0012758,0.28227,0.31577,1,1
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0025648,0.28207,0.28758,1,1
3,GO RESPONSE TO FLUID SHEAR STRESS,0.00072571,0.28178,0.41631,1,1
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0015041,0.28166,0.33278,1,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.023112,0.28163,0.27375,1,1
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0027019,0.28134,0.29764,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0003797,0.28101,0.29317,1,1
3,GO RUFFLE ORGANIZATION,0.00096503,0.28096,0.3034,1,1
3,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.0044907,0.28072,0.26211,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00031664,0.28031,0.3182,1,1
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.0172,0.28001,0.23783,1,1
3,GO RESPONSE TO STEROL,0.0015041,0.27939,0.29282,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00057531,0.27928,0.32891,1,1
3,GO B CELL APOPTOTIC PROCESS,0.00068502,0.27924,0.32371,1,1
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0057394,0.27914,0.25266,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.026142,0.27912,0.26619,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0013481,0.27906,0.36032,1,1
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00091199,0.27868,0.30681,1,1
3,GO RESPONSE TO INTERLEUKIN 12,0.00072571,0.27853,0.26881,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0017696,0.27849,0.2912,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0016767,0.27839,0.24948,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0096484,0.27834,0.26954,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0017696,0.27826,0.29343,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0029965,0.27816,0.34248,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0057394,0.27805,0.25865,1,1
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00026348,0.27797,0.3778,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00091199,0.27758,0.37231,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0025648,0.2775,0.31394,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.00096503,0.27748,0.28042,1,1
3,GO ARGININE METABOLIC PROCESS,0.00086166,0.2772,0.29176,1,1
3,GO POSITIVE REGULATION OF JNK CASCADE,0.0015882,0.27686,0.30675,1,1
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.010101,0.27668,0.30716,1,1
3,GO HEPATOCYTE DIFFERENTIATION,0.033245,0.27655,0.20686,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0015882,0.27637,0.31732,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,0.0019699,0.27617,0.32381,1,1
3,GO PLATELET AGGREGATION,0.0066311,0.27527,0.34116,1,1
3,GO SALIVA SECRETION,0.0066311,0.27499,0.28941,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.0018673,0.27488,0.29318,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0016767,0.27471,0.28093,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0038653,0.27422,0.28052,1,1
3,GO GLOMERULUS DEVELOPMENT,0.0049572,0.27405,0.35165,1,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.014457,0.27403,0.24145,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00014989,0.27398,0.30905,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.010101,0.27395,0.2512,1,1
3,GO ENDODERM FORMATION,0.0012758,0.27352,0.39585,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.040368,0.27335,0.19833,1,1
3,GO HEAT GENERATION,0.0034935,0.2733,0.27207,1,1
3,GO ARACHIDONIC ACID SECRETION,0.00332,0.27327,0.25231,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00012367,0.27287,0.26722,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0018673,0.27273,0.30717,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0020776,0.27273,0.26032,1,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.025096,0.27162,0.23861,1,1
3,GO TRABECULA MORPHOGENESIS,0.018736,0.27155,0.27539,1,1
3,GO OVULATION,0.0010798,0.27118,0.32482,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00040321,0.27088,0.29727,1,1
3,GO COAGULATION,0.0052065,0.27072,0.28687,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0021907,0.2707,0.32037,1,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00086166,0.27066,0.29926,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.011574,0.26953,0.22112,1,1
3,GO REGULATION OF PROTEIN MATURATION,0.00020554,0.26938,0.32357,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.028348,0.26914,0.21322,1,1
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0010209,0.26834,0.35832,1,1
3,GO DRUG METABOLIC PROCESS,0.0012758,0.26815,0.28821,1,1
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0044907,0.26771,0.29894,1,1
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.006955,0.2677,0.23225,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0025648,0.26766,0.33773,1,1
3,GO TRACHEA DEVELOPMENT,0.0016767,0.26758,0.34758,1,1
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.007293,0.26752,0.39994,1,1
3,GO ENDODERM DEVELOPMENT,0.007293,0.26752,0.2929,1,1
3,GO LYMPH VESSEL MORPHOGENESIS,0.0052065,0.26728,0.37285,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00072571,0.26637,0.29115,1,1
3,GO ISOPRENOID METABOLIC PROCESS,3.0304e-05,0.26631,0.25674,1,1
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00086166,0.26615,0.39551,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,8.9327e-05,0.26586,0.30181,1,1
3,GO SERTOLI CELL DIFFERENTIATION,0.0060238,0.26563,0.27609,1,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00096503,0.26528,0.29852,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.006955,0.26481,0.25327,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00068502,0.26466,0.32207,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0029965,0.26466,0.33105,1,1
3,GO PULMONARY VALVE DEVELOPMENT,0.0092139,0.26398,0.35494,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00023283,0.26382,0.33596,1,1
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00064645,0.26379,0.32544,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00019306,0.26375,0.29097,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0038653,0.2636,0.28701,1,1
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0083971,0.26358,0.3027,1,1
3,GO RESPONSE TO ATP,0.0003797,0.26332,0.30347,1,1
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00048214,0.26322,0.32396,1,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0047188,0.26321,0.37711,1,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0013481,0.26318,0.27409,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0010798,0.26286,0.28295,1,1
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00029789,0.26267,0.2729,1,1
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0025648,0.26251,0.39573,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0063209,0.26208,0.25144,1,1
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00072571,0.26206,0.24836,1,1
3,GO PRIMARY MIRNA PROCESSING,0.0023095,0.26204,0.36674,1,1
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0063209,0.26201,0.27958,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00068502,0.26183,0.27366,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.007293,0.26176,0.31274,1,1
3,GO PEPTIDE CATABOLIC PROCESS,0.0024341,0.26174,0.3242,1,1
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00081392,0.26126,0.32808,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.0023095,0.2612,0.29706,1,1
3,GO REPLACEMENT OSSIFICATION,0.0047188,0.26099,0.30567,1,1
3,GO WOUND HEALING,0.0027019,0.26097,0.29502,1,1
3,GO ARTERY DEVELOPMENT,0.0016767,0.2608,0.34014,1,1
3,GO REGULATION OF WOUND HEALING,0.0013481,0.2607,0.3407,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014989,0.26056,0.28401,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.0010209,0.26034,0.34292,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0013481,0.26018,0.28548,1,1
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0172,0.26007,0.29566,1,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0024341,0.25995,0.26502,1,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.0047188,0.25915,0.24708,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010101,0.25912,0.30405,1,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0003797,0.25844,0.35336,1,1
3,GO AMINO SUGAR METABOLIC PROCESS,0.00035748,0.25796,0.32519,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.0015041,0.25784,0.28574,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.027226,0.25751,0.24412,1,1
3,GO SULFATION,0.014457,0.25742,0.25223,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0024341,0.25705,0.32255,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.015776,0.25658,0.2415,1,1
3,GO CELL CELL RECOGNITION,0.00019306,0.25656,0.27843,1,1
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0060238,0.25505,0.27001,1,1
3,GO AMELOGENESIS,0.00072571,0.255,0.32653,1,1
3,GO VIRAL GENOME REPLICATION,0.0017696,0.25487,0.27529,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0003797,0.25477,0.25841,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0052065,0.25474,0.30256,1,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0021907,0.25468,0.32422,1,1
3,GO O GLYCAN PROCESSING,0.020391,0.2546,0.2125,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0083971,0.25438,0.35659,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00011593,0.25407,0.32351,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.013834,0.25401,0.22833,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0017696,0.2539,0.26287,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.0063209,0.25381,0.31242,1,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.041938,0.2537,0.28866,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00057531,0.25337,0.30261,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00060992,0.25336,0.29718,1,1
3,GO VIRAL LIFE CYCLE,0.00045436,0.25326,0.2711,1,1
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.023112,0.25324,0.27058,1,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.014457,0.25263,0.24374,1,1
3,GO CELLULAR OXIDANT DETOXIFICATION,0.00019306,0.25257,0.26276,1,1
3,GO REGULATION OF CELL SHAPE,0.0011418,0.25189,0.30315,1,1
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0012071,0.25188,0.32263,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.0031545,0.25162,0.23944,1,1
3,GO MATERNAL PLACENTA DEVELOPMENT,0.0020776,0.25153,0.28665,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.0012071,0.25148,0.30528,1,1
3,GO FOREGUT MORPHOGENESIS,0.0080134,0.25128,0.30419,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00081392,0.25115,0.28501,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0021907,0.25109,0.26656,1,1
3,GO MRNA TRANSCRIPTION,0.0019699,0.251,0.30136,1,1
3,GO TISSUE MIGRATION,0.0023095,0.251,0.30064,1,1
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.008797,0.25089,0.2528,1,1
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.010572,0.25051,0.33269,1,1
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.015104,0.25044,0.2704,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,6.4139e-05,0.25024,0.29061,1,1
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0076456,0.2502,0.31455,1,1
3,GO FACE DEVELOPMENT,0.031957,0.25005,0.24096,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0047188,0.25002,0.26537,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0018673,0.24999,0.2857,1,1
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0052065,0.24946,0.31158,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0025648,0.24942,0.35303,1,1
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.025096,0.2493,0.25044,1,1
3,GO GLAND MORPHOGENESIS,0.0054671,0.2484,0.30085,1,1
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0060238,0.24793,0.28901,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0080134,0.24774,0.27536,1,1
3,GO ENAMEL MINERALIZATION,0.00081392,0.24734,0.3806,1,1
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.015104,0.24728,0.25096,1,1
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0047188,0.24694,0.22576,1,1
3,GO PROTEIN KINASE B SIGNALING,0.00091199,0.24689,0.29064,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.022172,0.24687,0.21645,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0042727,0.24686,0.20218,1,1
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0066311,0.2466,0.34641,1,1
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.022172,0.24655,0.24195,1,1
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.012106,0.2465,0.30542,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.050584,0.24633,0.20532,1,1
3,GO ODONTOGENESIS,0.0024341,0.24606,0.26125,1,1
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.0010209,0.24601,0.297,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00076864,0.24592,0.2837,1,1
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0060238,0.24576,0.34421,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.00068502,0.2457,0.30465,1,1
3,GO MUSCLE CELL PROLIFERATION,0.00068502,0.24556,0.31242,1,1
3,GO MANGANESE ION TRANSPORT,0.0031545,0.24556,0.24157,1,1
3,GO EPIBOLY,0.0018673,0.2455,0.30716,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00091199,0.24522,0.25199,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0021907,0.24507,0.25952,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0036751,0.24497,0.27324,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.048745,0.24493,0.28621,1,1
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00091199,0.24422,0.273,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,7.3279e-05,0.24416,0.26854,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.00096503,0.24414,0.28809,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00072571,0.24395,0.3607,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00045436,0.24373,0.28834,1,1
3,GO CELL MATRIX ADHESION,0.0063209,0.24367,0.31066,1,1
3,GO CELL SUBSTRATE ADHESION,0.0063209,0.24362,0.31533,1,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.027226,0.24359,0.23733,1,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0031545,0.24359,0.23738,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0024341,0.24355,0.3084,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013834,0.24354,0.23464,1,1
3,GO REGULATION OF GASTRULATION,0.0012071,0.24288,0.28898,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.00057531,0.24287,0.26752,1,1
3,GO CELL REDOX HOMEOSTASIS,0.0010209,0.24258,0.26314,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.006955,0.24256,0.2883,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.048745,0.24231,0.19919,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0017696,0.2423,0.32857,1,1
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0010798,0.24203,0.24172,1,1
3,GO CELL VOLUME HOMEOSTASIS,0.0017696,0.24152,0.28621,1,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0042727,0.24093,0.26475,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0003797,0.24069,0.26092,1,1
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.031957,0.2405,0.21347,1,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.017954,0.24042,0.23215,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.0052065,0.24039,0.22653,1,1
3,GO PROSTATE GLAND DEVELOPMENT,0.0083971,0.24026,0.26955,1,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0029965,0.24022,0.27254,1,1
3,GO HYALURONAN METABOLIC PROCESS,0.0034935,0.24012,0.33142,1,1
3,GO RESPONSE TO FATTY ACID,0.0010209,0.23988,0.24544,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.0038653,0.23963,0.29717,1,1
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.015776,0.23936,0.19021,1,1
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0027019,0.23889,0.36543,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00021879,0.23847,0.30364,1,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.0034935,0.23823,0.24355,1,1
3,GO BLOOD VESSEL MORPHOGENESIS,0.0016767,0.23794,0.33763,1,1
3,GO FEMALE GENITALIA DEVELOPMENT,0.0092139,0.23781,0.20295,1,1
3,GO KERATINOCYTE MIGRATION,0.0080134,0.23728,0.26948,1,1
3,GO TOOTH MINERALIZATION,0.0080134,0.23695,0.30565,1,1
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.037377,0.23655,0.27415,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0076456,0.23639,0.28088,1,1
3,GO PLASMA MEMBRANE FUSION,0.008797,0.23613,0.26304,1,1
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00091199,0.23564,0.37491,1,1
3,GO SECRETION BY TISSUE,0.0021907,0.23563,0.22444,1,1
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0066311,0.23519,0.2257,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0066311,0.23513,0.23543,1,1
3,GO ERBB2 SIGNALING PATHWAY,0.00068502,0.2351,0.26044,1,1
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.00332,0.23502,0.24529,1,1
3,GO AORTA DEVELOPMENT,0.0020776,0.23499,0.31642,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0015041,0.23438,0.26769,1,1
3,GO VASCULATURE DEVELOPMENT,0.0011418,0.23435,0.32848,1,1
3,GO CERAMIDE CATABOLIC PROCESS,0.011063,0.23407,0.291,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0049572,0.23401,0.2492,1,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.0034935,0.23379,0.25265,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00026348,0.23352,0.2534,1,1
3,GO REGULATION OF BONE MINERALIZATION,0.011063,0.23302,0.2808,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.019548,0.23282,0.23996,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.0083971,0.23252,0.25655,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0049572,0.23237,0.26445,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.013834,0.23222,0.27172,1,1
3,GO TISSUE REGENERATION,0.0017696,0.2322,0.22872,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0013481,0.23175,0.29479,1,1
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.015104,0.2317,0.20167,1,1
3,GO PANCREATIC JUICE SECRETION,0.018736,0.23165,0.2438,1,1
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0047188,0.23146,0.29721,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0027019,0.23133,0.27218,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0036751,0.23128,0.23783,1,1
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.033245,0.23123,0.20862,1,1
3,GO GLIAL CELL MIGRATION,0.026142,0.23113,0.23555,1,1
3,GO STEROL TRANSPORT,0.0010798,0.23077,0.26936,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00332,0.23072,0.33371,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0096484,0.23057,0.29137,1,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00086166,0.2304,0.28885,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0021907,0.23034,0.26987,1,1
3,GO RESPONSE TO LIPID,0.0010798,0.23019,0.25176,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0054671,0.22992,0.28742,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00042807,0.22941,0.27669,1,1
3,GO AMYLOID BETA FORMATION,0.0027019,0.22913,0.25054,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0017696,0.22823,0.22345,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00026348,0.22727,0.25711,1,1
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.010572,0.2272,0.2252,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.043559,0.22711,0.20632,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0012758,0.2271,0.25321,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0076456,0.22701,0.20094,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.00068502,0.227,0.23121,1,1
3,GO TROPHOBLAST CELL MIGRATION,0.0015041,0.22659,0.28737,1,1
3,GO RESPONSE TO RETINOIC ACID,0.0024341,0.22653,0.25717,1,1
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0036751,0.22646,0.25864,1,1
3,GO MIDGUT DEVELOPMENT,0.02951,0.22638,0.2452,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00086166,0.22612,0.2614,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.0011418,0.22608,0.28097,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0010798,0.22607,0.24541,1,1
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.023112,0.22595,0.19183,1,1
3,GO CELL CELL ADHESION,0.0052065,0.22586,0.25216,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0028457,0.22583,0.29339,1,1
3,GO BONE DEVELOPMENT,0.0023095,0.22567,0.27656,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.012106,0.22512,0.27094,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.00086166,0.22498,0.22807,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.038848,0.22486,0.22868,1,1
3,GO RESPONSE TO WOUNDING,0.0060238,0.22485,0.2594,1,1
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00010181,0.22464,0.26127,1,1
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0020776,0.22457,0.19276,1,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0025648,0.22456,0.2541,1,1
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0017696,0.22448,0.26293,1,1
3,GO DETOXIFICATION,0.00048214,0.22331,0.22344,1,1
3,GO FATTY ACID TRANSPORT,0.00048214,0.22311,0.25969,1,1
3,GO RESPONSE TO ISCHEMIA,0.0047188,0.22302,0.26519,1,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.0021907,0.22254,0.24029,1,1
3,GO LIPID HOMEOSTASIS,0.00040321,0.22219,0.25576,1,1
3,GO EXOCYTOSIS,0.0054671,0.22218,0.22407,1,1
3,GO EMBRYO IMPLANTATION,0.0013481,0.22215,0.30939,1,1
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.0040644,0.22194,0.23972,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.018736,0.22194,0.30292,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0012758,0.22155,0.24051,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00051151,0.22114,0.23981,1,1
3,GO RESPONSE TO GAMMA RADIATION,0.0015882,0.22101,0.24343,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00091199,0.22095,0.24665,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0012071,0.22065,0.25343,1,1
3,GO HOMOTYPIC CELL CELL ADHESION,0.006955,0.22057,0.29153,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019699,0.22042,0.27643,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00086166,0.22001,0.23194,1,1
3,GO RESPONSE TO ESTROGEN,0.0021907,0.21959,0.25682,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.015104,0.21916,0.2444,1,1
3,GO GENITALIA DEVELOPMENT,0.024086,0.21878,0.1964,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.034576,0.21828,0.28942,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0015882,0.21816,0.30929,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.01266,0.21786,0.18258,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0014241,0.21781,0.25302,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0066311,0.21742,0.29155,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0025648,0.21686,0.32556,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.00091199,0.21682,0.24937,1,1
3,GO CELLULAR RESPONSE TO ATP,0.0016767,0.21678,0.26835,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0016767,0.21667,0.24197,1,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.015104,0.21649,0.23717,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00054254,0.21631,0.2618,1,1
3,GO LIPID STORAGE,0.0038653,0.21606,0.24264,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.037377,0.21604,0.19504,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00064645,0.216,0.23623,1,1
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.013235,0.21593,0.22862,1,1
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0060238,0.2158,0.23353,1,1
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0020776,0.21561,0.2666,1,1
3,GO CELL CELL JUNCTION MAINTENANCE,0.014457,0.21558,0.27221,1,1
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0012071,0.21526,0.26904,1,1
3,GO AORTA MORPHOGENESIS,0.0092139,0.21522,0.30455,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0027019,0.21458,0.28355,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.008797,0.21447,0.23435,1,1
3,GO PULMONARY VALVE MORPHOGENESIS,0.025096,0.21395,0.32052,1,1
3,GO NEPHRON TUBULE FORMATION,0.006955,0.21384,0.29977,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00332,0.21365,0.19366,1,1
3,GO BILE ACID METABOLIC PROCESS,0.00064645,0.21358,0.22367,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.01266,0.21351,0.23114,1,1
3,GO REGULATION OF BIOMINERALIZATION,0.019548,0.21336,0.25382,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0038653,0.21318,0.33805,1,1
3,GO HEPARIN METABOLIC PROCESS,0.008797,0.21292,0.27882,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00064645,0.21272,0.24035,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.011574,0.21249,0.22608,1,1
3,GO REGULATION OF DNA METHYLATION,0.031957,0.2124,0.16897,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.022172,0.21201,0.11988,1,1
3,GO RESPONSE TO X RAY,0.015104,0.21198,0.21696,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0019699,0.21192,0.25015,1,1
3,GO BICARBONATE TRANSPORT,0.040368,0.21173,0.17816,1,1
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0017696,0.21173,0.24678,1,1
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0063209,0.21151,0.30133,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010572,0.211,0.26378,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.018736,0.21078,0.21678,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0066311,0.21056,0.24946,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0038653,0.21042,0.29495,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.010572,0.21023,0.30874,1,1
3,GO TISSUE HOMEOSTASIS,0.00072571,0.21011,0.24844,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0054671,0.21008,0.25039,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0014241,0.21001,0.24499,1,1
3,GO REGULATION OF MAPK CASCADE,0.0034935,0.2098,0.24262,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.025096,0.2094,0.22275,1,1
3,GO ESTROUS CYCLE,0.046961,0.20934,0.21904,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0025648,0.2091,0.31152,1,1
3,GO RESPONSE TO SALT STRESS,0.038848,0.20906,0.17945,1,1
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.006955,0.20895,0.28288,1,1
3,GO ERBB SIGNALING PATHWAY,0.0011418,0.20877,0.2452,1,1
3,GO REGULATION OF LIPID LOCALIZATION,0.0024341,0.20852,0.23971,1,1
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0034935,0.20843,0.23864,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0015041,0.20842,0.23695,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.00081392,0.20803,0.24378,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.0029965,0.20802,0.24347,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0015041,0.20785,0.26193,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.025096,0.20736,0.22619,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013834,0.207,0.22495,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.0027019,0.20675,0.2203,1,1
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0015882,0.20673,0.25024,1,1
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.011574,0.2067,0.21283,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.024086,0.20659,0.24486,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0018673,0.20635,0.20021,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.01266,0.20607,0.24416,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00091199,0.20586,0.30698,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.037377,0.20585,0.19635,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00010866,0.20576,0.24183,1,1
3,GO PLATELET MORPHOGENESIS,0.0066311,0.20573,0.27712,1,1
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.046961,0.20573,0.20235,1,1
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0052065,0.2053,0.20358,1,1
3,GO BIOLOGICAL ADHESION,0.0066311,0.20525,0.25635,1,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.00081392,0.20517,0.26677,1,1
3,GO MYOTUBE DIFFERENTIATION,0.0049572,0.2051,0.24662,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.0025648,0.20489,0.21836,1,1
3,GO RNA DECAPPING,0.0080134,0.20478,0.21455,1,1
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0076456,0.20478,0.22625,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0016767,0.20475,0.25954,1,1
3,GO INTERMEMBRANE LIPID TRANSFER,0.0014241,0.20456,0.26914,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.0012758,0.20438,0.2202,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0012758,0.20424,0.23069,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.011063,0.20408,0.27507,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.01266,0.2039,0.27579,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,0.0076456,0.20388,0.25654,1,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0044907,0.20377,0.2301,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.045233,0.20291,0.30305,1,1
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.006955,0.2029,0.21598,1,1
3,GO GLUTATHIONE METABOLIC PROCESS,0.0025648,0.20261,0.18347,1,1
3,GO RESPONSE TO VITAMIN,0.011063,0.20209,0.21611,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.016475,0.20195,0.24194,1,1
3,GO SEQUESTERING OF TRIGLYCERIDE,0.010572,0.20169,0.25574,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00332,0.20159,0.22824,1,1
3,GO ERYTHROCYTE DEVELOPMENT,0.0019699,0.20103,0.24479,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.00086166,0.20072,0.22877,1,1
3,GO RECEPTOR RECYCLING,0.020391,0.20065,0.17991,1,1
3,GO TUBE MORPHOGENESIS,0.0040644,0.20055,0.26119,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0042727,0.2003,0.23795,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.016475,0.20016,0.19424,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00031664,0.20005,0.24695,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0034935,0.19997,0.22946,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0054671,0.19958,0.29203,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.023112,0.19944,0.15082,1,1
3,GO FIBROBLAST PROLIFERATION,0.00096503,0.1994,0.26723,1,1
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0083971,0.19922,0.24514,1,1
3,GO IRON ION HOMEOSTASIS,0.0010798,0.1991,0.25424,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0063209,0.19906,0.27785,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.0060238,0.19902,0.19046,1,1
3,GO BIOMINERALIZATION,0.019548,0.19901,0.21914,1,1
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0080134,0.19891,0.21197,1,1
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.027226,0.1989,0.24692,1,1
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.037377,0.19889,0.22309,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0036751,0.19883,0.22548,1,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.0016767,0.19857,0.23298,1,1
3,GO PROTEIN DEMANNOSYLATION,0.017954,0.19835,0.24787,1,1
3,GO REGULATION OF NECROTIC CELL DEATH,0.010101,0.19814,0.21319,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.008797,0.19791,0.21434,1,1
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.016475,0.19749,0.21789,1,1
3,GO LAMELLIPODIUM ORGANIZATION,0.0012758,0.19739,0.24093,1,1
3,GO LIVER REGENERATION,0.00051151,0.19725,0.24236,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0028457,0.19713,0.26673,1,1
3,GO COPPER ION HOMEOSTASIS,0.007293,0.1968,0.19622,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.0076456,0.19679,0.20613,1,1
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.023112,0.19679,0.19371,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0057394,0.19669,0.25911,1,1
3,GO ANIMAL ORGAN REGENERATION,0.00064645,0.1963,0.23664,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.0027019,0.19622,0.23922,1,1
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0023095,0.19621,0.21174,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.021265,0.19599,0.22002,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.014457,0.19572,0.22893,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.018736,0.19543,0.16957,1,1
3,GO MALE GENITALIA DEVELOPMENT,0.026142,0.19535,0.22406,1,1
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.0023095,0.19471,0.26575,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.022172,0.19463,0.20757,1,1
3,GO CELLULAR IRON ION HOMEOSTASIS,0.0038653,0.19426,0.21101,1,1
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.013834,0.19424,0.27126,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.011063,0.19409,0.23801,1,1
3,GO TAXIS,0.010101,0.19406,0.23548,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0066311,0.19387,0.24895,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.037377,0.19387,0.17211,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0014241,0.19363,0.20738,1,1
3,GO PROGESTERONE METABOLIC PROCESS,0.015776,0.19312,0.28233,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0083971,0.19304,0.21713,1,1
3,GO NUCLEOTIDE SALVAGE,0.0038653,0.19288,0.20628,1,1
3,GO CELLULAR RESPONSE TO CAMP,0.0040644,0.19252,0.2187,1,1
3,GO TONGUE DEVELOPMENT,0.045233,0.19226,0.17811,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.027226,0.19184,0.20063,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0052065,0.1916,0.20597,1,1
3,GO ERYTHROCYTE MATURATION,0.015104,0.19123,0.24618,1,1
3,GO REGULATION OF PROTEIN IMPORT,0.00040321,0.19118,0.22936,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.013834,0.19112,0.21821,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0092139,0.19107,0.21368,1,1
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.046961,0.19104,0.23537,1,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.028348,0.19104,0.18003,1,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0015041,0.19098,0.21273,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.00081392,0.19077,0.21203,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0044907,0.19077,0.22523,1,1
3,GO HEART VALVE DEVELOPMENT,0.022172,0.19075,0.28807,1,1
3,GO METAL ION HOMEOSTASIS,0.018736,0.1907,0.19159,1,1
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.006955,0.19061,0.25749,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0066311,0.19022,0.20791,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0012071,0.19012,0.28298,1,1
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.013235,0.19002,0.19398,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00086166,0.18977,0.18455,1,1
3,GO MUSCLE CELL MIGRATION,0.0063209,0.18968,0.25851,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0092139,0.18946,0.19434,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.00081392,0.18941,0.19419,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.024086,0.18938,0.20677,1,1
3,GO ETHER METABOLIC PROCESS,0.0020776,0.18915,0.21897,1,1
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0023095,0.18912,0.21706,1,1
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0083971,0.18905,0.24939,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.007293,0.18897,0.20608,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00072571,0.18889,0.23591,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.0025648,0.18879,0.17758,1,1
3,GO RESPONSE TO IONIZING RADIATION,0.010101,0.18852,0.18097,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034935,0.18801,0.19947,1,1
3,GO SKIN DEVELOPMENT,0.01266,0.188,0.19227,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.00054254,0.18799,0.20702,1,1
3,GO RESPONSE TO NUTRIENT,0.0047188,0.18794,0.21219,1,1
3,GO STEROL METABOLIC PROCESS,0.00057531,0.18792,0.22412,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0011418,0.18773,0.21774,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0080134,0.18733,0.23539,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.0027019,0.1873,0.20673,1,1
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0092139,0.18727,0.24445,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.017954,0.18725,0.21081,1,1
3,GO FOCAL ADHESION ASSEMBLY,0.018736,0.1872,0.25754,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.011063,0.18698,0.19489,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.013834,0.18694,0.20268,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.00068502,0.18649,0.20921,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0083971,0.18649,0.2674,1,1
3,GO ZINC ION HOMEOSTASIS,0.020391,0.18634,0.21463,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0096484,0.18614,0.21746,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.010572,0.18548,0.20588,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00054254,0.18542,0.227,1,1
3,GO RNA DESTABILIZATION,0.033245,0.18529,0.21453,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.013235,0.1852,0.23002,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0012758,0.18512,0.26829,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0057394,0.18492,0.21334,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0076456,0.18482,0.21533,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.007293,0.18478,0.22017,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.011574,0.18477,0.20461,1,1
3,GO PHOSPHOLIPID TRANSPORT,0.021265,0.18472,0.19668,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.022172,0.18417,0.16657,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.030713,0.18416,0.17991,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.0040644,0.18402,0.1832,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0031545,0.18367,0.2418,1,1
3,GO MYOBLAST PROLIFERATION,0.0063209,0.18345,0.28703,1,1
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.031957,0.18344,0.1703,1,1
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.011574,0.18315,0.21185,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.035953,0.18296,0.18029,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0080134,0.18295,0.19446,1,1
3,GO RESPONSE TO CAMP,0.011574,0.18293,0.21116,1,1
3,GO HEME METABOLIC PROCESS,0.00031664,0.18278,0.20911,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0052065,0.18198,0.21241,1,1
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.021265,0.1819,0.2694,1,1
3,GO AUTOPHAGOSOME MATURATION,0.0031545,0.18165,0.18041,1,1
3,GO PROTEIN PROCESSING,0.0034935,0.18152,0.23004,1,1
3,GO IMP BIOSYNTHETIC PROCESS,0.040368,0.18124,0.12305,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.0042727,0.18116,0.23295,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.046961,0.18104,0.19954,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.010101,0.18091,0.25963,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.01266,0.1809,0.20793,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.00023283,0.18085,0.23235,1,1
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0034935,0.18072,0.21154,1,1
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00332,0.1807,0.31038,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0013481,0.18055,0.21719,1,1
3,GO FORMATION OF PRIMARY GERM LAYER,0.0066311,0.18053,0.2726,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0092139,0.18045,0.21994,1,1
3,GO PLACENTA DEVELOPMENT,0.0076456,0.18006,0.20558,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.00072571,0.17994,0.22883,1,1
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.010572,0.17966,0.23998,1,1
3,GO EMBRYONIC HEMOPOIESIS,0.010572,0.17959,0.25213,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0036751,0.17908,0.2122,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.0015041,0.17902,0.22161,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0024341,0.17875,0.20482,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.011063,0.17874,0.18618,1,1
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0080134,0.17866,0.16797,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0003797,0.17863,0.2397,1,1
3,GO LIPID CATABOLIC PROCESS,0.0024341,0.17832,0.19382,1,1
3,GO RESPONSE TO UV B,0.008797,0.17801,0.20673,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0083971,0.17777,0.19173,1,1
3,GO CELL MOTILITY,0.010572,0.1776,0.21826,1,1
3,GO MIDDLE EAR MORPHOGENESIS,0.030713,0.17751,0.14347,1,1
3,GO MAINTENANCE OF LOCATION,0.0080134,0.17731,0.19639,1,1
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.01266,0.17708,0.20094,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.020391,0.17703,0.25211,1,1
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0092139,0.1769,0.23403,1,1
3,GO PORE COMPLEX ASSEMBLY,0.025096,0.17667,0.16303,1,1
3,GO ENDOCYTOSIS,0.0172,0.1766,0.20072,1,1
3,GO RESPONSE TO KETONE,0.0076456,0.17654,0.19941,1,1
3,GO CARDIOLIPIN METABOLIC PROCESS,0.0042727,0.17632,0.17788,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.018736,0.17628,0.16435,1,1
3,GO REGULATION OF HEAT GENERATION,0.02951,0.17625,0.2136,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.020391,0.17596,0.19346,1,1
3,GO EPIDERMIS DEVELOPMENT,0.013834,0.17579,0.183,1,1
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.041938,0.17574,0.17269,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00086166,0.17561,0.21341,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.010572,0.17559,0.20663,1,1
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.025096,0.17553,0.20245,1,1
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.17542,0.28807,1,1
3,GO LIPID IMPORT INTO CELL,0.015104,0.17525,0.19861,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.013235,0.17525,0.12323,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.0016767,0.17524,0.1849,1,1
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.028348,0.17513,0.14424,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00332,0.17494,0.22404,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0063209,0.17493,0.20643,1,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0049572,0.17444,0.216,1,1
3,GO LIPID OXIDATION,0.014457,0.17438,0.14713,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.02951,0.17421,0.18614,1,1
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.046961,0.17413,0.15152,1,1
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.027226,0.17408,0.18781,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0017696,0.17372,0.23709,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.013235,0.17288,0.19842,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0023095,0.17274,0.19668,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.021265,0.17257,0.17738,1,1
3,GO REGULATION OF PROTEOLYSIS,0.0013481,0.17256,0.20997,1,1
3,GO SYMBIOTIC PROCESS,0.00091199,0.17237,0.1846,1,1
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.015776,0.1722,0.18664,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0021907,0.17164,0.20008,1,1
3,GO BONE MORPHOGENESIS,0.013235,0.17115,0.24613,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0015041,0.17113,0.20203,1,1
3,GO STEROID METABOLIC PROCESS,0.00076864,0.17075,0.1929,1,1
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0025648,0.17027,0.18066,1,1
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.017954,0.16991,0.14904,1,1
3,GO MESODERMAL CELL FATE COMMITMENT,0.016475,0.1699,0.14702,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.019548,0.16981,0.1892,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.013834,0.1694,0.20596,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0028457,0.16933,0.21533,1,1
3,GO ION HOMEOSTASIS,0.018736,0.16912,0.17672,1,1
3,GO REGULATION OF LIPID TRANSPORT,0.0042727,0.16906,0.217,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.011063,0.1689,0.23343,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0076456,0.16875,0.23137,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0076456,0.16832,0.23614,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0080134,0.16816,0.1879,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.0172,0.16815,0.19517,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.024086,0.16801,0.19853,1,1
3,GO PERICARDIUM DEVELOPMENT,0.007293,0.16708,0.28021,1,1
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.011063,0.16706,0.20631,1,1
3,GO RUFFLE ASSEMBLY,0.0092139,0.16699,0.20525,1,1
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.01266,0.16678,0.17066,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.006955,0.16677,0.17955,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.021265,0.16654,0.18087,1,1
3,GO CORONARY VASCULATURE DEVELOPMENT,0.018736,0.16622,0.2665,1,1
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0049572,0.16601,0.21599,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.018736,0.16576,0.23976,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00332,0.16562,0.22303,1,1
3,GO JNK CASCADE,0.0060238,0.16557,0.21727,1,1
3,GO BLASTOCYST FORMATION,0.00068502,0.16551,0.19863,1,1
3,GO LAMELLIPODIUM ASSEMBLY,0.0092139,0.1654,0.19984,1,1
3,GO DIGESTIVE SYSTEM PROCESS,0.011574,0.16532,0.17939,1,1
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.0042727,0.16499,0.18943,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0063209,0.16497,0.1777,1,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0066311,0.16468,0.23455,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0010209,0.16437,0.20518,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.0023095,0.1642,0.22243,1,1
3,GO LIPID LOCALIZATION,0.0057394,0.16416,0.21004,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.011063,0.16415,0.19581,1,1
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.0096484,0.16409,0.18115,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.02951,0.16391,0.20671,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.00096503,0.16362,0.22955,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.019548,0.16352,0.17966,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0096484,0.16333,0.16788,1,1
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.016475,0.16317,0.15768,1,1
3,GO INTESTINAL ABSORPTION,0.035953,0.16315,0.24364,1,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.046961,0.16307,0.16195,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.0010798,0.16304,0.19711,1,1
3,GO ACTIVATION OF MAPKK ACTIVITY,0.052482,0.16299,0.17733,1,1
3,GO FAT CELL DIFFERENTIATION,0.007293,0.16285,0.22509,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0040644,0.16281,0.22274,1,1
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.038848,0.16273,0.15453,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.025096,0.16268,0.18212,1,1
3,GO REGULATION OF OSSIFICATION,0.022172,0.16221,0.22467,1,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0096484,0.16214,0.22567,1,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.0024341,0.16185,0.17464,1,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.027226,0.16177,0.21387,1,1
3,GO VITAMIN METABOLIC PROCESS,0.00054254,0.16167,0.19667,1,1
3,GO ANION HOMEOSTASIS,0.0040644,0.16156,0.22291,1,1
3,GO GASTRIC ACID SECRETION,0.040368,0.16144,0.16906,1,1
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.010572,0.16125,0.2366,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.00091199,0.16111,0.20363,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.01266,0.16081,0.17844,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.014457,0.16026,0.1841,1,1
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0052065,0.16022,0.18399,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0031545,0.1598,0.20887,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.010101,0.1598,0.15851,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.019548,0.1595,0.16415,1,1
3,GO RRNA MODIFICATION,0.038848,0.15911,0.09175,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0063209,0.1589,0.17579,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00332,0.15823,0.21507,1,1
3,GO GASTRULATION,0.0092139,0.1582,0.22576,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.011574,0.15815,0.1797,1,1
3,GO RESPONSE TO STEROID HORMONE,0.016475,0.15802,0.17793,1,1
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.006955,0.15786,0.20775,1,1
3,GO SECRETION,0.025096,0.1577,0.17376,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0076456,0.15752,0.1731,1,1
3,GO RESPONSE TO STEROL DEPLETION,0.043559,0.15746,0.19685,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.018736,0.15728,0.16754,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0034935,0.15726,0.19744,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0096484,0.15695,0.16175,1,1
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.028348,0.15672,0.21046,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.019548,0.15666,0.20773,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.021265,0.15622,0.20038,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.017954,0.15622,0.2143,1,1
3,GO OSTEOBLAST DIFFERENTIATION,0.015776,0.15616,0.19565,1,1
3,GO EPITHELIAL CELL PROLIFERATION,0.019548,0.15601,0.20523,1,1
3,GO GTP METABOLIC PROCESS,0.0017696,0.15589,0.1758,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0057394,0.15559,0.16371,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.015104,0.15557,0.17773,1,1
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.007293,0.1555,0.1845,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.021265,0.15513,0.17866,1,1
3,GO BLASTODERM SEGMENTATION,0.0036751,0.15502,0.23464,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.015104,0.15479,0.19306,1,1
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.028348,0.15454,0.21663,1,1
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.034576,0.15447,0.18603,1,1
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0024341,0.15423,0.20589,1,1
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.014457,0.15407,0.20627,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00045436,0.15395,0.19354,1,1
3,GO TUBE DEVELOPMENT,0.015776,0.15362,0.21617,1,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0015041,0.15355,0.3357,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.028348,0.15336,0.16193,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.028348,0.15317,0.20429,1,1
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.022172,0.15304,0.13668,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.010572,0.15302,0.15798,1,1
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0019699,0.15265,0.19741,1,1
3,GO VESICLE CARGO LOADING,0.027226,0.15258,0.15339,1,1
3,GO REGENERATION,0.0052065,0.15213,0.19241,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.011063,0.15171,0.1946,1,1
3,GO THIOESTER METABOLIC PROCESS,0.010101,0.15159,0.16307,1,1
3,GO VACUOLAR ACIDIFICATION,0.0096484,0.15157,0.18179,1,1
3,GO PROTEIN AUTOPROCESSING,0.046961,0.15157,0.15903,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0012071,0.15131,0.22715,1,1
3,GO NADP METABOLIC PROCESS,0.014457,0.15094,0.15825,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.020391,0.1509,0.21575,1,1
3,GO TOXIN TRANSPORT,0.041938,0.15083,0.14913,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.052482,0.15064,0.24323,1,1
3,GO LIPID METABOLIC PROCESS,0.0031545,0.15051,0.1742,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00076864,0.15021,0.20333,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.011574,0.15016,0.21452,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.016475,0.14984,0.20622,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0066311,0.14947,0.187,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.006955,0.14947,0.199,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.010572,0.14933,0.14552,1,1
3,GO VITAMIN TRANSPORT,0.013235,0.14924,0.19271,1,1
3,GO BODY FLUID SECRETION,0.035953,0.14922,0.14443,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.031957,0.149,0.21375,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.048745,0.1485,0.22548,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.0038653,0.1483,0.1741,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.016475,0.14813,0.17472,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.045233,0.14788,0.17083,1,1
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.02951,0.14775,0.15341,1,1
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.020391,0.14764,0.23866,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0049572,0.14748,0.21767,1,1
3,GO ACTIVATION OF JNKK ACTIVITY,0.052482,0.14695,0.19809,1,1
3,GO CARTILAGE DEVELOPMENT,0.014457,0.14655,0.22798,1,1
3,GO PROTEIN MATURATION,0.007293,0.14645,0.17842,1,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0092139,0.14627,0.19447,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.024086,0.14625,0.20417,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.050584,0.14622,0.16389,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.025096,0.14615,0.17096,1,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0096484,0.14611,0.29837,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0024341,0.14603,0.2014,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.015104,0.14597,0.17579,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.013834,0.14584,0.1709,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0029965,0.14559,0.18865,1,1
3,GO DIGESTION,0.021265,0.1451,0.17009,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.027226,0.14506,0.1402,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.0172,0.14498,0.21648,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.037377,0.14493,0.21812,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.012106,0.14487,0.17039,1,1
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0172,0.14479,0.20192,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.011574,0.14467,0.20119,1,1
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.050584,0.1446,0.15859,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.01266,0.14457,0.17461,1,1
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.013235,0.1442,0.16774,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0083971,0.14358,0.15939,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.015104,0.14342,0.26328,1,1
3,GO SELECTIVE AUTOPHAGY,0.017954,0.14337,0.16242,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.034576,0.14334,0.14396,1,1
3,GO REGULATION OF CELL DEATH,0.0024341,0.14332,0.18784,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0076456,0.14309,0.18682,1,1
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00081392,0.14284,0.1608,1,1
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0012758,0.14255,0.17195,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00332,0.14255,0.18844,1,1
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0019699,0.14205,0.15619,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.024086,0.14201,0.16219,1,1
3,GO REGULATION OF GTPASE ACTIVITY,0.028348,0.14182,0.18942,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.020391,0.14175,0.16746,1,1
3,GO VIRAL RELEASE FROM HOST CELL,0.020391,0.14116,0.13827,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.024086,0.14078,0.095329,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.026142,0.1407,0.21113,1,1
3,GO RESPONSE TO ALCOHOL,0.019548,0.14042,0.17465,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.011063,0.14028,0.16722,1,1
3,GO MUSCLE ADAPTATION,0.033245,0.13932,0.17376,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.022172,0.13919,0.19598,1,1
3,GO CELLULAR PIGMENTATION,0.011063,0.13902,0.17084,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.014457,0.13874,0.16686,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.015104,0.13862,0.1731,1,1
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.006955,0.13861,0.19465,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0031545,0.13784,0.159,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.0036751,0.13759,0.17679,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.010572,0.13674,0.14243,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.043559,0.13672,0.1185,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.033245,0.13612,0.18827,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.0020776,0.13544,0.16533,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.045233,0.1353,0.13294,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.02951,0.13503,0.20202,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.028348,0.1344,0.19418,1,1
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.017954,0.13434,0.14765,1,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.021265,0.134,0.19352,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.015776,0.13393,0.17473,1,1
3,GO CHEMICAL HOMEOSTASIS,0.043559,0.13388,0.1535,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.02951,0.13377,0.15938,1,1
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0083971,0.13369,0.1684,1,1
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.010101,0.13361,0.1711,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.021265,0.13358,0.18543,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.030713,0.13322,0.19933,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.027226,0.13282,0.22692,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.048745,0.13249,0.24998,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0172,0.13235,0.15546,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.01266,0.13153,0.1447,1,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.048745,0.13134,0.14837,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.034576,0.13122,0.1758,1,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.020391,0.13105,0.15734,1,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0172,0.13099,0.2142,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.028348,0.13091,0.16343,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0044907,0.13052,0.20195,1,1
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.01266,0.13049,0.23757,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.017954,0.13049,0.17148,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.0047188,0.13043,0.15702,1,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.025096,0.13033,0.16341,1,1
3,GO MICROVILLUS ORGANIZATION,0.031957,0.12989,0.15643,1,1
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.037377,0.12946,0.17144,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.045233,0.129,0.17043,1,1
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.043559,0.12855,0.1666,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0096484,0.12853,0.24651,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.012106,0.12788,0.16321,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.035953,0.12767,0.17482,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.026142,0.12761,0.1555,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.020391,0.12759,0.18346,1,1
3,GO SKELETAL SYSTEM DEVELOPMENT,0.021265,0.12752,0.19691,1,1
3,GO CELLULAR HOMEOSTASIS,0.027226,0.12728,0.1437,1,1
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0018673,0.12708,0.21219,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.016475,0.12702,0.14868,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.025096,0.12699,0.13855,1,1
3,GO RESPONSE TO VITAMIN A,0.041938,0.12693,0.17484,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.016475,0.12666,0.12651,1,1
3,GO RESPONSE TO HORMONE,0.022172,0.12641,0.1628,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.043559,0.12604,0.14118,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.015776,0.12545,0.16148,1,1
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.037377,0.12525,0.12429,1,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00048214,0.12509,0.18766,1,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.025096,0.12498,0.2044,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00332,0.12471,0.15728,1,1
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.019548,0.12455,0.16381,1,1
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.031957,0.12443,0.16559,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0063209,0.12433,0.2085,1,1
3,GO FIBROBLAST MIGRATION,0.038848,0.12425,0.19796,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.041938,0.12414,0.17709,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0096484,0.12364,0.1942,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0029965,0.12312,0.19259,1,1
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.010101,0.1229,0.14735,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0044907,0.12262,0.18705,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.021265,0.12256,0.15916,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.020391,0.12198,0.16923,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.0025648,0.12188,0.14443,1,1
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0029965,0.12187,0.14143,1,1
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.037377,0.12179,0.13168,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0049572,0.12109,0.16706,1,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.010101,0.12095,0.1719,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,0.0016767,0.12092,0.15886,1,1
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00332,0.12067,0.1649,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.008797,0.12066,0.18278,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.010101,0.12047,0.17045,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.043559,0.12044,0.1285,1,1
3,GO STEM CELL DIFFERENTIATION,0.02951,0.12042,0.14615,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.030713,0.12039,0.14003,1,1
3,GO PROTEIN TETRAMERIZATION,0.0092139,0.11985,0.1749,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0028457,0.11958,0.15217,1,1
3,GO LIPID MODIFICATION,0.034576,0.11934,0.14035,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.023112,0.11817,0.11662,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0076456,0.11813,0.18408,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.018736,0.11803,0.15926,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.020391,0.11791,0.17101,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0096484,0.11773,0.1638,1,1
3,GO ACTIN NUCLEATION,0.011574,0.11631,0.16385,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.046961,0.11622,0.1044,1,1
3,GO APOPTOTIC PROCESS,0.0066311,0.11595,0.16486,1,1
3,GO AUTOPHAGOSOME ORGANIZATION,0.048745,0.11561,0.13747,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.011063,0.11558,0.17676,1,1
3,GO AMP METABOLIC PROCESS,0.014457,0.11544,0.15188,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.040368,0.11509,0.16573,1,1
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0096484,0.11507,0.20498,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.02951,0.1143,0.14362,1,1
3,GO ACTIN FILAMENT BASED MOVEMENT,0.037377,0.11382,0.17194,1,1
3,GO HOMEOSTATIC PROCESS,0.020391,0.11363,0.15536,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.050584,0.1135,0.15393,1,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.027226,0.11335,0.13787,1,1
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.031957,0.11327,0.19138,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.038848,0.11321,0.17614,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0080134,0.11305,0.16633,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.013834,0.11282,0.15997,1,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0034935,0.11263,0.16452,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.045233,0.11157,0.14314,1,1
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.046961,0.11119,0.1359,1,1
3,GO CELL RECOGNITION,0.048745,0.11086,0.1596,1,1
3,GO REGULATION OF ORGAN GROWTH,0.013235,0.11053,0.19225,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.008797,0.10961,0.16214,1,1
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.028348,0.10941,0.19975,1,1
3,GO REGULATION OF METAL ION TRANSPORT,0.040368,0.10935,0.15228,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.026142,0.10888,0.14217,1,1
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.012106,0.10856,0.12579,1,1
3,GO IRON ION TRANSPORT,0.023112,0.10807,0.16188,1,1
3,GO RESPONSE TO PEPTIDE,0.035953,0.10793,0.15454,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.043559,0.10769,0.12997,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.048745,0.10748,0.14147,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.025096,0.10693,0.13701,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.037377,0.10678,0.14876,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.014457,0.10677,0.13907,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.031957,0.10661,0.15553,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.052482,0.10577,0.15163,1,1
3,GO RECEPTOR METABOLIC PROCESS,0.052482,0.10564,0.14209,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.035953,0.10452,0.14864,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.017954,0.10428,0.17126,1,1
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.016475,0.10373,0.1559,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.045233,0.10341,0.14056,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0096484,0.10337,0.14786,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.040368,0.10294,0.1214,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.016475,0.10156,0.12013,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0024341,0.10059,0.14256,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.026142,0.10034,0.15616,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015776,0.10004,0.16617,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.025096,0.10002,0.12919,1,1
3,GO COPII COATED VESICLE BUDDING,0.050584,0.09964,0.13019,1,1
3,GO ANDROGEN METABOLIC PROCESS,0.030713,0.09963,0.12484,1,1
3,GO CALCINEURIN MEDIATED SIGNALING,0.050584,0.09953,0.16257,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.011574,0.097126,0.16303,1,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.0066311,0.09626,0.1349,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.010572,0.096213,0.14202,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0083971,0.096003,0.16101,1,1
3,GO PROTEOLYSIS,0.020391,0.095978,0.14381,1,1
3,GO PROTEIN DESTABILIZATION,0.037377,0.094451,0.14751,1,1
3,GO GOLGI VESICLE BUDDING,0.050584,0.092516,0.13099,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.052482,0.091883,0.14233,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.091417,0.10075,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.048745,0.090049,0.15036,1,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.0096484,0.089033,0.14458,1,1
3,GO AGING,0.016475,0.089012,0.16294,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.031957,0.088968,0.16065,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.035953,0.088826,0.11636,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.037377,0.087785,0.14587,1,1
3,GO RESPONSE TO DRUG,0.037377,0.087432,0.14655,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.027226,0.087328,0.12594,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0172,0.085219,0.14178,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.041938,0.084754,0.12325,1,1
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.050584,0.084015,0.16764,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.037377,0.083835,0.078252,1,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.02951,0.083534,0.13922,1,1
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.016475,0.08326,0.12438,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.010101,0.082071,0.13417,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.01266,0.08197,0.13311,1,1
3,GO OXIDATION REDUCTION PROCESS,0.021265,0.080901,0.10864,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.046961,0.079578,0.14157,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.02951,0.078243,0.15106,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.043559,0.072567,0.13229,1,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.034576,0.072002,0.079137,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00040321,0.75503,0.5886,1,1
4,GO REGULATION OF SYNAPSE MATURATION,0.0012071,0.73274,0.51397,1,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00076864,0.64165,0.5586,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0011418,0.62234,0.54627,1,1
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00033648,0.62181,0.53982,1,1
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0019699,0.58129,0.46849,1,1
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00015974,0.57125,0.52227,1,1
4,GO PREPULSE INHIBITION,0.00020554,0.56354,0.57469,1,1
4,GO SYNAPSE MATURATION,0.00031664,0.54335,0.51967,1,1
4,GO VOCALIZATION BEHAVIOR,6.8565e-05,0.54202,0.54746,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0010798,0.52212,0.45089,1,1
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00072571,0.51415,0.44856,1,1
4,GO DISTAL TUBULE DEVELOPMENT,0.027226,0.51251,0.35695,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0020776,0.50601,0.54175,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.046961,0.49449,0.33029,1,1
4,GO INNER DYNEIN ARM ASSEMBLY,0.037377,0.49293,0.33686,1,1
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00014062,0.4905,0.44221,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00045436,0.48708,0.54035,1,1
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00051151,0.48469,0.45028,1,1
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00018128,0.48313,0.46615,1,1
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.015104,0.48015,0.39507,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.023112,0.47879,0.3415,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0057394,0.47867,0.35944,1,1
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00096503,0.47283,0.42888,1,1
4,GO LONG TERM SYNAPTIC DEPRESSION,0.00021879,0.47222,0.40378,1,1
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00031664,0.47129,0.49947,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0020776,0.46915,0.39772,1,1
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0017696,0.46468,0.44741,1,1
4,GO MICROTUBULE DEPOLYMERIZATION,0.00072571,0.45979,0.43282,1,1
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00033648,0.45704,0.4336,1,1
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0010209,0.45429,0.39469,1,1
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0020776,0.45139,0.40134,1,1
4,GO DENDRITIC TRANSPORT,0.0025648,0.44865,0.41961,1,1
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.010101,0.4467,0.40382,1,1
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00081392,0.44615,0.61719,1,1
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0042727,0.44354,0.47077,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00048214,0.44316,0.44058,1,1
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00060992,0.44255,0.37635,1,1
4,GO PROTEIN LOCALIZATION TO AXON,0.0031545,0.44179,0.41618,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0092139,0.43875,0.43839,1,1
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.0011418,0.43767,0.39276,1,1
4,GO SPINAL CORD PATTERNING,0.0031545,0.43739,0.37033,1,1
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0027019,0.43697,0.45781,1,1
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00013188,0.4351,0.41112,1,1
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0066311,0.43409,0.43496,1,1
4,GO AROMATIC AMINO ACID TRANSPORT,9.5377e-05,0.43159,0.46625,1,1
4,GO POSTSYNAPSE ASSEMBLY,0.00072571,0.43022,0.46699,1,1
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0013481,0.43005,0.34569,1,1
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00018128,0.42906,0.39931,1,1
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,5.2428e-05,0.4286,0.44842,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00081392,0.42704,0.38538,1,1
4,GO MEMBRANE HYPERPOLARIZATION,0.0010798,0.427,0.44572,1,1
4,GO TELENCEPHALON GLIAL CELL MIGRATION,6.4139e-05,0.426,0.4324,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0015041,0.42421,0.39501,1,1
4,GO HEART VALVE FORMATION,8.9327e-05,0.423,0.50594,1,1
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00018128,0.42255,0.42099,1,1
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.0036751,0.42235,0.38302,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00012367,0.41979,0.40627,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00033648,0.4197,0.55747,1,1
4,GO CARDIAC CHAMBER FORMATION,0.00064645,0.41951,0.45728,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00029789,0.41896,0.44224,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00068502,0.41889,0.41852,1,1
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00010866,0.41481,0.47977,1,1
4,GO REGULATION OF GLUTAMATE SECRETION,0.0015882,0.41339,0.43866,1,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00091199,0.41091,0.40766,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0011418,0.40891,0.37531,1,1
4,GO SYNAPTIC VESICLE BUDDING,0.00091199,0.4071,0.37208,1,1
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00054254,0.40596,0.39188,1,1
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0066311,0.40245,0.3598,1,1
4,GO RESPONSE TO POTASSIUM ION,0.0092139,0.40233,0.32154,1,1
4,GO REGULATION OF NEURON MIGRATION,0.0038653,0.40204,0.38396,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0040644,0.40188,0.34904,1,1
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.027226,0.40185,0.33462,1,1
4,GO FACIAL NERVE MORPHOGENESIS,0.033245,0.4018,0.30951,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00076864,0.40167,0.34156,1,1
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00057531,0.3977,0.3916,1,1
4,GO ANATOMICAL STRUCTURE REGRESSION,0.0049572,0.3958,0.35815,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.027226,0.39526,0.29838,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00031664,0.39462,0.38629,1,1
4,GO FOREBRAIN NEURON DEVELOPMENT,0.0027019,0.39387,0.31538,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00057531,0.39267,0.41322,1,1
4,GO SYNAPTIC VESICLE DOCKING,0.035953,0.39212,0.32259,1,1
4,GO TELENCEPHALON REGIONALIZATION,0.011063,0.38974,0.34774,1,1
4,GO NEURON CELLULAR HOMEOSTASIS,0.00042807,0.38937,0.3978,1,1
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00072571,0.38633,0.35739,1,1
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00015974,0.38594,0.37892,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,8.3641e-05,0.38554,0.42173,1,1
4,GO DIVALENT METAL ION EXPORT,0.00010181,0.38444,0.46523,1,1
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00057531,0.38133,0.36063,1,1
4,GO RECEPTOR CLUSTERING,0.0027019,0.3812,0.34008,1,1
4,GO REGULATION OF CYCLASE ACTIVITY,3.9936e-05,0.38043,0.36934,1,1
4,GO COLLATERAL SPROUTING,0.00054254,0.38022,0.38136,1,1
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00076864,0.37979,0.40471,1,1
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0015041,0.37925,0.4032,1,1
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0013481,0.37852,0.44296,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0080134,0.3783,0.29604,1,1
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0024341,0.37719,0.43128,1,1
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.00045436,0.37648,0.46466,1,1
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00096503,0.376,0.37122,1,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.025096,0.37315,0.34321,1,1
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00033648,0.37264,0.36069,1,1
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.035953,0.37238,0.312,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00011593,0.37153,0.42036,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00096503,0.37126,0.36409,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0027019,0.36918,0.35359,1,1
4,GO MITRAL VALVE DEVELOPMENT,0.027226,0.36826,0.25709,1,1
4,GO PARENTAL BEHAVIOR,0.024086,0.3677,0.34695,1,1
4,GO NOREPINEPHRINE SECRETION,0.00081392,0.36733,0.39873,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00019306,0.36613,0.38862,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00054254,0.3649,0.36633,1,1
4,GO NEUROMUSCULAR PROCESS,6.8565e-05,0.36432,0.39015,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0015882,0.36369,0.33141,1,1
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0036751,0.36276,0.3591,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00028019,0.36062,0.4014,1,1
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0012758,0.35961,0.34468,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0083971,0.35958,0.33867,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0010209,0.35955,0.40637,1,1
4,GO REGULATION OF COLLATERAL SPROUTING,0.0021907,0.3591,0.34568,1,1
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.00026348,0.35826,0.397,1,1
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0036751,0.35765,0.31488,1,1
4,GO REGULATION OF LYASE ACTIVITY,4.5779e-05,0.35754,0.34785,1,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.0080134,0.35745,0.26552,1,1
4,GO ALANINE TRANSPORT,0.00042807,0.35568,0.398,1,1
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0096484,0.35565,0.28302,1,1
4,GO OLFACTORY LOBE DEVELOPMENT,0.006955,0.35496,0.28773,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.011574,0.3545,0.24705,1,1
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0096484,0.35431,0.28598,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.010101,0.35315,0.28206,1,1
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00035748,0.35261,0.33535,1,1
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.030713,0.35209,0.30361,1,1
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0010798,0.3516,0.3408,1,1
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0021907,0.34922,0.30643,1,1
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00031664,0.34841,0.3534,1,1
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0042727,0.3469,0.39774,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00332,0.34639,0.35418,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00014062,0.34518,0.33147,1,1
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.035953,0.34498,0.28682,1,1
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.010101,0.34476,0.3341,1,1
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0020776,0.3446,0.34978,1,1
4,GO LIPID GLYCOSYLATION,0.0016767,0.3445,0.33194,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.0047188,0.34415,0.3739,1,1
4,GO RETROGRADE AXONAL TRANSPORT,0.0018673,0.34338,0.38225,1,1
4,GO RESPONSE TO ACETYLCHOLINE,0.00019306,0.3425,0.42091,1,1
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,4.5779e-05,0.34215,0.44378,1,1
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00072571,0.34159,0.43146,1,1
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0020776,0.34108,0.32926,1,1
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.00015974,0.33953,0.38469,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0034935,0.33952,0.42648,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00014062,0.3393,0.34511,1,1
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0040644,0.33873,0.34391,1,1
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.024086,0.33872,0.37988,1,1
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.00086166,0.33861,0.36285,1,1
4,GO THALAMUS DEVELOPMENT,0.011574,0.3384,0.31293,1,1
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.02951,0.33792,0.27901,1,1
4,GO CRANIAL NERVE MORPHOGENESIS,0.013834,0.33787,0.26939,1,1
4,GO MALE SEX DETERMINATION,0.026142,0.33773,0.28652,1,1
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.0057394,0.33733,0.39975,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00086166,0.33717,0.34493,1,1
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00072571,0.33637,0.35816,1,1
4,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.023112,0.33628,0.33147,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0080134,0.33591,0.30231,1,1
4,GO RETINA LAYER FORMATION,0.0057394,0.33578,0.30007,1,1
4,GO LIMB BUD FORMATION,0.024086,0.33567,0.30744,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.041938,0.33374,0.24288,1,1
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00091199,0.3329,0.34276,1,1
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0018673,0.33101,0.35693,1,1
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00012367,0.33062,0.35706,1,1
4,GO AZOLE TRANSMEMBRANE TRANSPORT,0.0017696,0.33021,0.35142,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0066311,0.32964,0.28806,1,1
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.00068502,0.32901,0.33082,1,1
4,GO HISTONE H3 K27 METHYLATION,0.01266,0.32766,0.29558,1,1
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0018673,0.3272,0.32473,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0076456,0.32618,0.26725,1,1
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00068502,0.32589,0.33586,1,1
4,GO STARTLE RESPONSE,0.00081392,0.3252,0.4136,1,1
4,GO LOCALIZATION WITHIN MEMBRANE,0.00332,0.32502,0.28387,1,1
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.00017019,0.3234,0.36677,1,1
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00054254,0.32278,0.42688,1,1
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0092139,0.32101,0.28014,1,1
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0029965,0.32077,0.32682,1,1
4,GO AORTIC VALVE DEVELOPMENT,0.015776,0.32063,0.26263,1,1
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00072571,0.32027,0.28657,1,1
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00035748,0.32024,0.29641,1,1
4,GO FUCOSYLATION,0.00033648,0.32001,0.3019,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.045233,0.31994,0.21263,1,1
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.00045436,0.31989,0.37229,1,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0096484,0.31967,0.30938,1,1
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0015882,0.31966,0.40027,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.00042807,0.31948,0.32634,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00064645,0.31825,0.39591,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0052065,0.31757,0.31681,1,1
4,GO POSTSYNAPSE ORGANIZATION,0.00081392,0.31743,0.31649,1,1
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0023095,0.31718,0.33423,1,1
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00054254,0.31679,0.3117,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0057394,0.31649,0.32919,1,1
4,GO RESPONSE TO LEUCINE,0.0016767,0.31571,0.3676,1,1
4,GO PROTEIN POLYGLUTAMYLATION,0.0015882,0.3154,0.34974,1,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.022172,0.31538,0.21587,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.017954,0.31503,0.2753,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0057394,0.31493,0.31451,1,1
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.00051151,0.31483,0.35777,1,1
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.006955,0.31442,0.25672,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0080134,0.31312,0.28523,1,1
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00031664,0.31198,0.3599,1,1
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.010572,0.31187,0.30761,1,1
4,GO CGMP METABOLIC PROCESS,0.0016767,0.31174,0.33356,1,1
4,GO GLUTAMATE SECRETION,0.0013481,0.31159,0.33084,1,1
4,GO PIGMENT ACCUMULATION,0.0057394,0.31138,0.32968,1,1
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0092139,0.31131,0.37449,1,1
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00081392,0.3113,0.32834,1,1
4,GO SYNAPTIC VESICLE CLUSTERING,0.0036751,0.31055,0.44087,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.010101,0.30974,0.31098,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00042807,0.30961,0.30224,1,1
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.0044907,0.30948,0.26937,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00029789,0.30947,0.35671,1,1
4,GO REGULATION OF VESICLE FUSION,0.0038653,0.30914,0.30093,1,1
4,GO EPITHELIAL CELL MATURATION,0.007293,0.30874,0.31732,1,1
4,GO SYNAPTIC VESICLE MATURATION,0.0040644,0.3087,0.40955,1,1
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.00048214,0.30867,0.30971,1,1
4,GO NEURON MATURATION,0.0063209,0.30852,0.26306,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.021265,0.30777,0.21777,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00068502,0.3076,0.35246,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.0092139,0.30755,0.2906,1,1
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0036751,0.3074,0.29997,1,1
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00064645,0.30726,0.32349,1,1
4,GO CELL JUNCTION MAINTENANCE,0.0013481,0.30715,0.35078,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.045233,0.30655,0.24376,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.015104,0.30648,0.25368,1,1
4,GO NEURONAL ION CHANNEL CLUSTERING,0.0054671,0.30594,0.3506,1,1
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00091199,0.30572,0.29736,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.02951,0.30547,0.2708,1,1
4,GO SYNAPTIC VESICLE LOCALIZATION,0.0042727,0.30529,0.29402,1,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0066311,0.30483,0.25851,1,1
4,GO MECHANOSENSORY BEHAVIOR,0.025096,0.30444,0.27163,1,1
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.00051151,0.30444,0.35342,1,1
4,GO CELL FATE SPECIFICATION,0.0016767,0.30414,0.26348,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.015104,0.30411,0.36502,1,1
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00054254,0.30389,0.34535,1,1
4,GO RESPONSE TO INSECTICIDE,0.0054671,0.30362,0.29707,1,1
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0057394,0.30335,0.29262,1,1
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00064645,0.30236,0.30707,1,1
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00024771,0.30202,0.3969,1,1
4,GO LEARNING,0.0023095,0.30185,0.29633,1,1
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00081392,0.30131,0.29539,1,1
4,GO DENDRITIC SPINE MORPHOGENESIS,0.0027019,0.30115,0.33052,1,1
4,GO NEURON FATE SPECIFICATION,0.0034935,0.30086,0.34459,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0010798,0.30053,0.31836,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00060992,0.30028,0.31568,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0029965,0.29997,0.28311,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0011418,0.29973,0.33448,1,1
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00064645,0.29961,0.32755,1,1
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.048745,0.29924,0.24759,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0017696,0.2991,0.34169,1,1
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0023095,0.29907,0.31156,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.00091199,0.29897,0.32629,1,1
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.0013481,0.29893,0.28979,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0066311,0.29855,0.35228,1,1
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.00072571,0.29822,0.3177,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.007293,0.29821,0.26673,1,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0017696,0.29792,0.29438,1,1
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00091199,0.29759,0.33145,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,0.0049572,0.2974,0.31371,1,1
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011063,0.29641,0.29126,1,1
4,GO RESPONSE TO GLUCAGON,0.0012758,0.29564,0.31068,1,1
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.027226,0.29504,0.2413,1,1
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0080134,0.29491,0.33664,1,1
4,GO LONG TERM SYNAPTIC POTENTIATION,0.0013481,0.29476,0.30741,1,1
4,GO NEURON FATE COMMITMENT,0.0038653,0.29455,0.28701,1,1
4,GO REGULATION OF MICROTUBULE BINDING,0.0011418,0.29427,0.38949,1,1
4,GO CELL PROLIFERATION IN FOREBRAIN,0.0054671,0.29423,0.32941,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0015041,0.2942,0.33788,1,1
4,GO HISTONE H3 K36 METHYLATION,0.023112,0.29398,0.2717,1,1
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0172,0.29388,0.23363,1,1
4,GO NEURON PROJECTION GUIDANCE,0.00091199,0.29364,0.33178,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0057394,0.29276,0.27291,1,1
4,GO CHEMOSENSORY BEHAVIOR,0.0012071,0.29267,0.2821,1,1
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0027019,0.29236,0.28026,1,1
4,GO LONG TERM MEMORY,0.00064645,0.2922,0.32486,1,1
4,GO CORPUS CALLOSUM DEVELOPMENT,0.00014062,0.29218,0.39477,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.011574,0.29195,0.28355,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00072571,0.29184,0.30951,1,1
4,GO NEUROTRANSMITTER SECRETION,0.0010798,0.29171,0.31743,1,1
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.040368,0.29154,0.27878,1,1
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0080134,0.29136,0.34436,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.00057531,0.29092,0.30976,1,1
4,GO AXON EXTENSION,0.00035748,0.29077,0.342,1,1
4,GO NEURAL CREST FORMATION,0.013235,0.2907,0.32762,1,1
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0092139,0.29045,0.29087,1,1
4,GO GROWTH HORMONE SECRETION,0.0023095,0.29041,0.36988,1,1
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0052065,0.29017,0.31832,1,1
4,GO FORELIMB MORPHOGENESIS,0.0018673,0.29003,0.30327,1,1
4,GO SPINAL CORD DEVELOPMENT,0.00081392,0.29003,0.30562,1,1
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00086166,0.28995,0.33784,1,1
4,GO ADAPTATION OF SIGNALING PATHWAY,0.00060992,0.28995,0.3705,1,1
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.0012071,0.28909,0.38058,1,1
4,GO REGULATION OF AXONOGENESIS,0.00045436,0.28902,0.35711,1,1
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0028457,0.28902,0.24076,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.028348,0.28869,0.25322,1,1
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00054254,0.28865,0.32145,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0031545,0.28858,0.2886,1,1
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0012758,0.28851,0.34634,1,1
4,GO MEIOTIC SPINDLE ORGANIZATION,0.0029965,0.2877,0.32984,1,1
4,GO NEURON MIGRATION,0.0015041,0.2874,0.31735,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0172,0.28715,0.21522,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0066311,0.28665,0.31739,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00028019,0.28655,0.31389,1,1
4,GO SYNAPTIC SIGNALING,0.00081392,0.28645,0.2946,1,1
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.045233,0.2863,0.24734,1,1
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.013834,0.28598,0.29583,1,1
4,GO ACTIN FILAMENT BASED TRANSPORT,0.0047188,0.28572,0.2937,1,1
4,GO NOREPINEPHRINE TRANSPORT,0.0010209,0.2857,0.40459,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0017696,0.28539,0.33959,1,1
4,GO NEURON PROJECTION ORGANIZATION,0.0012071,0.28517,0.32055,1,1
4,GO NUCLEAR MIGRATION,0.0063209,0.28507,0.33861,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0015882,0.28491,0.26963,1,1
4,GO DENDRITE MORPHOGENESIS,0.0052065,0.2843,0.29292,1,1
4,GO POTASSIUM ION HOMEOSTASIS,0.00068502,0.28417,0.27494,1,1
4,GO TORC1 SIGNALING,0.00057531,0.28363,0.33055,1,1
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00048214,0.28352,0.28506,1,1
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.052482,0.28331,0.25566,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0038653,0.28303,0.30379,1,1
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,8.3641e-05,0.28293,0.34059,1,1
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0019699,0.28267,0.30566,1,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0015882,0.28249,0.34388,1,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.0031545,0.28128,0.30484,1,1
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.0042727,0.28105,0.39346,1,1
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.022172,0.28097,0.26611,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00081392,0.28074,0.29574,1,1
4,GO NUCLEUS LOCALIZATION,0.0042727,0.28061,0.34799,1,1
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.018736,0.27983,0.28245,1,1
4,GO CARDIAC ATRIUM DEVELOPMENT,0.041938,0.27981,0.22552,1,1
4,GO NEUROBLAST PROLIFERATION,0.00081392,0.27978,0.30027,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.010572,0.27945,0.29877,1,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.020391,0.2792,0.20117,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0011418,0.2791,0.33285,1,1
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.022172,0.2787,0.22851,1,1
4,GO MUSCLE FIBER DEVELOPMENT,0.0052065,0.27835,0.24533,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.0036751,0.27794,0.28393,1,1
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0066311,0.27741,0.23752,1,1
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.00081392,0.27709,0.3229,1,1
4,GO VITAMIN CATABOLIC PROCESS,0.017954,0.27691,0.23681,1,1
4,GO SECRETORY GRANULE LOCALIZATION,0.020391,0.27671,0.26517,1,1
4,GO MICROTUBULE POLYMERIZATION,0.0020776,0.27649,0.30104,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.006955,0.27599,0.31126,1,1
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0076456,0.2755,0.31168,1,1
4,GO FOREGUT MORPHOGENESIS,0.0049572,0.27549,0.2731,1,1
4,GO NEURON CELL CELL ADHESION,0.008797,0.27508,0.43765,1,1
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.007293,0.27482,0.28509,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0052065,0.27461,0.27599,1,1
4,GO NEURAL TUBE PATTERNING,0.018736,0.27423,0.22382,1,1
4,GO WALKING BEHAVIOR,0.00048214,0.27411,0.31494,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00048214,0.27408,0.28983,1,1
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0024341,0.27337,0.34114,1,1
4,GO REGULATION OF TORC1 SIGNALING,0.00096503,0.27308,0.30379,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0029965,0.27305,0.30326,1,1
4,GO SYNAPSE ORGANIZATION,0.0018673,0.27281,0.29411,1,1
4,GO DENDRITE DEVELOPMENT,0.0021907,0.2724,0.29443,1,1
4,GO MYOTUBE CELL DEVELOPMENT,0.013834,0.27185,0.21255,1,1
4,GO NEURON RECOGNITION,0.0029965,0.2707,0.29752,1,1
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.011063,0.27038,0.26603,1,1
4,GO NEUROTRANSMITTER TRANSPORT,0.00076864,0.26992,0.31183,1,1
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.022172,0.2699,0.26855,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.012106,0.2696,0.23196,1,1
4,GO NEURON PROJECTION EXTENSION,0.00054254,0.2689,0.31424,1,1
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.013235,0.26888,0.39383,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0015882,0.26866,0.29845,1,1
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00045436,0.26846,0.30466,1,1
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00057531,0.26844,0.31296,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00020554,0.26815,0.35066,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0034935,0.26805,0.26763,1,1
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00035748,0.268,0.33706,1,1
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021907,0.26771,0.26893,1,1
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0024341,0.26735,0.37117,1,1
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0092139,0.26697,0.25643,1,1
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0080134,0.26653,0.28177,1,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.007293,0.26647,0.31172,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00076864,0.26629,0.26709,1,1
4,GO REGULATION OF AXON GUIDANCE,0.0057394,0.26595,0.29261,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0023095,0.26591,0.29472,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0049572,0.26589,0.23595,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.011063,0.26517,0.2745,1,1
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00057531,0.26513,0.27375,1,1
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.0018673,0.26456,0.27807,1,1
4,GO EMBRYONIC EYE MORPHOGENESIS,0.0060238,0.26455,0.28854,1,1
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00051151,0.26447,0.31347,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.013235,0.26429,0.28012,1,1
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0038653,0.2641,0.26946,1,1
4,GO EXPLORATION BEHAVIOR,0.027226,0.26407,0.22576,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.033245,0.26365,0.23883,1,1
4,GO AXONAL FASCICULATION,0.011063,0.26355,0.30761,1,1
4,GO ADULT BEHAVIOR,0.0016767,0.26355,0.29826,1,1
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.007293,0.26351,0.31069,1,1
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0027019,0.26334,0.27904,1,1
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0076456,0.26293,0.26725,1,1
4,GO CGMP MEDIATED SIGNALING,0.010572,0.26291,0.23436,1,1
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.016475,0.26276,0.22129,1,1
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0019699,0.26257,0.25259,1,1
4,GO EATING BEHAVIOR,0.00031664,0.26246,0.32851,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0018673,0.26244,0.31128,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0015041,0.26144,0.28524,1,1
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.021265,0.26143,0.21013,1,1
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.0018673,0.26069,0.27494,1,1
4,GO LATERAL VENTRICLE DEVELOPMENT,0.0029965,0.26064,0.33881,1,1
4,GO CELL PART MORPHOGENESIS,0.0018673,0.26045,0.28721,1,1
4,GO NEURON PROJECTION ARBORIZATION,0.021265,0.25989,0.28057,1,1
4,GO MICROTUBULE SEVERING,0.045233,0.25984,0.19597,1,1
4,GO RESPONSE TO NICOTINE,0.021265,0.25968,0.23142,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031957,0.25953,0.2079,1,1
4,GO NEURAL RETINA DEVELOPMENT,0.00091199,0.25924,0.32206,1,1
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.011574,0.25898,0.28388,1,1
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0040644,0.25874,0.23358,1,1
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.019548,0.25848,0.28098,1,1
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.007293,0.25835,0.3132,1,1
4,GO CARBOHYDRATE PHOSPHORYLATION,0.00068502,0.25824,0.27406,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.033245,0.25809,0.27819,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.011063,0.25753,0.27315,1,1
4,GO REPRODUCTIVE BEHAVIOR,0.025096,0.25747,0.24229,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.025096,0.25719,0.21265,1,1
4,GO PROTEIN KINASE C SIGNALING,0.011063,0.25687,0.28331,1,1
4,GO CALCINEURIN MEDIATED SIGNALING,0.0049572,0.25645,0.24148,1,1
4,GO MICROTUBULE NUCLEATION,0.0066311,0.2564,0.26735,1,1
4,GO LIPID TRANSLOCATION,0.013235,0.25633,0.27214,1,1
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0013481,0.25613,0.251,1,1
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.0017696,0.25525,0.29569,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0057394,0.25497,0.2082,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.010101,0.25493,0.24827,1,1
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00064645,0.25428,0.35274,1,1
4,GO APICAL PROTEIN LOCALIZATION,0.0066311,0.25413,0.23839,1,1
4,GO MEMBRANE DEPOLARIZATION,0.017954,0.25388,0.20783,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00045436,0.25372,0.29527,1,1
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00035748,0.25351,0.29639,1,1
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.0029965,0.25321,0.22819,1,1
4,GO GLIAL CELL MIGRATION,0.0038653,0.25308,0.28579,1,1
4,GO RESPONSE TO INACTIVITY,0.033245,0.25291,0.19829,1,1
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.026142,0.25245,0.23759,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0011418,0.25229,0.27006,1,1
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.026142,0.25185,0.30473,1,1
4,GO REGULATION OF MRNA BINDING,0.00332,0.25167,0.22369,1,1
4,GO FEAR RESPONSE,0.035953,0.25161,0.18436,1,1
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0060238,0.25151,0.25881,1,1
4,GO CELL MIGRATION IN HINDBRAIN,0.0052065,0.2512,0.33479,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0057394,0.25102,0.29911,1,1
4,GO FUCOSE METABOLIC PROCESS,0.0096484,0.25049,0.20322,1,1
4,GO BEHAVIOR,0.0029965,0.25025,0.2477,1,1
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0010798,0.25011,0.26132,1,1
4,GO AXON DEVELOPMENT,0.0020776,0.25007,0.29162,1,1
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0036751,0.24986,0.29311,1,1
4,GO HISTONE METHYLATION,0.007293,0.24985,0.237,1,1
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0023095,0.24939,0.25733,1,1
4,GO HISTONE H3 K9 MODIFICATION,0.011574,0.24935,0.22815,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.008797,0.24904,0.33722,1,1
4,GO NERVE DEVELOPMENT,0.013235,0.24894,0.2583,1,1
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018673,0.24877,0.31106,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.01266,0.24871,0.23781,1,1
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0013481,0.24828,0.29523,1,1
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.0047188,0.24779,0.30634,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.026142,0.24758,0.2123,1,1
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.021265,0.24751,0.26758,1,1
4,GO FOREBRAIN CELL MIGRATION,0.0054671,0.24741,0.27042,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0036751,0.24739,0.31711,1,1
4,GO GDP METABOLIC PROCESS,0.0024341,0.24731,0.28327,1,1
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0038653,0.24729,0.27236,1,1
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00019306,0.24705,0.26853,1,1
4,GO COLLECTING DUCT DEVELOPMENT,0.027226,0.24701,0.34162,1,1
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.015776,0.24668,0.23841,1,1
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.0042727,0.24654,0.27137,1,1
4,GO TUBULIN DEACETYLATION,0.0029965,0.24648,0.29251,1,1
4,GO LOCOMOTORY BEHAVIOR,0.0025648,0.24645,0.28077,1,1
4,GO REGULATION OF GOLGI ORGANIZATION,0.00042807,0.24629,0.27857,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.0054671,0.24615,0.28849,1,1
4,GO RESPONSE TO ISCHEMIA,0.013834,0.24589,0.23013,1,1
4,GO REGULATION OF BEHAVIOR,0.012106,0.24509,0.19881,1,1
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.007293,0.24497,0.26008,1,1
4,GO SPINDLE MIDZONE ASSEMBLY,0.010572,0.24472,0.28582,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0036751,0.24467,0.23711,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.016475,0.2446,0.32524,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0013481,0.24402,0.27904,1,1
4,GO RESPONSE TO VITAMIN A,0.011574,0.24399,0.19323,1,1
4,GO FILOPODIUM ASSEMBLY,0.022172,0.24329,0.2123,1,1
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00091199,0.24312,0.28095,1,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00057531,0.24295,0.27734,1,1
4,GO ORGANIC CATION TRANSPORT,0.0172,0.24274,0.23187,1,1
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.014457,0.24266,0.19075,1,1
4,GO HISTONE H3 K9 METHYLATION,0.010572,0.24235,0.2582,1,1
4,GO AXO DENDRITIC TRANSPORT,0.0063209,0.24232,0.26283,1,1
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0029965,0.2423,0.20803,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,0.0172,0.24221,0.28565,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.010572,0.24216,0.21551,1,1
4,GO NEURAL CREST CELL MIGRATION,0.0047188,0.24203,0.27101,1,1
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0029965,0.24203,0.2298,1,1
4,GO GLUCOSE CATABOLIC PROCESS,0.00042807,0.2419,0.27972,1,1
4,GO SYNAPTIC VESICLE RECYCLING,0.0015041,0.24162,0.2794,1,1
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.011574,0.24157,0.25594,1,1
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.00076864,0.24126,0.27631,1,1
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0076456,0.24107,0.25405,1,1
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0029965,0.24099,0.30372,1,1
4,GO CELLULAR COMPONENT MAINTENANCE,0.0025648,0.24093,0.28895,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.015776,0.24071,0.18097,1,1
4,GO CHROMATIN DISASSEMBLY,0.0029965,0.24041,0.27396,1,1
4,GO ASSOCIATIVE LEARNING,0.0038653,0.24023,0.26828,1,1
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.046961,0.23993,0.20404,1,1
4,GO PROTEIN DEPOLYMERIZATION,0.0018673,0.23987,0.28126,1,1
4,GO PEPTIDE HORMONE SECRETION,0.0015882,0.23949,0.24426,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0038653,0.23892,0.24639,1,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.031957,0.23841,0.21364,1,1
4,GO PROTEIN KINASE A SIGNALING,0.007293,0.23793,0.22372,1,1
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0027019,0.23791,0.32183,1,1
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.0029965,0.23787,0.24913,1,1
4,GO FEEDING BEHAVIOR,0.00091199,0.23786,0.25803,1,1
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0038653,0.2377,0.26806,1,1
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00019306,0.23733,0.26764,1,1
4,GO NEURON DEVELOPMENT,0.0016767,0.23655,0.26635,1,1
4,GO CEREBRAL CORTEX DEVELOPMENT,0.0015882,0.23653,0.28743,1,1
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.0066311,0.23647,0.27919,1,1
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.015776,0.23646,0.27731,1,1
4,GO SKELETAL MUSCLE CONTRACTION,0.0017696,0.23644,0.24507,1,1
4,GO ADHERENS JUNCTION ASSEMBLY,0.0015882,0.2364,0.32484,1,1
4,GO GANGLION DEVELOPMENT,0.031957,0.23634,0.24392,1,1
4,GO NEUROTRANSMITTER REUPTAKE,0.0020776,0.23613,0.27646,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0021907,0.23611,0.22895,1,1
4,GO METENCEPHALON DEVELOPMENT,0.0020776,0.236,0.26205,1,1
4,GO RHYTHMIC BEHAVIOR,0.0016767,0.23593,0.27201,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0020776,0.23591,0.24865,1,1
4,GO PEPTIDYL LYSINE METHYLATION,0.013235,0.23571,0.22616,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0019699,0.23559,0.28307,1,1
4,GO CEREBELLAR CORTEX FORMATION,0.010572,0.23558,0.24371,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.011063,0.23547,0.23483,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0063209,0.23508,0.29196,1,1
4,GO CATECHOLAMINE UPTAKE,0.0018673,0.23494,0.34192,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.043559,0.23489,0.24641,1,1
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.021265,0.23463,0.21394,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020776,0.2338,0.26974,1,1
4,GO DEVELOPMENTAL CELL GROWTH,0.0016767,0.23337,0.27994,1,1
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.0080134,0.23336,0.21051,1,1
4,GO ATRIAL SEPTUM DEVELOPMENT,0.023112,0.23294,0.25909,1,1
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0036751,0.23284,0.23258,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.038848,0.23256,0.25656,1,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0028457,0.23235,0.26032,1,1
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.012106,0.23221,0.23291,1,1
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0024341,0.2317,0.28212,1,1
4,GO RESPONSE TO NITRIC OXIDE,0.012106,0.23166,0.23102,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0014241,0.23159,0.25991,1,1
4,GO CELLULAR RESPONSE TO PH,0.0016767,0.23125,0.30091,1,1
4,GO HEART VALVE DEVELOPMENT,0.015776,0.23124,0.25446,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.011574,0.23108,0.23859,1,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0054671,0.23108,0.27455,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00035748,0.231,0.26939,1,1
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0023095,0.23092,0.31966,1,1
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0096484,0.23055,0.26361,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.013235,0.23051,0.24039,1,1
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0024341,0.23047,0.23365,1,1
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0034935,0.23046,0.29137,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.008797,0.23045,0.21498,1,1
4,GO HISTONE H3 K9 TRIMETHYLATION,0.021265,0.23019,0.208,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0023095,0.23017,0.34249,1,1
4,GO DENDRITE SELF AVOIDANCE,0.02951,0.23003,0.23118,1,1
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00035748,0.22966,0.25802,1,1
4,GO INSULIN SECRETION,0.00091199,0.22942,0.26467,1,1
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0029965,0.22907,0.27013,1,1
4,GO DENDRITIC SPINE DEVELOPMENT,0.0023095,0.22907,0.29845,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0011418,0.22873,0.25891,1,1
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0025648,0.22863,0.25376,1,1
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0096484,0.22839,0.2473,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.048745,0.22831,0.22963,1,1
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0060238,0.22811,0.21744,1,1
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.043559,0.2281,0.19005,1,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0015882,0.22793,0.27402,1,1
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0010798,0.2279,0.34588,1,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0010209,0.22789,0.23687,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0015882,0.22787,0.28817,1,1
4,GO NEURON DIFFERENTIATION,0.0015041,0.22786,0.26007,1,1
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.023112,0.22785,0.19711,1,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0049572,0.22724,0.23534,1,1
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0060238,0.22693,0.21976,1,1
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00042807,0.22641,0.26651,1,1
4,GO HISTONE H3 K4 TRIMETHYLATION,0.046961,0.22603,0.24852,1,1
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.012106,0.22579,0.1989,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.041938,0.22559,0.16796,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.023112,0.2249,0.22038,1,1
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.012106,0.22473,0.27317,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.015104,0.22472,0.19645,1,1
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0014241,0.22415,0.29598,1,1
4,GO REGULATION OF CELL SIZE,0.0016767,0.2241,0.27877,1,1
4,GO REGULATION OF EXOCYTOSIS,0.0027019,0.22398,0.23625,1,1
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00033648,0.22389,0.2592,1,1
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0052065,0.22377,0.26998,1,1
4,GO REGULATION OF NEURON DIFFERENTIATION,0.0017696,0.22376,0.26327,1,1
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0015882,0.22369,0.25032,1,1
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.0066311,0.22369,0.25292,1,1
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0057394,0.22354,0.30365,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.017954,0.22311,0.27377,1,1
4,GO PROTEIN DEMETHYLATION,0.012106,0.22277,0.2614,1,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0172,0.22272,0.19538,1,1
4,GO NEURONAL ACTION POTENTIAL,0.031957,0.22265,0.17536,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0020776,0.22237,0.27144,1,1
4,GO LEFT RIGHT PATTERN FORMATION,0.026142,0.22226,0.19528,1,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.048745,0.22224,0.20133,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.018736,0.22218,0.22204,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0018673,0.22206,0.27352,1,1
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0019699,0.22197,0.24916,1,1
4,GO RESPONSE TO HYDROXYUREA,0.0092139,0.22053,0.23406,1,1
4,GO CAMP METABOLIC PROCESS,0.035953,0.22005,0.22186,1,1
4,GO POTASSIUM ION TRANSPORT,0.00060992,0.22001,0.27483,1,1
4,GO CARDIAC CONDUCTION,0.0027019,0.21983,0.23751,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0042727,0.21979,0.34589,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0015882,0.21975,0.22967,1,1
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00060992,0.21974,0.3163,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.0024341,0.21972,0.26853,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.018736,0.21942,0.14855,1,1
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00096503,0.21922,0.30074,1,1
4,GO HINDBRAIN MORPHOGENESIS,0.0047188,0.21915,0.22497,1,1
4,GO REGULATION OF STEM CELL PROLIFERATION,0.0027019,0.21903,0.23759,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.020391,0.21868,0.19604,1,1
4,GO REGULATION OF OOGENESIS,0.0015882,0.21851,0.22349,1,1
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0047188,0.21843,0.18705,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.0027019,0.21818,0.24002,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0031545,0.21785,0.28855,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.028348,0.21722,0.22603,1,1
4,GO NEURON APOPTOTIC PROCESS,0.0096484,0.21722,0.19145,1,1
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0011418,0.21718,0.23076,1,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.0096484,0.21711,0.27154,1,1
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.0018673,0.2169,0.29391,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0012071,0.21669,0.26734,1,1
4,GO RESPONSE TO DOPAMINE,0.00064645,0.21639,0.25308,1,1
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0038653,0.21635,0.23615,1,1
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0042727,0.21633,0.27187,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.015104,0.2163,0.18572,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.021265,0.21626,0.18656,1,1
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0015882,0.21598,0.31922,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.0036751,0.2151,0.24406,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0049572,0.21496,0.22766,1,1
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0052065,0.21466,0.23077,1,1
4,GO L AMINO ACID TRANSPORT,0.0036751,0.21411,0.21595,1,1
4,GO ENDOCYTIC RECYCLING,0.020391,0.2141,0.20998,1,1
4,GO RESPONSE TO ACIDIC PH,0.0057394,0.214,0.32042,1,1
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0024341,0.21392,0.25542,1,1
4,GO FOREBRAIN GENERATION OF NEURONS,0.018736,0.21376,0.17713,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.011574,0.21363,0.17318,1,1
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0040644,0.21342,0.25799,1,1
4,GO NEURAL CREST CELL DIFFERENTIATION,0.020391,0.21329,0.21412,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.00040321,0.21309,0.23724,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.018736,0.21254,0.25657,1,1
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0038653,0.21245,0.24487,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0096484,0.21238,0.19587,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0015882,0.21234,0.25537,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0080134,0.21202,0.25562,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.037377,0.21173,0.19005,1,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.052482,0.21164,0.23229,1,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.008797,0.21161,0.22496,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.010101,0.21137,0.23221,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.040368,0.21128,0.23208,1,1
4,GO ACTIN CROSSLINK FORMATION,0.027226,0.21121,0.22791,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.045233,0.21116,0.22193,1,1
4,GO MEMORY,0.0049572,0.21107,0.23416,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.0049572,0.21079,0.24594,1,1
4,GO REGULATION OF PROTON TRANSPORT,0.00086166,0.21073,0.21808,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.0014241,0.21066,0.30429,1,1
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.012106,0.21064,0.21439,1,1
4,GO SYNAPSE ASSEMBLY,0.010101,0.21056,0.26638,1,1
4,GO REGULATION OF ION TRANSPORT,0.0057394,0.21043,0.20856,1,1
4,GO CALCIUM ION IMPORT,0.0063209,0.21012,0.20991,1,1
4,GO REGULATION OF MITOPHAGY,0.0027019,0.21004,0.30059,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.037377,0.20987,0.20787,1,1
4,GO IMPORT INTO CELL,0.0011418,0.20951,0.23423,1,1
4,GO PONS DEVELOPMENT,0.033245,0.20943,0.35072,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0018673,0.20941,0.26161,1,1
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.028348,0.20939,0.2324,1,1
4,GO POSITIVE REGULATION OF RNA SPLICING,0.0063209,0.20932,0.20549,1,1
4,GO MITOCHONDRION LOCALIZATION,0.0042727,0.20929,0.24274,1,1
4,GO RECEPTOR INTERNALIZATION,0.0010798,0.2092,0.23975,1,1
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.040368,0.20916,0.23403,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.015776,0.20909,0.20775,1,1
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.010101,0.20898,0.22051,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.010101,0.20875,0.2667,1,1
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.019548,0.20833,0.28403,1,1
4,GO PLATELET MORPHOGENESIS,0.0024341,0.20816,0.30947,1,1
4,GO REGULATION OF RNA BINDING,0.011063,0.20807,0.18433,1,1
4,GO CARNITINE SHUTTLE,0.022172,0.20765,0.21424,1,1
4,GO LACTATION,0.018736,0.20748,0.18501,1,1
4,GO SCHWANN CELL DEVELOPMENT,0.0060238,0.20746,0.26857,1,1
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.043559,0.20735,0.22746,1,1
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0031545,0.20734,0.24453,1,1
4,GO SIALYLATION,0.021265,0.20729,0.25717,1,1
4,GO NEUROGENESIS,0.0016767,0.20717,0.25008,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.010572,0.20712,0.19347,1,1
4,GO MOTOR NEURON AXON GUIDANCE,0.011574,0.20704,0.25392,1,1
4,GO HINDLIMB MORPHOGENESIS,0.0080134,0.20694,0.24492,1,1
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0049572,0.20656,0.23482,1,1
4,GO PALLIUM DEVELOPMENT,0.0042727,0.20645,0.23362,1,1
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.012106,0.20628,0.23894,1,1
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0063209,0.2055,0.2335,1,1
4,GO NEURON DEATH,0.010572,0.2053,0.19063,1,1
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0018673,0.20523,0.23257,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.020391,0.20503,0.21327,1,1
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.022172,0.20502,0.2093,1,1
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.00013188,0.20473,0.28839,1,1
4,GO PODOSOME ASSEMBLY,0.043559,0.20459,0.24803,1,1
4,GO LOCOMOTOR RHYTHM,0.015104,0.20447,0.27431,1,1
4,GO CELL FATE COMMITMENT,0.00332,0.20442,0.20984,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.008797,0.20426,0.24929,1,1
4,GO GANGLIOSIDE METABOLIC PROCESS,0.0066311,0.20409,0.24378,1,1
4,GO HISTONE H4 K5 ACETYLATION,0.031957,0.20393,0.20755,1,1
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0096484,0.2039,0.21425,1,1
4,GO CELL MORPHOGENESIS,0.00332,0.2036,0.25054,1,1
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.02951,0.20323,0.19789,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.0042727,0.20317,0.22201,1,1
4,GO REGULATION OF HORMONE SECRETION,0.0057394,0.20308,0.20488,1,1
4,GO NEGATIVE CHEMOTAXIS,0.030713,0.20299,0.23186,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.014457,0.2027,0.20016,1,1
4,GO HINDBRAIN DEVELOPMENT,0.008797,0.20262,0.21613,1,1
4,GO REGULATION OF CELL MORPHOGENESIS,0.00332,0.2026,0.25967,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.010101,0.2023,0.17952,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.020391,0.20229,0.20315,1,1
4,GO DOPAMINE TRANSPORT,0.041938,0.20226,0.23017,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING,0.013235,0.20221,0.1792,1,1
4,GO PROTEIN METHYLATION,0.0172,0.20188,0.19947,1,1
4,GO HEAD DEVELOPMENT,0.0038653,0.20157,0.23063,1,1
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0038653,0.20113,0.22549,1,1
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0020776,0.20072,0.23285,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.035953,0.20066,0.17165,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0049572,0.20063,0.2073,1,1
4,GO REGULATION OF MEMBRANE POTENTIAL,0.0014241,0.20033,0.24637,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.0049572,0.20028,0.22383,1,1
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.01266,0.20025,0.2111,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.019548,0.20011,0.21516,1,1
4,GO DEVELOPMENTAL MATURATION,0.0096484,0.20007,0.21602,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00019306,0.19999,0.25051,1,1
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.043559,0.19972,0.17305,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.027226,0.19941,0.22713,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0014241,0.19927,0.2218,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.031957,0.19897,0.16384,1,1
4,GO CELL JUNCTION ASSEMBLY,0.02951,0.19883,0.19982,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.0023095,0.19872,0.3426,1,1
4,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.015776,0.19858,0.2423,1,1
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0024341,0.1984,0.24061,1,1
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.045233,0.19831,0.18025,1,1
4,GO CERAMIDE TRANSPORT,0.013834,0.19826,0.23817,1,1
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.0083971,0.19753,0.22065,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.01266,0.19753,0.22205,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.011574,0.19731,0.20876,1,1
4,GO FOREBRAIN DEVELOPMENT,0.0014241,0.19721,0.25139,1,1
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0052065,0.19706,0.23118,1,1
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.031957,0.19697,0.21874,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0038653,0.19691,0.22627,1,1
4,GO PLASMA MEMBRANE TUBULATION,0.0010209,0.19669,0.28917,1,1
4,GO PROTEIN TRIMERIZATION,0.027226,0.19647,0.25353,1,1
4,GO TELENCEPHALON DEVELOPMENT,0.0029965,0.19633,0.23911,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0031545,0.1963,0.22216,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.00057531,0.196,0.22215,1,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.0172,0.19565,0.23313,1,1
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0060238,0.19554,0.26771,1,1
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.030713,0.19547,0.27277,1,1
4,GO RESPIRATORY SYSTEM PROCESS,0.011063,0.19527,0.2754,1,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0076456,0.19523,0.23905,1,1
4,GO PULMONARY VALVE MORPHOGENESIS,0.031957,0.19519,0.24977,1,1
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.038848,0.19507,0.26076,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00035748,0.19505,0.23463,1,1
4,GO ACIDIC AMINO ACID TRANSPORT,0.00091199,0.19434,0.2791,1,1
4,GO MONOAMINE TRANSPORT,0.0036751,0.19406,0.28521,1,1
4,GO RESPONSE TO COCAINE,0.023112,0.19391,0.19743,1,1
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0080134,0.19334,0.1931,1,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.021265,0.19319,0.22901,1,1
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0031545,0.19298,0.23546,1,1
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0015882,0.19261,0.25369,1,1
4,GO SIGNAL RELEASE,0.008797,0.19257,0.19865,1,1
4,GO COGNITION,0.0044907,0.19253,0.22896,1,1
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0017696,0.19217,0.31425,1,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0049572,0.19191,0.23254,1,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.015776,0.19181,0.23301,1,1
4,GO NERVOUS SYSTEM PROCESS,0.00040321,0.19178,0.23404,1,1
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.011063,0.19163,0.17096,1,1
4,GO REGULATION OF TUBULIN DEACETYLATION,0.013235,0.19158,0.2208,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0080134,0.19136,0.20604,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0083971,0.19131,0.19632,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0021907,0.19125,0.25779,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0083971,0.19112,0.21675,1,1
4,GO SENSORY PERCEPTION OF PAIN,0.008797,0.19099,0.20333,1,1
4,GO SENSORY PERCEPTION,0.00040321,0.19097,0.20291,1,1
4,GO STEM CELL PROLIFERATION,0.0028457,0.19087,0.23737,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0040644,0.19081,0.22614,1,1
4,GO HORMONE TRANSPORT,0.0042727,0.19072,0.21311,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.040368,0.19048,0.17025,1,1
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00076864,0.19028,0.27316,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.015776,0.19023,0.16905,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0054671,0.19013,0.24965,1,1
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.013235,0.18997,0.24806,1,1
4,GO PITUITARY GLAND DEVELOPMENT,0.015104,0.18966,0.17827,1,1
4,GO VISUAL BEHAVIOR,0.0038653,0.18956,0.22312,1,1
4,GO RESPONSE TO PH,0.0060238,0.18951,0.28394,1,1
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.010572,0.18938,0.28278,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0015041,0.18933,0.24405,1,1
4,GO OVULATION CYCLE PROCESS,0.020391,0.18918,0.18,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.006955,0.18883,0.20313,1,1
4,GO NEUROTRANSMITTER UPTAKE,0.0034935,0.18874,0.22483,1,1
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0049572,0.1887,0.22208,1,1
4,GO MRNA TRANSCRIPTION,0.034576,0.1883,0.20961,1,1
4,GO DETECTION OF VISIBLE LIGHT,0.0019699,0.18821,0.31832,1,1
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.012106,0.18815,0.21776,1,1
4,GO PANCREAS DEVELOPMENT,0.020391,0.18814,0.17172,1,1
4,GO DORSAL VENTRAL PATTERN FORMATION,0.0092139,0.18797,0.20908,1,1
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.012106,0.18773,0.16624,1,1
4,GO ERYTHROCYTE MATURATION,0.040368,0.18763,0.20327,1,1
4,GO CELLULAR RESPONSE TO ATP,0.0066311,0.18742,0.2233,1,1
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.017954,0.18726,0.18726,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.016475,0.18718,0.1795,1,1
4,GO OUTFLOW TRACT MORPHOGENESIS,0.046961,0.18713,0.19254,1,1
4,GO AMINO ACID TRANSPORT,0.0017696,0.18706,0.23061,1,1
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.019548,0.18703,0.28306,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.031957,0.18695,0.17383,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.021265,0.18679,0.18108,1,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0034935,0.18658,0.21442,1,1
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.026142,0.18658,0.20498,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.0038653,0.18652,0.22003,1,1
4,GO CELL JUNCTION ORGANIZATION,0.0066311,0.18631,0.24085,1,1
4,GO HISTONE H3 K4 METHYLATION,0.037377,0.18621,0.18805,1,1
4,GO NADH METABOLIC PROCESS,0.0010209,0.18607,0.23208,1,1
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0096484,0.18586,0.25712,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.0040644,0.18583,0.22231,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0027019,0.18575,0.20502,1,1
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.043559,0.18557,0.17007,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.019548,0.18534,0.24083,1,1
4,GO CELL PROJECTION ORGANIZATION,0.0052065,0.18487,0.22258,1,1
4,GO PRESYNAPSE ORGANIZATION,0.037377,0.18485,0.2071,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.048745,0.18484,0.2062,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.016475,0.18474,0.20426,1,1
4,GO MULTICELLULAR ORGANISM GROWTH,0.0036751,0.18471,0.24213,1,1
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.0027019,0.18466,0.2275,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0024341,0.18462,0.23281,1,1
4,GO DNA DEMETHYLATION,0.017954,0.18462,0.1922,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0096484,0.18457,0.2474,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00086166,0.18453,0.23717,1,1
4,GO CELL CELL SIGNALING,0.0066311,0.18444,0.20639,1,1
4,GO NAD METABOLIC PROCESS,0.00057531,0.1844,0.22022,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0031545,0.18421,0.23648,1,1
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0049572,0.18396,0.19771,1,1
4,GO DENDRITE EXTENSION,0.011063,0.18388,0.22523,1,1
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.011574,0.18365,0.19875,1,1
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0038653,0.18352,0.24638,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0020776,0.18309,0.2017,1,1
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.028348,0.18308,0.19542,1,1
4,GO SPECIFICATION OF SYMMETRY,0.021265,0.18272,0.18512,1,1
4,GO REGULATION OF METAL ION TRANSPORT,0.012106,0.18259,0.1938,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.011063,0.18255,0.22216,1,1
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.010101,0.18252,0.22204,1,1
4,GO REGULATION OF PROTEIN TARGETING,0.0038653,0.18234,0.18371,1,1
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.048745,0.18221,0.18723,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.02951,0.18216,0.17103,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.020391,0.18196,0.20631,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.02951,0.18196,0.20881,1,1
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0047188,0.18193,0.23141,1,1
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0034935,0.18169,0.21958,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.015776,0.18149,0.17281,1,1
4,GO EMBRYONIC HEMOPOIESIS,0.034576,0.18139,0.18967,1,1
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.012106,0.18098,0.21415,1,1
4,GO INCLUSION BODY ASSEMBLY,0.0036751,0.18098,0.25319,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0024341,0.1809,0.20084,1,1
4,GO CRISTAE FORMATION,0.025096,0.18067,0.17838,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.01266,0.18036,0.21294,1,1
4,GO ARGININE METABOLIC PROCESS,0.024086,0.17999,0.17008,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0027019,0.17993,0.23722,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0012758,0.1799,0.21123,1,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0076456,0.17968,0.25494,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0096484,0.1796,0.22957,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.028348,0.17956,0.16709,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.014457,0.17941,0.24085,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.010572,0.17932,0.19517,1,1
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022172,0.17925,0.21591,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.017954,0.1789,0.15033,1,1
4,GO MITOCHONDRION DISTRIBUTION,0.012106,0.17874,0.23799,1,1
4,GO EXOCYTIC PROCESS,0.0060238,0.17868,0.2025,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.00033648,0.17864,0.26798,1,1
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.017954,0.17861,0.16255,1,1
4,GO NEGATIVE REGULATION OF CELL AGING,0.023112,0.17855,0.16441,1,1
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.031957,0.17844,0.21812,1,1
4,GO MEMBRANE REPOLARIZATION,0.025096,0.17819,0.18416,1,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.011574,0.17817,0.20517,1,1
4,GO FATTY ACID HOMEOSTASIS,0.011063,0.17817,0.24003,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.025096,0.17803,0.20053,1,1
4,GO XENOBIOTIC TRANSPORT,0.043559,0.17778,0.19897,1,1
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.0010209,0.1777,0.22014,1,1
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0052065,0.17751,0.26478,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0013481,0.17745,0.18992,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.028348,0.17745,0.22692,1,1
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0076456,0.17739,0.21304,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.01266,0.17703,0.20758,1,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0038653,0.17694,0.20569,1,1
4,GO HISTONE H3 DEACETYLATION,0.008797,0.17675,0.21848,1,1
4,GO HISTONE DEUBIQUITINATION,0.030713,0.17671,0.21062,1,1
4,GO SENSORY SYSTEM DEVELOPMENT,0.0024341,0.1764,0.23992,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0042727,0.17623,0.2061,1,1
4,GO REGULATION OF TOR SIGNALING,0.026142,0.17587,0.18444,1,1
4,GO REGULATION OF CELL DEVELOPMENT,0.00332,0.17587,0.22486,1,1
4,GO REGULATION OF HORMONE LEVELS,0.010572,0.17578,0.17036,1,1
4,GO RECEPTOR METABOLIC PROCESS,0.0066311,0.17578,0.19034,1,1
4,GO REGULATION OF GONAD DEVELOPMENT,0.0027019,0.1756,0.23153,1,1
4,GO MEMBRANE FISSION,0.037377,0.17556,0.19237,1,1
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.0036751,0.17519,0.24057,1,1
4,GO RECEPTOR RECYCLING,0.050584,0.17511,0.14732,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027226,0.17511,0.20331,1,1
4,GO DNA DEALKYLATION,0.0080134,0.17499,0.1882,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.037377,0.17489,0.20286,1,1
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.048745,0.17478,0.21008,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0023095,0.17452,0.25214,1,1
4,GO MALE MEIOSIS I,0.0172,0.17411,0.1937,1,1
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013235,0.17396,0.21763,1,1
4,GO REGULATION OF MRNA PROCESSING,0.038848,0.17378,0.1585,1,1
4,GO DICARBOXYLIC ACID TRANSPORT,0.0031545,0.17363,0.22492,1,1
4,GO PATTERN SPECIFICATION PROCESS,0.008797,0.1736,0.19151,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00076864,0.17325,0.2073,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.017954,0.1732,0.16984,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.019548,0.17312,0.25526,1,1
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0096484,0.17299,0.18147,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.031957,0.17298,0.17702,1,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.015776,0.17295,0.19631,1,1
4,GO LIPID PHOSPHORYLATION,0.024086,0.17288,0.1952,1,1
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.022172,0.17287,0.18319,1,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.030713,0.17281,0.25798,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.015776,0.17274,0.228,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.014457,0.17274,0.23137,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0042727,0.17273,0.19592,1,1
4,GO POSITIVE REGULATION OF DNA BINDING,0.016475,0.1724,0.16631,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.017954,0.17218,0.2094,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,0.0015882,0.17202,0.20082,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0063209,0.17189,0.17813,1,1
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.033245,0.17188,0.16668,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.011063,0.17151,0.20594,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.017954,0.17148,0.22372,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0036751,0.17145,0.18477,1,1
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.031957,0.17127,0.16204,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.031957,0.1707,0.21558,1,1
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0023095,0.17065,0.20228,1,1
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0092139,0.17061,0.1988,1,1
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0083971,0.17042,0.23901,1,1
4,GO RESPONSE TO FOOD,0.030713,0.16956,0.15906,1,1
4,GO DEMETHYLATION,0.0092139,0.16952,0.20346,1,1
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0027019,0.16948,0.29404,1,1
4,GO EYE MORPHOGENESIS,0.0049572,0.16946,0.23816,1,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0066311,0.16946,0.22804,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0172,0.16934,0.20889,1,1
4,GO REGULATION OF GLIOGENESIS,0.037377,0.16922,0.15552,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.015776,0.16895,0.17733,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0052065,0.16886,0.19318,1,1
4,GO CARDIAC SEPTUM DEVELOPMENT,0.050584,0.16879,0.20002,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.038848,0.16876,0.15828,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.035953,0.16868,0.17615,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.017954,0.16857,0.19147,1,1
4,GO PEPTIDYL ARGININE MODIFICATION,0.021265,0.16837,0.16197,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.010101,0.16788,0.16375,1,1
4,GO FATTY ACID BETA OXIDATION,0.043559,0.16774,0.14018,1,1
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0049572,0.1675,0.2289,1,1
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.035953,0.16731,0.18233,1,1
4,GO CAMERA TYPE EYE DEVELOPMENT,0.0017696,0.16719,0.24508,1,1
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.008797,0.16689,0.23498,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.043559,0.16674,0.18699,1,1
4,GO HISTONE H4 ACETYLATION,0.016475,0.16667,0.21005,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0172,0.16654,0.22536,1,1
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0021907,0.16637,0.2393,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0063209,0.16635,0.22535,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.010101,0.16633,0.19987,1,1
4,GO G0 TO G1 TRANSITION,0.035953,0.16631,0.17664,1,1
4,GO DETECTION OF LIGHT STIMULUS,0.0025648,0.16626,0.32207,1,1
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.033245,0.16625,0.17058,1,1
4,GO VESICLE DOCKING,0.017954,0.16612,0.17906,1,1
4,GO PEPTIDYL ARGININE METHYLATION,0.007293,0.16591,0.20101,1,1
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.021265,0.16587,0.17645,1,1
4,GO CIRCADIAN RHYTHM,0.0092139,0.16586,0.183,1,1
4,GO APPENDAGE MORPHOGENESIS,0.016475,0.16568,0.21041,1,1
4,GO NEURAL TUBE DEVELOPMENT,0.037377,0.16531,0.19287,1,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.033245,0.16519,0.19044,1,1
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.011574,0.16492,0.18675,1,1
4,GO CELLULAR RESPONSE TO CAMP,0.045233,0.16477,0.15418,1,1
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0096484,0.16468,0.21608,1,1
4,GO ACID SECRETION,0.0027019,0.16467,0.19944,1,1
4,GO MUSCLE CONTRACTION,0.0092139,0.1644,0.18121,1,1
4,GO OOCYTE DIFFERENTIATION,0.031957,0.16436,0.14056,1,1
4,GO MIRNA METABOLIC PROCESS,0.0031545,0.16432,0.20905,1,1
4,GO REGULATION OF MYELINATION,0.046961,0.1643,0.18271,1,1
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0057394,0.16408,0.22807,1,1
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0024341,0.16403,0.22108,1,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.0044907,0.16399,0.20159,1,1
4,GO NOTCH SIGNALING PATHWAY,0.034576,0.16392,0.16719,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.018736,0.1638,0.19184,1,1
4,GO METAL ION TRANSPORT,0.0066311,0.1637,0.19011,1,1
4,GO CATION TRANSPORT,0.0052065,0.16356,0.19327,1,1
4,GO ACTION POTENTIAL,0.0036751,0.16304,0.20806,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.012106,0.16303,0.28403,1,1
4,GO RESPONSE TO BMP,0.048745,0.1629,0.18946,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.015776,0.16269,0.19285,1,1
4,GO UV PROTECTION,0.016475,0.16268,0.24083,1,1
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.035953,0.16248,0.16962,1,1
4,GO SOMITE DEVELOPMENT,0.045233,0.16247,0.16624,1,1
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.045233,0.16239,0.16118,1,1
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.0080134,0.16227,0.22183,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.018736,0.16219,0.17328,1,1
4,GO CATECHOLAMINE SECRETION,0.010101,0.16204,0.27627,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0080134,0.16197,0.18808,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015104,0.16194,0.18478,1,1
4,GO LIPOPROTEIN LOCALIZATION,0.040368,0.16192,0.20695,1,1
4,GO PROTEIN AUTOPHOSPHORYLATION,0.021265,0.16186,0.20986,1,1
4,GO COBALAMIN METABOLIC PROCESS,0.023112,0.16181,0.19708,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.007293,0.16143,0.21729,1,1
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0049572,0.1614,0.24034,1,1
4,GO CELL MATURATION,0.040368,0.16138,0.15165,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.012106,0.16136,0.20884,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.0054671,0.16116,0.17867,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0020776,0.16077,0.24364,1,1
4,GO REGULATION OF TRANSPOSITION,0.046961,0.1607,0.17809,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.045233,0.16069,0.16082,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.011574,0.16021,0.20678,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.026142,0.16019,0.19464,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.00332,0.16015,0.21314,1,1
4,GO DENDRITIC SPINE MAINTENANCE,0.02951,0.16011,0.22863,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.031957,0.16004,0.25077,1,1
4,GO POST EMBRYONIC DEVELOPMENT,0.024086,0.16,0.20941,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.006955,0.15999,0.20631,1,1
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.022172,0.15946,0.18566,1,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.050584,0.15925,0.22933,1,1
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.020391,0.15914,0.22402,1,1
4,GO ORGANELLE LOCALIZATION,0.025096,0.15912,0.16496,1,1
4,GO PROTEIN POLYMERIZATION,0.0034935,0.15893,0.21155,1,1
4,GO SENSORY ORGAN DEVELOPMENT,0.0049572,0.15887,0.21913,1,1
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0063209,0.15869,0.2515,1,1
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.011574,0.15847,0.2018,1,1
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.041938,0.15822,0.16955,1,1
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.017954,0.15819,0.18252,1,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.0013481,0.15808,0.21002,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.027226,0.15796,0.18781,1,1
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0049572,0.15793,0.20288,1,1
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.018736,0.15792,0.1507,1,1
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.023112,0.15785,0.15777,1,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00054254,0.15752,0.19066,1,1
4,GO MEMBRANE BIOGENESIS,0.023112,0.1573,0.18891,1,1
4,GO DEVELOPMENTAL GROWTH,0.010572,0.15694,0.19833,1,1
4,GO TOR SIGNALING,0.016475,0.15684,0.18833,1,1
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0063209,0.15683,0.22024,1,1
4,GO COVALENT CHROMATIN MODIFICATION,0.019548,0.15683,0.19623,1,1
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0010798,0.15678,0.17632,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0092139,0.15677,0.19393,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.013834,0.15674,0.1901,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.01266,0.15663,0.20412,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0066311,0.15631,0.17125,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.031957,0.15631,0.17087,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.013235,0.15617,0.2678,1,1
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0096484,0.15614,0.16564,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0060238,0.15613,0.18709,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.038848,0.15549,0.16177,1,1
4,GO REGULATION OF RNA SPLICING,0.046961,0.15539,0.14183,1,1
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.020391,0.15527,0.18225,1,1
4,GO MEMBRANE DOCKING,0.034576,0.15512,0.17456,1,1
4,GO MYOFIBRIL ASSEMBLY,0.027226,0.15494,0.18461,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.010572,0.15481,0.26734,1,1
4,GO REGULATION OF TRANSPORT,0.021265,0.15479,0.17147,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.025096,0.15441,0.24383,1,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.041938,0.15435,0.19275,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.052482,0.15434,0.19328,1,1
4,GO CHROMATIN REMODELING,0.033245,0.1542,0.16883,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.050584,0.15416,0.16437,1,1
4,GO RESPONSE TO WATER,0.048745,0.15384,0.14381,1,1
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.027226,0.15368,0.15866,1,1
4,GO MEMBRANE DISASSEMBLY,0.019548,0.15367,0.22255,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.022172,0.15353,0.25525,1,1
4,GO CELL RECOGNITION,0.041938,0.1535,0.17155,1,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.011063,0.15308,0.22074,1,1
4,GO LIMBIC SYSTEM DEVELOPMENT,0.013235,0.15305,0.18646,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.033245,0.15301,0.17976,1,1
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.006955,0.15245,0.21072,1,1
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.043559,0.15237,0.18115,1,1
4,GO SODIUM ION TRANSPORT,0.0054671,0.15232,0.19566,1,1
4,GO REGIONALIZATION,0.011574,0.15231,0.17374,1,1
4,GO MULTICELLULAR ORGANISM AGING,0.031957,0.15211,0.16329,1,1
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.017954,0.15208,0.18876,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.0034935,0.15196,0.1833,1,1
4,GO SNORNA METABOLIC PROCESS,0.01266,0.15147,0.16358,1,1
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0016767,0.15144,0.24529,1,1
4,GO EAR MORPHOGENESIS,0.022172,0.15092,0.16769,1,1
4,GO MITOPHAGY,0.018736,0.15071,0.21315,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0076456,0.15048,0.25043,1,1
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.024086,0.15019,0.19902,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.0092139,0.15014,0.16452,1,1
4,GO PIGMENT CELL DIFFERENTIATION,0.033245,0.15007,0.1873,1,1
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.01266,0.14994,0.21448,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.050584,0.14983,0.1685,1,1
4,GO RETINAL CONE CELL DIFFERENTIATION,0.025096,0.14951,0.35099,1,1
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0034935,0.1495,0.21505,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.023112,0.14936,0.18379,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.043559,0.14922,0.15289,1,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.0029965,0.14921,0.18891,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.048745,0.149,0.18589,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,0.0060238,0.1488,0.1836,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.015776,0.14862,0.1845,1,1
4,GO ORGANIC ACID TRANSPORT,0.027226,0.1485,0.14466,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0083971,0.14846,0.19203,1,1
4,GO PHAGOSOME MATURATION,0.043559,0.14845,0.15345,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.027226,0.14845,0.17561,1,1
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.021265,0.14811,0.16622,1,1
4,GO DIENCEPHALON DEVELOPMENT,0.016475,0.1481,0.19274,1,1
4,GO CHROMATIN ORGANIZATION,0.023112,0.14808,0.18175,1,1
4,GO HEART PROCESS,0.022172,0.14794,0.16362,1,1
4,GO ROOF OF MOUTH DEVELOPMENT,0.052482,0.14787,0.16463,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.020391,0.14761,0.20116,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.030713,0.14748,0.1688,1,1
4,GO MUSCLE SYSTEM PROCESS,0.021265,0.14689,0.16833,1,1
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.010572,0.14686,0.31568,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.021265,0.14682,0.17256,1,1
4,GO REGULATION OF FIBROBLAST MIGRATION,0.021265,0.14663,0.20688,1,1
4,GO POLYOL METABOLIC PROCESS,0.0047188,0.14631,0.18622,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0040644,0.14624,0.19363,1,1
4,GO MACROMOLECULE DEACYLATION,0.028348,0.14593,0.16929,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0024341,0.1458,0.18614,1,1
4,GO REGULATION OF GTPASE ACTIVITY,0.02951,0.14556,0.2098,1,1
4,GO HIPPOCAMPUS DEVELOPMENT,0.018736,0.14546,0.18126,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.008797,0.14544,0.21561,1,1
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.043559,0.14539,0.13887,1,1
4,GO GLIOGENESIS,0.02951,0.14485,0.1791,1,1
4,GO AMINE TRANSPORT,0.0066311,0.14477,0.25088,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.013235,0.14469,0.17217,1,1
4,GO METHYLATION,0.041938,0.14466,0.13998,1,1
4,GO SENSORY ORGAN MORPHOGENESIS,0.011063,0.14459,0.20186,1,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.023112,0.14438,0.18805,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.006955,0.14434,0.17614,1,1
4,GO REGULATION OF SECRETION,0.026142,0.14422,0.17798,1,1
4,GO SULFATE TRANSPORT,0.050584,0.14389,0.18338,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.023112,0.14388,0.14141,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.017954,0.14375,0.13444,1,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0057394,0.14352,0.22694,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.028348,0.14331,0.16534,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.040368,0.14291,0.18763,1,1
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.035953,0.14289,0.18549,1,1
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.048745,0.14284,0.20184,1,1
4,GO HISTONE DEACETYLATION,0.026142,0.14277,0.18199,1,1
4,GO REGULATION OF DNA REPAIR,0.028348,0.14273,0.16443,1,1
4,GO RRNA TRANSCRIPTION,0.0063209,0.14272,0.17335,1,1
4,GO ION TRANSPORT,0.0092139,0.14235,0.17132,1,1
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0038653,0.14229,0.33629,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.033245,0.14222,0.13008,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.025096,0.14222,0.18555,1,1
4,GO GENETIC IMPRINTING,0.033245,0.14218,0.21346,1,1
4,GO CELL PROJECTION ASSEMBLY,0.045233,0.14214,0.17081,1,1
4,GO APPENDAGE DEVELOPMENT,0.014457,0.14198,0.20711,1,1
4,GO OOGENESIS,0.040368,0.14194,0.13617,1,1
4,GO TRANSFERRIN TRANSPORT,0.020391,0.14149,0.14504,1,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.030713,0.14144,0.21307,1,1
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.024086,0.14113,0.1734,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.046961,0.14107,0.15863,1,1
4,GO LYSOSOMAL TRANSPORT,0.041938,0.14087,0.18456,1,1
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.046961,0.14075,0.18004,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.016475,0.14038,0.20651,1,1
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.043559,0.14026,0.18972,1,1
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.0172,0.14007,0.16847,1,1
4,GO INNER EAR MORPHOGENESIS,0.023112,0.13983,0.16046,1,1
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.046961,0.13976,0.15094,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.010101,0.13976,0.16962,1,1
4,GO SPLEEN DEVELOPMENT,0.012106,0.13958,0.21035,1,1
4,GO REGULATION OF CELL CYCLE ARREST,0.014457,0.13956,0.16386,1,1
4,GO ACTIN FILAMENT BASED PROCESS,0.020391,0.13919,0.19201,1,1
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.046961,0.13915,0.16435,1,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.028348,0.13907,0.19838,1,1
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.022172,0.13887,0.18059,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.050584,0.13884,0.14697,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.045233,0.1387,0.16957,1,1
4,GO RHYTHMIC PROCESS,0.0172,0.13866,0.17106,1,1
4,GO GLIAL CELL DIFFERENTIATION,0.033245,0.13866,0.17132,1,1
4,GO REGULATION OF PROTEIN BINDING,0.018736,0.13844,0.18033,1,1
4,GO PROTEIN ACYLATION,0.040368,0.13844,0.17147,1,1
4,GO ACTIN FILAMENT ORGANIZATION,0.038848,0.13842,0.1759,1,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.043559,0.13826,0.19906,1,1
4,GO TRANSPOSITION,0.034576,0.13822,0.17578,1,1
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.030713,0.13818,0.16791,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.013834,0.13813,0.17615,1,1
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.052482,0.13799,0.16294,1,1
4,GO RESPONSE TO ALKALOID,0.045233,0.13785,0.13281,1,1
4,GO ENSHEATHMENT OF NEURONS,0.037377,0.13771,0.15731,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.014457,0.13755,0.19648,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.023112,0.13702,0.18938,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.027226,0.13648,0.15385,1,1
4,GO LIPID MODIFICATION,0.045233,0.13642,0.13477,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.015104,0.13642,0.18383,1,1
4,GO RESPONSE TO ATP,0.030713,0.13639,0.18798,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.018736,0.13638,0.14883,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031957,0.13629,0.16228,1,1
4,GO CYTOSKELETON ORGANIZATION,0.010572,0.13577,0.19404,1,1
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.048745,0.13512,0.1699,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.011063,0.13477,0.15957,1,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.018736,0.13447,0.20006,1,1
4,GO PEPTIDYL SERINE MODIFICATION,0.008797,0.13398,0.18613,1,1
4,GO INTERMEMBRANE LIPID TRANSFER,0.030713,0.13395,0.1928,1,1
4,GO RRNA CATABOLIC PROCESS,0.011574,0.1338,0.1699,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.038848,0.13372,0.15471,1,1
4,GO CLATHRIN COAT ASSEMBLY,0.046961,0.13336,0.15176,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0172,0.13315,0.1931,1,1
4,GO CANONICAL WNT SIGNALING PATHWAY,0.025096,0.13307,0.16471,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.017954,0.13298,0.17873,1,1
4,GO HISTONE H2A ACETYLATION,0.02951,0.13296,0.16674,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.006955,0.13287,0.19159,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0031545,0.13256,0.20065,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.015776,0.13237,0.17726,1,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.019548,0.13222,0.19836,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.037377,0.13211,0.14233,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.017954,0.13211,0.18838,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.028348,0.13201,0.12156,1,1
4,GO CARDIAC MUSCLE CONTRACTION,0.026142,0.1315,0.15471,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.040368,0.13146,0.13921,1,1
4,GO CELL GROWTH,0.014457,0.13144,0.19416,1,1
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.030713,0.1313,0.17479,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.007293,0.13127,0.16093,1,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.043559,0.131,0.20253,1,1
4,GO GLIAL CELL DEVELOPMENT,0.035953,0.13075,0.17945,1,1
4,GO EAR DEVELOPMENT,0.035953,0.13049,0.16504,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.0076456,0.13029,0.16296,1,1
4,GO FIBROBLAST MIGRATION,0.025096,0.13022,0.20622,1,1
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.050584,0.12999,0.18176,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.024086,0.12914,0.17153,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.033245,0.12897,0.17944,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.050584,0.12896,0.17545,1,1
4,GO LAMELLIPODIUM ASSEMBLY,0.050584,0.1289,0.16533,1,1
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.050584,0.12883,0.16474,1,1
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.050584,0.12874,0.12743,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.0042727,0.12856,0.14289,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.025096,0.12849,0.11996,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.028348,0.12847,0.12301,1,1
4,GO REGULATION OF HISTONE MODIFICATION,0.018736,0.12835,0.17487,1,1
4,GO SCHWANN CELL DIFFERENTIATION,0.021265,0.12821,0.20291,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.016475,0.12802,0.15985,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.040368,0.12792,0.17975,1,1
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.034576,0.12771,0.19519,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,0.017954,0.12769,0.24716,1,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.02951,0.12768,0.16836,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.027226,0.12727,0.16333,1,1
4,GO HEART MORPHOGENESIS,0.052482,0.1272,0.17538,1,1
4,GO PROTEIN ACETYLATION,0.028348,0.12696,0.17152,1,1
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.017954,0.12692,0.17931,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.016475,0.12684,0.1703,1,1
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.022172,0.12683,0.17822,1,1
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0052065,0.12675,0.18069,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.027226,0.12636,0.18209,1,1
4,GO REGULATION OF DNA BINDING,0.014457,0.12624,0.16291,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.048745,0.12618,0.1032,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0096484,0.12617,0.1957,1,1
4,GO CHROMOSOME ORGANIZATION,0.048745,0.12602,0.14934,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.048745,0.12594,0.14959,1,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.034576,0.12562,0.17846,1,1
4,GO RESPONSE TO AMINO ACID STARVATION,0.013235,0.12555,0.18133,1,1
4,GO REGULATION OF CELL MATURATION,0.025096,0.12543,0.14902,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0040644,0.12527,0.13741,1,1
4,GO GMP METABOLIC PROCESS,0.011574,0.12506,0.16827,1,1
4,GO REGULATION OF CYTOKINESIS,0.038848,0.12486,0.16862,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.021265,0.1247,0.12797,1,1
4,GO POSITIVE REGULATION OF GROWTH,0.026142,0.12468,0.18219,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.019548,0.12453,0.20254,1,1
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.01266,0.12448,0.17727,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.033245,0.12427,0.10742,1,1
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.027226,0.12419,0.22327,1,1
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.023112,0.12407,0.12359,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.018736,0.12398,0.17956,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.026142,0.12357,0.18119,1,1
4,GO GLUCOSE METABOLIC PROCESS,0.014457,0.12342,0.16106,1,1
4,GO REGULATION OF HISTONE UBIQUITINATION,0.014457,0.12329,0.17751,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.027226,0.12325,0.12539,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.045233,0.12323,0.12025,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.026142,0.12315,0.18456,1,1
4,GO PROTEIN INSERTION INTO MEMBRANE,0.034576,0.12306,0.10637,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.038848,0.12284,0.15255,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.052482,0.12263,0.12775,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.046961,0.12222,0.11507,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.02951,0.12171,0.15593,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.034576,0.12137,0.14081,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.014457,0.12118,0.14156,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.028348,0.12099,0.16951,1,1
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.050584,0.12083,0.1504,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.041938,0.12083,0.14129,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.011574,0.12064,0.14995,1,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.027226,0.12058,0.15165,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.037377,0.12031,0.16081,1,1
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.038848,0.12,0.14078,1,1
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.025096,0.11982,0.18453,1,1
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0047188,0.11963,0.15655,1,1
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.020391,0.11933,0.12236,1,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.021265,0.11932,0.1777,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.016475,0.1193,0.20171,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.041938,0.11924,0.12628,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.006955,0.11906,0.173,1,1
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.045233,0.11904,0.11537,1,1
4,GO CELL CELL SIGNALING BY WNT,0.016475,0.11886,0.16732,1,1
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.014457,0.11872,0.19058,1,1
4,GO AXIS SPECIFICATION,0.052482,0.11867,0.13003,1,1
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.033245,0.11854,0.15568,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.035953,0.11847,0.1471,1,1
4,GO MEMBRANE ORGANIZATION,0.030713,0.11815,0.14622,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.043559,0.11786,0.13977,1,1
4,GO PHOTOTRANSDUCTION,0.007293,0.1176,0.30466,1,1
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.017954,0.11705,0.11603,1,1
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.048745,0.1166,0.15251,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.031957,0.11642,0.15926,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.02951,0.11633,0.21874,1,1
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.052482,0.1161,0.10813,1,1
4,GO VACUOLAR TRANSPORT,0.048745,0.11608,0.15607,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.027226,0.11585,0.18015,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.041938,0.11566,0.13078,1,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.023112,0.11562,0.17259,1,1
4,GO DNA METHYLATION,0.040368,0.11557,0.14795,1,1
4,GO REGULATION OF DEPHOSPHORYLATION,0.026142,0.11534,0.16145,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.020391,0.1152,0.11973,1,1
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0096484,0.11494,0.17316,1,1
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.050584,0.11494,0.16903,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.024086,0.11492,0.16424,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.031957,0.11435,0.14919,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.011574,0.11423,0.15618,1,1
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.048745,0.1139,0.14438,1,1
4,GO MUSCLE FILAMENT SLIDING,0.026142,0.11379,0.17948,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.02951,0.11338,0.14197,1,1
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.046961,0.11299,0.17162,1,1
4,GO CELL CYCLE ARREST,0.041938,0.11276,0.1409,1,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.019548,0.1124,0.1792,1,1
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.02951,0.1122,0.11984,1,1
4,GO RESPONSE TO STARVATION,0.040368,0.11198,0.13502,1,1
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.034576,0.11183,0.13769,1,1
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.034576,0.11183,0.14311,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.033245,0.1116,0.1379,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.035953,0.11118,0.1701,1,1
4,GO NCRNA CATABOLIC PROCESS,0.046961,0.11114,0.11883,1,1
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0172,0.11107,0.1605,1,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.019548,0.11057,0.13449,1,1
4,GO EMBRYONIC PATTERN SPECIFICATION,0.035953,0.1101,0.1223,1,1
4,GO POSITIVE REGULATION OF BINDING,0.011574,0.10946,0.15441,1,1
4,GO EMBRYONIC MORPHOGENESIS,0.02951,0.10888,0.1737,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.045233,0.10866,0.14047,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.015776,0.10844,0.17525,1,1
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.025096,0.10837,0.15451,1,1
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0080134,0.10804,0.24147,1,1
4,GO VESICLE LOCALIZATION,0.028348,0.10756,0.15661,1,1
4,GO DNA METHYLATION OR DEMETHYLATION,0.021265,0.10752,0.15233,1,1
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.025096,0.1075,0.15776,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.026142,0.10745,0.15678,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.020391,0.10726,0.17068,1,1
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.048745,0.10636,0.14879,1,1
4,GO DETECTION OF STIMULUS,0.0096484,0.10628,0.13895,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.030713,0.10532,0.15528,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.019548,0.10523,0.1669,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0172,0.10502,0.13528,1,1
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.034576,0.10497,0.17359,1,1
4,GO EMBRYO DEVELOPMENT,0.020391,0.10475,0.16967,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.038848,0.10434,0.1331,1,1
4,GO SEXUAL REPRODUCTION,0.048745,0.10362,0.12424,1,1
4,GO GROWTH,0.022172,0.10343,0.16587,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0172,0.10271,0.19203,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.041938,0.10202,0.1404,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.028348,0.10187,0.1316,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.025096,0.10149,0.11257,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.02951,0.1011,0.16454,1,1
4,GO NEGATIVE REGULATION OF BINDING,0.048745,0.10108,0.15151,1,1
4,GO MULTI ORGANISM PROCESS,0.052482,0.10105,0.11979,1,1
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.017954,0.10099,0.16859,1,1
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.025096,0.099913,0.098284,1,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.033245,0.099703,0.15251,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.031957,0.099474,0.098018,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.050584,0.099373,0.13179,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.052482,0.09936,0.16062,1,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.025096,0.098574,0.19801,1,1
4,GO DEPHOSPHORYLATION,0.033245,0.098138,0.13368,1,1
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.048745,0.098063,0.17206,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.046961,0.097631,0.14953,1,1
4,GO ACTIN FILAMENT BASED MOVEMENT,0.030713,0.097283,0.17513,1,1
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.034576,0.096823,0.15502,1,1
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.030713,0.096282,0.17509,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.035953,0.096018,0.13407,1,1
4,GO RESPONSE TO LIGHT STIMULUS,0.010572,0.095936,0.16254,1,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.019548,0.095634,0.16763,1,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.043559,0.095484,0.13395,1,1
4,GO REGULATION OF BINDING,0.031957,0.095,0.15847,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.025096,0.094895,0.12132,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION,0.048745,0.09425,0.12282,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.048745,0.093992,0.17541,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.041938,0.093712,0.15448,1,1
4,GO DNA MODIFICATION,0.024086,0.093456,0.14312,1,1
4,GO GASTRIC ACID SECRETION,0.046961,0.091733,0.13808,1,1
4,GO ORGANELLE ASSEMBLY,0.052482,0.09151,0.14232,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.019548,0.09133,0.19992,1,1
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.037377,0.090816,0.14802,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.034576,0.088924,0.10168,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.015104,0.088664,0.18729,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.025096,0.08792,0.10541,1,1
4,GO CYTOSOLIC TRANSPORT,0.045233,0.087743,0.17391,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.033245,0.087555,0.14703,1,1
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.050584,0.087504,0.1112,1,1
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.040368,0.087439,0.11037,1,1
4,GO PHOTOPERIODISM,0.019548,0.087221,0.16342,1,1
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.043559,0.086982,0.13794,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.041938,0.085959,0.16121,1,1
4,GO ATP METABOLIC PROCESS,0.0057394,0.085258,0.105,1,1
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.046961,0.08477,0.14635,1,1
4,GO PIGMENT METABOLIC PROCESS,0.037377,0.08428,0.1063,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.033245,0.084015,0.15424,1,1
4,GO SECONDARY METABOLIC PROCESS,0.043559,0.083612,0.1166,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.052482,0.082934,0.12621,1,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.041938,0.082343,0.14498,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.040368,0.081221,0.15307,1,1
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.027226,0.080261,0.10317,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.028348,0.079601,0.090608,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.043559,0.079415,0.13415,1,1
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.046961,0.079372,0.14315,1,1
4,GO RESPONSE TO RADIATION,0.041938,0.07821,0.12992,1,1
4,GO PROTEIN DEPHOSPHORYLATION,0.035953,0.074937,0.13374,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.034576,0.073322,0.11778,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.037377,0.072036,0.092214,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.046961,0.071529,0.10676,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.020391,0.07126,0.11988,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.041938,0.067726,0.12141,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.046961,0.066848,0.084863,1,1
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.052482,0.065445,0.10274,1,1
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.017954,0.35245,0.24592,1,1
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.034576,0.23926,0.29829,1,1
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0036751,0.20328,0.22418,1,1
5,GO PROTEIN REFOLDING,0.035953,0.17981,0.15833,1,1
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.041938,0.16756,0.14419,1,1
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.011063,0.16299,0.1218,1,1
5,GO URONIC ACID METABOLIC PROCESS,0.020391,0.16254,0.11697,1,1
5,GO TRNA 5 LEADER REMOVAL,0.018736,0.15802,0.11636,1,1
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.050584,0.14838,0.15074,1,1
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.026142,0.14751,0.15569,1,1
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0057394,0.14689,0.12695,1,1
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0027019,0.14242,0.14621,1,1
5,GO MITOCHONDRIAL TRANSLATION,0.027226,0.13271,0.10053,1,1
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.027226,0.1271,0.16092,1,1
5,GO TRANSLATIONAL TERMINATION,0.027226,0.12139,0.096923,1,1
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.022172,0.12046,0.1414,1,1
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.034576,0.11016,0.1217,1,1
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.011063,0.10854,0.14857,1,1
5,GO TRANSLATIONAL ELONGATION,0.010101,0.10441,0.10061,1,1
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0042727,0.10299,0.12276,1,1
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.014457,0.097621,0.11629,1,1
5,GO TRNA 5 END PROCESSING,0.037377,0.095309,0.093766,1,1
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.010101,0.086006,0.10723,1,1
5,GO OXIDATIVE PHOSPHORYLATION,0.015776,0.070081,0.097966,1,1
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,1.3909e-05,0.37482,0.40681,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,1.8524e-05,0.26399,0.31207,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00057531,0.23345,0.21034,1,1
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.024086,0.14255,0.13196,1,1
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.045233,0.12388,0.1132,1,1
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00054254,0.11832,0.14949,1,1
7,GO OUTER DYNEIN ARM ASSEMBLY,0.00011593,0.76036,0.78617,1,1
7,GO INNER DYNEIN ARM ASSEMBLY,0.0010798,0.68926,0.63533,1,1
7,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,9.5377e-05,0.67795,0.70091,1,1
7,GO LOOP OF HENLE DEVELOPMENT,0.00011593,0.65891,0.61083,1,1
7,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0019699,0.63229,0.50498,1,1
7,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,3.7287e-05,0.63035,0.63516,1,1
7,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0014241,0.5861,0.52679,1,1
7,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0018673,0.57554,0.50357,1,1
7,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,5.9985e-05,0.55906,0.64578,1,1
7,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00015974,0.53059,0.72251,1,1
7,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00060992,0.52838,0.58115,1,1
7,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.00028019,0.52327,0.50497,1,1
7,GO SYNAPTIC VESICLE DOCKING,0.00010866,0.52171,0.70853,1,1
7,GO PONS DEVELOPMENT,8.9327e-05,0.52057,0.63466,1,1
7,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00014989,0.51429,0.5162,1,1
7,GO AXONEME ASSEMBLY,4.8997e-05,0.51202,0.58776,1,1
7,GO ADHESION OF SYMBIONT TO HOST,0.019548,0.50612,0.42412,1,1
7,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0020776,0.50342,0.52083,1,1
7,GO SPONTANEOUS SYNAPTIC TRANSMISSION,8.3641e-05,0.50158,0.66258,1,1
7,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0052065,0.50042,0.47818,1,1
7,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00028019,0.5003,0.4714,1,1
7,GO REGULATION OF CGMP MEDIATED SIGNALING,0.00017019,0.49961,0.51867,1,1
7,GO COLLECTING DUCT DEVELOPMENT,0.00040321,0.49288,0.48741,1,1
7,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0013481,0.49205,0.59085,1,1
7,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0014241,0.49095,0.4862,1,1
7,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00064645,0.48895,0.67952,1,1
7,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0054671,0.4884,0.37708,1,1
7,GO MICROTUBULE BUNDLE FORMATION,4.2763e-05,0.48161,0.49694,1,1
7,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.017954,0.48149,0.36138,1,1
7,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0031545,0.48005,0.42677,1,1
7,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00021879,0.47841,0.6479,1,1
7,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00332,0.47746,0.40886,1,1
7,GO RESPONSE TO POTASSIUM ION,0.00057531,0.47527,0.50806,1,1
7,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00010866,0.47462,0.49639,1,1
7,GO PREPULSE INHIBITION,0.00096503,0.46915,0.5032,1,1
7,GO MRNA SPLICE SITE SELECTION,0.00054254,0.46784,0.39225,1,1
7,GO SENSORY PERCEPTION OF BITTER TASTE,0.0003797,0.46721,0.37017,1,1
7,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0013481,0.46652,0.5198,1,1
7,GO DENDRITIC TRANSPORT,0.0020776,0.46586,0.41667,1,1
7,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.0057394,0.46244,0.33843,1,1
7,GO EXTRACELLULAR TRANSPORT,4.2763e-05,0.46198,0.53749,1,1
7,GO IRON COORDINATION ENTITY TRANSPORT,0.00014062,0.46072,0.51881,1,1
7,GO CELL AGGREGATION,0.0031545,0.45763,0.36106,1,1
7,GO CILIUM MOVEMENT,6.8565e-05,0.45725,0.45931,1,1
7,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0014241,0.44991,0.3774,1,1
7,GO MOTILE CILIUM ASSEMBLY,0.00019306,0.44981,0.47763,1,1
7,GO DETECTION OF CALCIUM ION,0.00081392,0.44883,0.42867,1,1
7,GO DENSE CORE GRANULE TRANSPORT,0.00064645,0.44643,0.55769,1,1
7,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.013235,0.44547,0.38742,1,1
7,GO PARENTAL BEHAVIOR,0.0040644,0.44354,0.49676,1,1
7,GO MEIOTIC CHROMOSOME SEPARATION,0.0052065,0.44209,0.33853,1,1
7,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0027019,0.44198,0.4377,1,1
7,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00051151,0.44088,0.47396,1,1
7,GO CELL JUNCTION MAINTENANCE,0.00028019,0.44008,0.39894,1,1
7,GO SYNAPTIC MEMBRANE ADHESION,0.0034935,0.43507,0.40462,1,1
7,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0015041,0.43263,0.46335,1,1
7,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,8.9327e-05,0.42887,0.5476,1,1
7,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00024771,0.42678,0.37676,1,1
7,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00054254,0.42469,0.61463,1,1
7,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00040321,0.42465,0.46863,1,1
7,GO REGULATION OF GLUTAMATE SECRETION,0.0049572,0.42336,0.38531,1,1
7,GO AXO DENDRITIC PROTEIN TRANSPORT,0.00048214,0.42275,0.46313,1,1
7,GO NEURON REMODELING,0.0096484,0.42252,0.3605,1,1
7,GO INTESTINAL LIPID ABSORPTION,0.00028019,0.42125,0.48423,1,1
7,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,7.3279e-05,0.4212,0.44594,1,1
7,GO SEGMENT SPECIFICATION,0.00024771,0.42079,0.41887,1,1
7,GO SYNAPSE MATURATION,0.022172,0.41524,0.32235,1,1
7,GO STARTLE RESPONSE,0.00040321,0.41521,0.40873,1,1
7,GO INHIBITORY SYNAPSE ASSEMBLY,0.00091199,0.4146,0.5246,1,1
7,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00023283,0.41394,0.37306,1,1
7,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00086166,0.4134,0.66473,1,1
7,GO MALE SEX DETERMINATION,0.0063209,0.41277,0.33775,1,1
7,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,1.7249e-05,0.4125,0.45109,1,1
7,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,3.248e-05,0.41247,0.4004,1,1
7,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0025648,0.41244,0.45601,1,1
7,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00010866,0.41097,0.41087,1,1
7,GO INTRACILIARY RETROGRADE TRANSPORT,0.00023283,0.40963,0.42059,1,1
7,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00021879,0.40904,0.45004,1,1
7,GO NEURON CELLULAR HOMEOSTASIS,0.0092139,0.40735,0.3167,1,1
7,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00018128,0.40261,0.4624,1,1
7,GO NEURON MATURATION,0.00033648,0.40218,0.36703,1,1
7,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00072571,0.40205,0.36117,1,1
7,GO INTERLEUKIN 5 PRODUCTION,0.030713,0.40089,0.30586,1,1
7,GO MEMBRANE DEPOLARIZATION,8.9327e-05,0.40087,0.41292,1,1
7,GO REGULATION OF CILIUM ASSEMBLY,4.8997e-05,0.40019,0.40503,1,1
7,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00023283,0.39976,0.41558,1,1
7,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00013188,0.39875,0.41035,1,1
7,GO PROTEIN LOCALIZATION TO CILIUM,0.00042807,0.39872,0.35626,1,1
7,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0036751,0.39357,0.46434,1,1
7,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0052065,0.39343,0.39985,1,1
7,GO SPERM MOTILITY,0.00017019,0.39151,0.36351,1,1
7,GO PROTEIN POLYGLUTAMYLATION,0.00026348,0.39094,0.39025,1,1
7,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0015041,0.3906,0.44683,1,1
7,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.015776,0.39054,0.32484,1,1
7,GO GLUTAMATE SECRETION,0.00021879,0.39021,0.40003,1,1
7,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00091199,0.3894,0.54928,1,1
7,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00081392,0.38926,0.30811,1,1
7,GO REGULATION OF APPETITE,0.00029789,0.38734,0.41854,1,1
7,GO LUTEINIZATION,0.006955,0.38564,0.38426,1,1
7,GO REGULATION OF NEURON MIGRATION,0.010572,0.38437,0.34294,1,1
7,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.8267e-05,0.38298,0.41351,1,1
7,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00020554,0.38272,0.53489,1,1
7,GO NEURONAL ION CHANNEL CLUSTERING,0.0038653,0.3827,0.37361,1,1
7,GO MICROTUBULE SEVERING,0.00028019,0.38245,0.37021,1,1
7,GO RESPONSE TO AUDITORY STIMULUS,0.0054671,0.38211,0.3228,1,1
7,GO HISTONE H3 K27 METHYLATION,0.00051151,0.38176,0.42689,1,1
7,GO HISTONE H3 K9 DEMETHYLATION,0.00048214,0.38086,0.38627,1,1
7,GO FEAR RESPONSE,0.00029789,0.38038,0.32622,1,1
7,GO MICROTUBULE BASED MOVEMENT,4.2763e-05,0.37968,0.3667,1,1
7,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00091199,0.37909,0.41294,1,1
7,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0015041,0.37905,0.4032,1,1
7,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0003797,0.3788,0.4617,1,1
7,GO INTRACILIARY TRANSPORT,0.00033648,0.37801,0.34809,1,1
7,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0012071,0.37699,0.36497,1,1
7,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0027019,0.37601,0.34287,1,1
7,GO CHEMOSENSORY BEHAVIOR,3.7287e-05,0.37545,0.44712,1,1
7,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00015974,0.37492,0.56027,1,1
7,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.00091199,0.37382,0.3905,1,1
7,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0040644,0.37282,0.38432,1,1
7,GO MICROTUBULE ANCHORING,0.00026348,0.37273,0.40486,1,1
7,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0025648,0.37252,0.37403,1,1
7,GO RETINA LAYER FORMATION,0.0052065,0.37236,0.40095,1,1
7,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00060992,0.37231,0.38515,1,1
7,GO DERMATAN SULFATE METABOLIC PROCESS,0.0076456,0.37131,0.36233,1,1
7,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0014241,0.37121,0.42356,1,1
7,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00048214,0.37118,0.41914,1,1
7,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0047188,0.37052,0.38032,1,1
7,GO PANCREATIC JUICE SECRETION,0.0011418,0.37003,0.34389,1,1
7,GO LYSINE METABOLIC PROCESS,0.00011593,0.36906,0.36583,1,1
7,GO LIPID DIGESTION,0.00060992,0.36899,0.42965,1,1
7,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00068502,0.36835,0.33213,1,1
7,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00096503,0.36792,0.3548,1,1
7,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00023283,0.36784,0.31932,1,1
7,GO LONG TERM SYNAPTIC DEPRESSION,0.00081392,0.36633,0.37352,1,1
7,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00072571,0.36576,0.50257,1,1
7,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,9.5377e-05,0.36453,0.33292,1,1
7,GO ADULT BEHAVIOR,0.00068502,0.36361,0.32877,1,1
7,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0034935,0.36319,0.31858,1,1
7,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0015041,0.36152,0.36561,1,1
7,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00096503,0.36132,0.40063,1,1
7,GO NODAL SIGNALING PATHWAY,4.5779e-05,0.36126,0.38737,1,1
7,GO SECRETORY GRANULE LOCALIZATION,0.0042727,0.35989,0.38736,1,1
7,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0017696,0.35788,0.39364,1,1
7,GO LATERAL VENTRICLE DEVELOPMENT,0.00035748,0.35721,0.39986,1,1
7,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,8.9327e-05,0.35585,0.3769,1,1
7,GO EXCITATORY SYNAPSE ASSEMBLY,0.00064645,0.35564,0.4651,1,1
7,GO CILIUM ORGANIZATION,6.8565e-05,0.35506,0.36511,1,1
7,GO DRUG CATABOLIC PROCESS,0.0040644,0.35505,0.3086,1,1
7,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0011418,0.35472,0.40308,1,1
7,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0010209,0.35456,0.45537,1,1
7,GO SECONDARY PALATE DEVELOPMENT,0.0027019,0.35449,0.38996,1,1
7,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00086166,0.35273,0.42704,1,1
7,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,8.9327e-05,0.35259,0.37956,1,1
7,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0011418,0.35217,0.39177,1,1
7,GO LEYDIG CELL DIFFERENTIATION,0.0010209,0.35206,0.45303,1,1
7,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0038653,0.35201,0.34541,1,1
7,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00060992,0.35155,0.43876,1,1
7,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0031545,0.35103,0.38675,1,1
7,GO CALCIUM ION IMPORT INTO CYTOSOL,0.011574,0.35078,0.34485,1,1
7,GO PHOTORECEPTOR CELL DEVELOPMENT,4.8997e-05,0.35049,0.36887,1,1
7,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0017696,0.35047,0.36702,1,1
7,GO DOSAGE COMPENSATION,0.0013481,0.34923,0.32785,1,1
7,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0019699,0.34899,0.41853,1,1
7,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.00023283,0.34876,0.3788,1,1
7,GO POSITIVE REGULATION OF BEHAVIOR,0.0015882,0.34805,0.29246,1,1
7,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0031545,0.34767,0.34082,1,1
7,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00045436,0.34634,0.39846,1,1
7,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0015882,0.3447,0.30416,1,1
7,GO FACIAL NERVE MORPHOGENESIS,0.0042727,0.34466,0.38945,1,1
7,GO POSITIVE REGULATION OF HAIR CYCLE,0.027226,0.34393,0.27338,1,1
7,GO MITOCHONDRIAL RNA PROCESSING,0.0025648,0.34383,0.25173,1,1
7,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0092139,0.34251,0.3007,1,1
7,GO SEX DETERMINATION,0.00018128,0.34248,0.37655,1,1
7,GO ADRENAL GLAND DEVELOPMENT,0.0016767,0.3424,0.35585,1,1
7,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0083971,0.34116,0.30219,1,1
7,GO HAIR CELL DIFFERENTIATION,3.0304e-05,0.34035,0.38375,1,1
7,GO SYNAPTIC VESICLE BUDDING,0.0076456,0.33957,0.2871,1,1
7,GO SYNAPSE ASSEMBLY,0.00035748,0.33956,0.4105,1,1
7,GO SPERM AXONEME ASSEMBLY,0.00040321,0.33886,0.31482,1,1
7,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0018673,0.33858,0.36986,1,1
7,GO WATER HOMEOSTASIS,0.0013481,0.33816,0.29535,1,1
7,GO SYNAPTIC VESICLE LOCALIZATION,0.00042807,0.33698,0.37352,1,1
7,GO NEURON CELL CELL ADHESION,0.0012071,0.3366,0.47163,1,1
7,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00091199,0.33529,0.33948,1,1
7,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0024341,0.33453,0.35932,1,1
7,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.011574,0.33421,0.27872,1,1
7,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0172,0.33395,0.52805,1,1
7,GO LEARNING,0.00064645,0.33369,0.32967,1,1
7,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00010866,0.33325,0.39398,1,1
7,GO BASEMENT MEMBRANE ASSEMBLY,0.0025648,0.33321,0.42598,1,1
7,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0060238,0.33301,0.28249,1,1
7,GO CGMP MEDIATED SIGNALING,0.0011418,0.33288,0.34934,1,1
7,GO SENSORY PERCEPTION OF TASTE,0.00035748,0.33266,0.30524,1,1
7,GO O GLYCAN PROCESSING,0.0015882,0.33224,0.30646,1,1
7,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00042807,0.33167,0.50331,1,1
7,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00081392,0.33156,0.30528,1,1
7,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0083971,0.33139,0.31042,1,1
7,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0057394,0.33063,0.41898,1,1
7,GO DORSAL SPINAL CORD DEVELOPMENT,0.0044907,0.33037,0.31367,1,1
7,GO HISTONE H3 K4 TRIMETHYLATION,0.0017696,0.32952,0.37958,1,1
7,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00028019,0.32915,0.39322,1,1
7,GO CHROMATIN SILENCING AT TELOMERE,0.0013481,0.32864,0.29305,1,1
7,GO PROTEIN DEMETHYLATION,0.00017019,0.32807,0.40943,1,1
7,GO INNERVATION,0.02951,0.32694,0.31001,1,1
7,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0016767,0.32655,0.2738,1,1
7,GO SPECIFICATION OF SYMMETRY,0.00013188,0.32648,0.31767,1,1
7,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0076456,0.32646,0.30752,1,1
7,GO OTIC VESICLE DEVELOPMENT,0.0172,0.32644,0.23618,1,1
7,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0010798,0.32644,0.37796,1,1
7,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0027019,0.32573,0.33342,1,1
7,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.024086,0.32548,0.31539,1,1
7,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0172,0.32541,0.24889,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0063209,0.32535,0.31407,1,1
7,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00021879,0.32533,0.34324,1,1
7,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0025648,0.32482,0.31416,1,1
7,GO EMBRYONIC BODY MORPHOGENESIS,0.0012071,0.32463,0.36353,1,1
7,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00081392,0.32459,0.32574,1,1
7,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0036751,0.32457,0.28875,1,1
7,GO NEUROTRANSMITTER TRANSPORT,0.00042807,0.32436,0.38181,1,1
7,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057394,0.32407,0.3614,1,1
7,GO INOSITOL METABOLIC PROCESS,0.0023095,0.32389,0.29811,1,1
7,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0012758,0.32381,0.4502,1,1
7,GO COLLATERAL SPROUTING,0.0038653,0.32345,0.35055,1,1
7,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0018673,0.32215,0.40451,1,1
7,GO REGULATION OF SYNAPSE ASSEMBLY,0.0012071,0.32193,0.35634,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.008797,0.32191,0.35125,1,1
7,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0040644,0.32186,0.39822,1,1
7,GO MICROTUBULE BASED TRANSPORT,9.5377e-05,0.32144,0.33142,1,1
7,GO SPERM CAPACITATION,0.00029789,0.3207,0.31115,1,1
7,GO REGULATION OF COLLATERAL SPROUTING,0.0096484,0.31941,0.33192,1,1
7,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0023095,0.31939,0.34604,1,1
7,GO MECHANOSENSORY BEHAVIOR,0.017954,0.31917,0.29055,1,1
7,GO MICROTUBULE POLYMERIZATION,0.00096503,0.31907,0.31387,1,1
7,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0016767,0.31876,0.39621,1,1
7,GO SYNAPSE ORGANIZATION,0.0010798,0.31874,0.3336,1,1
7,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.00048214,0.31786,0.36756,1,1
7,GO PIGMENT GRANULE LOCALIZATION,0.0012758,0.31714,0.29722,1,1
7,GO TUBULIN DEACETYLATION,0.0010209,0.31714,0.36832,1,1
7,GO REGULATION OF AXON GUIDANCE,0.0010798,0.31684,0.37691,1,1
7,GO CAMP METABOLIC PROCESS,0.00045436,0.31683,0.37861,1,1
7,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00045436,0.31665,0.34693,1,1
7,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0034935,0.31602,0.32089,1,1
7,GO ACIDIC AMINO ACID TRANSPORT,7.8298e-05,0.31563,0.34874,1,1
7,GO ADHERENS JUNCTION ORGANIZATION,0.00064645,0.31542,0.32418,1,1
7,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0020776,0.31538,0.32707,1,1
7,GO MUSCLE FIBER DEVELOPMENT,0.0012071,0.31504,0.27361,1,1
7,GO FOREBRAIN NEURON DEVELOPMENT,0.0057394,0.31489,0.29527,1,1
7,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00048214,0.31477,0.30295,1,1
7,GO RECEPTOR CLUSTERING,0.0066311,0.31438,0.30904,1,1
7,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0047188,0.31421,0.35655,1,1
7,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00086166,0.31349,0.31082,1,1
7,GO NEUROEPITHELIAL CELL DIFFERENTIATION,2.8267e-05,0.31332,0.38718,1,1
7,GO NEUROTRANSMITTER SECRETION,0.00051151,0.31287,0.40703,1,1
7,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.007293,0.31274,0.36751,1,1
7,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.02951,0.31235,0.27071,1,1
7,GO REPRODUCTIVE BEHAVIOR,0.0021907,0.31231,0.32206,1,1
7,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0015882,0.31206,0.2908,1,1
7,GO GOLGI RIBBON FORMATION,0.0010209,0.31199,0.35449,1,1
7,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0012071,0.31144,0.38126,1,1
7,GO NON MOTILE CILIUM ASSEMBLY,0.00028019,0.31136,0.312,1,1
7,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00017019,0.31118,0.35636,1,1
7,GO REPLICATION FORK PROCESSING,0.022172,0.31076,0.25986,1,1
7,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.007293,0.3107,0.25841,1,1
7,GO RESPONSE TO GLUCAGON,0.0052065,0.31057,0.2497,1,1
7,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0023095,0.30985,0.3663,1,1
7,GO ASSOCIATIVE LEARNING,0.00081392,0.30977,0.32008,1,1
7,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.035953,0.30961,0.23712,1,1
7,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.006955,0.30905,0.30452,1,1
7,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00064645,0.30897,0.44172,1,1
7,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00091199,0.30886,0.38628,1,1
7,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.015104,0.30868,0.31292,1,1
7,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0016767,0.30828,0.28931,1,1
7,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00057531,0.3082,0.42457,1,1
7,GO BEHAVIORAL RESPONSE TO COCAINE,0.00076864,0.3079,0.34872,1,1
7,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0052065,0.30767,0.27789,1,1
7,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00068502,0.30761,0.26788,1,1
7,GO SYNAPTIC SIGNALING,0.00035748,0.30755,0.34798,1,1
7,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0054671,0.30738,0.3161,1,1
7,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0013481,0.30714,0.27546,1,1
7,GO INSEMINATION,0.030713,0.30695,0.25411,1,1
7,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.8565e-05,0.30618,0.36859,1,1
7,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.00024771,0.30585,0.30079,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0013481,0.30561,0.3798,1,1
7,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.025096,0.30548,0.25541,1,1
7,GO MITOCHONDRION LOCALIZATION,0.00021879,0.30535,0.32522,1,1
7,GO ENTRY OF BACTERIUM INTO HOST CELL,0.01266,0.30532,0.26386,1,1
7,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0054671,0.30526,0.36673,1,1
7,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0015882,0.30489,0.29902,1,1
7,GO AXON EXTENSION,0.0010798,0.30477,0.33202,1,1
7,GO UV DAMAGE EXCISION REPAIR,0.00019306,0.30452,0.3357,1,1
7,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00081392,0.30415,0.31781,1,1
7,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0042727,0.3037,0.24404,1,1
7,GO BRAIN MORPHOGENESIS,0.00064645,0.30299,0.33116,1,1
7,GO DENDRITE MORPHOGENESIS,0.0021907,0.30281,0.31118,1,1
7,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00024771,0.3028,0.39331,1,1
7,GO LIPID TRANSLOCATION,0.0031545,0.30259,0.29881,1,1
7,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,3.9936e-05,0.3025,0.36307,1,1
7,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,4.2763e-05,0.30173,0.38362,1,1
7,GO ACROSOME REACTION,0.00026348,0.30067,0.27748,1,1
7,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0010209,0.30041,0.3256,1,1
7,GO MEIOTIC CHROMOSOME SEGREGATION,0.011574,0.30034,0.23409,1,1
7,GO RESPONSE TO COCAINE,0.0027019,0.30032,0.28726,1,1
7,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0003797,0.30021,0.37943,1,1
7,GO CELL PROJECTION ORGANIZATION,0.00054254,0.30013,0.28366,1,1
7,GO FUCOSYLATION,0.0015041,0.29996,0.30585,1,1
7,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0024341,0.29991,0.3295,1,1
7,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0025648,0.29927,0.27537,1,1
7,GO MICROTUBULE BASED PROCESS,0.00018128,0.29916,0.2958,1,1
7,GO SYNAPTIC VESICLE RECYCLING,0.00020554,0.29899,0.39229,1,1
7,GO PROTEIN PALMITOYLATION,4.2763e-05,0.2987,0.36935,1,1
7,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0038653,0.29864,0.30663,1,1
7,GO TRANSCYTOSIS,0.0027019,0.29851,0.32441,1,1
7,GO ACTIVATION OF JNKK ACTIVITY,0.024086,0.29778,0.25697,1,1
7,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00091199,0.29749,0.3459,1,1
7,GO LYMPH VESSEL DEVELOPMENT,0.010572,0.29692,0.34193,1,1
7,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00072571,0.2968,0.35109,1,1
7,GO REGULATION OF RESPONSE TO FOOD,0.0010209,0.29648,0.34986,1,1
7,GO RESPONSE TO NERVE GROWTH FACTOR,0.00091199,0.29648,0.28457,1,1
7,GO HISTONE H3 K9 TRIMETHYLATION,0.00033648,0.2962,0.34272,1,1
7,GO PRESYNAPTIC ENDOCYTOSIS,0.00026348,0.29597,0.39057,1,1
7,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00086166,0.29568,0.29616,1,1
7,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00019306,0.29563,0.33891,1,1
7,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.010572,0.29552,0.29587,1,1
7,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.0029965,0.29544,0.27334,1,1
7,GO NUCLEUS LOCALIZATION,0.00076864,0.29535,0.42559,1,1
7,GO HOMOLOGOUS RECOMBINATION,0.0080134,0.29451,0.24839,1,1
7,GO REGULATION OF CHOLESTEROL EFFLUX,0.0063209,0.29441,0.28751,1,1
7,GO NEURON PROJECTION EXTENSION,0.00054254,0.29439,0.3339,1,1
7,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0066311,0.29434,0.29352,1,1
7,GO PEPTIDYL ARGININE METHYLATION,0.00057531,0.29422,0.29336,1,1
7,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0010798,0.29413,0.33779,1,1
7,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0010209,0.29411,0.30432,1,1
7,GO FAT CELL PROLIFERATION,0.0015041,0.29392,0.29773,1,1
7,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.021265,0.29383,0.26592,1,1
7,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.0024341,0.29364,0.34081,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0063209,0.2936,0.34743,1,1
7,GO REFLEX,0.010101,0.29338,0.32794,1,1
7,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0040644,0.29327,0.38297,1,1
7,GO GENETIC IMPRINTING,0.0031545,0.2931,0.30731,1,1
7,GO REGULATION OF AMINO ACID TRANSPORT,0.00060992,0.29302,0.31673,1,1
7,GO MECHANORECEPTOR DIFFERENTIATION,0.00031664,0.293,0.33278,1,1
7,GO SYNAPTIC VESICLE TRANSPORT,0.00051151,0.29257,0.32639,1,1
7,GO REGULATION OF TELOMERE CAPPING,0.0003797,0.29226,0.31096,1,1
7,GO NOTCH RECEPTOR PROCESSING,0.0034935,0.2921,0.35887,1,1
7,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0012071,0.29206,0.31263,1,1
7,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.014457,0.29158,0.31337,1,1
7,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0024341,0.29142,0.33456,1,1
7,GO NEUROMUSCULAR PROCESS,0.0018673,0.29141,0.29848,1,1
7,GO SMOOTHENED SIGNALING PATHWAY,0.0012758,0.2914,0.26633,1,1
7,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0076456,0.29136,0.31081,1,1
7,GO POTASSIUM ION TRANSPORT,0.00018128,0.29097,0.34043,1,1
7,GO SCHWANN CELL DEVELOPMENT,0.018736,0.29085,0.25142,1,1
7,GO CELL PROJECTION ASSEMBLY,0.00014062,0.29032,0.29348,1,1
7,GO CYTOPLASM ORGANIZATION,0.0025648,0.28991,0.31774,1,1
7,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028457,0.28976,0.34341,1,1
7,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0054671,0.28973,0.35291,1,1
7,GO NEURAL RETINA DEVELOPMENT,0.0080134,0.2897,0.23354,1,1
7,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0024341,0.28964,0.3023,1,1
7,GO HISTONE H3 K9 MODIFICATION,0.00081392,0.28919,0.31343,1,1
7,GO NEURON PROJECTION GUIDANCE,0.0024341,0.2889,0.29415,1,1
7,GO AXO DENDRITIC TRANSPORT,0.00051151,0.28878,0.32875,1,1
7,GO HISTONE METHYLATION,0.00045436,0.2886,0.30747,1,1
7,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0017696,0.28847,0.35509,1,1
7,GO NOREPINEPHRINE SECRETION,0.017954,0.28839,0.29583,1,1
7,GO SUCKLING BEHAVIOR,0.027226,0.28798,0.2295,1,1
7,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.00045436,0.28789,0.31389,1,1
7,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0021907,0.28785,0.30461,1,1
7,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00072571,0.28773,0.33004,1,1
7,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.027226,0.28765,0.23657,1,1
7,GO DIVALENT METAL ION EXPORT,0.011063,0.28761,0.27422,1,1
7,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0029965,0.28754,0.30389,1,1
7,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0080134,0.28751,0.32069,1,1
7,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00048214,0.28704,0.28416,1,1
7,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0034935,0.28692,0.33462,1,1
7,GO CELLULAR COMPONENT MAINTENANCE,0.0003797,0.28674,0.31371,1,1
7,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.011574,0.28666,0.26272,1,1
7,GO CELL PART MORPHOGENESIS,0.00081392,0.28643,0.2897,1,1
7,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0016767,0.28616,0.42141,1,1
7,GO MYOTUBE CELL DEVELOPMENT,0.0010798,0.28613,0.25999,1,1
7,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00332,0.28605,0.28844,1,1
7,GO LOCOMOTORY BEHAVIOR,0.0014241,0.28585,0.30379,1,1
7,GO RESPONSE TO PAIN,0.0028457,0.28577,0.33492,1,1
7,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0034935,0.28554,0.30122,1,1
7,GO DOPAMINE TRANSPORT,0.00040321,0.28554,0.43445,1,1
7,GO REGULATION OF DENDRITE DEVELOPMENT,0.0012758,0.2855,0.29569,1,1
7,GO NOREPINEPHRINE TRANSPORT,0.018736,0.28544,0.30621,1,1
7,GO CARDIAC MYOFIBRIL ASSEMBLY,0.00024771,0.28544,0.39332,1,1
7,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0025648,0.28514,0.28382,1,1
7,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00048214,0.28512,0.29772,1,1
7,GO POSITIVE REGULATION OF AXONOGENESIS,0.0014241,0.2851,0.32311,1,1
7,GO REGULATION OF CHROMATIN ASSEMBLY,0.0018673,0.28507,0.29444,1,1
7,GO TRANSPORT ALONG MICROTUBULE,0.00024771,0.28484,0.2944,1,1
7,GO AMMONIUM ION METABOLIC PROCESS,0.0096484,0.28454,0.29028,1,1
7,GO CELLULAR COMPONENT MORPHOGENESIS,0.00072571,0.28389,0.28755,1,1
7,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0013481,0.28372,0.30195,1,1
7,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0066311,0.28359,0.2976,1,1
7,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00068502,0.28349,0.34199,1,1
7,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.010572,0.28338,0.29939,1,1
7,GO AZOLE TRANSMEMBRANE TRANSPORT,0.011063,0.28338,0.28704,1,1
7,GO DENDRITE DEVELOPMENT,0.0021907,0.28332,0.28643,1,1
7,GO ADULT LOCOMOTORY BEHAVIOR,0.0015041,0.28312,0.28199,1,1
7,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.010101,0.28303,0.20871,1,1
7,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0049572,0.28302,0.31416,1,1
7,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.00086166,0.28245,0.29751,1,1
7,GO NEGATIVE CHEMOTAXIS,0.0020776,0.2824,0.35384,1,1
7,GO PEPTIDYL LYSINE METHYLATION,0.00051151,0.28238,0.31524,1,1
7,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00091199,0.28238,0.28224,1,1
7,GO HISTONE H4 K5 ACETYLATION,0.00042807,0.28208,0.3061,1,1
7,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0057394,0.28154,0.27197,1,1
7,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0015882,0.28153,0.30059,1,1
7,GO SULFATION,0.016475,0.28139,0.24886,1,1
7,GO MEMBRANE DOCKING,0.00020554,0.28133,0.28026,1,1
7,GO PROTEIN O LINKED GLYCOSYLATION,0.00029789,0.2813,0.30639,1,1
7,GO LONG TERM MEMORY,0.020391,0.28126,0.28163,1,1
7,GO POSTSYNAPSE ORGANIZATION,0.0018673,0.28126,0.29578,1,1
7,GO VENTRICULAR SYSTEM DEVELOPMENT,0.00024771,0.28098,0.34358,1,1
7,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0021907,0.28085,0.26603,1,1
7,GO CELL JUNCTION ASSEMBLY,0.00060992,0.28082,0.31244,1,1
7,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.021265,0.2804,0.20739,1,1
7,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.027226,0.28011,0.24847,1,1
7,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0063209,0.28002,0.24037,1,1
7,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0054671,0.27988,0.32669,1,1
7,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.0016767,0.27983,0.30602,1,1
7,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.023112,0.27983,0.28051,1,1
7,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.018736,0.27973,0.30159,1,1
7,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00091199,0.27964,0.26911,1,1
7,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.008797,0.27925,0.31813,1,1
7,GO NEURON PROJECTION ARBORIZATION,0.008797,0.27923,0.28722,1,1
7,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0012758,0.27868,0.32254,1,1
7,GO BODY MORPHOGENESIS,0.0020776,0.27866,0.30287,1,1
7,GO REGULATION OF GONAD DEVELOPMENT,0.0044907,0.27864,0.25632,1,1
7,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0012758,0.27857,0.29435,1,1
7,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0060238,0.27825,0.22199,1,1
7,GO REGULATION OF TUBULIN DEACETYLATION,0.00057531,0.27797,0.37755,1,1
7,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00060992,0.27782,0.36919,1,1
7,GO MONOAMINE TRANSPORT,0.00068502,0.27778,0.34354,1,1
7,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00014062,0.27763,0.35079,1,1
7,GO OXIDATIVE DEMETHYLATION,0.00051151,0.27741,0.35638,1,1
7,GO CGMP METABOLIC PROCESS,0.0011418,0.27663,0.36487,1,1
7,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0016767,0.27639,0.31497,1,1
7,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0024341,0.27639,0.37198,1,1
7,GO REGULATION OF HIPPO SIGNALING,0.0012071,0.27612,0.32667,1,1
7,GO MEMORY,0.0017696,0.27595,0.30324,1,1
7,GO AMINE TRANSPORT,0.00057531,0.27593,0.32783,1,1
7,GO OOCYTE MATURATION,0.00054254,0.2759,0.27575,1,1
7,GO TRANSMISSION OF NERVE IMPULSE,0.0054671,0.27571,0.31275,1,1
7,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0015882,0.27566,0.27909,1,1
7,GO BEHAVIOR,0.0017696,0.27497,0.27123,1,1
7,GO DENDRITIC SPINE MORPHOGENESIS,0.0027019,0.27488,0.32711,1,1
7,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0036751,0.27466,0.24621,1,1
7,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0029965,0.27441,0.28992,1,1
7,GO REGULATION OF MRNA PROCESSING,0.00096503,0.27435,0.25974,1,1
7,GO DENDRITE SELF AVOIDANCE,0.035953,0.27339,0.26517,1,1
7,GO EXTRACELLULAR MATRIX ASSEMBLY,0.018736,0.27325,0.32731,1,1
7,GO AXONAL TRANSPORT,0.0010798,0.27295,0.31192,1,1
7,GO AXON DEVELOPMENT,0.0015882,0.2728,0.27897,1,1
7,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00057531,0.27274,0.43334,1,1
7,GO MAINTENANCE OF ORGANELLE LOCATION,0.0018673,0.27258,0.2897,1,1
7,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.022172,0.27248,0.2505,1,1
7,GO SECONDARY METABOLIC PROCESS,0.00054254,0.27232,0.26904,1,1
7,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00076864,0.27201,0.28711,1,1
7,GO NEUROTRANSMITTER REUPTAKE,0.0017696,0.27193,0.30871,1,1
7,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0017696,0.27175,0.28366,1,1
7,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.0057394,0.27175,0.26776,1,1
7,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00019306,0.27171,0.29502,1,1
7,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0038653,0.27158,0.28991,1,1
7,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00023283,0.27157,0.32569,1,1
7,GO LYMPHANGIOGENESIS,0.018736,0.2713,0.3007,1,1
7,GO DEFINITIVE HEMOPOIESIS,0.011574,0.27111,0.30453,1,1
7,GO VISUAL BEHAVIOR,0.00010181,0.27105,0.33037,1,1
7,GO SODIUM ION TRANSPORT,0.00020554,0.27101,0.34366,1,1
7,GO HYALURONAN BIOSYNTHETIC PROCESS,0.028348,0.27088,0.30576,1,1
7,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.013834,0.27083,0.26468,1,1
7,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0027019,0.27018,0.3213,1,1
7,GO CELLULAR RESPONSE TO VITAMIN D,0.028348,0.27001,0.23356,1,1
7,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0011418,0.2699,0.25496,1,1
7,GO HINDBRAIN DEVELOPMENT,0.0015882,0.26966,0.25068,1,1
7,GO REGULATION OF EXTENT OF CELL GROWTH,0.0042727,0.26964,0.30023,1,1
7,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.019548,0.26931,0.24556,1,1
7,GO CATECHOLAMINE UPTAKE,0.00332,0.26925,0.35106,1,1
7,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0096484,0.26921,0.24381,1,1
7,GO CATECHOLAMINE SECRETION,0.00021879,0.26877,0.40771,1,1
7,GO HISTONE H3 DEACETYLATION,0.0003797,0.26874,0.31338,1,1
7,GO OOGENESIS,8.3641e-05,0.26867,0.27149,1,1
7,GO REGULATION OF LYASE ACTIVITY,0.0057394,0.26858,0.22991,1,1
7,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0052065,0.26818,0.22775,1,1
7,GO OOCYTE DIFFERENTIATION,4.8997e-05,0.26802,0.30256,1,1
7,GO REGULATION OF MRNA POLYADENYLATION,0.0003797,0.26786,0.32971,1,1
7,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0031545,0.26783,0.33775,1,1
7,GO NEURONAL ACTION POTENTIAL,0.00332,0.26767,0.38473,1,1
7,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.007293,0.26761,0.34283,1,1
7,GO DNA DOUBLE STRAND BREAK PROCESSING,0.034576,0.26754,0.19943,1,1
7,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.048745,0.26727,0.21208,1,1
7,GO REGULATION OF VESICLE FUSION,0.0054671,0.26716,0.32441,1,1
7,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0083971,0.26703,0.24361,1,1
7,GO PARTURITION,0.00060992,0.26688,0.30865,1,1
7,GO REGULATION OF HEART RATE,0.0040644,0.26683,0.28548,1,1
7,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.00332,0.26675,0.2424,1,1
7,GO POSITIVE REGULATION OF AXON EXTENSION,0.0027019,0.26665,0.30214,1,1
7,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00076864,0.26648,0.3074,1,1
7,GO SOMITE DEVELOPMENT,0.00060992,0.26639,0.2716,1,1
7,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0028457,0.26631,0.26576,1,1
7,GO PHOTORECEPTOR CELL MAINTENANCE,0.00020554,0.26617,0.32017,1,1
7,GO EMBRYONIC BRAIN DEVELOPMENT,0.035953,0.2659,0.21406,1,1
7,GO HEAD MORPHOGENESIS,0.0080134,0.26586,0.3075,1,1
7,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.024086,0.2656,0.20053,1,1
7,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0076456,0.26549,0.32012,1,1
7,GO REGULATION OF CYCLASE ACTIVITY,0.0057394,0.26528,0.239,1,1
7,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0040644,0.26512,0.28001,1,1
7,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00012367,0.26506,0.34962,1,1
7,GO TELOMERE CAPPING,0.00035748,0.26501,0.28933,1,1
7,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0003797,0.26498,0.25213,1,1
7,GO ALANINE TRANSPORT,0.02951,0.26493,0.27423,1,1
7,GO RESPONSE TO REDOX STATE,0.0021907,0.26486,0.32236,1,1
7,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.013235,0.26484,0.23495,1,1
7,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00086166,0.26464,0.29096,1,1
7,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0016767,0.26457,0.36709,1,1
7,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0172,0.26448,0.32431,1,1
7,GO NEURON DEVELOPMENT,0.00081392,0.26446,0.28557,1,1
7,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.010572,0.26444,0.26921,1,1
7,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00042807,0.26433,0.28715,1,1
7,GO THYROID GLAND DEVELOPMENT,0.0080134,0.26414,0.23899,1,1
7,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.01266,0.26409,0.25135,1,1
7,GO BASE EXCISION REPAIR AP SITE FORMATION,0.00048214,0.26399,0.26065,1,1
7,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00332,0.26385,0.32312,1,1
7,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0013481,0.26382,0.32293,1,1
7,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0057394,0.26376,0.24043,1,1
7,GO MEIOSIS I CELL CYCLE PROCESS,0.0092139,0.26339,0.22514,1,1
7,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0015882,0.26339,0.27436,1,1
7,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0013481,0.2633,0.29284,1,1
7,GO NEURON MIGRATION,0.007293,0.26304,0.25415,1,1
7,GO REGULATION OF RNA SPLICING,0.00040321,0.26296,0.26233,1,1
7,GO DEVELOPMENTAL CELL GROWTH,0.0012758,0.26295,0.29382,1,1
7,GO METHIONINE BIOSYNTHETIC PROCESS,0.0042727,0.26264,0.22007,1,1
7,GO OLIGODENDROCYTE DEVELOPMENT,0.00048214,0.26264,0.27333,1,1
7,GO CARDIAC CONDUCTION,0.0012758,0.26261,0.32281,1,1
7,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0015882,0.26254,0.29446,1,1
7,GO REGULATION OF BLOOD CIRCULATION,0.0018673,0.26254,0.27235,1,1
7,GO HISTONE H3 K9 METHYLATION,0.00091199,0.26238,0.33385,1,1
7,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0042727,0.26233,0.32039,1,1
7,GO PROTEIN METHYLATION,0.00057531,0.2619,0.28613,1,1
7,GO RENAL WATER HOMEOSTASIS,0.0014241,0.26175,0.31794,1,1
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0018673,0.26168,0.32789,1,1
7,GO PROTEIN O LINKED MANNOSYLATION,0.00072571,0.26155,0.27398,1,1
7,GO CELL JUNCTION ORGANIZATION,0.0012758,0.26133,0.29764,1,1
7,GO NUCLEAR MIGRATION,0.0011418,0.26116,0.40962,1,1
7,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00033648,0.26112,0.3122,1,1
7,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.018736,0.26112,0.28633,1,1
7,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00017019,0.26093,0.30628,1,1
7,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0013481,0.26086,0.2995,1,1
7,GO DEVELOPMENTAL MATURATION,0.00076864,0.26076,0.27432,1,1
7,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0092139,0.26057,0.29518,1,1
7,GO THALAMUS DEVELOPMENT,0.008797,0.26054,0.26768,1,1
7,GO ADHERENS JUNCTION ASSEMBLY,0.0015041,0.26054,0.3345,1,1
7,GO RESPONSE TO INACTIVITY,0.019548,0.25973,0.23225,1,1
7,GO REGULATION OF SYNAPTIC PLASTICITY,0.0010798,0.2597,0.3492,1,1
7,GO CLATHRIN COAT ASSEMBLY,0.00060992,0.25966,0.34626,1,1
7,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00045436,0.25956,0.28418,1,1
7,GO SOMITOGENESIS,0.0021907,0.25945,0.25629,1,1
7,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0034935,0.25945,0.31187,1,1
7,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0011418,0.25924,0.30912,1,1
7,GO PROTEIN KINASE A SIGNALING,0.0047188,0.25893,0.23326,1,1
7,GO PROTEIN AUTO ADP RIBOSYLATION,0.016475,0.25892,0.2326,1,1
7,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00040321,0.25886,0.33567,1,1
7,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00072571,0.2588,0.27358,1,1
7,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0015882,0.25831,0.32955,1,1
7,GO HISTONE DEUBIQUITINATION,0.0029965,0.25829,0.28394,1,1
7,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045436,0.25823,0.37149,1,1
7,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00076864,0.25797,0.26247,1,1
7,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00068502,0.25782,0.28648,1,1
7,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0021907,0.25754,0.29037,1,1
7,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0020776,0.25733,0.36828,1,1
7,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0049572,0.25713,0.25882,1,1
7,GO LENS FIBER CELL DEVELOPMENT,0.0036751,0.25701,0.26701,1,1
7,GO GLOMERULUS DEVELOPMENT,0.019548,0.25687,0.2943,1,1
7,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00091199,0.25683,0.31511,1,1
7,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00086166,0.2568,0.254,1,1
7,GO DIET INDUCED THERMOGENESIS,0.013834,0.25678,0.25546,1,1
7,GO SUBPALLIUM DEVELOPMENT,0.027226,0.25676,0.24161,1,1
7,GO RESPONSE TO LEAD ION,0.00048214,0.25644,0.28976,1,1
7,GO CAMERA TYPE EYE MORPHOGENESIS,0.0015041,0.25641,0.27119,1,1
7,GO PROTEIN HETEROTETRAMERIZATION,0.0019699,0.25623,0.2376,1,1
7,GO NEURON DIFFERENTIATION,0.00096503,0.2561,0.26855,1,1
7,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0172,0.25609,0.23399,1,1
7,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00096503,0.25595,0.27693,1,1
7,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0028457,0.25572,0.27944,1,1
7,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0028457,0.25568,0.29766,1,1
7,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0012071,0.25568,0.32888,1,1
7,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0014241,0.25566,0.27697,1,1
7,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00072571,0.25528,0.38108,1,1
7,GO LEFT RIGHT PATTERN FORMATION,0.0012071,0.25523,0.3025,1,1
7,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0019699,0.25512,0.32677,1,1
7,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0092139,0.25496,0.34392,1,1
7,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0025648,0.25479,0.37019,1,1
7,GO PRESYNAPSE ORGANIZATION,0.0011418,0.25448,0.3584,1,1
7,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0010798,0.25423,0.26574,1,1
7,GO STRIATUM DEVELOPMENT,0.011063,0.25416,0.26875,1,1
7,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00017019,0.25392,0.32132,1,1
7,GO BASEMENT MEMBRANE ORGANIZATION,0.0063209,0.25385,0.32663,1,1
7,GO OLIGOPEPTIDE TRANSPORT,0.0038653,0.2537,0.2735,1,1
7,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.034576,0.25365,0.23214,1,1
7,GO REGULATION OF ACTION POTENTIAL,0.0025648,0.25349,0.33098,1,1
7,GO EXPORT ACROSS PLASMA MEMBRANE,0.0010209,0.25334,0.3111,1,1
7,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.008797,0.25326,0.28705,1,1
7,GO CARDIAC MUSCLE CELL CONTRACTION,0.0060238,0.25306,0.30614,1,1
7,GO POLYOL CATABOLIC PROCESS,0.00054254,0.25286,0.29672,1,1
7,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0044907,0.25276,0.24754,1,1
7,GO REGULATION OF HISTONE DEACETYLATION,0.0013481,0.2526,0.27114,1,1
7,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0029965,0.25245,0.24843,1,1
7,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.0054671,0.25244,0.24792,1,1
7,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0015041,0.25237,0.30134,1,1
7,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.034576,0.25224,0.20883,1,1
7,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00018128,0.25167,0.34932,1,1
7,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.013834,0.25164,0.29232,1,1
7,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0020776,0.25156,0.30075,1,1
7,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0083971,0.25129,0.23913,1,1
7,GO REGULATION OF AXONOGENESIS,0.0044907,0.2512,0.29603,1,1
7,GO HINDLIMB MORPHOGENESIS,0.0052065,0.25119,0.25865,1,1
7,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0083971,0.25116,0.30751,1,1
7,GO REGULATION OF METANEPHROS DEVELOPMENT,0.031957,0.25109,0.25918,1,1
7,GO TOXIN METABOLIC PROCESS,0.018736,0.25097,0.22181,1,1
7,GO PROTEIN KINASE C SIGNALING,0.014457,0.25082,0.28676,1,1
7,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00068502,0.25062,0.3472,1,1
7,GO SPINAL CORD DEVELOPMENT,0.0057394,0.25043,0.2658,1,1
7,GO BONE MATURATION,0.0083971,0.2504,0.26578,1,1
7,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0096484,0.25038,0.25821,1,1
7,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0076456,0.25019,0.31713,1,1
7,GO SKELETAL MUSCLE ADAPTATION,0.0080134,0.25015,0.30055,1,1
7,GO CARNITINE SHUTTLE,0.0057394,0.25013,0.27685,1,1
7,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00332,0.25004,0.2558,1,1
7,GO MITOTIC RECOMBINATION,0.0052065,0.24995,0.26533,1,1
7,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.026142,0.24992,0.19628,1,1
7,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00042807,0.2498,0.26727,1,1
7,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00076864,0.24965,0.37841,1,1
7,GO MAINTENANCE OF CELL POLARITY,0.011574,0.24953,0.25265,1,1
7,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0049572,0.24945,0.26113,1,1
7,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.006955,0.24932,0.28845,1,1
7,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0013481,0.24907,0.28973,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010101,0.24905,0.26689,1,1
7,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.024086,0.2489,0.2413,1,1
7,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0012071,0.24888,0.25231,1,1
7,GO HISTONE H3 K4 METHYLATION,0.0018673,0.24875,0.27453,1,1
7,GO MELANOCYTE DIFFERENTIATION,0.0042727,0.24854,0.26422,1,1
7,GO LEFT RIGHT AXIS SPECIFICATION,0.045233,0.24803,0.20404,1,1
7,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0066311,0.2479,0.27669,1,1
7,GO SENSORY PERCEPTION OF SMELL,0.0057394,0.24776,0.20637,1,1
7,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0023095,0.24751,0.2939,1,1
7,GO AMINE BIOSYNTHETIC PROCESS,0.0013481,0.24741,0.25551,1,1
7,GO CELL VOLUME HOMEOSTASIS,0.00068502,0.2474,0.301,1,1
7,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0076456,0.24712,0.24239,1,1
7,GO CRISTAE FORMATION,0.00068502,0.24688,0.23641,1,1
7,GO NEURAL TUBE PATTERNING,0.01266,0.24653,0.23676,1,1
7,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0063209,0.24646,0.2815,1,1
7,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.007293,0.24642,0.30448,1,1
7,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014062,0.24642,0.32341,1,1
7,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0015882,0.24622,0.26116,1,1
7,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0092139,0.24617,0.31495,1,1
7,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.02951,0.24606,0.23858,1,1
7,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0013481,0.246,0.31902,1,1
7,GO PROTEIN MANNOSYLATION,0.00020554,0.24586,0.28998,1,1
7,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0014241,0.24573,0.33408,1,1
7,GO NEGATIVE REGULATION OF BEHAVIOR,0.038848,0.24573,0.16345,1,1
7,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0018673,0.2457,0.27365,1,1
7,GO REGULATION OF HORMONE SECRETION,0.00057531,0.24568,0.25508,1,1
7,GO EYE MORPHOGENESIS,0.0012758,0.24563,0.26761,1,1
7,GO POTASSIUM ION HOMEOSTASIS,0.00033648,0.24535,0.3072,1,1
7,GO ACROSOME ASSEMBLY,0.019548,0.24528,0.22392,1,1
7,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.024086,0.24521,0.25335,1,1
7,GO HISTONE H4 ACETYLATION,0.00054254,0.24509,0.27812,1,1
7,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0060238,0.24506,0.28075,1,1
7,GO REGULATION OF CELL SIZE,0.0018673,0.245,0.28005,1,1
7,GO LOCALIZATION WITHIN MEMBRANE,0.013834,0.245,0.26172,1,1
7,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0018673,0.2447,0.27477,1,1
7,GO PHOTOPERIODISM,0.00076864,0.24438,0.26619,1,1
7,GO PROTEIN DEPOLYMERIZATION,0.0024341,0.24431,0.27715,1,1
7,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00332,0.24411,0.23329,1,1
7,GO REGULATION OF MITOPHAGY,0.00048214,0.24398,0.37808,1,1
7,GO REGULATION OF GLUCONEOGENESIS,0.00017019,0.24393,0.32633,1,1
7,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.021265,0.24355,0.2472,1,1
7,GO HISTONE H4 K16 ACETYLATION,0.0029965,0.24351,0.26626,1,1
7,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00031664,0.24334,0.31047,1,1
7,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.0021907,0.24328,0.2436,1,1
7,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.015104,0.24313,0.29463,1,1
7,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.0042727,0.2431,0.25698,1,1
7,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0034935,0.24307,0.26999,1,1
7,GO SPERMATID DIFFERENTIATION,6.4139e-05,0.24302,0.28615,1,1
7,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.00040321,0.24294,0.31437,1,1
7,GO RESPONSE TO ALKALOID,0.0014241,0.24292,0.23449,1,1
7,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.00040321,0.24291,0.30417,1,1
7,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01266,0.24266,0.24657,1,1
7,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0019699,0.24257,0.31408,1,1
7,GO EXPLORATION BEHAVIOR,0.016475,0.24228,0.26959,1,1
7,GO LENS FIBER CELL DIFFERENTIATION,0.0036751,0.24228,0.24131,1,1
7,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.015104,0.24211,0.27148,1,1
7,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0014241,0.24206,0.29834,1,1
7,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0016767,0.24203,0.28053,1,1
7,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00024771,0.24188,0.24134,1,1
7,GO HISTONE DEACETYLATION,0.00096503,0.24174,0.27625,1,1
7,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0011418,0.24168,0.27866,1,1
7,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0018673,0.24161,0.28753,1,1
7,GO ACTION POTENTIAL,0.0018673,0.24156,0.3287,1,1
7,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0038653,0.24156,0.25131,1,1
7,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00076864,0.2414,0.34801,1,1
7,GO GLYCEROLIPID CATABOLIC PROCESS,0.0015882,0.24122,0.25409,1,1
7,GO EMBRYONIC AXIS SPECIFICATION,0.0018673,0.24106,0.23032,1,1
7,GO METANEPHROS MORPHOGENESIS,0.0047188,0.24099,0.2566,1,1
7,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0012071,0.24085,0.37184,1,1
7,GO PEPTIDYL LYSINE MODIFICATION,0.00068502,0.24067,0.24837,1,1
7,GO PROTEIN HETEROOLIGOMERIZATION,0.00081392,0.24066,0.2723,1,1
7,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0036751,0.24064,0.27506,1,1
7,GO MITOPHAGY,0.00051151,0.24062,0.30415,1,1
7,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0038653,0.2403,0.2538,1,1
7,GO CATECHOLAMINE METABOLIC PROCESS,0.0012071,0.24027,0.29021,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.007293,0.24026,0.29194,1,1
7,GO TOOTH MINERALIZATION,0.0076456,0.24015,0.30869,1,1
7,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00014062,0.24014,0.25307,1,1
7,GO LIPID DROPLET ORGANIZATION,0.00019306,0.24008,0.24666,1,1
7,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0034935,0.24004,0.25007,1,1
7,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00091199,0.23993,0.28683,1,1
7,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00086166,0.23965,0.25327,1,1
7,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0080134,0.23958,0.26151,1,1
7,GO HEART FIELD SPECIFICATION,0.013235,0.23958,0.25522,1,1
7,GO DIOL BIOSYNTHETIC PROCESS,0.0015041,0.23949,0.25082,1,1
7,GO SENSORY SYSTEM DEVELOPMENT,0.0012758,0.23943,0.25194,1,1
7,GO CHLORIDE TRANSPORT,0.0040644,0.23937,0.28544,1,1
7,GO SEXUAL REPRODUCTION,0.00015974,0.23936,0.24262,1,1
7,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.013235,0.23926,0.22404,1,1
7,GO MEIOTIC SPINDLE ORGANIZATION,0.0083971,0.23923,0.27703,1,1
7,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,8.3641e-05,0.23904,0.33287,1,1
7,GO NEUROTRANSMITTER UPTAKE,0.0031545,0.23891,0.24839,1,1
7,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0066311,0.23886,0.26191,1,1
7,GO LONG TERM SYNAPTIC POTENTIATION,0.0092139,0.23884,0.29395,1,1
7,GO MALE MEIOTIC NUCLEAR DIVISION,0.019548,0.23884,0.21297,1,1
7,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018736,0.23877,0.25445,1,1
7,GO COGNITION,0.0023095,0.23864,0.26588,1,1
7,GO DOPAMINE METABOLIC PROCESS,0.0076456,0.23854,0.27276,1,1
7,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0076456,0.23839,0.20844,1,1
7,GO PEPTIDYL LYSINE DIMETHYLATION,0.0044907,0.23835,0.28288,1,1
7,GO REGULATION OF TORC1 SIGNALING,0.0012071,0.23818,0.29469,1,1
7,GO MEIOTIC CELL CYCLE,0.0036751,0.23817,0.2219,1,1
7,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.015776,0.2381,0.30198,1,1
7,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00015974,0.23803,0.39552,1,1
7,GO MITOCHONDRION DISTRIBUTION,0.0013481,0.2378,0.31819,1,1
7,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0012071,0.23779,0.28135,1,1
7,GO MANGANESE ION TRANSPORT,0.0063209,0.23778,0.2256,1,1
7,GO REGULATION OF TUBE SIZE,0.0038653,0.23777,0.22271,1,1
7,GO NEURON PROJECTION ORGANIZATION,0.0044907,0.23767,0.28778,1,1
7,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0021907,0.23766,0.29538,1,1
7,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.015104,0.23751,0.19387,1,1
7,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,8.9327e-05,0.23747,0.24078,1,1
7,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0080134,0.23744,0.31665,1,1
7,GO G0 TO G1 TRANSITION,0.011063,0.23737,0.23836,1,1
7,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00068502,0.2373,0.3067,1,1
7,GO REGULATION OF PROTEIN DEACETYLATION,0.00086166,0.23721,0.28465,1,1
7,GO ORGANELLE LOCALIZATION,0.00021879,0.23699,0.24793,1,1
7,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.00045436,0.23693,0.34586,1,1
7,GO GOLGI TO VACUOLE TRANSPORT,0.00086166,0.23687,0.33779,1,1
7,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0092139,0.23687,0.25503,1,1
7,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0019699,0.23683,0.2896,1,1
7,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.010572,0.23681,0.27986,1,1
7,GO HISTONE H2A MONOUBIQUITINATION,0.0013481,0.23676,0.30299,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0047188,0.23673,0.27207,1,1
7,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00029789,0.23671,0.27189,1,1
7,GO STRIATED MUSCLE ADAPTATION,0.0012071,0.23651,0.32682,1,1
7,GO CHROMATIN REMODELING,0.0012758,0.23647,0.24472,1,1
7,GO MIRNA METABOLIC PROCESS,0.0010798,0.23645,0.26495,1,1
7,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0016767,0.23635,0.32489,1,1
7,GO HISTONE H3 K9 ACETYLATION,0.0057394,0.23632,0.23165,1,1
7,GO TORC1 SIGNALING,0.0011418,0.23627,0.30463,1,1
7,GO REGULATION OF HISTONE H4 ACETYLATION,0.00064645,0.23623,0.2303,1,1
7,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.0012758,0.23597,0.34426,1,1
7,GO SINGLE STRAND BREAK REPAIR,0.00040321,0.23589,0.31662,1,1
7,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0063209,0.23544,0.28131,1,1
7,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0083971,0.2354,0.23846,1,1
7,GO REGULATION OF NEURON DIFFERENTIATION,0.0027019,0.2353,0.25336,1,1
7,GO LUNG ALVEOLUS DEVELOPMENT,0.0020776,0.23526,0.33356,1,1
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0027019,0.2351,0.26791,1,1
7,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.033245,0.23507,0.17716,1,1
7,GO NERVOUS SYSTEM PROCESS,0.00051151,0.23507,0.26015,1,1
7,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0042727,0.23504,0.33506,1,1
7,GO PEPTIDYL LYSINE ACETYLATION,0.00057531,0.23487,0.25789,1,1
7,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.00042807,0.23439,0.28439,1,1
7,GO MACROMOLECULE DEACYLATION,0.00068502,0.23419,0.26915,1,1
7,GO METHYLATION,0.00054254,0.23415,0.22754,1,1
7,GO MALE GAMETE GENERATION,0.00020554,0.2341,0.2422,1,1
7,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0052065,0.23409,0.27913,1,1
7,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0012071,0.23365,0.28372,1,1
7,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0063209,0.23356,0.30494,1,1
7,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0010798,0.23351,0.29611,1,1
7,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.010572,0.23327,0.21522,1,1
7,GO PHOSPHOLIPID CATABOLIC PROCESS,0.014457,0.23327,0.2349,1,1
7,GO ERYTHROCYTE MATURATION,0.0027019,0.2332,0.30415,1,1
7,GO HEAD DEVELOPMENT,0.00086166,0.23318,0.24566,1,1
7,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00091199,0.23296,0.2757,1,1
7,GO REGULATION OF GOLGI ORGANIZATION,0.0042727,0.23281,0.31444,1,1
7,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015882,0.2326,0.2898,1,1
7,GO CAMERA TYPE EYE DEVELOPMENT,0.0018673,0.23249,0.24491,1,1
7,GO PEPTIDE HORMONE SECRETION,0.00040321,0.23247,0.28613,1,1
7,GO SPHINGOMYELIN METABOLIC PROCESS,0.0025648,0.23247,0.2574,1,1
7,GO METENCEPHALON DEVELOPMENT,0.0023095,0.23231,0.26388,1,1
7,GO NEURAL NUCLEUS DEVELOPMENT,0.00026348,0.23227,0.29497,1,1
7,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0027019,0.23215,0.23117,1,1
7,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00081392,0.23208,0.28713,1,1
7,GO NEUROGENESIS,0.0010798,0.23203,0.25457,1,1
7,GO CENTRIOLE ASSEMBLY,0.013834,0.23187,0.23781,1,1
7,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0015041,0.23185,0.2662,1,1
7,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0013481,0.23182,0.27455,1,1
7,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.010572,0.23177,0.22437,1,1
7,GO MICROTUBULE NUCLEATION,0.0063209,0.23159,0.27854,1,1
7,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.0038653,0.23129,0.24497,1,1
7,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0015882,0.23122,0.27194,1,1
7,GO INSULIN SECRETION,0.00048214,0.23118,0.28129,1,1
7,GO GAMETE GENERATION,0.00012367,0.2311,0.24792,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0034935,0.23085,0.29148,1,1
7,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0024341,0.23076,0.27749,1,1
7,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.02951,0.23072,0.24967,1,1
7,GO CARDIAC SEPTUM MORPHOGENESIS,0.022172,0.23068,0.21423,1,1
7,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.017954,0.23059,0.28164,1,1
7,GO DENDRITIC SPINE DEVELOPMENT,0.0042727,0.23053,0.28514,1,1
7,GO RESPONSE TO DOPAMINE,0.0021907,0.23047,0.22853,1,1
7,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00031664,0.2304,0.31499,1,1
7,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00064645,0.23039,0.27581,1,1
7,GO HYPEROSMOTIC RESPONSE,0.010572,0.23037,0.27519,1,1
7,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.016475,0.23024,0.27442,1,1
7,GO MEGAKARYOCYTE DEVELOPMENT,0.0019699,0.23022,0.31007,1,1
7,GO BRONCHUS DEVELOPMENT,0.013834,0.23014,0.33197,1,1
7,GO HISTONE H4 DEACETYLATION,0.0057394,0.23012,0.20729,1,1
7,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.013834,0.23011,0.22268,1,1
7,GO LYMPH VESSEL MORPHOGENESIS,0.014457,0.23004,0.30501,1,1
7,GO RNA POLYADENYLATION,0.00048214,0.22998,0.28426,1,1
7,GO HEART PROCESS,0.0031545,0.22997,0.25562,1,1
7,GO GLUCOCORTICOID METABOLIC PROCESS,0.007293,0.2299,0.24244,1,1
7,GO ORGANELLE ASSEMBLY,8.3641e-05,0.22968,0.25964,1,1
7,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.030713,0.22964,0.22065,1,1
7,GO ESTROUS CYCLE,0.011574,0.22946,0.26408,1,1
7,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.017954,0.22938,0.27163,1,1
7,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00026348,0.22927,0.29306,1,1
7,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.046961,0.22918,0.2026,1,1
7,GO CORNIFICATION,0.035953,0.22911,0.16069,1,1
7,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0029965,0.22899,0.2183,1,1
7,GO PHOTOTRANSDUCTION VISIBLE LIGHT,5.6086e-05,0.22895,0.23585,1,1
7,GO COVALENT CHROMATIN MODIFICATION,0.0010798,0.22852,0.26411,1,1
7,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00068502,0.22819,0.27801,1,1
7,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0013481,0.22816,0.25252,1,1
7,GO REGULATION OF MEMBRANE POTENTIAL,0.00076864,0.22816,0.30705,1,1
7,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0013481,0.22815,0.24099,1,1
7,GO PROTEIN ACYLATION,0.00033648,0.22797,0.26381,1,1
7,GO REGULATION OF MEIOTIC CELL CYCLE,0.00068502,0.22796,0.24231,1,1
7,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.013834,0.22793,0.25742,1,1
7,GO CHLORIDE ION HOMEOSTASIS,0.0023095,0.22783,0.28718,1,1
7,GO MYELIN ASSEMBLY,0.0040644,0.22773,0.30756,1,1
7,GO REGULATION OF ORGANELLE ASSEMBLY,0.00064645,0.22766,0.24697,1,1
7,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0011418,0.22765,0.23903,1,1
7,GO SEGMENTATION,0.0027019,0.22761,0.22595,1,1
7,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0016767,0.22745,0.30436,1,1
7,GO HISTONE H3 ACETYLATION,0.0020776,0.22726,0.22547,1,1
7,GO SECRETORY GRANULE ORGANIZATION,0.0080134,0.22725,0.24033,1,1
7,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.00086166,0.2272,0.25159,1,1
7,GO CELL MATURATION,0.00054254,0.22718,0.24317,1,1
7,GO EPIDERMAL CELL DIFFERENTIATION,0.0083971,0.22717,0.18714,1,1
7,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00076864,0.22717,0.26196,1,1
7,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.014457,0.22699,0.17906,1,1
7,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.00096503,0.22694,0.33594,1,1
7,GO REGULATION OF DENDRITE EXTENSION,0.0018673,0.22693,0.4725,1,1
7,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0027019,0.22685,0.31756,1,1
7,GO POST EMBRYONIC DEVELOPMENT,0.0017696,0.22677,0.25822,1,1
7,GO CELL MORPHOGENESIS,0.0019699,0.22666,0.26047,1,1
7,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00332,0.22633,0.22969,1,1
7,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0024341,0.22623,0.23647,1,1
7,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00086166,0.22613,0.19759,1,1
7,GO COBALAMIN METABOLIC PROCESS,0.00060992,0.22601,0.27199,1,1
7,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0013481,0.22591,0.30045,1,1
7,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00060992,0.22583,0.28019,1,1
7,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0080134,0.22574,0.2206,1,1
7,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.043559,0.2257,0.19994,1,1
7,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.00072571,0.22566,0.24671,1,1
7,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0015041,0.22555,0.28516,1,1
7,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0047188,0.22551,0.24445,1,1
7,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.014457,0.22549,0.23072,1,1
7,GO REGULATION OF CARDIAC CONDUCTION,0.0011418,0.22545,0.31185,1,1
7,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0012758,0.22542,0.28929,1,1
7,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.014457,0.22537,0.21583,1,1
7,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0028457,0.22534,0.29613,1,1
7,GO GERM CELL DEVELOPMENT,0.00010181,0.22523,0.26924,1,1
7,GO POSITIVE REGULATION OF RNA SPLICING,0.0012758,0.22523,0.22593,1,1
7,GO RESPONSE TO CATECHOLAMINE,0.0031545,0.22507,0.23617,1,1
7,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.0024341,0.22494,0.23804,1,1
7,GO SCHWANN CELL DIFFERENTIATION,0.015104,0.22493,0.2337,1,1
7,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0042727,0.2249,0.21532,1,1
7,GO PATTERN SPECIFICATION PROCESS,0.0025648,0.22481,0.22521,1,1
7,GO PIGMENTATION,0.00057531,0.22464,0.26425,1,1
7,GO REGULATION OF FEEDING BEHAVIOR,0.0020776,0.22457,0.23775,1,1
7,GO IMPORT ACROSS PLASMA MEMBRANE,0.0034935,0.22454,0.23466,1,1
7,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0020776,0.22445,0.26163,1,1
7,GO REGULATION OF EXOCYTOSIS,0.0034935,0.22437,0.27722,1,1
7,GO DENDRITE EXTENSION,0.0010798,0.22435,0.40886,1,1
7,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0027019,0.22429,0.24999,1,1
7,GO PARAXIAL MESODERM DEVELOPMENT,0.015104,0.22413,0.22312,1,1
7,GO REGULATION OF JUN KINASE ACTIVITY,0.0083971,0.22337,0.26544,1,1
7,GO PANCREAS DEVELOPMENT,0.0029965,0.22315,0.2686,1,1
7,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.007293,0.22312,0.29775,1,1
7,GO DETECTION OF VISIBLE LIGHT,0.00015974,0.2231,0.21744,1,1
7,GO G2 DNA DAMAGE CHECKPOINT,0.006955,0.22308,0.2337,1,1
7,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0052065,0.22305,0.25001,1,1
7,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0024341,0.22293,0.24011,1,1
7,GO DICARBOXYLIC ACID TRANSPORT,6.4139e-05,0.22286,0.29964,1,1
7,GO HISTONE H3 K14 ACETYLATION,0.0010209,0.22273,0.32889,1,1
7,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0028457,0.22244,0.27972,1,1
7,GO PURINE NUCLEOTIDE TRANSPORT,0.00033648,0.22243,0.2373,1,1
7,GO REGULATION OF INSULIN SECRETION,0.00040321,0.22212,0.28315,1,1
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00076864,0.22185,0.25619,1,1
7,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00068502,0.22183,0.2692,1,1
7,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0010209,0.22174,0.32166,1,1
7,GO CHOLESTEROL EFFLUX,0.050584,0.22155,0.18913,1,1
7,GO CATION TRANSMEMBRANE TRANSPORT,0.00086166,0.22125,0.2618,1,1
7,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.040368,0.22122,0.23496,1,1
7,GO ANIMAL ORGAN MATURATION,0.011574,0.22119,0.24718,1,1
7,GO REGULATION OF SODIUM ION TRANSPORT,0.0015882,0.22099,0.28649,1,1
7,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00076864,0.22089,0.28797,1,1
7,GO MESENCHYMAL CELL DIFFERENTIATION,0.011574,0.2208,0.2153,1,1
7,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0080134,0.22067,0.23622,1,1
7,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0014241,0.2206,0.29347,1,1
7,GO MEIOTIC CELL CYCLE PROCESS,0.007293,0.22047,0.21536,1,1
7,GO KERATAN SULFATE METABOLIC PROCESS,0.048745,0.22043,0.20314,1,1
7,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.016475,0.22042,0.23084,1,1
7,GO METHIONINE METABOLIC PROCESS,0.0015882,0.2204,0.23369,1,1
7,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0017696,0.22035,0.26063,1,1
7,GO SENSORY PERCEPTION,0.00054254,0.2203,0.23285,1,1
7,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0034935,0.22011,0.27828,1,1
7,GO HORMONE TRANSPORT,0.00060992,0.21997,0.25169,1,1
7,GO CALCIUM ION IMPORT,0.00068502,0.21996,0.31602,1,1
7,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0034935,0.21986,0.23423,1,1
7,GO AXIS SPECIFICATION,0.0010798,0.21985,0.2185,1,1
7,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0016767,0.21982,0.26914,1,1
7,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0018673,0.21974,0.27551,1,1
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0092139,0.21972,0.24975,1,1
7,GO AMINOGLYCAN METABOLIC PROCESS,0.017954,0.21971,0.22136,1,1
7,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.022172,0.2195,0.20833,1,1
7,GO PEPTIDYL THREONINE MODIFICATION,0.00081392,0.21915,0.27942,1,1
7,GO LOCOMOTOR RHYTHM,0.0015882,0.21889,0.35985,1,1
7,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0013481,0.21881,0.23417,1,1
7,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00013188,0.21878,0.25545,1,1
7,GO IMPORT INTO CELL,0.0021907,0.21859,0.24686,1,1
7,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00010181,0.21852,0.29605,1,1
7,GO RNA DESTABILIZATION,0.010572,0.21844,0.25866,1,1
7,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00045436,0.21798,0.28834,1,1
7,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.007293,0.21798,0.27773,1,1
7,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0024341,0.21789,0.26847,1,1
7,GO RESPONSE TO AMPHETAMINE,0.01266,0.21782,0.21735,1,1
7,GO REGULATION OF PH,0.0023095,0.21781,0.20415,1,1
7,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0013481,0.21773,0.23408,1,1
7,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0024341,0.21768,0.31298,1,1
7,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028457,0.21759,0.23281,1,1
7,GO ANATOMICAL STRUCTURE MATURATION,0.00086166,0.21759,0.24455,1,1
7,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00086166,0.21755,0.24482,1,1
7,GO NEGATIVE REGULATION OF JNK CASCADE,0.0021907,0.21751,0.24547,1,1
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.037377,0.21746,0.25102,1,1
7,GO REGULATION OF HISTONE MODIFICATION,0.0015882,0.21737,0.23294,1,1
7,GO PROTEIN ACETYLATION,0.00068502,0.21719,0.24668,1,1
7,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,6.4139e-05,0.21714,0.23894,1,1
7,GO ACTIN CROSSLINK FORMATION,0.027226,0.21711,0.23798,1,1
7,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.00057531,0.21709,0.25005,1,1
7,GO TRIGLYCERIDE CATABOLIC PROCESS,0.011063,0.21706,0.2087,1,1
7,GO DNA METHYLATION,0.0060238,0.21678,0.21124,1,1
7,GO ION TRANSMEMBRANE TRANSPORT,0.00081392,0.21676,0.25929,1,1
7,GO ESCRT COMPLEX DISASSEMBLY,0.00072571,0.21664,0.22646,1,1
7,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.017954,0.21652,0.22062,1,1
7,GO REGULATION OF HISTONE METHYLATION,0.00096503,0.21648,0.27391,1,1
7,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.045233,0.21636,0.18199,1,1
7,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0096484,0.21614,0.20626,1,1
7,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.006955,0.21597,0.22764,1,1
7,GO FEMALE GAMETE GENERATION,0.00042807,0.21597,0.23287,1,1
7,GO NEURAL TUBE DEVELOPMENT,0.0092139,0.21587,0.2235,1,1
7,GO RESPONSE TO IMMOBILIZATION STRESS,0.015776,0.21583,0.22472,1,1
7,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00024771,0.21582,0.23116,1,1
7,GO NUCLEOTIDE TRANSPORT,0.00081392,0.21547,0.21371,1,1
7,GO DETECTION OF LIGHT STIMULUS,0.00014989,0.21546,0.22036,1,1
7,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.037377,0.21538,0.23464,1,1
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.028348,0.21528,0.25409,1,1
7,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.012106,0.21524,0.21658,1,1
7,GO NOTCH SIGNALING PATHWAY,0.0010798,0.21511,0.2636,1,1
7,GO REGULATION OF CHROMATIN ORGANIZATION,0.0019699,0.21508,0.23064,1,1
7,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0014241,0.21501,0.27566,1,1
7,GO PROTON TRANSMEMBRANE TRANSPORT,7.3279e-05,0.21494,0.22885,1,1
7,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00068502,0.21493,0.32564,1,1
7,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.035953,0.21491,0.20216,1,1
7,GO MESENCHYME DEVELOPMENT,0.0052065,0.21489,0.22277,1,1
7,GO CYTOSKELETON ORGANIZATION,0.0012758,0.21489,0.2446,1,1
7,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0010798,0.21486,0.25183,1,1
7,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.028348,0.21485,0.24201,1,1
7,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.007293,0.21484,0.27172,1,1
7,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.008797,0.2148,0.29126,1,1
7,GO ATP DEPENDENT CHROMATIN REMODELING,0.023112,0.21478,0.1949,1,1
7,GO HISTONE MONOUBIQUITINATION,0.0021907,0.21468,0.25677,1,1
7,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0021907,0.21422,0.25927,1,1
7,GO CELL CELL JUNCTION ORGANIZATION,0.0010798,0.2142,0.25061,1,1
7,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0025648,0.21404,0.2663,1,1
7,GO AMINO ACID BETAINE METABOLIC PROCESS,0.025096,0.21403,0.226,1,1
7,GO DIOL METABOLIC PROCESS,0.0057394,0.21402,0.24207,1,1
7,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.035953,0.214,0.16232,1,1
7,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020776,0.21387,0.27557,1,1
7,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0021907,0.21374,0.25681,1,1
7,GO POSITIVE REGULATION OF DNA REPLICATION,0.0023095,0.21357,0.22545,1,1
7,GO ORGANIC CATION TRANSPORT,0.026142,0.21319,0.19403,1,1
7,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0010798,0.2131,0.24387,1,1
7,GO MRNA 3 END PROCESSING,0.00332,0.21299,0.2117,1,1
7,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0063209,0.21295,0.27456,1,1
7,GO EPITHELIAL TUBE FORMATION,0.0036751,0.21282,0.22661,1,1
7,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.016475,0.21281,0.22034,1,1
7,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.00076864,0.21277,0.22821,1,1
7,GO NUCLEAR CHROMOSOME SEGREGATION,0.043559,0.21257,0.16055,1,1
7,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0076456,0.21254,0.25003,1,1
7,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.008797,0.21237,0.23339,1,1
7,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.02951,0.21236,0.19786,1,1
7,GO CHONDROCYTE PROLIFERATION,0.041938,0.21224,0.258,1,1
7,GO CHROMATIN DISASSEMBLY,0.025096,0.21221,0.21851,1,1
7,GO AROMATIC AMINO ACID TRANSPORT,0.040368,0.21208,0.24011,1,1
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0036751,0.21202,0.33367,1,1
7,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00081392,0.21195,0.27416,1,1
7,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0031545,0.21195,0.27456,1,1
7,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0028457,0.21183,0.22218,1,1
7,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.019548,0.21174,0.23311,1,1
7,GO RECOMBINATIONAL REPAIR,0.034576,0.21174,0.19588,1,1
7,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0047188,0.21174,0.27658,1,1
7,GO AMINO ACID TRANSPORT,0.00026348,0.21171,0.26891,1,1
7,GO EXOCYTIC PROCESS,0.0029965,0.21166,0.29038,1,1
7,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00048214,0.21123,0.2674,1,1
7,GO SENSORY ORGAN MORPHOGENESIS,0.0034935,0.21112,0.21972,1,1
7,GO SPHINGOID METABOLIC PROCESS,0.010101,0.21085,0.24458,1,1
7,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0049572,0.2106,0.25872,1,1
7,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0028457,0.21054,0.25038,1,1
7,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020776,0.21051,0.23919,1,1
7,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00064645,0.21046,0.25963,1,1
7,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.01266,0.21043,0.23878,1,1
7,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0063209,0.21032,0.24756,1,1
7,GO FACE DEVELOPMENT,0.021265,0.20997,0.25308,1,1
7,GO STRIATED MUSCLE CONTRACTION,0.0025648,0.20997,0.27898,1,1
7,GO TRANSFERRIN TRANSPORT,0.00018128,0.20996,0.27277,1,1
7,GO NUCLEAR BODY ORGANIZATION,0.00045436,0.20989,0.272,1,1
7,GO REGULATION OF NEURON MATURATION,0.0083971,0.20986,0.27133,1,1
7,GO MATING,0.0066311,0.20958,0.25068,1,1
7,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0054671,0.20953,0.24065,1,1
7,GO LIPID OXIDATION,0.0027019,0.2095,0.20971,1,1
7,GO PROTEIN AUTOUBIQUITINATION,0.00019306,0.20934,0.25787,1,1
7,GO SIGNAL RELEASE,0.0025648,0.20933,0.2397,1,1
7,GO FUCOSE METABOLIC PROCESS,0.010572,0.20922,0.19877,1,1
7,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0010209,0.20916,0.30478,1,1
7,GO RESPONSE TO FOOD,0.0054671,0.20914,0.22639,1,1
7,GO FOCAL ADHESION ASSEMBLY,0.0076456,0.20912,0.27154,1,1
7,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.012106,0.20906,0.19019,1,1
7,GO CENTROSOME DUPLICATION,0.020391,0.20905,0.21188,1,1
7,GO NEPHRON DEVELOPMENT,0.0057394,0.20904,0.25089,1,1
7,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.00060992,0.20893,0.24475,1,1
7,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0057394,0.20888,0.26254,1,1
7,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.052482,0.2088,0.25041,1,1
7,GO DEMETHYLATION,0.0011418,0.20876,0.26987,1,1
7,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.0038653,0.20863,0.24947,1,1
7,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0019699,0.2086,0.22364,1,1
7,GO SENSORY ORGAN DEVELOPMENT,0.0038653,0.20848,0.21857,1,1
7,GO MEMBRANE REPOLARIZATION,0.0019699,0.20837,0.33028,1,1
7,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011063,0.20823,0.23424,1,1
7,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.017954,0.20822,0.23827,1,1
7,GO REGULATION OF CELL MATURATION,0.0031545,0.20774,0.2001,1,1
7,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.037377,0.20762,0.28284,1,1
7,GO P BODY ASSEMBLY,0.0076456,0.20747,0.2619,1,1
7,GO REGULATION OF SPINDLE ORGANIZATION,0.0080134,0.20734,0.20983,1,1
7,GO OVARIAN FOLLICLE DEVELOPMENT,0.0092139,0.20732,0.20456,1,1
7,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.037377,0.20728,0.26112,1,1
7,GO ALCOHOL CATABOLIC PROCESS,0.0047188,0.20726,0.20339,1,1
7,GO OVULATION CYCLE,0.0096484,0.20721,0.25524,1,1
7,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00086166,0.20702,0.25252,1,1
7,GO IRON SULFUR CLUSTER ASSEMBLY,0.0012758,0.20692,0.17963,1,1
7,GO COPII COATED VESICLE BUDDING,0.0015882,0.20675,0.22788,1,1
7,GO PHOTOTRANSDUCTION,8.9327e-05,0.20675,0.20184,1,1
7,GO DEVELOPMENTAL GROWTH,0.0015882,0.2066,0.23658,1,1
7,GO HETEROCHROMATIN ORGANIZATION,0.0015041,0.20655,0.27824,1,1
7,GO POSITIVE REGULATION OF MITOPHAGY,0.0012758,0.20636,0.39978,1,1
7,GO CALCINEURIN MEDIATED SIGNALING,0.0080134,0.20632,0.22837,1,1
7,GO HISTONE H2A UBIQUITINATION,0.00332,0.20628,0.24479,1,1
7,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.028348,0.20625,0.21129,1,1
7,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.038848,0.20618,0.1984,1,1
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0010209,0.20594,0.20449,1,1
7,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0038653,0.20562,0.2169,1,1
7,GO FATTY ACID BETA OXIDATION,0.0012758,0.20502,0.23423,1,1
7,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0027019,0.20489,0.25767,1,1
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.019548,0.20486,0.29985,1,1
7,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.0063209,0.20477,0.23831,1,1
7,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0052065,0.20471,0.31045,1,1
7,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0012758,0.20464,0.24231,1,1
7,GO CELLULAR RESPONSE TO ALKALOID,0.0034935,0.20436,0.20646,1,1
7,GO RESPONSE TO UV,0.0021907,0.20435,0.1979,1,1
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0010209,0.20401,0.1983,1,1
7,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0013481,0.20384,0.23453,1,1
7,GO ENERGY HOMEOSTASIS,0.0021907,0.20371,0.2762,1,1
7,GO REGULATION OF HORMONE LEVELS,0.00091199,0.20352,0.22399,1,1
7,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.031957,0.20345,0.21779,1,1
7,GO REGULATION OF CELLULAR PH,0.0031545,0.20344,0.20511,1,1
7,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023095,0.2034,0.21365,1,1
7,GO TISSUE REGENERATION,0.034576,0.20339,0.17294,1,1
7,GO ENDOCYTIC RECYCLING,0.0036751,0.20337,0.27839,1,1
7,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.013834,0.20323,0.34906,1,1
7,GO SECOND MESSENGER MEDIATED SIGNALING,0.021265,0.2031,0.19361,1,1
7,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0012071,0.20306,0.25336,1,1
7,GO SULFUR COMPOUND CATABOLIC PROCESS,0.023112,0.20298,0.21053,1,1
7,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0018673,0.20297,0.20706,1,1
7,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.022172,0.20295,0.23662,1,1
7,GO REGULATION OF TOR SIGNALING,0.00081392,0.20288,0.23767,1,1
7,GO ERYTHROCYTE DEVELOPMENT,0.0029965,0.20279,0.24753,1,1
7,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0014241,0.20255,0.23232,1,1
7,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0021907,0.20255,0.19133,1,1
7,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.012106,0.20254,0.27192,1,1
7,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0010798,0.20244,0.22008,1,1
7,GO PLASMA MEMBRANE ORGANIZATION,0.008797,0.20244,0.24787,1,1
7,GO ACTIVATION OF JUN KINASE ACTIVITY,0.011574,0.2023,0.29518,1,1
7,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.034576,0.20215,0.19302,1,1
7,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.010572,0.20215,0.2098,1,1
7,GO CELL CELL JUNCTION ASSEMBLY,0.00096503,0.20214,0.25151,1,1
7,GO GOLGI ORGANIZATION,0.00086166,0.20213,0.27631,1,1
7,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0172,0.20212,0.17737,1,1
7,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.017954,0.20207,0.35207,1,1
7,GO REGULATION OF CILIUM MOVEMENT,0.0047188,0.20205,0.2995,1,1
7,GO PROTEIN POLYUBIQUITINATION,0.00096503,0.20193,0.19891,1,1
7,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0060238,0.20193,0.21351,1,1
7,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00091199,0.2019,0.20303,1,1
7,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0019699,0.20165,0.26861,1,1
7,GO INORGANIC ANION TRANSPORT,0.00332,0.2015,0.24136,1,1
7,GO LIPID PHOSPHORYLATION,0.011063,0.20143,0.21758,1,1
7,GO REGULATION OF ION TRANSPORT,0.0028457,0.20137,0.2445,1,1
7,GO HEART MORPHOGENESIS,0.0083971,0.20115,0.215,1,1
7,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.018736,0.20095,0.20006,1,1
7,GO CHROMOSOME SEGREGATION,0.048745,0.20068,0.15562,1,1
7,GO 3 UTR MEDIATED MRNA STABILIZATION,0.010101,0.20064,0.23828,1,1
7,GO CARDIAC MUSCLE CONTRACTION,0.0040644,0.20055,0.2712,1,1
7,GO MULTI ORGANISM PROCESS,0.00033648,0.20051,0.21623,1,1
7,GO ANION TRANSMEMBRANE TRANSPORT,0.0010209,0.20033,0.24091,1,1
7,GO OLIGODENDROCYTE DIFFERENTIATION,0.0066311,0.2003,0.18675,1,1
7,GO SPLEEN DEVELOPMENT,0.008797,0.20019,0.22989,1,1
7,GO CELLULAR PIGMENTATION,0.0010798,0.20018,0.23942,1,1
7,GO RESPONSE TO MISFOLDED PROTEIN,0.0015882,0.20016,0.26413,1,1
7,GO REGULATION OF DNA REPAIR,0.0029965,0.20003,0.22213,1,1
7,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0017696,0.19995,0.23011,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0019699,0.1999,0.22965,1,1
7,GO GLUTAMATE METABOLIC PROCESS,0.00040321,0.19986,0.2665,1,1
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0054671,0.19966,0.28155,1,1
7,GO MRNA PROCESSING,0.00086166,0.1996,0.21102,1,1
7,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0080134,0.19952,0.22696,1,1
7,GO MYOFIBRIL ASSEMBLY,0.0027019,0.19949,0.24932,1,1
7,GO INTRA S DNA DAMAGE CHECKPOINT,0.0052065,0.19937,0.27012,1,1
7,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0066311,0.19935,0.21955,1,1
7,GO RNA SPLICING,0.0015041,0.19919,0.19664,1,1
7,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0012758,0.19907,0.2399,1,1
7,GO ADAPTATION OF SIGNALING PATHWAY,0.025096,0.19898,0.2838,1,1
7,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.027226,0.19895,0.19781,1,1
7,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0076456,0.19895,0.22841,1,1
7,GO MANNOSYLATION,0.0013481,0.19886,0.21181,1,1
7,GO CARNITINE METABOLIC PROCESS,0.020391,0.19885,0.20517,1,1
7,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0054671,0.19881,0.22928,1,1
7,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.010572,0.19865,0.18689,1,1
7,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.019548,0.19856,0.20615,1,1
7,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0040644,0.19847,0.22933,1,1
7,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0028457,0.19831,0.20857,1,1
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0047188,0.19817,0.24582,1,1
7,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0052065,0.19813,0.24886,1,1
7,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.010572,0.198,0.24238,1,1
7,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.018736,0.19795,0.23035,1,1
7,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.01266,0.19792,0.25385,1,1
7,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00086166,0.19792,0.27575,1,1
7,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0036751,0.19792,0.26016,1,1
7,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0036751,0.1976,0.21619,1,1
7,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.007293,0.19757,0.20837,1,1
7,GO REGULATION OF SYSTEM PROCESS,0.0014241,0.19751,0.24143,1,1
7,GO METAL ION TRANSPORT,0.0015041,0.1974,0.24802,1,1
7,GO KERATINIZATION,0.019548,0.19738,0.16563,1,1
7,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0066311,0.1973,0.2376,1,1
7,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0018673,0.19728,0.25696,1,1
7,GO RESPONSE TO AMINE,0.010572,0.19728,0.2095,1,1
7,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00024771,0.19722,0.24414,1,1
7,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0024341,0.19703,0.21986,1,1
7,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0019699,0.19697,0.21695,1,1
7,GO DIGESTION,0.017954,0.19697,0.16546,1,1
7,GO DNA PACKAGING,0.014457,0.19692,0.19563,1,1
7,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0080134,0.19687,0.2725,1,1
7,GO NEURAL CREST CELL DIFFERENTIATION,0.017954,0.19674,0.20714,1,1
7,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0049572,0.19671,0.19858,1,1
7,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.010101,0.19669,0.23432,1,1
7,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0060238,0.19654,0.27733,1,1
7,GO ACTIN MEDIATED CELL CONTRACTION,0.0049572,0.19652,0.2496,1,1
7,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.031957,0.1965,0.17123,1,1
7,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.038848,0.19641,0.23784,1,1
7,GO PRO B CELL DIFFERENTIATION,0.046961,0.19634,0.24743,1,1
7,GO FOREBRAIN DEVELOPMENT,0.0066311,0.19633,0.21261,1,1
7,GO MULTICELLULAR ORGANISM GROWTH,0.0028457,0.19633,0.24999,1,1
7,GO CHROMATIN ORGANIZATION,0.0011418,0.19629,0.25558,1,1
7,GO AMEBOIDAL TYPE CELL MIGRATION,0.038848,0.19614,0.19146,1,1
7,GO REGULATION OF ENDOCRINE PROCESS,0.024086,0.19612,0.18173,1,1
7,GO GPI ANCHOR METABOLIC PROCESS,0.00086166,0.19588,0.20224,1,1
7,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00091199,0.19582,0.29897,1,1
7,GO ATP TRANSPORT,0.00054254,0.19565,0.22884,1,1
7,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0011418,0.19561,0.22273,1,1
7,GO CIRCULATORY SYSTEM PROCESS,0.0044907,0.19556,0.22583,1,1
7,GO LUNG EPITHELIUM DEVELOPMENT,0.0060238,0.19555,0.27403,1,1
7,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00072571,0.19539,0.23684,1,1
7,GO RESPONSE TO LIGHT STIMULUS,0.00019306,0.19537,0.23174,1,1
7,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0014241,0.19525,0.24105,1,1
7,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.027226,0.19524,0.16324,1,1
7,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00045436,0.19507,0.20205,1,1
7,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.019548,0.19497,0.19892,1,1
7,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.007293,0.19496,0.21831,1,1
7,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0036751,0.19473,0.21872,1,1
7,GO NUCLEAR ENVELOPE ORGANIZATION,0.0020776,0.19468,0.21156,1,1
7,GO REGULATION OF HAIR CYCLE,0.010572,0.19466,0.22663,1,1
7,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0014241,0.19465,0.21869,1,1
7,GO PEPTIDE CATABOLIC PROCESS,0.0172,0.19456,0.21955,1,1
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.024086,0.19455,0.17652,1,1
7,GO REGULATION OF PROTEIN POLYMERIZATION,0.0017696,0.19453,0.23996,1,1
7,GO POSITIVE REGULATION OF CELL GROWTH,0.00086166,0.19452,0.25657,1,1
7,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0021907,0.19434,0.28194,1,1
7,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.018736,0.1943,0.27548,1,1
7,GO REGULATION OF CELL DEVELOPMENT,0.0028457,0.19429,0.22111,1,1
7,GO POSITIVE REGULATION OF TOR SIGNALING,0.0010798,0.19403,0.23831,1,1
7,GO POSITIVE REGULATION OF DNA REPAIR,0.0029965,0.19403,0.23899,1,1
7,GO STRESS FIBER ASSEMBLY,0.0047188,0.19384,0.24593,1,1
7,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00023283,0.19374,0.21701,1,1
7,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0044907,0.19363,0.18733,1,1
7,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0011418,0.19345,0.27188,1,1
7,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.019548,0.19342,0.24641,1,1
7,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.00091199,0.1933,0.27826,1,1
7,GO REGULATION OF MYELINATION,0.050584,0.19321,0.17552,1,1
7,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0063209,0.19318,0.21334,1,1
7,GO NEGATIVE REGULATION OF AXONOGENESIS,0.013834,0.19317,0.2983,1,1
7,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.019548,0.19306,0.16554,1,1
7,GO REPRODUCTION,0.00068502,0.19305,0.20943,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE,0.0010798,0.19289,0.20746,1,1
7,GO RESPONSE TO OSMOTIC STRESS,0.020391,0.19288,0.1862,1,1
7,GO SENSORY PERCEPTION OF PAIN,0.0060238,0.19284,0.19898,1,1
7,GO POSITIVE REGULATION OF GROWTH,0.0010798,0.19279,0.25111,1,1
7,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0076456,0.19275,0.36022,1,1
7,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0010798,0.19272,0.22336,1,1
7,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.010572,0.19271,0.24446,1,1
7,GO REGULATION OF SISTER CHROMATID COHESION,0.028348,0.19269,0.1914,1,1
7,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.019548,0.19269,0.24535,1,1
7,GO GLYCOSYLATION,0.0014241,0.1926,0.21762,1,1
7,GO MRNA METHYLATION,0.0096484,0.19258,0.20085,1,1
7,GO ION TRANSPORT,0.0014241,0.19253,0.23107,1,1
7,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0029965,0.19252,0.24173,1,1
7,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.012106,0.1923,0.21482,1,1
7,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.010572,0.1923,0.19438,1,1
7,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0018673,0.19199,0.21793,1,1
7,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0019699,0.19188,0.24244,1,1
7,GO SULFATE TRANSPORT,0.018736,0.19186,0.2034,1,1
7,GO PEPTIDYL SERINE MODIFICATION,0.0020776,0.19169,0.23573,1,1
7,GO ENDOCARDIUM DEVELOPMENT,0.0066311,0.19168,0.22873,1,1
7,GO CARBOHYDRATE HOMEOSTASIS,0.0015041,0.19143,0.2023,1,1
7,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.011574,0.19137,0.21949,1,1
7,GO REGULATION OF CELL MORPHOGENESIS,0.0063209,0.19131,0.23075,1,1
7,GO SELECTIVE AUTOPHAGY,0.0019699,0.1913,0.24776,1,1
7,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0044907,0.19128,0.26363,1,1
7,GO PROTEIN HOMOOLIGOMERIZATION,0.0042727,0.19122,0.21831,1,1
7,GO VESICLE LOCALIZATION,0.00033648,0.19106,0.27491,1,1
7,GO SNARE COMPLEX ASSEMBLY,0.0092139,0.19105,0.29751,1,1
7,GO MUSCLE CONTRACTION,0.0029965,0.19095,0.23663,1,1
7,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0038653,0.1908,0.2277,1,1
7,GO OVULATION CYCLE PROCESS,0.008797,0.19078,0.2605,1,1
7,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0031545,0.19066,0.2495,1,1
7,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.006955,0.19043,0.21344,1,1
7,GO ENAMEL MINERALIZATION,0.048745,0.19033,0.22792,1,1
7,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.013834,0.19022,0.18902,1,1
7,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0018673,0.19006,0.24977,1,1
7,GO REGULATION OF CARTILAGE DEVELOPMENT,0.023112,0.18996,0.22724,1,1
7,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.040368,0.18992,0.20523,1,1
7,GO AORTA DEVELOPMENT,0.028348,0.1899,0.25033,1,1
7,GO MAGNESIUM ION TRANSPORT,0.0096484,0.18983,0.27468,1,1
7,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.031957,0.18982,0.18636,1,1
7,GO REGULATION OF TRANSPORTER ACTIVITY,0.00332,0.18981,0.27236,1,1
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.015776,0.18977,0.19882,1,1
7,GO HISTONE UBIQUITINATION,0.0018673,0.18969,0.24437,1,1
7,GO LUNG CELL DIFFERENTIATION,0.019548,0.18968,0.27199,1,1
7,GO DNA MODIFICATION,0.0049572,0.18961,0.17851,1,1
7,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0025648,0.18953,0.25318,1,1
7,GO CHROMATIN SILENCING,0.0049572,0.18933,0.22424,1,1
7,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.012106,0.18929,0.27423,1,1
7,GO CATION TRANSPORT,0.00091199,0.18923,0.24076,1,1
7,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0018673,0.18914,0.25313,1,1
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0172,0.1891,0.24077,1,1
7,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0021907,0.18897,0.2201,1,1
7,GO MOLTING CYCLE,0.0036751,0.18871,0.24036,1,1
7,GO REGULATION OF DNA CATABOLIC PROCESS,0.0092139,0.18869,0.17092,1,1
7,GO RESPONSE TO CAFFEINE,0.011574,0.18863,0.25088,1,1
7,GO MESONEPHROS DEVELOPMENT,0.043559,0.18862,0.17241,1,1
7,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0038653,0.18861,0.24514,1,1
7,GO UV PROTECTION,0.0012071,0.18859,0.28302,1,1
7,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00051151,0.18857,0.2766,1,1
7,GO NEURAL CREST CELL MIGRATION,0.0172,0.18849,0.22737,1,1
7,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0017696,0.18841,0.228,1,1
7,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.010101,0.1883,0.27966,1,1
7,GO CELL CELL SIGNALING,0.0019699,0.18819,0.2344,1,1
7,GO REGULATION OF ACTIN NUCLEATION,0.035953,0.1881,0.18618,1,1
7,GO CELL GROWTH,0.0014241,0.18808,0.23285,1,1
7,GO FERTILIZATION,0.00064645,0.18798,0.19472,1,1
7,GO REGULATION OF CHROMATIN BINDING,0.025096,0.18796,0.19316,1,1
7,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0057394,0.18786,0.21407,1,1
7,GO ORGANELLE FISSION,0.0083971,0.18777,0.18496,1,1
7,GO RESPONSE TO CALCIUM ION,0.0014241,0.1874,0.26459,1,1
7,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0047188,0.18739,0.20745,1,1
7,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0025648,0.18732,0.214,1,1
7,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.043559,0.1873,0.21393,1,1
7,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0036751,0.18718,0.20494,1,1
7,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0038653,0.18718,0.21177,1,1
7,GO CARDIAC MUSCLE CELL PROLIFERATION,0.014457,0.18709,0.19983,1,1
7,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.018736,0.18687,0.23726,1,1
7,GO ACTIN FILAMENT BASED PROCESS,0.0054671,0.18674,0.22968,1,1
7,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0054671,0.18666,0.21816,1,1
7,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0020776,0.18653,0.23617,1,1
7,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.015104,0.18648,0.2093,1,1
7,GO PIGMENT CELL DIFFERENTIATION,0.0060238,0.1863,0.22915,1,1
7,GO DETECTION OF ABIOTIC STIMULUS,0.00015974,0.18621,0.23222,1,1
7,GO CARDIAC CHAMBER MORPHOGENESIS,0.024086,0.18616,0.19946,1,1
7,GO ARTERY DEVELOPMENT,0.025096,0.18613,0.2289,1,1
7,GO CELLULAR ION HOMEOSTASIS,0.043559,0.18584,0.1574,1,1
7,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0020776,0.18578,0.1956,1,1
7,GO ARTERY MORPHOGENESIS,0.020391,0.18562,0.24106,1,1
7,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0038653,0.18549,0.2218,1,1
7,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0172,0.1853,0.23944,1,1
7,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.006955,0.18516,0.20594,1,1
7,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.015104,0.18513,0.25375,1,1
7,GO ADAPTIVE THERMOGENESIS,0.014457,0.18511,0.17772,1,1
7,GO MRNA CLEAVAGE,0.00035748,0.18495,0.2344,1,1
7,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013481,0.1848,0.23892,1,1
7,GO ORGANELLE MEMBRANE FUSION,0.0052065,0.18477,0.24915,1,1
7,GO CIRCULATORY SYSTEM DEVELOPMENT,0.034576,0.18468,0.18325,1,1
7,GO SKIN DEVELOPMENT,0.014457,0.1846,0.18182,1,1
7,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0057394,0.18457,0.20744,1,1
7,GO RNA 3 END PROCESSING,0.0029965,0.18455,0.18494,1,1
7,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0016767,0.18453,0.27449,1,1
7,GO HISTONE H2A ACETYLATION,0.0017696,0.18447,0.25194,1,1
7,GO DEPHOSPHORYLATION,0.0012758,0.18438,0.23188,1,1
7,GO ANION TRANSPORT,0.0013481,0.18435,0.2181,1,1
7,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0013481,0.18428,0.27998,1,1
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.010101,0.18421,0.21747,1,1
7,GO METAL ION HOMEOSTASIS,0.046961,0.18416,0.15836,1,1
7,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.012106,0.18403,0.27134,1,1
7,GO REGULATION OF CENTROSOME CYCLE,0.015776,0.18399,0.1888,1,1
7,GO COCHLEA DEVELOPMENT,0.034576,0.1838,0.17477,1,1
7,GO DNA RECOMBINATION,0.033245,0.18373,0.168,1,1
7,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00086166,0.1837,0.22762,1,1
7,GO TRANSMEMBRANE TRANSPORT,0.00096503,0.18363,0.22983,1,1
7,GO GOLGI VESICLE BUDDING,0.0024341,0.18349,0.22529,1,1
7,GO POLYSACCHARIDE METABOLIC PROCESS,0.0027019,0.18344,0.22159,1,1
7,GO RESPONSE TO UV C,0.017954,0.18331,0.20485,1,1
7,GO RNA INTERFERENCE,0.01266,0.18329,0.20024,1,1
7,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0021907,0.18328,0.22108,1,1
7,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0013481,0.18321,0.2004,1,1
7,GO GLUCOSE METABOLIC PROCESS,0.0013481,0.18316,0.20242,1,1
7,GO REGULATION OF MUSCLE CONTRACTION,0.0060238,0.1831,0.20236,1,1
7,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0024341,0.18308,0.33495,1,1
7,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.046961,0.18291,0.20085,1,1
7,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0017696,0.18275,0.19199,1,1
7,GO RNA EXPORT FROM NUCLEUS,0.0054671,0.18261,0.19086,1,1
7,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.01266,0.18251,0.24282,1,1
7,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0029965,0.18247,0.25338,1,1
7,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.013235,0.18246,0.2528,1,1
7,GO CARDIAC VENTRICLE DEVELOPMENT,0.0063209,0.18244,0.22402,1,1
7,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.046961,0.18222,0.19318,1,1
7,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0080134,0.18218,0.24948,1,1
7,GO TRANSCRIPTION BY RNA POLYMERASE III,0.00068502,0.18213,0.20848,1,1
7,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0019699,0.18186,0.2104,1,1
7,GO REGULATION OF DEPHOSPHORYLATION,0.0020776,0.18167,0.23157,1,1
7,GO REGULATION OF ORGANELLE ORGANIZATION,0.0012071,0.1816,0.21394,1,1
7,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0024341,0.1816,0.2424,1,1
7,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00332,0.18147,0.18506,1,1
7,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00096503,0.18145,0.24753,1,1
7,GO POLYOL METABOLIC PROCESS,0.00040321,0.18137,0.22831,1,1
7,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0025648,0.18135,0.22792,1,1
7,GO EAR MORPHOGENESIS,0.012106,0.18125,0.18328,1,1
7,GO HEART DEVELOPMENT,0.0031545,0.18121,0.22189,1,1
7,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0017696,0.18115,0.31102,1,1
7,GO TRNA MODIFICATION,0.0044907,0.18095,0.17296,1,1
7,GO TOR SIGNALING,0.00064645,0.18083,0.22582,1,1
7,GO MRNA MODIFICATION,0.024086,0.18081,0.15375,1,1
7,GO MITOTIC SISTER CHROMATID COHESION,0.050584,0.18079,0.17887,1,1
7,GO EPITHELIAL CELL DIFFERENTIATION,0.0044907,0.18075,0.19548,1,1
7,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0020776,0.18063,0.25679,1,1
7,GO ION HOMEOSTASIS,0.02951,0.18057,0.16786,1,1
7,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.018736,0.1805,0.24648,1,1
7,GO CYTOKINESIS,0.0024341,0.1804,0.21123,1,1
7,GO REGULATION OF SENSORY PERCEPTION,0.013235,0.18033,0.20878,1,1
7,GO ORGANIC ACID TRANSPORT,0.0012071,0.18032,0.21323,1,1
7,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.1803,0.26064,1,1
7,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0057394,0.18028,0.24097,1,1
7,GO REGULATION OF PROTEIN ACETYLATION,0.0015041,0.18024,0.2138,1,1
7,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0025648,0.18011,0.21105,1,1
7,GO CELLULAR RESPONSE TO PH,0.013235,0.18003,0.23138,1,1
7,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021907,0.17991,0.21404,1,1
7,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00332,0.17984,0.29336,1,1
7,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00042807,0.17956,0.17136,1,1
7,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0019699,0.17946,0.30307,1,1
7,GO EXCRETION,0.0083971,0.17933,0.24165,1,1
7,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0080134,0.17931,0.27493,1,1
7,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0025648,0.1793,0.17832,1,1
7,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.030713,0.17913,0.17035,1,1
7,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.025096,0.17885,0.20842,1,1
7,GO CYTOSOLIC TRANSPORT,0.00064645,0.17869,0.28156,1,1
7,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0052065,0.17862,0.26648,1,1
7,GO ACTIN FILAMENT BASED MOVEMENT,0.0057394,0.17861,0.2471,1,1
7,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.020391,0.17857,0.17012,1,1
7,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.025096,0.17834,0.22002,1,1
7,GO REGULATION OF TELOMERE MAINTENANCE,0.0029965,0.17777,0.21917,1,1
7,GO REGULATION OF BLOOD PRESSURE,0.007293,0.17759,0.20669,1,1
7,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0044907,0.17758,0.22715,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0012758,0.17746,0.34246,1,1
7,GO INNER EAR MORPHOGENESIS,0.0080134,0.17735,0.20678,1,1
7,GO DEVELOPMENTAL PIGMENTATION,0.0025648,0.17721,0.23772,1,1
7,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.040368,0.17713,0.16301,1,1
7,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0052065,0.17712,0.19771,1,1
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.020391,0.17708,0.21675,1,1
7,GO INTRACELLULAR STEROL TRANSPORT,0.050584,0.17707,0.17272,1,1
7,GO CELLULAR RESPONSE TO STEROL,0.019548,0.17707,0.2566,1,1
7,GO REGULATION OF CELL CYCLE,0.0024341,0.17686,0.18823,1,1
7,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.00064645,0.17684,0.19952,1,1
7,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0024341,0.17683,0.19736,1,1
7,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0025648,0.17682,0.2065,1,1
7,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0040644,0.17679,0.21736,1,1
7,GO HORMONE METABOLIC PROCESS,0.008797,0.17668,0.16138,1,1
7,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0010798,0.17662,0.18441,1,1
7,GO TRNA WOBBLE BASE MODIFICATION,0.0060238,0.17662,0.17446,1,1
7,GO ECTODERMAL PLACODE DEVELOPMENT,0.046961,0.17655,0.17496,1,1
7,GO CHROMOSOME ORGANIZATION,0.0023095,0.17654,0.21748,1,1
7,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00096503,0.17641,0.26982,1,1
7,GO EMBRYONIC PATTERN SPECIFICATION,0.0021907,0.17632,0.25344,1,1
7,GO MEGAKARYOCYTE DIFFERENTIATION,0.0012758,0.17628,0.2489,1,1
7,GO GENE SILENCING,0.0016767,0.17626,0.20801,1,1
7,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0042727,0.17612,0.18807,1,1
7,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0014241,0.17609,0.23424,1,1
7,GO MRNA EXPORT FROM NUCLEUS,0.0021907,0.17605,0.21765,1,1
7,GO ERBB2 SIGNALING PATHWAY,0.012106,0.17591,0.22751,1,1
7,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.025096,0.17583,0.21291,1,1
7,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.019548,0.17582,0.15817,1,1
7,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0038653,0.17562,0.24784,1,1
7,GO RESPONSE TO MONOSACCHARIDE,0.0015041,0.1756,0.21621,1,1
7,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.006955,0.17551,0.23934,1,1
7,GO PROTEIN LOCALIZATION TO VACUOLE,0.0092139,0.17551,0.20627,1,1
7,GO DNA REPLICATION,0.048745,0.17527,0.161,1,1
7,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.014457,0.1752,0.16118,1,1
7,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00086166,0.17518,0.21074,1,1
7,GO TOXIN TRANSPORT,0.019548,0.17512,0.20767,1,1
7,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.014457,0.17509,0.20909,1,1
7,GO NEPHRON MORPHOGENESIS,0.041938,0.17507,0.1794,1,1
7,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0012071,0.17507,0.20971,1,1
7,GO LIPOPROTEIN METABOLIC PROCESS,0.0010209,0.17506,0.19066,1,1
7,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.050584,0.17495,0.16885,1,1
7,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0060238,0.17493,0.23925,1,1
7,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0049572,0.17487,0.19853,1,1
7,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0031545,0.17485,0.23959,1,1
7,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.011063,0.17448,0.28583,1,1
7,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.011063,0.1744,0.21319,1,1
7,GO EXIT FROM MITOSIS,0.011574,0.17434,0.184,1,1
7,GO DORSAL VENTRAL PATTERN FORMATION,0.013235,0.17428,0.20447,1,1
7,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0076456,0.17427,0.20509,1,1
7,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0025648,0.17393,0.2518,1,1
7,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.010572,0.17389,0.25917,1,1
7,GO ENDOTHELIUM DEVELOPMENT,0.052482,0.17388,0.2043,1,1
7,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0027019,0.17381,0.23367,1,1
7,GO DEVELOPMENTAL INDUCTION,0.013834,0.17355,0.1981,1,1
7,GO RHYTHMIC PROCESS,0.0036751,0.17352,0.20793,1,1
7,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0172,0.17328,0.21334,1,1
7,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0049572,0.17328,0.21082,1,1
7,GO PHOSPHOLIPID METABOLIC PROCESS,0.0031545,0.17323,0.21151,1,1
7,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0031545,0.17306,0.20174,1,1
7,GO MEMBRANE FUSION,0.0042727,0.17299,0.22725,1,1
7,GO ORGANELLE FUSION,0.0017696,0.1729,0.2426,1,1
7,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.038848,0.17278,0.23562,1,1
7,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0172,0.17278,0.19735,1,1
7,GO REGULATION OF VASCULAR PERMEABILITY,0.024086,0.17277,0.23178,1,1
7,GO NON RECOMBINATIONAL REPAIR,0.0057394,0.17275,0.1929,1,1
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.011574,0.17273,0.21681,1,1
7,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.050584,0.17271,0.18504,1,1
7,GO EPIDERMIS DEVELOPMENT,0.01266,0.17267,0.17797,1,1
7,GO REGULATION OF VASOCONSTRICTION,0.050584,0.17266,0.20132,1,1
7,GO HISTONE H2B UBIQUITINATION,0.020391,0.1726,0.16597,1,1
7,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0172,0.17246,0.20615,1,1
7,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0066311,0.17243,0.19933,1,1
7,GO MUSCLE STRUCTURE DEVELOPMENT,0.0049572,0.17239,0.20959,1,1
7,GO REGULATION OF ANION TRANSPORT,0.01266,0.17238,0.18488,1,1
7,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0028457,0.17223,0.22415,1,1
7,GO REGULATION OF CELLULAR LOCALIZATION,0.0047188,0.17222,0.21083,1,1
7,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.015776,0.17221,0.20498,1,1
7,GO REGULATION OF MESODERM DEVELOPMENT,0.024086,0.1722,0.19385,1,1
7,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00042807,0.17206,0.28487,1,1
7,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.018736,0.17201,0.22629,1,1
7,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0016767,0.172,0.22329,1,1
7,GO REGULATION OF CELL CYCLE CHECKPOINT,0.048745,0.17187,0.1817,1,1
7,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0054671,0.1718,0.23774,1,1
7,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0042727,0.17174,0.25685,1,1
7,GO ACID SECRETION,0.0014241,0.17167,0.25069,1,1
7,GO VESICLE BUDDING FROM MEMBRANE,0.0042727,0.17143,0.20233,1,1
7,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00332,0.17143,0.20668,1,1
7,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0063209,0.17123,0.22959,1,1
7,GO GROWTH,0.0017696,0.17123,0.20801,1,1
7,GO LIPID MODIFICATION,0.0023095,0.17121,0.22323,1,1
7,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0020776,0.17121,0.18692,1,1
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028457,0.1711,0.2477,1,1
7,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0014241,0.17109,0.22777,1,1
7,GO GLYCEROLIPID METABOLIC PROCESS,0.0027019,0.17103,0.22051,1,1
7,GO CELLULAR RESPONSE TO SALT STRESS,0.028348,0.17101,0.20975,1,1
7,GO RENAL SYSTEM PROCESS,0.011063,0.17084,0.23124,1,1
7,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0083971,0.17072,0.20616,1,1
7,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0038653,0.17067,0.21963,1,1
7,GO NUCLEOSOME ORGANIZATION,0.011063,0.17063,0.1865,1,1
7,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00051151,0.17061,0.17825,1,1
7,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0021907,0.1706,0.21284,1,1
7,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0019699,0.17053,0.22438,1,1
7,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.01266,0.17051,0.19976,1,1
7,GO REGULATION OF CIRCADIAN RHYTHM,0.0047188,0.17046,0.21774,1,1
7,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0036751,0.17042,0.26713,1,1
7,GO TRNA PROCESSING,0.0031545,0.1704,0.15834,1,1
7,GO RESPONSE TO LEPTIN,0.013235,0.17032,0.23423,1,1
7,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00048214,0.17029,0.20545,1,1
7,GO RESPONSE TO STEROL,0.035953,0.17006,0.21536,1,1
7,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.02951,0.17006,0.17449,1,1
7,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0054671,0.16994,0.23798,1,1
7,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0044907,0.16994,0.20741,1,1
7,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0036751,0.16993,0.22137,1,1
7,GO ISOPRENOID METABOLIC PROCESS,0.025096,0.16986,0.13213,1,1
7,GO MRNA TRANSPORT,0.0052065,0.1698,0.19215,1,1
7,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.014457,0.16978,0.19402,1,1
7,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.00020554,0.1697,0.17904,1,1
7,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.0029965,0.16958,0.2695,1,1
7,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0060238,0.16956,0.1818,1,1
7,GO ENSHEATHMENT OF NEURONS,0.016475,0.16954,0.17451,1,1
7,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0028457,0.16952,0.17289,1,1
7,GO SISTER CHROMATID COHESION,0.027226,0.16946,0.18422,1,1
7,GO REGULATION OF CENTROSOME DUPLICATION,0.01266,0.16935,0.19002,1,1
7,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.008797,0.16931,0.25398,1,1
7,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.014457,0.1693,0.20241,1,1
7,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0013481,0.16917,0.33427,1,1
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0044907,0.16917,0.1918,1,1
7,GO MUSCLE ORGAN DEVELOPMENT,0.00332,0.16916,0.21012,1,1
7,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.010101,0.16908,0.25147,1,1
7,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0023095,0.16904,0.34336,1,1
7,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.028348,0.16901,0.16792,1,1
7,GO ORGANIC ANION TRANSPORT,0.0017696,0.16894,0.20046,1,1
7,GO CEREBELLAR CORTEX FORMATION,0.0052065,0.16885,0.27278,1,1
7,GO PROTEOGLYCAN METABOLIC PROCESS,0.011063,0.16878,0.22635,1,1
7,GO ERAD PATHWAY,0.0020776,0.16866,0.21837,1,1
7,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0092139,0.16851,0.28896,1,1
7,GO REGULATION OF FATTY ACID OXIDATION,0.026142,0.16845,0.20686,1,1
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.027226,0.16844,0.16099,1,1
7,GO REGULATION OF MIRNA METABOLIC PROCESS,0.040368,0.16833,0.23552,1,1
7,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0049572,0.16833,0.19479,1,1
7,GO STRESS GRANULE ASSEMBLY,0.007293,0.16827,0.22568,1,1
7,GO LYSOSOMAL TRANSPORT,0.0031545,0.16822,0.27009,1,1
7,GO PROTEIN AUTOPHOSPHORYLATION,0.028348,0.16822,0.20899,1,1
7,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0036751,0.16821,0.18016,1,1
7,GO CELLULAR RESPONSE TO CALCIUM ION,0.0028457,0.16816,0.25921,1,1
7,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00072571,0.16814,0.19387,1,1
7,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0066311,0.16809,0.20416,1,1
7,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.010572,0.16807,0.25535,1,1
7,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0021907,0.16806,0.18906,1,1
7,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0040644,0.16806,0.21553,1,1
7,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00332,0.16804,0.19248,1,1
7,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0029965,0.16799,0.23901,1,1
7,GO MESENCHYME MORPHOGENESIS,0.052482,0.16783,0.19463,1,1
7,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.046961,0.16778,0.20471,1,1
7,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0025648,0.16764,0.18384,1,1
7,GO ERBB SIGNALING PATHWAY,0.011063,0.1676,0.20707,1,1
7,GO EPITHELIUM DEVELOPMENT,0.0040644,0.16751,0.19407,1,1
7,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0047188,0.1673,0.19614,1,1
7,GO CARDIAC CHAMBER DEVELOPMENT,0.01266,0.16724,0.2183,1,1
7,GO SPINDLE ORGANIZATION,0.040368,0.16722,0.19005,1,1
7,GO CELL CYCLE,0.0028457,0.16715,0.19124,1,1
7,GO MUSCLE CELL DIFFERENTIATION,0.0038653,0.16711,0.21895,1,1
7,GO VESICLE TARGETING,0.00060992,0.16703,0.23482,1,1
7,GO ALCOHOL METABOLIC PROCESS,0.00332,0.16701,0.18939,1,1
7,GO CELLULAR RESPONSE TO ALCOHOL,0.020391,0.16699,0.20662,1,1
7,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.027226,0.16682,0.16719,1,1
7,GO RESPONSE TO GROWTH FACTOR,0.00332,0.16682,0.21879,1,1
7,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0063209,0.16662,0.17992,1,1
7,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0012758,0.16658,0.18518,1,1
7,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.020391,0.16652,0.15405,1,1
7,GO POSITIVE REGULATION OF ANION TRANSPORT,0.033245,0.16652,0.17553,1,1
7,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.013235,0.16648,0.18909,1,1
7,GO PEPTIDYL CYSTEINE MODIFICATION,0.0014241,0.16634,0.20875,1,1
7,GO REGULATION OF GROWTH,0.0020776,0.1663,0.20291,1,1
7,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.011063,0.16616,0.20029,1,1
7,GO GLYCOPROTEIN METABOLIC PROCESS,0.0057394,0.16615,0.19488,1,1
7,GO REGIONALIZATION,0.011574,0.16606,0.19198,1,1
7,GO CELL CYCLE PROCESS,0.0052065,0.166,0.1842,1,1
7,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00057531,0.166,0.17266,1,1
7,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.015776,0.1659,0.18755,1,1
7,GO CIRCADIAN RHYTHM,0.0060238,0.16585,0.19691,1,1
7,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0052065,0.16578,0.2645,1,1
7,GO REGULATION OF RIBOSOME BIOGENESIS,0.030713,0.16577,0.17558,1,1
7,GO ANIMAL ORGAN MORPHOGENESIS,0.007293,0.16575,0.19735,1,1
7,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0016767,0.16574,0.21392,1,1
7,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0054671,0.16563,0.22818,1,1
7,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.020391,0.16556,0.21974,1,1
7,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0020776,0.16553,0.28286,1,1
7,GO MUSCLE CELL FATE COMMITMENT,0.033245,0.16553,0.22443,1,1
7,GO PROTEIN K63 LINKED UBIQUITINATION,0.0060238,0.16534,0.18529,1,1
7,GO EMBRYO DEVELOPMENT,0.0031545,0.16534,0.21185,1,1
7,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.020391,0.16533,0.19929,1,1
7,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.030713,0.16532,0.27587,1,1
7,GO REGULATION OF MITOCHONDRIAL FISSION,0.0012071,0.16516,0.24853,1,1
7,GO FATTY ACID CATABOLIC PROCESS,0.00091199,0.16512,0.22196,1,1
7,GO PROTEIN POLYMERIZATION,0.0024341,0.1649,0.21883,1,1
7,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.025096,0.16488,0.20995,1,1
7,GO NEURON PROJECTION REGENERATION,0.012106,0.16479,0.2232,1,1
7,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.010101,0.16469,0.2112,1,1
7,GO LACTATION,0.018736,0.16465,0.21813,1,1
7,GO C4 DICARBOXYLATE TRANSPORT,0.0040644,0.16461,0.18959,1,1
7,GO REGULATION OF TRANSPORT,0.0054671,0.16459,0.20445,1,1
7,GO DNA CONFORMATION CHANGE,0.017954,0.16458,0.18637,1,1
7,GO CELLULAR LIPID CATABOLIC PROCESS,0.0060238,0.16447,0.18174,1,1
7,GO VESICLE DOCKING,0.00072571,0.16428,0.30665,1,1
7,GO CELL CYCLE ARREST,0.010572,0.16416,0.16598,1,1
7,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.013235,0.16403,0.1844,1,1
7,GO BODY FLUID SECRETION,0.0047188,0.16386,0.19557,1,1
7,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0036751,0.16367,0.18286,1,1
7,GO KETONE BODY METABOLIC PROCESS,0.0019699,0.16366,0.24037,1,1
7,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0038653,0.1634,0.22326,1,1
7,GO TUBE DEVELOPMENT,0.041938,0.16335,0.18039,1,1
7,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.016475,0.1633,0.17889,1,1
7,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0052065,0.16318,0.15955,1,1
7,GO REGULATION OF CELL DIVISION,0.012106,0.16318,0.17723,1,1
7,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0019699,0.16311,0.21956,1,1
7,GO MUSCLE SYSTEM PROCESS,0.0063209,0.16297,0.21436,1,1
7,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.041938,0.16292,0.16276,1,1
7,GO RNA PROCESSING,0.0015882,0.16284,0.17148,1,1
7,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0020776,0.16279,0.19612,1,1
7,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0047188,0.16277,0.16449,1,1
7,GO HAIR FOLLICLE MATURATION,0.025096,0.16266,0.21629,1,1
7,GO CELLULAR RESPONSE TO UV,0.0049572,0.1625,0.17229,1,1
7,GO ACTIN NUCLEATION,0.024086,0.16249,0.17505,1,1
7,GO TISSUE HOMEOSTASIS,0.01266,0.16237,0.20279,1,1
7,GO REGULATION OF MRNA 3 END PROCESSING,0.0096484,0.16227,0.21273,1,1
7,GO RESPONSE TO ESTRADIOL,0.015104,0.16215,0.17259,1,1
7,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.031957,0.16201,0.18049,1,1
7,GO DETECTION OF STIMULUS,0.00057531,0.16187,0.18504,1,1
7,GO NUCLEUS ORGANIZATION,0.00054254,0.16182,0.21757,1,1
7,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.015776,0.16175,0.18066,1,1
7,GO MACROMOLECULE DEPALMITOYLATION,0.0031545,0.16175,0.17296,1,1
7,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00096503,0.16172,0.20883,1,1
7,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0015882,0.16167,0.20717,1,1
7,GO CHEMICAL HOMEOSTASIS,0.013834,0.16144,0.17908,1,1
7,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0014241,0.16135,0.25581,1,1
7,GO SINGLE FERTILIZATION,0.0018673,0.16132,0.17546,1,1
7,GO RETINAL CONE CELL DIFFERENTIATION,0.0044907,0.16128,0.20671,1,1
7,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.01266,0.16126,0.21313,1,1
7,GO HEART TRABECULA MORPHOGENESIS,0.048745,0.16102,0.1885,1,1
7,GO FATTY ACID METABOLIC PROCESS,0.0049572,0.16085,0.17051,1,1
7,GO IRON ION TRANSPORT,0.0020776,0.16082,0.21507,1,1
7,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0031545,0.1606,0.19758,1,1
7,GO MITOCHONDRION MORPHOGENESIS,0.00068502,0.16057,0.19046,1,1
7,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0044907,0.16054,0.21464,1,1
7,GO AUTOPHAGOSOME MATURATION,0.0013481,0.16052,0.26679,1,1
7,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.040368,0.16038,0.20053,1,1
7,GO PROTEIN DEPHOSPHORYLATION,0.0017696,0.16035,0.21369,1,1
7,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.010572,0.16031,0.21975,1,1
7,GO VASODILATION,0.045233,0.16025,0.17256,1,1
7,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0021907,0.16025,0.20675,1,1
7,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.028348,0.16012,0.22324,1,1
7,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.006955,0.15978,0.16494,1,1
7,GO CELLULAR RESPONSE TO KETONE,0.033245,0.15964,0.15117,1,1
7,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.030713,0.15958,0.19587,1,1
7,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0066311,0.15948,0.22936,1,1
7,GO NEUTRAL LIPID METABOLIC PROCESS,0.011574,0.15937,0.19321,1,1
7,GO NEGATIVE REGULATION OF CELL CYCLE,0.015104,0.15937,0.15182,1,1
7,GO RESPONSE TO CARBOHYDRATE,0.00332,0.15934,0.19747,1,1
7,GO RESPONSE TO RADIATION,0.00068502,0.15929,0.19287,1,1
7,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.011063,0.15922,0.17453,1,1
7,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0042727,0.15916,0.18932,1,1
7,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0038653,0.15906,0.23816,1,1
7,GO REGULATION OF GLUCOSE IMPORT,0.0057394,0.15901,0.20328,1,1
7,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0044907,0.15898,0.21351,1,1
7,GO POSITIVE REGULATION OF SECRETION,0.015776,0.15894,0.18489,1,1
7,GO MITOTIC NUCLEAR DIVISION,0.048745,0.15886,0.15795,1,1
7,GO GLIAL CELL DEVELOPMENT,0.046961,0.15886,0.15533,1,1
7,GO DNA REPAIR,0.0040644,0.1588,0.19364,1,1
7,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0019699,0.15879,0.23908,1,1
7,GO PH REDUCTION,0.021265,0.15868,0.15001,1,1
7,GO REGULATION OF SECRETION,0.010572,0.15857,0.19985,1,1
7,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.045233,0.15849,0.16938,1,1
7,GO TRNA METHYLATION,0.01266,0.15821,0.15783,1,1
7,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0034935,0.15817,0.18817,1,1
7,GO ENDOCRINE HORMONE SECRETION,0.019548,0.15809,0.17385,1,1
7,GO OSSIFICATION,0.041938,0.15807,0.16326,1,1
7,GO BASE EXCISION REPAIR,0.0080134,0.15793,0.18548,1,1
7,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0049572,0.15765,0.23699,1,1
7,GO UTP METABOLIC PROCESS,0.00332,0.1575,0.22559,1,1
7,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0027019,0.15736,0.20211,1,1
7,GO KERATINOCYTE DIFFERENTIATION,0.040368,0.15715,0.1411,1,1
7,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00332,0.15676,0.19621,1,1
7,GO LATERAL MESODERM DEVELOPMENT,0.023112,0.15659,0.20618,1,1
7,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.050584,0.15651,0.22359,1,1
7,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0044907,0.15651,0.21096,1,1
7,GO PROTEIN TARGETING TO VACUOLE,0.0054671,0.15636,0.21673,1,1
7,GO REGULATION OF FERTILIZATION,0.011063,0.15633,0.16222,1,1
7,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.018736,0.15594,0.19533,1,1
7,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.015104,0.15593,0.15723,1,1
7,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0096484,0.15584,0.22337,1,1
7,GO RNA STABILIZATION,0.014457,0.15583,0.17703,1,1
7,GO LIPID CATABOLIC PROCESS,0.012106,0.15574,0.16131,1,1
7,GO SULFUR COMPOUND TRANSPORT,0.0012071,0.15572,0.23123,1,1
7,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.012106,0.15559,0.19944,1,1
7,GO CELLULAR RESPONSE TO RADIATION,0.0060238,0.15553,0.14887,1,1
7,GO POSITIVE REGULATION OF ION TRANSPORT,0.0092139,0.15552,0.19184,1,1
7,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.016475,0.1555,0.15922,1,1
7,GO MIDBRAIN DEVELOPMENT,0.0060238,0.15532,0.16077,1,1
7,GO SPERM EGG RECOGNITION,0.0010209,0.15526,0.15197,1,1
7,GO ENDOCRINE PROCESS,0.043559,0.15523,0.15117,1,1
7,GO MUSCLE TISSUE DEVELOPMENT,0.0044907,0.15503,0.20528,1,1
7,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0023095,0.15498,0.21263,1,1
7,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.006955,0.15497,0.20922,1,1
7,GO GOLGI TO ENDOSOME TRANSPORT,0.0052065,0.15492,0.30469,1,1
7,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0172,0.15485,0.18844,1,1
7,GO EAR DEVELOPMENT,0.011574,0.15475,0.18322,1,1
7,GO CARBOHYDRATE PHOSPHORYLATION,0.031957,0.15474,0.1822,1,1
7,GO RESPONSE TO CAMP,0.046961,0.15465,0.14929,1,1
7,GO DNA METHYLATION OR DEMETHYLATION,0.015104,0.1546,0.17183,1,1
7,GO RESPONSE TO STEROID HORMONE,0.015104,0.15455,0.18146,1,1
7,GO GOLGI VESICLE TRANSPORT,0.00048214,0.15447,0.23734,1,1
7,GO ENDOSOMAL TRANSPORT,0.0011418,0.1544,0.23318,1,1
7,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.018736,0.15439,0.22662,1,1
7,GO REGULATION OF METAL ION TRANSPORT,0.014457,0.15432,0.20855,1,1
7,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0025648,0.1543,0.20991,1,1
7,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0021907,0.15421,0.17457,1,1
7,GO KETONE BIOSYNTHETIC PROCESS,0.0057394,0.15403,0.20674,1,1
7,GO PEPTIDYL METHIONINE MODIFICATION,0.011063,0.15389,0.18754,1,1
7,GO REGULATION OF ATPASE ACTIVITY,5.9985e-05,0.15388,0.19144,1,1
7,GO EMBRYONIC MORPHOGENESIS,0.0092139,0.15387,0.20106,1,1
7,GO CARDIOLIPIN METABOLIC PROCESS,0.021265,0.15386,0.14208,1,1
7,GO EMBRYONIC ORGAN DEVELOPMENT,0.014457,0.15382,0.19475,1,1
7,GO MUSCLE HYPERTROPHY,0.037377,0.15345,0.18128,1,1
7,GO REGULATION OF PROTEIN BINDING,0.0083971,0.15326,0.1973,1,1
7,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0044907,0.15303,0.21104,1,1
7,GO FAT CELL DIFFERENTIATION,0.030713,0.15301,0.1694,1,1
7,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0018673,0.15299,0.25519,1,1
7,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0015882,0.15297,0.18942,1,1
7,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.018736,0.15295,0.19637,1,1
7,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0038653,0.15266,0.18666,1,1
7,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0047188,0.1525,0.17945,1,1
7,GO DIENCEPHALON DEVELOPMENT,0.016475,0.15245,0.20354,1,1
7,GO KIDNEY MORPHOGENESIS,0.017954,0.15243,0.20425,1,1
7,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.010572,0.15242,0.18767,1,1
7,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0096484,0.15241,0.14887,1,1
7,GO VACUOLAR TRANSPORT,0.0015041,0.15239,0.25375,1,1
7,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0034935,0.15231,0.16275,1,1
7,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.024086,0.15225,0.2095,1,1
7,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011063,0.15224,0.16073,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.007293,0.1522,0.18747,1,1
7,GO NEGATIVE REGULATION OF CELL GROWTH,0.0083971,0.15216,0.19575,1,1
7,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00054254,0.15214,0.19538,1,1
7,GO PEPTIDYL ARGININE MODIFICATION,0.030713,0.15208,0.11972,1,1
7,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00042807,0.15196,0.21052,1,1
7,GO RNA MODIFICATION,0.0047188,0.15191,0.1529,1,1
7,GO TRANSITION METAL ION TRANSPORT,0.0025648,0.15191,0.18453,1,1
7,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.013235,0.15172,0.23848,1,1
7,GO RESPONSE TO INORGANIC SUBSTANCE,0.0092139,0.15171,0.16528,1,1
7,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.022172,0.15162,0.21845,1,1
7,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.048745,0.15158,0.15201,1,1
7,GO REGULATION OF MACROAUTOPHAGY,0.00048214,0.15157,0.23157,1,1
7,GO REGULATION OF GTPASE ACTIVITY,0.016475,0.15121,0.22117,1,1
7,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.015776,0.15118,0.1882,1,1
7,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.035953,0.15111,0.14143,1,1
7,GO ESTABLISHMENT OF CELL POLARITY,0.0063209,0.151,0.22806,1,1
7,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0031545,0.15091,0.21761,1,1
7,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0047188,0.15089,0.24649,1,1
7,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0066311,0.15049,0.15047,1,1
7,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0042727,0.15033,0.20529,1,1
7,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0015882,0.15031,0.20224,1,1
7,GO AUTOPHAGOSOME ORGANIZATION,0.00048214,0.15013,0.24916,1,1
7,GO ORGANELLE DISASSEMBLY,0.0003797,0.15009,0.22465,1,1
7,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.011574,0.15002,0.1907,1,1
7,GO NEURAL PRECURSOR CELL PROLIFERATION,0.02951,0.14985,0.18678,1,1
7,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0011418,0.14985,0.18454,1,1
7,GO FEMALE SEX DIFFERENTIATION,0.019548,0.14984,0.17153,1,1
7,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00081392,0.14983,0.19981,1,1
7,GO NEGATIVE REGULATION OF CELL AGING,0.026142,0.14979,0.1602,1,1
7,GO ACTIVATION OF GTPASE ACTIVITY,0.013834,0.14966,0.27789,1,1
7,GO STEROL BIOSYNTHETIC PROCESS,0.0063209,0.14961,0.16163,1,1
7,GO REGULATION OF CYTOKINESIS,0.010572,0.1496,0.19246,1,1
7,GO MOTOR NEURON AXON GUIDANCE,0.046961,0.1495,0.20454,1,1
7,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0024341,0.14943,0.18023,1,1
7,GO MESODERM DEVELOPMENT,0.019548,0.14936,0.16856,1,1
7,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0040644,0.14932,0.19088,1,1
7,GO RETINA HOMEOSTASIS,0.00091199,0.14931,0.26796,1,1
7,GO RESPONSE TO PEPTIDE HORMONE,0.0057394,0.1493,0.17822,1,1
7,GO MACROAUTOPHAGY,0.00042807,0.14929,0.21963,1,1
7,GO PROTEIN K48 LINKED UBIQUITINATION,0.010572,0.14925,0.17591,1,1
7,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.018736,0.14902,0.17888,1,1
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0040644,0.14888,0.16312,1,1
7,GO RNA METHYLATION,0.0063209,0.14885,0.1654,1,1
7,GO CELLULAR HOMEOSTASIS,0.023112,0.14865,0.15232,1,1
7,GO NUCLEOTIDE PHOSPHORYLATION,0.0092139,0.1486,0.17027,1,1
7,GO POSITIVE REGULATION OF CYTOKINESIS,0.011063,0.14844,0.18738,1,1
7,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0042727,0.1483,0.17825,1,1
7,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.024086,0.14824,0.17847,1,1
7,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.019548,0.14821,0.18806,1,1
7,GO NADP METABOLIC PROCESS,0.017954,0.14817,0.13612,1,1
7,GO LAMELLIPODIUM ASSEMBLY,0.018736,0.14809,0.19917,1,1
7,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0054671,0.14803,0.22907,1,1
7,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0047188,0.14789,0.18125,1,1
7,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.041938,0.14788,0.16892,1,1
7,GO MONOCARBOXYLIC ACID TRANSPORT,0.020391,0.14788,0.17027,1,1
7,GO DIVALENT INORGANIC CATION TRANSPORT,0.019548,0.14787,0.19298,1,1
7,GO LIMBIC SYSTEM DEVELOPMENT,0.0172,0.1478,0.17847,1,1
7,GO PROTEIN CATABOLIC PROCESS,0.0018673,0.14779,0.18325,1,1
7,GO CELLULAR RESPONSE TO CHOLESTEROL,0.012106,0.14766,0.27709,1,1
7,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.011574,0.14761,0.18295,1,1
7,GO TISSUE MORPHOGENESIS,0.011063,0.14755,0.18416,1,1
7,GO RESPONSE TO METAL ION,0.0066311,0.14737,0.17215,1,1
7,GO NEUROTROPHIN SIGNALING PATHWAY,0.037377,0.1472,0.17511,1,1
7,GO LAMELLIPODIUM ORGANIZATION,0.024086,0.14706,0.1877,1,1
7,GO PIRNA METABOLIC PROCESS,0.034576,0.14691,0.14319,1,1
7,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0092139,0.1469,0.19247,1,1
7,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0040644,0.14683,0.21751,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.008797,0.14679,0.18144,1,1
7,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0016767,0.14651,0.18332,1,1
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0052065,0.14645,0.19195,1,1
7,GO INTRACELLULAR TRANSPORT,0.0003797,0.14641,0.19136,1,1
7,GO RRNA TRANSCRIPTION,0.0096484,0.1463,0.18532,1,1
7,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.017954,0.14605,0.15643,1,1
7,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.050584,0.14605,0.18817,1,1
7,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0066311,0.14588,0.15452,1,1
7,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0049572,0.14587,0.19137,1,1
7,GO RESPONSE TO HORMONE,0.013834,0.14574,0.17177,1,1
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0015041,0.14566,0.17721,1,1
7,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.015776,0.14554,0.15489,1,1
7,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0040644,0.14545,0.17865,1,1
7,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0020776,0.14541,0.19304,1,1
7,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.00091199,0.14538,0.1745,1,1
7,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00332,0.1452,0.1988,1,1
7,GO EPITHELIAL TUBE MORPHOGENESIS,0.011574,0.1452,0.20646,1,1
7,GO REGULATION OF REPRODUCTIVE PROCESS,0.014457,0.14503,0.14986,1,1
7,GO HOMEOSTATIC PROCESS,0.010101,0.14503,0.17015,1,1
7,GO CELL FATE DETERMINATION,0.0076456,0.14485,0.22104,1,1
7,GO NCRNA TRANSCRIPTION,0.0015041,0.14475,0.18912,1,1
7,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00033648,0.14457,0.23796,1,1
7,GO DNA METABOLIC PROCESS,0.0057394,0.14445,0.17075,1,1
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.006955,0.14432,0.23264,1,1
7,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0016767,0.14427,0.17527,1,1
7,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00051151,0.14425,0.20466,1,1
7,GO NEGATIVE REGULATION OF SIGNALING,0.007293,0.14421,0.19181,1,1
7,GO VIRAL BUDDING,0.0015882,0.14416,0.16746,1,1
7,GO PROTEIN MONOUBIQUITINATION,0.0036751,0.14391,0.21183,1,1
7,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011574,0.14391,0.19455,1,1
7,GO EMBRYONIC EYE MORPHOGENESIS,0.014457,0.1438,0.25073,1,1
7,GO PEPTIDE SECRETION,0.021265,0.14361,0.18445,1,1
7,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0031545,0.1436,0.17798,1,1
7,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0080134,0.14356,0.1809,1,1
7,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.008797,0.14351,0.17737,1,1
7,GO REGULATION OF MRNA METABOLIC PROCESS,0.0021907,0.14349,0.18288,1,1
7,GO MONOSACCHARIDE METABOLIC PROCESS,0.0057394,0.14331,0.16585,1,1
7,GO REGULATION OF DNA REPLICATION,0.030713,0.1433,0.15651,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.014457,0.14329,0.15662,1,1
7,GO ANION HOMEOSTASIS,0.027226,0.14316,0.18072,1,1
7,GO MAMMARY GLAND DEVELOPMENT,0.0092139,0.14311,0.22345,1,1
7,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.006955,0.14303,0.19498,1,1
7,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0034935,0.14275,0.22837,1,1
7,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0042727,0.14264,0.19198,1,1
7,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.015776,0.1426,0.17021,1,1
7,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.028348,0.14255,0.15663,1,1
7,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0044907,0.14252,0.1926,1,1
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.015776,0.14251,0.1539,1,1
7,GO NEGATIVE REGULATION OF RNA SPLICING,0.019548,0.14251,0.16621,1,1
7,GO AMINO ACID ACTIVATION,0.011063,0.14237,0.13156,1,1
7,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0060238,0.14233,0.22752,1,1
7,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0016767,0.14209,0.20633,1,1
7,GO DORSAL VENTRAL AXIS SPECIFICATION,0.022172,0.14207,0.23257,1,1
7,GO ESTABLISHMENT OF RNA LOCALIZATION,0.007293,0.14206,0.1684,1,1
7,GO SMALL MOLECULE CATABOLIC PROCESS,0.0054671,0.14195,0.15713,1,1
7,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0025648,0.14175,0.21445,1,1
7,GO ACTIN FILAMENT ORGANIZATION,0.010572,0.14175,0.20843,1,1
7,GO VESICLE ORGANIZATION,0.0013481,0.14173,0.22596,1,1
7,GO RESPONSE TO INSULIN,0.0063209,0.1416,0.1803,1,1
7,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0025648,0.14157,0.178,1,1
7,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0057394,0.14156,0.18526,1,1
7,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.026142,0.14148,0.26213,1,1
7,GO MODULATION BY VIRUS OF HOST PROCESS,0.0096484,0.14147,0.17171,1,1
7,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.041938,0.14139,0.14729,1,1
7,GO EMBRYONIC ORGAN MORPHOGENESIS,0.015104,0.14134,0.19651,1,1
7,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.020391,0.14125,0.1719,1,1
7,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.040368,0.14118,0.22857,1,1
7,GO DNA CATABOLIC PROCESS,0.0042727,0.14115,0.1712,1,1
7,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0017696,0.14112,0.18993,1,1
7,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0042727,0.14107,0.16635,1,1
7,GO REGULATION OF CATABOLIC PROCESS,0.0023095,0.141,0.1854,1,1
7,GO REGULATION OF PROTEIN FOLDING,0.0038653,0.14079,0.20542,1,1
7,GO CELLULAR COMPONENT DISASSEMBLY,0.0025648,0.14069,0.16899,1,1
7,GO STEM CELL DIFFERENTIATION,0.026142,0.14065,0.15248,1,1
7,GO RNA SURVEILLANCE,0.022172,0.1406,0.13658,1,1
7,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0080134,0.14058,0.17787,1,1
7,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0015041,0.14051,0.17044,1,1
7,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0031545,0.14047,0.19933,1,1
7,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.012106,0.14039,0.17547,1,1
7,GO MORPHOGENESIS OF AN EPITHELIUM,0.021265,0.14033,0.18006,1,1
7,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0076456,0.14032,0.1865,1,1
7,GO PROTEOLYSIS,0.0042727,0.14017,0.17771,1,1
7,GO PEPTIDYL AMINO ACID MODIFICATION,0.0040644,0.1401,0.20031,1,1
7,GO MITOTIC CELL CYCLE CHECKPOINT,0.033245,0.14007,0.17768,1,1
7,GO PIGMENT BIOSYNTHETIC PROCESS,0.00054254,0.14006,0.15878,1,1
7,GO CELLULAR LIPID METABOLIC PROCESS,0.0052065,0.13998,0.18061,1,1
7,GO RESPONSE TO NITROGEN COMPOUND,0.0083971,0.13995,0.17467,1,1
7,GO PHAGOSOME MATURATION,0.006955,0.1399,0.22003,1,1
7,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00086166,0.13985,0.22905,1,1
7,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0017696,0.13975,0.16774,1,1
7,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0042727,0.1397,0.2454,1,1
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00040321,0.13965,0.16625,1,1
7,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.011063,0.13961,0.18081,1,1
7,GO NEGATIVE REGULATION OF NEURON DEATH,0.017954,0.13949,0.17752,1,1
7,GO REGULATION OF PROTEIN LOCALIZATION,0.0042727,0.13937,0.18213,1,1
7,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.026142,0.13935,0.27603,1,1
7,GO SPHINGOLIPID METABOLIC PROCESS,0.0096484,0.13934,0.18362,1,1
7,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.013834,0.13917,0.20117,1,1
7,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0012071,0.13914,0.17356,1,1
7,GO REGULATION OF CELL CYCLE PROCESS,0.007293,0.13912,0.17012,1,1
7,GO SEX DIFFERENTIATION,0.0172,0.13909,0.16086,1,1
7,GO CELL DIVISION,0.013834,0.13902,0.17499,1,1
7,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.0044907,0.13898,0.19869,1,1
7,GO SNRNA TRANSCRIPTION,0.0047188,0.13895,0.17327,1,1
7,GO PHAGOSOME ACIDIFICATION,0.0054671,0.13852,0.18957,1,1
7,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0012758,0.13839,0.2111,1,1
7,GO CELL CELL SIGNALING BY WNT,0.00332,0.13825,0.20008,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.035953,0.13799,0.1674,1,1
7,GO REGULATION OF ENDOCYTOSIS,0.033245,0.13793,0.20056,1,1
7,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0024341,0.1379,0.20172,1,1
7,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.013834,0.13779,0.14238,1,1
7,GO HORMONE BIOSYNTHETIC PROCESS,0.0040644,0.13777,0.16666,1,1
7,GO GLUCOSE IMPORT,0.006955,0.13733,0.1922,1,1
7,GO POSITIVE REGULATION OF HEART GROWTH,0.038848,0.1372,0.17882,1,1
7,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0054671,0.13716,0.19822,1,1
7,GO DNA GEOMETRIC CHANGE,0.038848,0.13715,0.16321,1,1
7,GO NEGATIVE REGULATION OF GROWTH,0.021265,0.13712,0.16257,1,1
7,GO HEART GROWTH,0.020391,0.1371,0.18002,1,1
7,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.015776,0.137,0.20594,1,1
7,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0096484,0.13696,0.21172,1,1
7,GO REGULATION OF PROTEIN TARGETING,0.0066311,0.13669,0.20327,1,1
7,GO ORGAN GROWTH,0.014457,0.13664,0.1882,1,1
7,GO PROTEIN TARGETING TO MITOCHONDRION,0.0014241,0.13655,0.13369,1,1
7,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.010572,0.13649,0.16624,1,1
7,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.010101,0.13634,0.21949,1,1
7,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.028348,0.13629,0.12354,1,1
7,GO NUCLEAR EXPORT,0.0063209,0.13591,0.17819,1,1
7,GO MITOTIC CELL CYCLE,0.012106,0.13588,0.16832,1,1
7,GO EPITHELIAL CELL DEVELOPMENT,0.0040644,0.13585,0.22463,1,1
7,GO SULFUR COMPOUND METABOLIC PROCESS,0.0028457,0.13582,0.166,1,1
7,GO REGULATION OF ATP METABOLIC PROCESS,0.0080134,0.13582,0.16304,1,1
7,GO MUSCLE ORGAN MORPHOGENESIS,0.017954,0.13579,0.21381,1,1
7,GO MAINTENANCE OF CELL NUMBER,0.0063209,0.13575,0.19367,1,1
7,GO REGULATION OF PEPTIDE TRANSPORT,0.012106,0.13563,0.17394,1,1
7,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.022172,0.1356,0.15694,1,1
7,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.016475,0.13553,0.18437,1,1
7,GO SNRNA PROCESSING,0.0066311,0.13537,0.13518,1,1
7,GO STRIATED MUSCLE CELL PROLIFERATION,0.035953,0.13531,0.16925,1,1
7,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.013235,0.13523,0.20305,1,1
7,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015104,0.13522,0.18134,1,1
7,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0024341,0.13503,0.14718,1,1
7,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0031545,0.13499,0.17446,1,1
7,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00076864,0.13464,0.21844,1,1
7,GO TEMPERATURE HOMEOSTASIS,0.016475,0.1346,0.16793,1,1
7,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.02951,0.13448,0.1615,1,1
7,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.020391,0.13441,0.17424,1,1
7,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0049572,0.13423,0.16541,1,1
7,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.035953,0.13423,0.13082,1,1
7,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.006955,0.13415,0.19038,1,1
7,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.008797,0.13396,0.21933,1,1
7,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0049572,0.13382,0.18552,1,1
7,GO MITOCHONDRIAL DNA REPLICATION,0.027226,0.13374,0.14955,1,1
7,GO LIPID METABOLIC PROCESS,0.0047188,0.13361,0.17911,1,1
7,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0047188,0.13322,0.17735,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0024341,0.13318,0.20454,1,1
7,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.026142,0.13312,0.17866,1,1
7,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.010572,0.13296,0.18515,1,1
7,GO REGULATION OF DEACETYLASE ACTIVITY,0.007293,0.13278,0.25771,1,1
7,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.010572,0.13275,0.15109,1,1
7,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.019548,0.13267,0.18559,1,1
7,GO EXECUTION PHASE OF APOPTOSIS,0.0080134,0.13267,0.172,1,1
7,GO PEROXISOMAL MEMBRANE TRANSPORT,0.011063,0.13264,0.20448,1,1
7,GO RESPONSE TO PEPTIDE,0.01266,0.1326,0.17009,1,1
7,GO RESPONSE TO DRUG,0.013834,0.13258,0.15629,1,1
7,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0063209,0.1323,0.17184,1,1
7,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0014241,0.13225,0.24167,1,1
7,GO MUSCLE CELL DEVELOPMENT,0.0057394,0.13192,0.20663,1,1
7,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0057394,0.13181,0.20163,1,1
7,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0042727,0.13175,0.18374,1,1
7,GO INTRACELLULAR PROTEIN TRANSPORT,0.00040321,0.13154,0.17352,1,1
7,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0029965,0.13137,0.17946,1,1
7,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0066311,0.1312,0.18167,1,1
7,GO VIRAL RELEASE FROM HOST CELL,0.0031545,0.13109,0.16907,1,1
7,GO MODIFIED AMINO ACID TRANSPORT,0.0049572,0.13107,0.22438,1,1
7,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.026142,0.13094,0.17191,1,1
7,GO POLYOL BIOSYNTHETIC PROCESS,0.0049572,0.13061,0.16793,1,1
7,GO INTRACELLULAR LIPID TRANSPORT,0.031957,0.13,0.17705,1,1
7,GO RESPONSE TO PH,0.048745,0.12997,0.19538,1,1
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.013834,0.12968,0.21358,1,1
7,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.038848,0.12962,0.10904,1,1
7,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0096484,0.1293,0.16627,1,1
7,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.010572,0.12907,0.13294,1,1
7,GO STEROID BIOSYNTHETIC PROCESS,0.0054671,0.12873,0.14792,1,1
7,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0080134,0.12872,0.22338,1,1
7,GO NUCLEOTIDE EXCISION REPAIR,0.0029965,0.12864,0.15616,1,1
7,GO CARTILAGE DEVELOPMENT,0.046961,0.12863,0.17955,1,1
7,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0036751,0.12862,0.15351,1,1
7,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0049572,0.12845,0.15485,1,1
7,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0080134,0.12814,0.18328,1,1
7,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.013834,0.12783,0.17793,1,1
7,GO TETRAPYRROLE METABOLIC PROCESS,0.0054671,0.12722,0.14652,1,1
7,GO CYTOKINETIC PROCESS,0.00051151,0.12694,0.19825,1,1
7,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.035953,0.12688,0.15603,1,1
7,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0096484,0.12678,0.17318,1,1
7,GO CELL CYCLE G2 M PHASE TRANSITION,0.026142,0.12678,0.14898,1,1
7,GO MRNA METABOLIC PROCESS,0.0052065,0.12674,0.13492,1,1
7,GO MITOCHONDRIAL FUSION,0.00332,0.12643,0.1914,1,1
7,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0011418,0.12641,0.15913,1,1
7,GO REGULATION OF AUTOPHAGY,0.0040644,0.12626,0.21084,1,1
7,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.013834,0.12621,0.16375,1,1
7,GO MULTIVESICULAR BODY ORGANIZATION,0.0012071,0.12616,0.1596,1,1
7,GO CELLULAR RESPONSE TO STARVATION,0.0052065,0.12613,0.18797,1,1
7,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0025648,0.12603,0.15731,1,1
7,GO REGULATION OF PROTEIN STABILITY,0.0047188,0.12588,0.15495,1,1
7,GO CARBOHYDRATE METABOLIC PROCESS,0.0040644,0.12579,0.17278,1,1
7,GO CERAMIDE METABOLIC PROCESS,0.0080134,0.12563,0.18537,1,1
7,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0057394,0.12547,0.17306,1,1
7,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0027019,0.12537,0.18043,1,1
7,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.012106,0.12536,0.1772,1,1
7,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.010101,0.12532,0.13824,1,1
7,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0014241,0.12512,0.19781,1,1
7,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.023112,0.12509,0.13035,1,1
7,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.02951,0.12481,0.15764,1,1
7,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.021265,0.12434,0.15613,1,1
7,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.010101,0.12432,0.19043,1,1
7,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0036751,0.12423,0.18269,1,1
7,GO REGULATION OF BEHAVIOR,0.048745,0.12417,0.13672,1,1
7,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0024341,0.12413,0.20143,1,1
7,GO RESPONSE TO AMINO ACID STARVATION,0.010101,0.12399,0.17523,1,1
7,GO COENZYME A METABOLIC PROCESS,0.011574,0.12385,0.14401,1,1
7,GO REGULATION OF MITOTIC CELL CYCLE,0.010572,0.1238,0.16254,1,1
7,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.007293,0.12367,0.14021,1,1
7,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.046961,0.12365,0.11785,1,1
7,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.024086,0.1234,0.14858,1,1
7,GO NUCLEAR TRANSPORT,0.014457,0.12338,0.15588,1,1
7,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.050584,0.12324,0.17539,1,1
7,GO REGULATION OF GENE SILENCING,0.0096484,0.12284,0.17638,1,1
7,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0083971,0.12276,0.1666,1,1
7,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.013834,0.1227,0.16079,1,1
7,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.00332,0.1226,0.14852,1,1
7,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.026142,0.12224,0.15202,1,1
7,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0023095,0.12219,0.14571,1,1
7,GO PROTEIN DESTABILIZATION,0.0063209,0.12182,0.1767,1,1
7,GO PEROXISOME ORGANIZATION,0.011063,0.12169,0.15271,1,1
7,GO NEGATIVE REGULATION OF ION TRANSPORT,0.022172,0.12129,0.17222,1,1
7,GO ESTROGEN METABOLIC PROCESS,0.050584,0.12112,0.18285,1,1
7,GO ORGANELLE INHERITANCE,0.0018673,0.12108,0.17655,1,1
7,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.015104,0.12107,0.1649,1,1
7,GO RNA LOCALIZATION,0.013235,0.12101,0.1518,1,1
7,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.0080134,0.12096,0.13322,1,1
7,GO MACROMOLECULE CATABOLIC PROCESS,0.0025648,0.12084,0.15275,1,1
7,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00045436,0.1207,0.17561,1,1
7,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.013235,0.12065,0.14968,1,1
7,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.046961,0.12064,0.15679,1,1
7,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.013834,0.12056,0.17559,1,1
7,GO QUINONE METABOLIC PROCESS,0.025096,0.12055,0.10151,1,1
7,GO CELL CYCLE PHASE TRANSITION,0.026142,0.11996,0.14564,1,1
7,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0060238,0.11967,0.16906,1,1
7,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.020391,0.11894,0.16314,1,1
7,GO REGULATION OF CELL DIFFERENTIATION,0.016475,0.11886,0.17652,1,1
7,GO ENDOSOME ORGANIZATION,0.0019699,0.11873,0.18616,1,1
7,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0042727,0.11872,0.14259,1,1
7,GO PROTEIN TETRAMERIZATION,0.023112,0.11867,0.1619,1,1
7,GO REGULATION OF DNA METABOLIC PROCESS,0.0057394,0.11848,0.17394,1,1
7,GO PIGMENT GRANULE ORGANIZATION,0.046961,0.11835,0.15025,1,1
7,GO MITOCHONDRIAL TRANSPORT,0.00076864,0.1181,0.15239,1,1
7,GO SKELETAL MUSCLE CONTRACTION,0.0054671,0.11793,0.28627,1,1
7,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.035953,0.11764,0.1603,1,1
7,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.016475,0.11751,0.17159,1,1
7,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0034935,0.11734,0.14122,1,1
7,GO UBIQUINONE METABOLIC PROCESS,0.0038653,0.1173,0.1471,1,1
7,GO RESPONSE TO ABIOTIC STIMULUS,0.0049572,0.11721,0.15724,1,1
7,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.023112,0.1171,0.17144,1,1
7,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.010572,0.11695,0.17757,1,1
7,GO REGULATION OF STEROID METABOLIC PROCESS,0.016475,0.11688,0.14671,1,1
7,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.037377,0.11684,0.17163,1,1
7,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.018736,0.11683,0.1485,1,1
7,GO CARDIOCYTE DIFFERENTIATION,0.02951,0.11673,0.18732,1,1
7,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.015104,0.11655,0.16547,1,1
7,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.024086,0.11651,0.13006,1,1
7,GO MAINTENANCE OF PROTEIN LOCATION,0.0076456,0.11643,0.15212,1,1
7,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.010101,0.11633,0.24132,1,1
7,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.023112,0.11632,0.14592,1,1
7,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0060238,0.11619,0.16878,1,1
7,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.006955,0.11601,0.16377,1,1
7,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.024086,0.11594,0.15474,1,1
7,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.040368,0.11567,0.20248,1,1
7,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0042727,0.11564,0.14862,1,1
7,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0172,0.11554,0.13082,1,1
7,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010572,0.11508,0.19324,1,1
7,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.007293,0.11502,0.16404,1,1
7,GO RRNA CATABOLIC PROCESS,0.034576,0.11483,0.16221,1,1
7,GO NEURON APOPTOTIC PROCESS,0.014457,0.11468,0.16862,1,1
7,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.007293,0.11464,0.17943,1,1
7,GO REGULATION OF DNA RECOMBINATION,0.037377,0.11456,0.16706,1,1
7,GO PROTEIN SUMOYLATION,0.0076456,0.1144,0.1875,1,1
7,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.018736,0.11439,0.15043,1,1
7,GO NCRNA CATABOLIC PROCESS,0.0060238,0.1139,0.17877,1,1
7,GO FATTY ACYL COA METABOLIC PROCESS,0.011574,0.11357,0.15843,1,1
7,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.027226,0.11352,0.11046,1,1
7,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.02951,0.11305,0.1724,1,1
7,GO CELLULAR RESPONSE TO PEPTIDE,0.015776,0.11293,0.17388,1,1
7,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0034935,0.11288,0.14549,1,1
7,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.045233,0.11287,0.12637,1,1
7,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.011574,0.11284,0.17158,1,1
7,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.027226,0.11255,0.11666,1,1
7,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.015776,0.11247,0.1466,1,1
7,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.040368,0.11242,0.10763,1,1
7,GO NEGATIVE REGULATION OF TRANSPORT,0.052482,0.11235,0.13283,1,1
7,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0063209,0.1121,0.17011,1,1
7,GO HEMOGLOBIN METABOLIC PROCESS,0.0092139,0.11206,0.19737,1,1
7,GO COPII COATED VESICLE CARGO LOADING,0.026142,0.11202,0.21286,1,1
7,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0076456,0.11202,0.1757,1,1
7,GO MEMBRANE LIPID METABOLIC PROCESS,0.0054671,0.11161,0.1828,1,1
7,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.043559,0.1114,0.14933,1,1
7,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.007293,0.11137,0.17361,1,1
7,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.007293,0.11082,0.2068,1,1
7,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.033245,0.11067,0.15496,1,1
7,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.052482,0.11056,0.11991,1,1
7,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.038848,0.11042,0.14711,1,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.030713,0.11017,0.12944,1,1
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.040368,0.1101,0.14025,1,1
7,GO TELOMERE ORGANIZATION,0.031957,0.10998,0.15403,1,1
7,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.021265,0.10944,0.1573,1,1
7,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.035953,0.10933,0.16073,1,1
7,GO ENERGY RESERVE METABOLIC PROCESS,0.010101,0.1088,0.19057,1,1
7,GO TRNA WOBBLE URIDINE MODIFICATION,0.038848,0.10844,0.12763,1,1
7,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.027226,0.10799,0.14194,1,1
7,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0054671,0.10792,0.15353,1,1
7,GO REGULATION OF NUCLEAR DIVISION,0.016475,0.10741,0.15686,1,1
7,GO NEURON DEATH,0.030713,0.10724,0.16788,1,1
7,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.011063,0.1065,0.17853,1,1
7,GO SNRNA METABOLIC PROCESS,0.0080134,0.10648,0.13322,1,1
7,GO MITOCHONDRION ORGANIZATION,0.00029789,0.10643,0.14458,1,1
7,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0172,0.10628,0.16965,1,1
7,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.046961,0.1062,0.21593,1,1
7,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.035953,0.10611,0.13273,1,1
7,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.026142,0.10598,0.14258,1,1
7,GO REGULATION OF MULTI ORGANISM PROCESS,0.038848,0.10586,0.12906,1,1
7,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.019548,0.10561,0.1611,1,1
7,GO PEROXISOMAL TRANSPORT,0.015104,0.10487,0.12857,1,1
7,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.013235,0.10478,0.16294,1,1
7,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.007293,0.10451,0.14233,1,1
7,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.023112,0.10433,0.17809,1,1
7,GO MALE SEX DIFFERENTIATION,0.017954,0.10403,0.17221,1,1
7,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0060238,0.10297,0.14122,1,1
7,GO RESPONSE TO TEMPERATURE STIMULUS,0.014457,0.10295,0.15317,1,1
7,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0172,0.10294,0.19791,1,1
7,GO RNA CAPPING,0.017954,0.10206,0.11556,1,1
7,GO PIGMENT METABOLIC PROCESS,0.00332,0.10166,0.14265,1,1
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0036751,0.101,0.14855,1,1
7,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.038848,0.099996,0.14776,1,1
7,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.02951,0.099414,0.16805,1,1
7,GO PROTEIN FOLDING,0.0015882,0.099096,0.14457,1,1
7,GO LIPOSACCHARIDE METABOLIC PROCESS,0.010101,0.098486,0.16152,1,1
7,GO OXIDATION REDUCTION PROCESS,0.0040644,0.098447,0.13568,1,1
7,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.022172,0.097858,0.16182,1,1
7,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0025648,0.097562,0.153,1,1
7,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0013481,0.095874,0.13537,1,1
7,GO GLAND DEVELOPMENT,0.018736,0.095794,0.17708,1,1
7,GO ALPHA AMINO ACID METABOLIC PROCESS,0.007293,0.095451,0.14044,1,1
7,GO BLASTOCYST DEVELOPMENT,0.0052065,0.095012,0.14504,1,1
7,GO DNA BIOSYNTHETIC PROCESS,0.0054671,0.092366,0.15086,1,1
7,GO MITOTIC CYTOKINETIC PROCESS,0.0017696,0.091713,0.15559,1,1
7,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.041938,0.091597,0.18492,1,1
7,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.019548,0.091378,0.13723,1,1
7,GO REGULATION OF ERAD PATHWAY,0.028348,0.091008,0.15873,1,1
7,GO REGULATION OF ORGAN GROWTH,0.048745,0.090125,0.1607,1,1
7,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.012106,0.088387,0.14387,1,1
7,GO MULTIVESICULAR BODY SORTING PATHWAY,0.022172,0.087166,0.14357,1,1
7,GO RESPONSE TO ETHANOL,0.038848,0.085623,0.14244,1,1
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.052482,0.083488,0.13195,1,1
7,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.024086,0.082631,0.11277,1,1
7,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.045233,0.079268,0.077172,1,1
7,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0054671,0.076435,0.10505,1,1
7,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.046961,0.076038,0.16871,1,1
7,GO PEPTIDE BIOSYNTHETIC PROCESS,0.021265,0.071909,0.074566,1,1
7,GO AMIDE BIOSYNTHETIC PROCESS,0.01266,0.069997,0.088409,1,1
7,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.046961,0.065361,0.080892,1,1
7,GO PEPTIDE METABOLIC PROCESS,0.0052065,0.062985,0.090118,1,1
7,GO CELLULAR AMIDE METABOLIC PROCESS,0.0042727,0.062788,0.10211,1,1
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.027226,0.056418,0.063004,1,1
